
<html lang="en"     class="pb-page"  data-request-id="aca7519f-c636-426f-a200-d3118a14399a"  
><head data-pb-dropzone="head"><meta name="pbContext" content=";requestedJournal:journal:jmcmar;journal:journal:jmcmar;page:string:Article/Chapter View;issue:issue:10.1021/jmcmar.2011.54.issue-21;ctype:string:Journal Content;wgroup:string:ACHS website Group;article:article:10.1021/jm200939b;website:website:acspubs;pageGroup:string:Publication Pages;subPage:string:Full Text"/></meta>




        <link rel="schema.DC" href="http://purl.org/DC/elements/1.0/" /></link><meta name="dc.Title" content="Discovery of Two Clinical Histamine H3 Receptor Antagonists: trans-N-Ethyl-3-fluoro-3-[3-fluoro-4-(pyrrolidinylmethyl)phenyl]cyclobutanecarboxamide (PF-03654746) and trans-3-Fluoro-3-[3-fluoro-4-(pyrrolidin-1-ylmethyl)phenyl]-N-(2-methylpropyl)cyclobutanecarboxamide (PF-03654764)" /></meta><meta name="dc.Creator" content="Travis T.  Wager" /></meta><meta name="dc.Creator" content="Betty A.  Pettersen" /></meta><meta name="dc.Creator" content="Anne W.  Schmidt" /></meta><meta name="dc.Creator" content="Douglas K.  Spracklin" /></meta><meta name="dc.Creator" content="Scot  Mente" /></meta><meta name="dc.Creator" content="Todd W.  Butler" /></meta><meta name="dc.Creator" content="Harry  Howard, Jr" /></meta><meta name="dc.Creator" content="Daniel J.  Lettiere" /></meta><meta name="dc.Creator" content="David M.  Rubitski" /></meta><meta name="dc.Creator" content="Diane F.  Wong" /></meta><meta name="dc.Creator" content="Frank M.  Nedza" /></meta><meta name="dc.Creator" content="Frederick R.  Nelson" /></meta><meta name="dc.Creator" content="Hans  Rollema" /></meta><meta name="dc.Creator" content="Jeffrey W.  Raggon" /></meta><meta name="dc.Creator" content="Jiri  Aubrecht" /></meta><meta name="dc.Creator" content="Jody K.  Freeman" /></meta><meta name="dc.Creator" content="John M.  Marcek" /></meta><meta name="dc.Creator" content="Julie  Cianfrogna" /></meta><meta name="dc.Creator" content="Karen W.  Cook" /></meta><meta name="dc.Creator" content="Larry C.  James" /></meta><meta name="dc.Creator" content="Linda A.  Chatman" /></meta><meta name="dc.Creator" content="Philip A.  Iredale" /></meta><meta name="dc.Creator" content="Michael J.  Banker" /></meta><meta name="dc.Creator" content="Michael L.  Homiski" /></meta><meta name="dc.Creator" content="Jennifer B.  Munzner" /></meta><meta name="dc.Creator" content="Rama Y.  Chandrasekaran" /></meta><meta name="dc.Description" content="The discovery of two histamine H3 antagonist clinical candidates is disclosed. The pathway to identification of the two clinical candidates, 6 (PF-03654746) and 7 (PF-03654764) required five hypoth..." /></meta><meta name="Description" content="The discovery of two histamine H3 antagonist clinical candidates is disclosed. The pathway to identification of the two clinical candidates, 6 (PF-03654746) and 7 (PF-03654764) required five hypoth..." /></meta><meta name="dc.Publisher" content="American Chemical Society" /></meta><meta name="dc.Date" scheme="WTN8601" content="October 7, 2011" /></meta><meta name="dc.Type" content="research-article" /></meta><meta name="dc.Format" content="text/HTML" /></meta><meta name="dc.Identifier" scheme="doi" content="10.1021/jm200939b" /></meta><meta name="dc.Language" content="EN" /></meta><meta name="dc.Coverage" content="world" /></meta><meta name="dc.Rights" content="© 2011 American Chemical Society" /></meta>
        
        

        
            <link rel="meta" type="application/atom+xml" href="https://doi.org/10.1021%2Fjm200939b" /></link>
            <link rel="meta" type="application/rdf+json" href="https://doi.org/10.1021%2Fjm200939b" /></link>
            <link rel="meta" type="application/unixref+xml" href="https://doi.org/10.1021%2Fjm200939b" /></link>
        
    
    

<title>Discovery of Two Clinical Histamine H3 Receptor Antagonists: trans-N-Ethyl-3-fluoro-3-[3-fluoro-4-(pyrrolidinylmethyl)phenyl]cyclobutanecarboxamide (PF-03654746) and trans-3-Fluoro-3-[3-fluoro-4-(pyrrolidin-1-ylmethyl)phenyl]-N-(2-methylpropyl)cyclobutanecarboxamide (PF-03654764) | Journal of Medicinal Chemistry</title>












<meta charset="UTF-8">




<meta name="robots" content="noarchive"/></meta>
<meta name="pb-robots-disabled">









        <meta property="og:url" content="https://pubs.acs.org/doi/full/10.1021/jm200939b" /></meta><meta property="og:title" content="Discovery of Two Clinical Histamine H3 Receptor Antagonists: trans-N-Ethyl-3-fluoro-3-[3-fluoro-4-(pyrrolidinylmethyl)phenyl]cyclobutanecarboxamide (PF-03654746) and trans-3-Fluoro-3-[3-fluoro-4-(pyrrolidin-1-ylmethyl)phenyl]-N-(2-methylpropyl)cyclobutanecarboxamide (PF-03654764)" /></meta><meta property="og:image" content="https://pubs.acs.org/na101/home/literatum/publisher/achs/journals/content/jmcmar/2011/jmcmar.2011.54.issue-21/jm200939b/production/images/large/jm-2011-00939b_0017.jpeg" /></meta><meta property="og:description" content="The discovery of two histamine H3 antagonist clinical candidates is disclosed. The pathway to identification of the two clinical candidates, 6 (PF-03654746) and 7 (PF-03654764) required five hypothesis driven design cycles. The key to success in identifying these clinical candidates was the development of a compound design strategy that leveraged medicinal chemistry knowledge and traditional assays in conjunction with computational and in vitro safety tools. Overall, clinical compounds 6 and 7 exceeded conservative safety margins and possessed optimal pharmacological and pharmacokinetic profiles, thus achieving our initial goal of identifying compounds with fully aligned oral drug attributes, “best-in-class” molecules." /></meta><meta property="og:type" content="Article" /></meta><meta property="og:site_name" content="ACS Publications" /></meta><meta name="twitter:card" content="summary_large_image" /></meta><meta name="twitter:site" content="@ACSPublications" /></meta>
    


    <meta name="viewport" content="width=device-width,initial-scale=1,maximum-scale=10, user-scalable=0"/></meta>















    

    <meta name="dc.identifier" content="10.1021/jm200939b"/></meta>



<meta name="format-detection" content="telephone=no">













<link rel="stylesheet" type="text/css" href="/wro/kfa7~product.css">


    <link rel="stylesheet" href="/products/achs/releasedAssets/fonts/achs-fonts/font-roboto/font-roboto.css"/></link><link rel="stylesheet" href="/products/achs/releasedAssets/css/build-f32cfd249ff7cb4cf9c7.css"/></link><link rel="stylesheet" href="/products/achs/releasedAssets/fonts/achs-fonts/font-lato/font-lato.css"/></link>




<meta http-equiv="X-UA-Compatible" content="IE=edge">
<meta http-equiv="content-type" content="text/html; charset=UTF-8">
<link rel="stylesheet" type="text/css" href="/pb-assets/styles/achs-1625058702970.css">
<link rel="stylesheet" type="text/css" href="/pb-assets/styles/acs-1622125181777.css">
<script type="text/javascript" src="/templates/jsp/js/jquery-3.1.1.min.js"></script>
<script type="text/javascript" src="/pb-assets/javascript/eloqua-1619549134767.js"></script>
<script async="" type="text/javascript" src="https://www.googletagservices.com/tag/js/gpt.js" rel="preconnect"></script>

<script defer src="https://static.cloudflareinsights.com/beacon.min.js" data-cf-beacon='{"rayId":"5200035e6e4d5180","startTime":1570117212010}'></script>






    








    
        
            <script type="text/javascript">
                (function (i, s, o, g, r, a, m) {
                    i['GoogleAnalyticsObject'] = r;
                    i[r] = i[r] || function () {
                        (i[r].q = i[r].q || []).push(arguments)
                    }, i[r].l = 1 * new Date();
                    a = s.createElement(o), m = s.getElementsByTagName(o)[0];
                    a.async = 1;
                    a.src = g;
                    m.parentNode.insertBefore(a, m)
                })(window, document, 'script', '//www.google-analytics.com/analytics.js', 'ga');
                ga('create', 'UA-7663985-4'
                    
                    
                    , 'auto'
                    
                    );
                
                
                ga('send', 'pageview');
            </script>
            
        
    















    
    
            
                
                

                <link rel="canonical" href="https://pubs.acs.org/doi/10.1021/jm200939b">
            
        




























    
    

    
    
    
    
    <script src="//unpkg.com/@theidentityselector/thiss-ds"></script>

    <script type="text/javascript">

        var SeamlessAccessService = {
            spUrl: "/action/ssostart",
            returnURL: window.location.href,
            my_context: 'seamlessaccess.org',
            timeout: 5000,

            getWAYFLessUrl: function (entityId) {
                return this.spUrl + "?idp=" + encodeURIComponent(entityId)
                    + "&redirectUri=" + encodeURIComponent(this.returnURL);
            },
            retrieveEntity: function (ms) {
                var self = this;
                var persistService = new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                if(ms == undefined || ms === ''){
                    ms = this.timeout;
                }

                return new Promise(function (resolve, reject) {
                    persistService.entities(self.my_context)
                        .then(function (res) {
                            // get the results
                            var results = res.data;
                            return resolve(results);
                        }, function (err) {
                            // failed
                            reject('retrieve entity error: ' + err);
                        });
                        // Set up the timeout
                        setTimeout(function() {
                            reject('Promise timed out ' + ms + ' ms');
                        }, ms);
                });
            },
            updateEntity: function (entitydata) {
                var self = this;
                var persistService =  new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                var jsonObj = {};
                try {
                    //try to parse it, if it is a json string
                    jsonObj = JSON.parse(entitydata.val());
                } catch (e) {
                    jsonObj = entitydata;
                }
                return new Promise(function (resolve, reject) {
                    persistService.update(self.my_context, jsonObj)
                        .then(function (res) {
                            // Process the results
                            var ssoInstitutions = res.data;
                            return resolve(ssoInstitutions);
                        }, function (err) {
                            // failed
                            console.log('failed to update the local storage duo to: ' + err);
                            reject(err);
                        });
                })
            },
            removeEntity: function (entityId) {
                var self = this;
                var persistService =  new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                return new Promise(function (resolve) {
                    persistService.remove(self.my_context, entityId)
                        .then(function (res) {
                            return resolve(res);
                        }, function (err) {
                            // failed
                            console.log('failed to remove from local storage duo to: ' + err);
                        });
                })
            },
            getAccessibleEntityStatus: function (doi, entityId) {
                return new Promise(function (resolve) {
                    $.ajax({
                        type: 'POST',
                        url: '/action/seamlessAccess',
                        accept: {
                            text: "application/json"
                        },
                        data: {doi: doi, entityid: entityId}

                    }).done(function (status) {
                        return resolve(status);
                    });
                });
            },
            getEntitiesWithAllInfo: function (doi) {
                let self = this,
                    arrayOfPromises = [];
                return new Promise(function (resolve, reject) {
                    self.retrieveEntity().then(function (res) {
                        let allSsoInstitutions = res;
                        for (i = 0; i < allSsoInstitutions.length; i++) {
                            let ssoInstitution = allSsoInstitutions[i];
                            arrayOfPromises.push(new Promise(function (resolve) {
                                self.getAccessibleEntityStatus(doi, ssoInstitution.entity.entityID)
                                    .then(function (entityStatus) {
                                        resolve({
                                            entityID: ssoInstitution.entity.entityID,
                                            entityTitle: ssoInstitution.entity.title,
                                            entityStatusObj: entityStatus,
                                            entitySsoUrl: self.getWAYFLessUrl(ssoInstitution.entity.entityID)
                                        });
                                    }, function (err) {
                                        console.log('failed to get the entity status: ' + err);
                                    });
                            }));
                        }
                        Promise.all(arrayOfPromises)
                            .then(function (finalResponse) {
                                resolve(finalResponse);
                            });

                    }).catch(function (err) {
                        reject(err);
                    })
                });
            }
        };

        window.addEventListener('load', function () {
            document.querySelectorAll(".sso-institution").forEach(function (institution) {
                var entityId = institution.getAttribute('data-entityid');
                var entityName = institution.getAttribute('data-name');
                var entitydata = {
                    entityID: entityId,
                    title: entityName
                };
                institution.addEventListener("click", function (e) {
                    e.preventDefault();
                    var self = this;
                    SeamlessAccessService.updateEntity(entitydata).then(function (res) {
                        console.log(res);
                        window.location.href = self.href;
                    }).catch(function (err){
                        window.location.href = self.href;
                    });
                });
            });
        });

    </script>




























    






    <meta name="google-site-verification" content="uBHpu2M2kL7VihPCSRXWyBSxooDf7L_BGgfHA3cjSfY" /></meta>


<link rel="prefetch" href="https://tpc.googlesyndication.com/safeframe/1-0-29/html/container.html"></head>
<body class="pb-ui">


























<script type="text/javascript">

    if(false) {
        document.getElementById("skipNavigationLink").onclick =function skipElement () {
            var element = document.getElementById('');
            if(element == null || element == undefined) {
                element = document.getElementsByClassName('').item(0);
            }
            element.setAttribute('tabindex','0');
            element.focus();

        }

    }

</script>











    <div id="pb-page-content" data-ng-non-bindable>
        <div data-pb-dropzone="main" data-pb-dropzone-name="Main">










        <div data-widget-def="UX3HTMLWidget" data-widget-id="ed6ae788-7707-48f4-b02c-3187c75e10db" class="hide">
        



        
        

        </div>
    




        
        




        
        



        <div class="pb-ad">
            <script type="text/javascript">
	var dartInstitutionType = 'none';
	var dartMember = 'false';
</script>
        </div>
    





        
        <script type="text/javascript">
$(document).ready(function() {
	setTimeout(function() {
		// var journalTitle = 'medicinal_chemistry';
		var taxonomyKeywords = $('.article_header-taxonomy');
		var articleKeyword = $('meta[name="keywords"]');
		var articleTitle = $('meta[name="dc.Title"]');
		var articleDescription = $('meta[name="dc.Description"]');
		var abstractKeyword = $('p.articleBody_abstractText:contains("Keywords: ")');
		var searchTerms = [];

		if (taxonomyKeywords.length > 0) {
			$(taxonomyKeywords).children(".rlist--inline").children("li").each(function() {
				searchTerms.push($(this).text());
			});
		}
		else if (articleKeyword.length > 0) { 
			searchTerms = searchTerms.concat(articleKeyword.prop('content').split(', '));
		}
		else if (abstractKeyword.length > 0) {
			searchTerms = searchTerms.concat(abstractKeyword.text().split("Keywords: ")[1].split('; '));
		}
		else if (articleDescription.length > 0) {
			$(articleDescription).each(function() {
				articleDescriptionKeywords = $(this).prop('content');
				articleDescriptionKeywords = articleDescriptionKeywords.replace(/.,/g,"");
				articleDescriptionKeywords = articleDescriptionKeywords.replace(/\s{2,}/g," ");
				searchTerms = searchTerms.concat(articleDescriptionKeywords.split(' '));
			});
		}

		if (articleTitle.length > 0) {
			searchTerms = searchTerms.concat(articleTitle.prop('content').split(' '));
		}

		googletag.cmd.push(function() {
			var mappingLeader = googletag.sizeMapping().
			addSize([320, 400], [320, 50]).
			addSize([320, 700], [320, 50]).
			addSize([750, 200], [728, 90]). 
			addSize([980, 690], [728, 90]).
			addSize([1024, 768], [728, 90]).
			build();
			//leaderboard
			googletag.defineSlot('/8868/journal/medicinal_chemistry/article', [728, 90], 'dfp-journal-article-leaderboard').defineSizeMapping(mappingLeader).setTargeting('location', 'leaderboard1').setTargeting('Keyword', searchTerms).addService(googletag.pubads());
			//recommend
			googletag.defineSlot("/8868/journal/medicinal_chemistry/article", [1, 1], "dfp-journal-article-recommend").setTargeting("ntvPlacement", ["1100167"]).setTargeting("location", "recommend").setTargeting('Keyword', searchTerms).addService(googletag.pubads());
			//googletag.pubads().enableSingleRequest();
			googletag.pubads().collapseEmptyDivs();
			googletag.pubads().setTargeting('inst',dartInstitutionType).setTargeting('memb',dartMember);
			googletag.pubads().addEventListener("slotRenderEnded", function(event) {
				if((event.isEmpty === false) && (event.slot.getSlotElementId() != "dfp-journal-article-recommend")) {
					$("#" + event.slot.getSlotElementId()).parents(".advertisement").slideDown();
				}
			});
			googletag.enableServices();
		});
	}, 1000);
});
</script>





        
        <script src="https://common.ccdc.cam.ac.uk/ccdc-widget/1.0.0.76/Widget.min.js"></script>




        
        <header class="header header_article_inactive">



        
        <div class="header_topbar hidden-sm hidden-xs">



        
        <div class="container"><div class="row"><div class="col-lg-3 col-md-4 col-sm-5 header_topbar_left">









        <div data-widget-def="UX3HTMLWidget" data-widget-id="0be92cec-36a8-4b4d-9a08-a28c790ce306" class="header_mainmenu">
        



        
        <ul>
	<li>
		<a href="http://www.acs.org">ACS</a>
	</li>
	<li class="header_mainmenu_current">
		<a href="/">ACS Publications</a>
	</li>
	<li>
		<a href="https://cen.acs.org">C&EN</a>
	</li>
	<li>
		<a href="https://www.cas.org">CAS</a>
	</li>
</ul>

        </div>
    
</div><div class="col-lg-9 col-md-8 col-sm-7 header_topbar_right">



        
        <div class="institution"><span class="institution-info-wrapper"><span class="institution__intro">Access provided by</span><span class="institution__name">Hong Kong University of Science and Technology Library</span></span></div>




        
        <div class="user-login-bar"><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><input type="hidden" name="heartBeatReloadInterval" value="1740000" class="heartBeatReloadInterval"/></input><input type="hidden" name="logoutUrl" value="https://pubs.acs.org/action/doLogout?logoutRedirectUrl=https%3A%2F%2Fsso.acs.org%2Fidp%2Fglogout%3Fappid%3Datypon-live%26returnURL%3Dhttps%253A%252F%252Fpubs.acs.org%252F" class="logoutUrl"/></input><img src="https://sso.acs.org/idp/heartbeat?appid=atypon-lives&amp;max_auth_age=2592000" alt="Blank image" class="ssoHeartBeatImg"/></img><span class="user-login-bar__value"><a href="https://pubs.acs.org/action/ssoRequestForLoginPage" class="user-login-bar__Login">Log In</a></span><input type="hidden" name="isUserLoggedIn" value="false" class="user-login-bar_is-loggedin"/></input><input type="hidden" name="isPaired" value="false" class="pair-device-is-paired"/></input><input type="hidden" name="isStronglyAuthenticated" value="false" class="isStronglyAuthenticated"/></input></div>
</div></div></div>
</div>




        
        <div class="header_content">



        
        <div class="container"><div class="row"><div class="header_content_main">



        
        <div class="header_content_row">



        
        <div class="header_content_left pull-left">



        
        <a href="/" title="ACS Publications. Most Trusted. Most Cited. Most Read"><img id="" alt="ACS Publications. Most Trusted. Most Cited. Most Read" src="/pb-assets/ux3/pubs-logo-481x82-1523435513963.png"/></img></a>




        
        <div class="pj-badge"></div><a href="/journal/jmcmar" title="journal logo" class="header_article-logo"><img src="/na101/home/literatum/publisher/achs/journals/covergifs/jmcmar/title.png" alt="Journal Logo"></a><div class="header_article-separator"></div>
</div><div class="header_content_center">



        
        <div class="header_contnav">
    <div class="header_contnav-row">
         <a href="#" title="Previous" class="header_contnav-pre">
                <i class="icon-angle-left"></i>
        </a>
       <div class="header_contnav-title">
            <span>
                <a href="#" title=""></a>
            </span>
        </div>
         <a href="#" title="Next" class="header_contnav-next">
                <i class="icon-angle-right"></i>
            </a>
    </div>
</div>
</div><div class="header_content_right pull-right">



        
        <div class="header_qv-link"><a href="#" title="Quick View" data-slide-target=".article_qv-xs-container" class="w-slide__btn slide-active icon-quickview">Quick View</a></div>




        
        <div class="header_article-share">



        
        <script type="text/javascript" async="async" src="//s7.addthis.com/js/300/addthis_widget.js#pubid=xa-4faab26f2cff13a7"></script><div class="share"><div class="share_button"><span class="share__label">Share</span><a href="#" data-db-target-for="527d28d6-3414-4cb2-9560-99e677e62c0d" data-db-switch="icon-close_thin" aria-label="share button" class="share__ctrl"><i aria-hidden="true" class="icon-Icon_Share"></i></a></div><div class="pb-dropzone" data-pb-dropzone="ShareDropzone1" title="ShareDropzone1"></div><div class="pb-dropzone" data-pb-dropzone="ShareDropzone2" title="ShareDropzone2"></div><div data-db-target-of="527d28d6-3414-4cb2-9560-99e677e62c0d" id="527d28d6-3414-4cb2-9560-99e677e62c0d_Pop" class="share__block dropBlock__holder fixed"><div class="pb-dropzone" data-pb-dropzone="shareBlock" title="shareBlock"></div><span class="sr-only">Share on</span><ul class="rlist w-slide--list addthis addthis_toolbox addthis_default_style addthis_32x32_style"><li><a role="link" class="addthis_button_facebook"><i aria-hidden="true" class="at-icon-wrapper icon-facebook"></i>Facebook</a></li><li><a role="link" class="addthis_button_twitter"><i aria-hidden="true" class="at-icon-wrapper icon-twitter"></i>Twitter</a></li><li><a role="link" class="addthis_button_wechat"><i aria-hidden="true" class="at-icon-wrapper icon-wechat"></i>WeChat</a></li><li><a role="link" class="addthis_button_linkedin"><i aria-hidden="true" class="at-icon-wrapper icon-linkedin"></i>Linked In</a></li><li><a role="link" class="addthis_button_reddit"><i aria-hidden="true" class="at-icon-wrapper icon-reddit"></i>Reddit</a></li><li><a role="link" class="addthis_button_email"><i aria-hidden="true" class="at-icon-wrapper icon-envelope-o"></i>Email</a></li></ul></div></div>
</div>




        
        <div class="header_article-separator"></div>




        
        <div class="quick-search"><a href="#" aria-label="quick search" class="quick-search_icon icon-search"></a><div class="quick-search_content"><form action="/action/checkIsValidDoi" name="defaultQuickSearch" method="get" title="Quick Search" autocomplete="off" class="quick-search_default"><input type="search" name="AllField" placeholder="Search text, DOI, authors, etc." aria-label="Search text, DOI, authors, etc." data-auto-complete-max-words="7" data-auto-complete-max-chars="32" data-contributors-conf="3" data-topics-conf="3" data-publication-titles-conf="3" data-history-items-conf="3" value="" required="true" class="quick-search_all-field autocomplete"/></input><button type="submit" title="Search" class="icon-search"></button><div role="radiogroup" aria-labelledby="journal filter" class="quick-search_journal-filter"><label for="thisJournalRadio" tabindex="0" aria-checked="true" role="radio" class="radio--primary"><input id="thisJournalRadio" type="radio" value="jmcmar" name="SeriesKey" checked="checked" class="all-content"/></input><span>J. Med. Chem.</span></label><label for="allPubRadio" tabindex="0" aria-checked="false" role="radio" class="radio--primary"><input id="allPubRadio" type="radio" value="" name="SeriesKey" class="all-content"/></input><span>All Publications/Website</span></label></div></form><p>OR SEARCH CITATIONS</p><form action="/action/quickLink" name="citationQuickSearch" method="get" title="Quick Search" class="quick-search_citation"><input type="hidden" name="quickLink" value="true"/></input><select name="quickLinkJournal" class="quick-search_journals-select"><option value="jmcmar">Journal of Medicinal Chemistry</option><option value="achre4">Accounts of Chemical Research</option><option value="amrcda">Accounts of Materials Research</option><option value="aastgj">ACS Agricultural Science & Technology</option><option value="aabmcb">ACS Applied Bio Materials</option><option value="aaembp">ACS Applied Electronic Materials</option><option value="aaemcq">ACS Applied Energy Materials</option><option value="aamick">ACS Applied Materials & Interfaces</option><option value="aanmf6">ACS Applied Nano Materials</option><option value="aapmcd">ACS Applied Polymer Materials</option><option value="abmcb8">ACS Bio & Med Chem Au</option><option value="abseba">ACS Biomaterials Science & Engineering</option><option value="accacs">ACS Catalysis</option><option value="acscii">ACS Central Science</option><option value="acbcct">ACS Chemical Biology</option><option value="achsc5">ACS Chemical Health & Safety</option><option value="acncdm">ACS Chemical Neuroscience</option><option value="acsccc">ACS Combinatorial Science</option><option value="aesccq">ACS Earth and Space Chemistry</option><option value="aelccp">ACS Energy Letters</option><option value="aeacb3">ACS Engineering Au</option><option value="aeacc4">ACS Environmental Au</option><option value="aeecco">ACS ES&T Engineering</option><option value="aewcaa">ACS ES&T Water</option><option value="afsthl">ACS Food Science & Technology</option><option value="aidcbc">ACS Infectious Diseases</option><option value="amlccd">ACS Macro Letters</option><option value="amacgu">ACS Materials Au</option><option value="amlcef">ACS Materials Letters</option><option value="amachv">ACS Measurement Science Au</option><option value="amclct">ACS Medicinal Chemistry Letters</option><option value="ancac3">ACS Nano</option><option value="anaccx">ACS Nanoscience Au</option><option value="acsodf">ACS Omega</option><option value="aoiab5">ACS Organic & Inorganic Au</option><option value="aptsfn">ACS Pharmacology & Translational Science</option><option value="apchd5">ACS Photonics</option><option value="apcach">ACS Physical Chemistry Au</option><option value="apaccd">ACS Polymers Au</option><option value="ascefj">ACS Sensors</option><option value="ascecg">ACS Sustainable Chemistry & Engineering</option><option value="asbcd6">ACS Synthetic Biology</option><option value="ancham">Analytical Chemistry</option><option value="bichaw">Biochemistry</option><option value="bcches">Bioconjugate Chemistry</option><option value="bomaf6">Biomacromolecules</option><option value="bipret">Biotechnology Progress</option><option value="cgeabj">C&EN Global Enterprise</option><option value="cenear">Chemical & Engineering News Archive</option><option value="chlseg">Chemical Health & Safety</option><option value="chlseg0">Chemical Health & Safety</option><option value="crtoec">Chemical Research in Toxicology</option><option value="chreay">Chemical Reviews</option><option value="cmatex">Chemistry of Materials</option><option value="cgdefu">Crystal Growth & Design</option><option value="enfuem">Energy & Fuels</option><option value="esthag">Environmental Science & Technology</option><option value="estlcu">Environmental Science & Technology Letters</option><option value="iepra6.2">I&EC Product Research and Development</option><option value="iechad">Industrial & Engineering Chemistry</option><option value="iecac0">Industrial & Engineering Chemistry Analytical Edition</option><option value="iecjc0">Industrial & Engineering Chemistry Chemical & Engineering Data Series</option><option value="iecfa7">Industrial & Engineering Chemistry Fundamentals</option><option value="iepdaw">Industrial & Engineering Chemistry Process Design and Development</option><option value="iepra6">Industrial & Engineering Chemistry Product Research and Development</option><option value="iecred">Industrial & Engineering Chemistry Research</option><option value="iecnav">Industrial and Engineering Chemistry, News Edition</option><option value="inocaj">Inorganic Chemistry</option><option value="jaaucr">JACS Au</option><option value="jacsat">Journal of the American Chemical Society</option><option value="jafcau">Journal of Agricultural and Food Chemistry</option><option value="jceaax">Journal of Chemical & Engineering Data</option><option value="jci001">Journal of Chemical Documentation</option><option value="jceda8">Journal of Chemical Education</option><option value="jchsc2">Journal of Chemical Health & Safety</option><option value="jchsc20">Journal of Chemical Health & Safety</option><option value="jcics1">Journal of Chemical Information and Computer Sciences</option><option value="jcisd8">Journal of Chemical Information and Modeling</option><option value="jctcce">Journal of Chemical Theory and Computation</option><option value="jcchff">Journal of Combinatorial Chemistry</option><option value="iechad.1">Journal of Industrial & Engineering Chemistry</option><option value="jmcmar.1">Journal of Medicinal and Pharmaceutical Chemistry</option><option value="jnprdf">Journal of Natural Products</option><option value="joceah">The Journal of Organic Chemistry</option><option value="jpchax">The Journal of Physical Chemistry</option><option value="jpchax.2">The Journal of Physical Chemistry</option><option value="jpcafh">The Journal of Physical Chemistry A</option><option value="jpcbfk">The Journal of Physical Chemistry B</option><option value="jpccck">The Journal of Physical Chemistry C</option><option value="jpclcd">The Journal of Physical Chemistry Letters</option><option value="jprobs">Journal of Proteome Research</option><option value="jamsef">Journal of the American Society for Mass Spectrometry</option><option value="jamsef1">Journal of the American Society for Mass Spectrometry</option><option value="jamsef0">Journal of the American Society for Mass Spectrometry</option><option value="langd5">Langmuir</option><option value="mamobx">Macromolecules</option><option value="mpohbp">Molecular Pharmaceutics</option><option value="nalefd">Nano Letters</option><option value="neaca9">News Edition, American Chemical Society</option><option value="orlef7">Organic Letters</option><option value="oprdfk">Organic Process Research & Development</option><option value="orgnd7">Organometallics</option><option value="iepra6.1">Product R&D</option><option value="scimts">SciMeetings</option><option value="jpchax.1">The Journal of Physical and Colloid Chemistry</option></select><input type="search" inputmode="numeric" pattern="[0-9]*" name="quickLinkVolume" autoComplete="false" placeholder="Vol" required="required" class="quick-search_volume-input"/></input><input type="search" inputmode="numeric" pattern="[0-9]*" name="quickLinkPage" autoComplete="false" placeholder="Page" required="required" class="quick-search_page-input"/></input><button type="submit" title="Search" class="icon-search"></button></form></div></div>




        
        <div class="header_my-activity">



        
        <a href="#"><i class="icon-id-badge" aria-hidden=”true”></i><span>My Activity</span></a>
<div class="header_my-activity-content">
    <div class="header_my-activity-single">
        <i aria-hidden="true" aria-label="close" class="icon-close"></i>
        <div class="" data-name="recentlyViewedDropzone">



        
        <div class="show-recently"><div class="show-recently-header">Recently Viewed</div><h6 class="show-recently-empty">You have not visited any articles yet, Please visit some articles to see contents here. </h6></div>
</div>
    </div>
</div>
</div>




        
        <div class="header_publications">



        
        <a href="#" class="pubModal_button"><i class="icon-book" aria-hidden=”true”></i><span>Publications</span></a>

</div>




        
        <div class="header_burger-menu">



        
        <a href="#?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuIcon&amp;utm_campaign=Pubs_Refere" class="header_burger-menu_button" title="menu button" aria-label="menu button"><i class="icon-navicon"></i><i
        class="icon-close"></i></a>
<div class="header_burger-menu_content">
    <ul class="hidden-lg">
        <li><a href="#" class="pubModal_button"><i class="icon-book" aria-hidden=”true”></i><span>publications</span></a></li>
        <li class="myActivityMobile"><a href="#" class="openTabletActivity"><i class="icon-id-badge" aria-hidden=”true”></i><span>my Activity</span></a>
            <ul>
                <li><a href="javascript:void(0)" class="recentlyViewed--open">Recently Viewed</a></li>
            </ul>
        </li>
    </ul>
    <ul>
        <li><a href="#">user resources</a>
            <ul>
                <li><a href="/page/remoteaccess"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Access Options');">Access Options</a></li>
                <li><a href="https://publish.acs.org/publish/"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Authors & Reviewers');">Authors &
                        Reviewers</a></li>
                <li><a href="http://www.acs.org/content/acs/en/membership-and-networks/acs/benefits/professional/publications-benefits.html"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'ACS Members');">ACS Members</a></li>
                <li><a href="https://preferences.acspubs.org/journals"
                        onclick="ga('send', 'event', 'Home_MainMenu', 'Click', 'eAlert');">eAlerts</a></li>
                <li><a href="/page/follow.html?widget=follow-pane-mobile"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'RSS & Mobile');">RSS & Mobile</a></li>
            </ul>
        </li>
		<li><a href="#">for organizations</a>
			<ul>
			    <li><a href="https://solutions.acs.org/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Products & Services');">Products & Services</a></li>
				<li><a href="https://solutions.acs.org/access-options/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Get Access');">Get Access</a></li>
				<li><a href="https://solutions.acs.org/resources/manage-my-account/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Manage My Account');">Manage My Account</a></li>
			</ul>
		</li>
        <li><a href="#">support</a>
            <ul>
                <li><a href="/page/demo/index.html">Website Demos & Tutorials</a></li>
                <li><a href="https://acs.service-now.com/acs"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Support FAQs');">Support FAQs </a></li>
                <li><a href="#"
                        onClick="SnapEngage.startLink();return false; ga('send', 'event', 'Top Nav', 'Menu', 'Live Chat with Agent');"
                        class="help help-chat">Live Chat with Agent</a></li>
                <li><a href="https://acsmediakit.org/digital/acs-pubs/?utm_source=Nav&amp;utm_medium=Pubs&amp;utm_campaign=CEN"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'For Advertisers');">For Advertisers</a></li>
                <li><a href="https://solutions.acs.org/help/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'For Librarians & Account Managers');">For
                        Librarians & Account Managers</a></li>
            </ul>
        </li>
        <li class="hidden-sm hidden-xs"><a href="#">pairing</a>
            <ul>
                <li><a class="header_burger-menu_pairadevice-link" href="/pairdevice">Pair a device</a></li>
                <li><a class="header_burger-menu_pairthisdevice-link" href="/action/devicePairingSubmitCode"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Pair this device');">Pair this device</a></li>
                <li><a class="header_burger-menu_pairedstatus" href="/action/devicePairingSubmitCode">Paired status</a>
                </li>
            </ul>
        </li>
        <li class="hidden-lg hidden-md">
            <a class="header_burger-menu_my-profile-link" href="/action/showPreferences">My Profile</a>
            <a class="header_burger-menu_login-link" href="/action/ssoRequestForLoginPage">Login</a>
            <a class="header_burger-menu_logout-link" href="#">Logout</a>
            <a class="header_burger-menu_pairadevice-link" href="/pairdevice">Pair a device</a>
            <a class="header_burger-menu_pairthisdevice-link" href="/action/devicePairingSubmitCode">Pair this
                device</a>
            <a class="header_burger-menu_pairedstatus" href="/action/devicePairingSubmitCode">Paired status</a>
        </li>
        <li><a href="#">about us</a>
            <ul>
                <li><a href="/page/about-us.html"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Overview');">Overview</a></li>
                <li><a href="http://acsopenscience.org"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'ACS & Open Access');">ACS & Open Access</a>
                </li>
                <li><a href="/#partners" onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Partners');">Partners</a></li>
                <li><a href="http://acsoncampus.acs.org"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Events');">Events</a></li>
            </ul>
        </li>
    </ul>
</div>
<div class="activity-container-tablet"><i aria-hidden="true" class="icon-close"></i></div>


<script type="text/javascript">
  (function() {
    var se = document.createElement('script'); se.type = 'text/javascript'; se.async = true;
    se.src = 'https://storage.googleapis.com/code.snapengage.com/js/921a4ec7-cecf-43a6-afa5-6cd1346520b1.js';
    var done = false;
    se.onload = se.onreadystatechange = function() {
      if (!done&&(!this.readyState||this.readyState==='loaded'||this.readyState==='complete')) {
        done = true;
        /* Place your SnapEngage JS API code below */
        /* SnapEngage.allowChatSound(true); Example JS API: Enable sounds for Visitors. */
      }
    };
    var s = document.getElementsByTagName('script')[0]; s.parentNode.insertBefore(se, s);
  })();
</script>

<style>
    #SnapABug_Button,
    #designstudio-button {
        display: none;
    }
</style>

</div>
</div>
</div>
</div></div></div>
</div>




        
        <div class="pub"><div aria-live="polite" aria-atomic="true" class="pub-modal"><div class="pub-modal_content loop-trap"><a href="#" aria-label="close" tabindex="0" class="pub-modal_close icon-close pull-right"></a><div class="pub-modal_row"><div class="pub-modal_left"><div class="pub-modal_left-content"><div class="pub-modal_control hidden-lg hidden-md"><span class="pub-modal_control-text">Publications</span><a href="#" title="Back button" class="pub-modal_back"><i class="icon-angle-left"></i></a></div><div class="pub-modal_types"><h6>CONTENT TYPES</h6><ul class="pub-modal_types-list"><li data-type="all" id="allID" class="pub-modal_types-active"><a href="#"><h4>All Types</h4></a></li></ul></div><div class="pub-modal_subjects hidden-sm hidden-xs"><h6>SUBJECTS</h6><ul class="pub-modal_subjects-list"></ul></div></div></div><div class="pub-modal_right"><div class="pub-modal_control hidden-lg hidden-md"><span class="pub-modal_control-text">Publications: All Types</span><a href="#" title="Back button" class="pub-modal_back"><i class="icon-angle-left"></i></a></div><div class="pub-modal_right--inner"><div class="pub-content"></div></div></div></div></div><input type="hidden" name="pubModalData" value="{&quot;types&quot;:[{&quot;code&quot;:&quot;journals&quot;,&quot;label&quot;:&quot;Journals&quot;},{&quot;code&quot;:&quot;books&quot;,&quot;label&quot;:&quot;Books and Reference&quot;},{&quot;code&quot;:&quot;news&quot;,&quot;label&quot;:&quot;News&quot;}],&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;,&quot;label&quot;:&quot;Analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;,&quot;label&quot;:&quot;Applied&quot;},{&quot;code&quot;:&quot;cat_biological&quot;,&quot;label&quot;:&quot;Biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;,&quot;label&quot;:&quot;Materials Science &amp; Engineering&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;,&quot;label&quot;:&quot;Organic-Inorganic&quot;},{&quot;code&quot;:&quot;cat_physical&quot;,&quot;label&quot;:&quot;Physical&quot;}],&quot;publications&quot;:[{&quot;char&quot;:&quot;A&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/achre4/2021/achre4.2021.54.issue-15/achre4.2021.54.issue-15/20210803/achre4.2021.54.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;achre4&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Accounts of Chemical Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/achre4&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amrcda/2021/amrcda.2021.2.issue-7/amrcda.2021.2.issue-7/20210723/amrcda.2021.2.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amrcda&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Accounts of Materials Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amrcda&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aastgj/2021/aastgj.2021.1.issue-3/aastgj.2021.1.issue-3/20210621/aastgj.2021.1.issue-3.largecover.jpg&quot;,&quot;code&quot;:&quot;aastgj&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;ACS Agricultural Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aastgj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aabmcb/2021/aabmcb.2021.4.issue-7/aabmcb.2021.4.issue-7/20210719/aabmcb.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aabmcb&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Bio Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aabmcb&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aaembp/2021/aaembp.2021.3.issue-7/aaembp.2021.3.issue-7/20210727/aaembp.2021.3.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aaembp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Electronic Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aaembp&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aaemcq/2021/aaemcq.2021.4.issue-7/aaemcq.2021.4.issue-7/20210726/aaemcq.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aaemcq&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Energy Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aaemcq&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aamick/2021/aamick.2021.13.issue-30/aamick.2021.13.issue-30/20210804/aamick.2021.13.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;aamick&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Materials &amp; Interfaces&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aamick&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aanmf6/2021/aanmf6.2021.4.issue-7/aanmf6.2021.4.issue-7/20210723/aanmf6.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aanmf6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Nano Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aanmf6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aapmcd/2021/aapmcd.2021.3.issue-7/aapmcd.2021.3.issue-7/20210709/aapmcd.2021.3.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aapmcd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Polymer Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aapmcd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/abmcb8/largecover.png&quot;,&quot;code&quot;:&quot;abmcb8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;}],&quot;name&quot;:&quot;ACS Bio &amp; Med Chem Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/abmcb8&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/abseba/2021/abseba.2021.7.issue-7/abseba.2021.7.issue-7/20210712/abseba.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;abseba&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Biomaterials Science &amp; Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/abseba&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/accacs/2021/accacs.2021.11.issue-14/accacs.2021.11.issue-14/20210716/accacs.2021.11.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;accacs&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Catalysis&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/accacs&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acscii/2021/acscii.2021.7.issue-7/acscii.2021.7.issue-7/20210728/acscii.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;acscii&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Central Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acscii&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acbcct/2021/acbcct.2021.16.issue-7/acbcct.2021.16.issue-7/20210716/acbcct.2021.16.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;acbcct&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Biology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acbcct&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/achsc5/2021/achsc5.2021.28.issue-4/achsc5.2021.28.issue-4/20210726/achsc5.2021.28.issue-4.largecover.jpg&quot;,&quot;code&quot;:&quot;achsc5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Health &amp; Safety&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/achsc5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acncdm/2021/acncdm.2021.12.issue-15/acncdm.2021.12.issue-15/20210804/acncdm.2021.12.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;acncdm&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Neuroscience&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acncdm&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acsccc/2020/acsccc.2020.22.issue-12/acsccc.2020.22.issue-12/20201214/acsccc.2020.22.issue-12.largecover.jpg&quot;,&quot;code&quot;:&quot;acsccc&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Combinatorial Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acsccc&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aesccq/2021/aesccq.2021.5.issue-7/aesccq.2021.5.issue-7/20210715/aesccq.2021.5.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aesccq&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Earth and Space Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aesccq&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aelccp/2021/aelccp.2021.6.issue-7/aelccp.2021.6.issue-7/20210709/aelccp.2021.6.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aelccp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Energy Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aelccp&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aeacb3/largecover.png&quot;,&quot;code&quot;:&quot;aeacb3&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;}],&quot;name&quot;:&quot;ACS Engineering Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeacb3&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aeacc4/largecover.png&quot;,&quot;code&quot;:&quot;aeacc4&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;}],&quot;name&quot;:&quot;ACS Environmental Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeacc4&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aeecco/2021/aeecco.2021.1.issue-7/aeecco.2021.1.issue-7/20210709/aeecco.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aeecco&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;ACS ES&amp;T Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeecco&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aewcaa/2021/aewcaa.2021.1.issue-7/aewcaa.2021.1.issue-7/20210709/aewcaa.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aewcaa&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS ES&amp;T Water&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aewcaa&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/afsthl/2021/afsthl.2021.1.issue-6/afsthl.2021.1.issue-6/20210716/afsthl.2021.1.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;afsthl&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Food Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/afsthl&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;styleguide&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;}],&quot;name&quot;:&quot;ACS Guide to Scholarly Communication&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/styleguide&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;infocus&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;ACS In Focus&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/infocus&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aidcbc/2021/aidcbc.2021.7.issue-7/aidcbc.2021.7.issue-7/20210709/aidcbc.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aidcbc&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Infectious Diseases&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aidcbc&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amlccd/2021/amlccd.2021.10.issue-7/amlccd.2021.10.issue-7/20210720/amlccd.2021.10.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amlccd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Macro Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amlccd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/amacgu/largecover.png&quot;,&quot;code&quot;:&quot;amacgu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Materials Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amacgu&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amlcef/2021/amlcef.2021.3.issue-8/amlcef.2021.3.issue-8/20210802/amlcef.2021.3.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;amlcef&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Materials Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amlcef&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/amachv/largecover.png&quot;,&quot;code&quot;:&quot;amachv&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;}],&quot;name&quot;:&quot;ACS Measurement Science Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amachv&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amclct/2021/amclct.2021.12.issue-7/amclct.2021.12.issue-7/20210708/amclct.2021.12.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amclct&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Medicinal Chemistry Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amclct&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ancac3/2021/ancac3.2021.15.issue-7/ancac3.2021.15.issue-7/20210727/ancac3.2021.15.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;ancac3&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Nano&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ancac3&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/anaccx/largecover.png&quot;,&quot;code&quot;:&quot;anaccx&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Nanoscience Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/anaccx&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acsodf/2021/acsodf.2021.6.issue-30/acsodf.2021.6.issue-30/20210803/acsodf.2021.6.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;acsodf&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Omega&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acsodf&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aoiab5/largecover.png&quot;,&quot;code&quot;:&quot;aoiab5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;}],&quot;name&quot;:&quot;ACS Organic &amp; Inorganic Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aoiab5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aptsfn/2021/aptsfn.2021.4.issue-3/aptsfn.2021.4.issue-3/20210611/aptsfn.2021.4.issue-3.largecover.jpg&quot;,&quot;code&quot;:&quot;aptsfn&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Pharmacology &amp; Translational Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aptsfn&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/apchd5/2021/apchd5.2021.8.issue-7/apchd5.2021.8.issue-7/20210721/apchd5.2021.8.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;apchd5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Photonics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apchd5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/apcach/largecover.png&quot;,&quot;code&quot;:&quot;apcach&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;}],&quot;name&quot;:&quot;ACS Physical Chemistry Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apcach&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/apaccd/largecover.png&quot;,&quot;code&quot;:&quot;apaccd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Polymers Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apaccd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/books/content/reagents/2017/acsreagents/acsreagents/20170228/acsreagents.largecover.png&quot;,&quot;code&quot;:&quot;reagents&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;ACS Reagent Chemicals&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/reagents&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ascefj/2021/ascefj.2021.6.issue-7/ascefj.2021.6.issue-7/20210723/ascefj.2021.6.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;ascefj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Sensors&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ascefj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ascecg/2021/ascecg.2021.9.issue-30/ascecg.2021.9.issue-30/20210802/ascecg.2021.9.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;ascecg&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Sustainable Chemistry &amp; Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ascecg&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/books/content/symposium/2021/bk-2021-1379/bk-2021-1379/20210430-01/bk-2021-1379.largecover.jpg&quot;,&quot;code&quot;:&quot;symposium&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;383784032&quot;}],&quot;name&quot;:&quot;ACS Symposium Series&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/symposium&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/asbcd6/2021/asbcd6.2021.10.issue-7/asbcd6.2021.10.issue-7/20210716/asbcd6.2021.10.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;asbcd6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Synthetic Biology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/asbcd6&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;advances&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;383784032&quot;}],&quot;name&quot;:&quot;Advances in Chemistry&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/advances&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ancham/2021/ancham.2021.93.issue-30/ancham.2021.93.issue-30/20210803/ancham.2021.93.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;ancham&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Analytical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ancham&quot;}]},{&quot;char&quot;:&quot;B&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bichaw/2021/bichaw.2021.60.issue-30/bichaw.2021.60.issue-30/20210803/bichaw.2021.60.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;bichaw&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Biochemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bichaw&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bcches/2021/bcches.2021.32.issue-7/bcches.2021.32.issue-7/20210721/bcches.2021.32.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;bcches&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Bioconjugate Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bcches&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bomaf6/2021/bomaf6.2021.22.issue-7/bomaf6.2021.22.issue-7/20210712/bomaf6.2021.22.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;bomaf6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Biomacromolecules&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bomaf6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/bipret/largecover.jpg&quot;,&quot;code&quot;:&quot;bipret&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;Biotechnology Progress&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bipret&quot;}]},{&quot;char&quot;:&quot;C&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cgeabj/2021/cgeabj.2021.99.issue-28/cgeabj.2021.99.issue-28/20210802/cgeabj.2021.99.issue-28.largecover.jpg&quot;,&quot;code&quot;:&quot;cgeabj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;C&amp;EN Global Enterprise&quot;,&quot;type&quot;:&quot;news&quot;,&quot;url&quot;:&quot;/journal/cgeabj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/crtoec/2021/crtoec.2021.34.issue-7/crtoec.2021.34.issue-7/20210719/crtoec.2021.34.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;crtoec&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemical Research in Toxicology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/crtoec&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/chreay/2021/chreay.2021.121.issue-14/chreay.2021.121.issue-14/20210728/chreay.2021.121.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;chreay&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;articletoc&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemical Reviews&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/chreay&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cmatex/2021/cmatex.2021.33.issue-14/cmatex.2021.33.issue-14/20210727/cmatex.2021.33.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;cmatex&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemistry of Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/cmatex&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cgdefu/2021/cgdefu.2021.21.issue-8/cgdefu.2021.21.issue-8/20210804/cgdefu.2021.21.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;cgdefu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Crystal Growth &amp; Design&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/cgdefu&quot;}]},{&quot;char&quot;:&quot;E&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/enfuem/2021/enfuem.2021.35.issue-14/enfuem.2021.35.issue-14/20210715/enfuem.2021.35.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;enfuem&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Energy &amp; Fuels&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/enfuem&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/esthag/2021/esthag.2021.55.issue-15/esthag.2021.55.issue-15/20210803/esthag.2021.55.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;esthag&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Environmental Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/esthag&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/estlcu/2021/estlcu.2021.8.issue-7/estlcu.2021.8.issue-7/20210713/estlcu.2021.8.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;estlcu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Environmental Science &amp; Technology Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/estlcu&quot;}]},{&quot;char&quot;:&quot;I&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6.2&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;I&amp;EC Product Research and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6.2&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iechad&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iechad&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecac0&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Analytical Edition&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecac0&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecjc0&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Chemical &amp; Engineering Data Series&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecjc0&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecfa7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Fundamentals&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecfa7&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepdaw&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Process Design and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepdaw&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Product Research and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/iecred/2021/iecred.2021.60.issue-30/iecred.2021.60.issue-30/20210804/iecred.2021.60.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;iecred&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecred&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/inocaj/2021/inocaj.2021.60.issue-15/inocaj.2021.60.issue-15/20210802/inocaj.2021.60.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;inocaj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Inorganic Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/inocaj&quot;}]},{&quot;char&quot;:&quot;J&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jaaucr/2021/jaaucr.2021.1.issue-7/jaaucr.2021.1.issue-7/20210726/jaaucr.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jaaucr&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;JACS Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jaaucr&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jafcau/2021/jafcau.2021.69.issue-30/jafcau.2021.69.issue-30/20210804/jafcau.2021.69.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;jafcau&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Agricultural and Food Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jafcau&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jceaax/2021/jceaax.2021.66.issue-7/jceaax.2021.66.issue-7/20210708/jceaax.2021.66.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jceaax&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical &amp; Engineering Data&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jceaax&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jci001&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Documentation&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jci001&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jceda8/2021/jceda8.2021.98.issue-7/jceda8.2021.98.issue-7/20210713/jceda8.2021.98.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jceda8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;divched&quot;}],&quot;name&quot;:&quot;Journal of Chemical Education&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jceda8&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jcics1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Information and Computer Sciences&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jcics1&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jcisd8/2021/jcisd8.2021.61.issue-7/jcisd8.2021.61.issue-7/20210726/jcisd8.2021.61.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jcisd8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Information and Modeling&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jcisd8&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jctcce/2021/jctcce.2021.17.issue-7/jctcce.2021.17.issue-7/20210713/jctcce.2021.17.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jctcce&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Theory and Computation&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jctcce&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iechad.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Industrial &amp; Engineering Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iechad.1&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jmcmar.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Medicinal and Pharmaceutical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jmcmar.1&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-14/jmcmar.2021.64.issue-14/20210722/jmcmar.2021.64.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;jmcmar&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Medicinal Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jmcmar&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jnprdf/2021/jnprdf.2021.84.issue-7/jnprdf.2021.84.issue-7/20210723/jnprdf.2021.84.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jnprdf&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Natural Products&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jnprdf&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/joceah/2021/joceah.2021.86.issue-14/joceah.2021.86.issue-14/20210716/joceah.2021.86.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;joceah&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Organic Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/joceah&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jpchax&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpchax&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpcafh/2021/jpcafh.2021.125.issue-29/jpcafh.2021.125.issue-29/20210729/jpcafh.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpcafh&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry A&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpcafh&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpcbfk/2021/jpcbfk.2021.125.issue-29/jpcbfk.2021.125.issue-29/20210729/jpcbfk.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpcbfk&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry B&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpcbfk&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpccck/2021/jpccck.2021.125.issue-29/jpccck.2021.125.issue-29/20210729/jpccck.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpccck&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry C&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpccck&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpclcd/2021/jpclcd.2021.12.issue-29/jpclcd.2021.12.issue-29/20210729/jpclcd.2021.12.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpclcd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpclcd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jprobs/2021/jprobs.2021.20.issue-7/jprobs.2021.20.issue-7/20210702/jprobs.2021.20.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jprobs&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Proteome Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jprobs&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jacsat/2021/jacsat.2021.143.issue-30/jacsat.2021.143.issue-30/20210804/jacsat.2021.143.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;jacsat&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of the American Chemical Society&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jacsat&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jamsef/2021/jamsef.2021.32.issue-8/jamsef.2021.32.issue-8/20210804/jamsef.2021.32.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;jamsef&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of the American Society for Mass Spectrometry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jamsef&quot;}]},{&quot;char&quot;:&quot;L&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/langd5/2021/langd5.2021.37.issue-30/langd5.2021.37.issue-30/20210803/langd5.2021.37.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;langd5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Langmuir&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/langd5&quot;}]},{&quot;char&quot;:&quot;M&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/mamobx/2021/mamobx.2021.54.issue-14/mamobx.2021.54.issue-14/20210727/mamobx.2021.54.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;mamobx&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Macromolecules&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/mamobx&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/mpohbp/2021/mpohbp.2021.18.issue-8/mpohbp.2021.18.issue-8/20210802/mpohbp.2021.18.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;mpohbp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Molecular Pharmaceutics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/mpohbp&quot;}]},{&quot;char&quot;:&quot;N&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/nalefd/2021/nalefd.2021.21.issue-14/nalefd.2021.21.issue-14/20210728/nalefd.2021.21.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;nalefd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Nano Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/nalefd&quot;}]},{&quot;char&quot;:&quot;O&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/orlef7/2021/orlef7.2021.23.issue-14/orlef7.2021.23.issue-14/20210716/orlef7.2021.23.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;orlef7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organic Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/orlef7&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/oprdfk/2021/oprdfk.2021.25.issue-7/oprdfk.2021.25.issue-7/20210716/oprdfk.2021.25.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;oprdfk&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organic Process Research &amp; Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/oprdfk&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/orgnd7/2021/orgnd7.2021.40.issue-14/orgnd7.2021.40.issue-14/20210726/orgnd7.2021.40.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;orgnd7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organometallics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/orgnd7&quot;}]},{&quot;char&quot;:&quot;P&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Product R&amp;D&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6.1&quot;}]}]}"/></input></div></div>
</header>




        
        <main data-widget-id="28284a6d-730d-4a56-93ad-909787c5ac1b" id="" class="content article"><article data-figures="https://pubs.acs.org/action/ajaxShowFigures?doi=10.1021%2Fjm200939b&amp;ajax=true" data-references="https://pubs.acs.org/action/ajaxShowEnhancedAbstract?doi=10.1021%2Fjm200939b&amp;ajax=true" data-enable-mathjax="true"><div class="figure-viewer"><div class="figure-viewer_row"><div class="figure-viewer_col loop-trap"><div aria-live="polite" aria-atomic="true" class="figure-viewer_modal"><a href="#" title="Close" aria-label="close" tabindex="0" class="figure-viewer_close icon-close"></a><h2 class="figure-viewer_label"><span class="figure-viewer_current"></span></h2><div class="figure-viewer_image"><a href="#" title="Next" class="figure-viewer_next icon-angle-right"></a><a href="#" title="Previous" class="figure-viewer_prev icon-angle-left"></a><div class="figure-viewer_image-content"><img src="" alt="Figure 1" class="fv-img"/></img><img src="/pb-assets/ux3/loading-1525090748317.gif" alt="Loading Img" class="loading-img"/></img></div></div><div class="figure-viewer_links"><a href="#" title="Download Hi-Res Image" target="_blank" class="figure-viewer_hi-res-link"><i class="icon-file-image-o"></i><span>Download Hi-Res Image</span></a><span class="fv-separator"></span><a href="#" title="Download to MS-PowerPoint" class="figure-viewer_ms-p-link"><i class="icon-file-powerpoint-o"></i><span>Download to MS-PowerPoint</span></a><span class="cit-this-container"><a href="/action/showCitFormats?doi=10.1021/jm200939b&amp;href=/doi/10.1021/jm200939b" title="Cite This" class="figure-viewer-cite-this-link"><i class="icon-check-circle"></i><span><strong>Cite This:</strong></span></a><span class="article_header-cite-this figure-viewer-cite-this"><span class="cit-fg-title"><i>J. Med. Chem.</i></span><span class="cit-fg-year"> 2011</span><span class="cit-fg-volume">, 54</span><span class="cit-fg-issue">, 21</span><span class="cit-fg-pageRange">, 7602-7620</span></span></span></div></div></div></div></div><div class="article_fullPage"><div class="article_header"><div class="articleHeaderDropzone5" data-pb-dropzone="articleHeaderDropzone5"><div class="advertisement">
	<div class="advertisement-link">
		<a href="http://acsmediakit.org">ADVERTISEMENT</a>
	</div>
	<div id="dfp-journal-article-leaderboard">
		<script type="text/javascript">
			$(document).ready(function() {
				setTimeout(function() {
					googletag.cmd.push(function() { googletag.display("dfp-journal-article-leaderboard"); });
				}, 1400);
			});
		</script>
	</div>
</div></div><div class="container container_scaled-down"><div class="row"><div class="col-xs-12.clearfix"><div class="article_header-left pull-left"><div class="article_header-dropzone-1"><div class="articleHeaderDropzone1" data-pb-dropzone="articleHeaderDropzone1"><div class="content-navigation clearfix"><a href="/toc/jmcmar/54/21" title="Return to Issue" id="returnToIssues" class="content-navigation__btn--return"><span>RETURN TO ISSUE</span></a><a href="/doi/10.1021/jm200937t" title="Previous" id="prevID" class="content-navigation__btn--pre"><i class="icon-angle-left"></i><span>PREV</span></a><span class="content-navigation__contentType">Article</span><a href="/doi/10.1021/jm2009138" title="Next" id="nextID" class="content-navigation__btn--next"><span>NEXT</span><i class="icon-angle-right"></i></a></div></div></div><div class="headerLogo_e-alertsMobile_container"><div class="article_header-logo hidden-lg"><div class="pj-badge"></div><a href="/journal/jmcmar" title="Journal Logo"><img src="/specs/ux3/releasedAssets/images/loader.gif" data-src="/na101/home/literatum/publisher/achs/journals/covergifs/jmcmar/title.png" alt="Journal Logo" /></img></a></div><div class="e-alertsMobile_container hidden-md hidden-lg"></div></div><h1 class="article_header-title"><span class="hlFld-Title">Discovery of Two Clinical Histamine H<sub>3</sub> Receptor Antagonists: <i>trans</i>-<i>N</i>-Ethyl-3-fluoro-3-[3-fluoro-4-(pyrrolidinylmethyl)phenyl]cyclobutanecarboxamide (PF-03654746) and <i>trans</i>-3-Fluoro-3-[3-fluoro-4-(pyrrolidin-1-ylmethyl)phenyl]-<i>N</i>-(2-methylpropyl)cyclobutanecarboxamide (PF-03654764)</span></h1><ul class="loa non-jats-loa"><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Travis+T.++Wager">Travis T. Wager</a></span><span class="author-xref-symbol "><sup>*</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Betty+A.++Pettersen">Betty A. Pettersen</a></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Anne+W.++Schmidt">Anne W. Schmidt</a></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Douglas+K.++Spracklin">Douglas K. Spracklin</a></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Scot++Mente">Scot Mente</a></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Todd+W.++Butler">Todd W. Butler</a></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Harry++Howard%2C++Jr">Harry Howard, Jr</a></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Daniel+J.++Lettiere">Daniel J. Lettiere</a></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=David+M.++Rubitski">David M. Rubitski</a></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Diane+F.++Wong">Diane F. Wong</a></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Frank+M.++Nedza">Frank M. Nedza</a></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Frederick+R.++Nelson">Frederick R. Nelson</a></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Hans++Rollema">Hans Rollema</a></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Jeffrey+W.++Raggon">Jeffrey W. Raggon</a></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Jiri++Aubrecht">Jiri Aubrecht</a></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Jody+K.++Freeman">Jody K. Freeman</a></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=John+M.++Marcek">John M. Marcek</a></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Julie++Cianfrogna">Julie Cianfrogna</a></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Karen+W.++Cook">Karen W. Cook</a></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Larry+C.++James">Larry C. James</a></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Linda+A.++Chatman">Linda A. Chatman</a></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Philip+A.++Iredale">Philip A. Iredale</a></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Michael+J.++Banker">Michael J. Banker</a></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Michael+L.++Homiski">Michael L. Homiski</a></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Jennifer+B.++Munzner">Jennifer B. Munzner</a></span></span></li><span class="comma-separator">, and </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Rama+Y.++Chandrasekaran">Rama Y. Chandrasekaran</a></span></span></li><span class="comma-separator"></span></ul><div class="affiliations"><div class="view-affs"><span class="title">View Author Information</span><i class="caret-icon icon-angle-down"></i></div><div class="all-aff-infos hlFld-Affiliation"><div class="aff-info" id="aff1"><span class="aff-text">Groton Laboratories, Pfizer Worldwide Research and Development, 558 Eastern Point Road, Groton, Connecticut 06340-5159, United States</span></div><div class="corresp-info">Phone: 860-715-4059. Fax: 860-686-6052. E-mail: <a href="/cdn-cgi/l/email-protection#46323427302f3568326831272123340636202f3c23346825292b"><span class="__cf_email__" data-cfemail="2c585e4d5a455f0258025b4d4b495e6c5c4a4556495e024f4341">[email protected]</span></a></div></div></div><div class="article_header-meta clearfix"><div class="article_header-meta-left pull-left"><input type="hidden" name="journalCodeForjhpLink" value="jmcmar" /></input><input type="hidden" name="journalNameForjhpLink" value="Journal of Medicinal Chemistry" /></input><div class="article_header-cite-this"><a href="/action/showCitFormats?doi=10.1021%2Fjm200939b&amp;href=/doi/10.1021%2Fjm200939b" title="Cite This"><i class="icon-check-circle"></i><strong>Cite this: </strong></a><span class="cit-title"><i>J. Med. Chem.</i></span> <span class="cit-year-info"><span>2011</span></span><span class="cit-volume">, 54</span><span class="cit-issue">, 21</span><span class="cit-pageRange">, 7602–7620</span></div><div class="article_header-epubdate"><span class="pub-date epub-date">Publication Date</span><span class="web-text"> (Web)</span><span class="date-separator">:</span><span class="pub-date-value">September 19, 2011</span><div class="article_header-history base dropBlock"><a href="#" data-db-target-for="article_header-history" title="History" target="_self" class="" aria-expanded="false"><i class="icon-angle-down"></i><i class="icon-angle-up"></i></a><div data-db-target-of="article_header-history" class="dropBlock__holder" aria-hidden="true"><div class="articleHeaderHistoryDropzone" data-pb-dropzone="articleHeaderHistoryDropzone"><h4>Publication History</h4>




        
        <ul class="rlist article-chapter-history-list"><li><span class="item_label"><b>Received</b></span>14 July 2011</li><li><span class="item_label"><b>Published</b> online</span>7 October 2011</li><li><span class="item_label"><b>Published</b> in</span><span class="item_label-issue">issue</span> 10 November 2011</li></ul></div></div></div></div><div class="article_header-doiurl"><a href="https://doi.org/10.1021/jm200939b" title="DOI URL">https://doi.org/10.1021/jm200939b</a></div><div class="article_header-article-copyright"><strong>Copyright © 2011 American Chemical Society</strong></div><div class="article_rightPermissionsLink"><div class="articleHeaderDropzone4" data-pb-dropzone="articleHeaderDropzone4"><div class="articleRightsPermissionsLink"><a href="/servlet/linkout?type=rightslink&amp;url=startPage%3D7602%26pageCount%3D19%26copyright%3DAmerican%2BChemical%2BSociety%26author%3DTravis%2BT.%2BWager%252C%2BBetty%2BA.%2BPettersen%252C%2BAnne%2BW.%2BSchmidt%252C%2Bet%2Bal%26orderBeanReset%3Dtrue%26imprint%3DAmerican%2BChemical%2BSociety%26volumeNum%3D54%26issueNum%3D21%26contentID%3Djm200939b%26title%3DDiscovery%2Bof%2BTwo%2BClinical%2BHistamine%2BH3%2BReceptor%2BAntagonists%253A%2Btrans-N-Ethyl-3-fluoro-3-%255B3-fluoro-4-%2528pyrrolidinylmethyl%2529phenyl%255Dcyclobutanecarboxamide%2B%2528PF-03654746%2529%2Band%2Btrans-3-Fluoro-3-%255B3-fluoro-4-%2528pyrrolidin-1-ylmethyl%2529phenyl%255D-N-%25282-methylpropyl%2529cyclobutanecarboxamide%2B%2528PF-03654764%2529%26numPages%3D19%26pa%3D%26issn%3D0022-2623%26publisherName%3Dacs%26publication%3Djmcmar%26rpt%3Dn%26endPage%3D7620%26publicationDate%3DNovember%2B2011">RIGHTS & PERMISSIONS</a></div></div></div><div class="article_header-access-block"><div class="article_header-open-access"></div><div class="article_header-access-icon"><img src="/products/achs/releasedAssets/images/subscribed.svg" alt="Subscribed Access" /></img></div></div></div><div class="article_header-meta-center pull-left"><div class="articleHeaderDropzone3" data-pb-dropzone="articleHeaderDropzone3"><div class="articleMetrics"><div class="articleMetrics_table"><div class="articleMetrics_row"><input type="hidden" name="articleMetricsDoi" value="10.1021/jm200939b"/></input><div class="articleMetrics_metric"><h6>Article Views</h6><div class="articleMetrics-val">3694</div></div><div class="articleMetrics_altmetric"><h6>Altmetric</h6><div class="articleMetrics-val articleMetrics_score">-</div><div class="altmetric-donut hidden"><div data-badge-details="right" data-badge-type="donut" data-hide-no-mentions="false" data-condensed="true" class="altmetric-embed"></div></div></div><div class="articleMetrics_count"><h6>Citations</h6><div class="articleMetrics-val"><a href="#citeThis" class="internalNav">52</a></div></div></div></div><div class="articleMetrics_about"><div class="base dropBlock"><a href="#" data-db-target-for="aboutArticleMetrics" class="article_aboutLink">LEARN ABOUT THESE METRICS</a><div data-db-target-of="aboutArticleMetrics" aria-live="polite" aria-atomic="true" role="alert" class="dropBlock__holder"><i aria-hidden="true" class="icon-close_thin"></i><p>Article Views are the COUNTER-compliant sum of full text article downloads since November 2008 (both PDF and HTML) across all institutions and individuals. These metrics are regularly updated to reflect usage leading up to the last few days.</p><p>Citations are the number of other articles citing this article, calculated by Crossref and updated daily.<a href="https://www.crossref.org/services/cited-by/" title="Find more information about Crossref citation counts"> Find more information about Crossref citation counts.</a></p><p>The Altmetric Attention Score is a quantitative measure of the attention that a research article has received online. Clicking on the donut icon will load a page at altmetric.com with additional details about the score and the social media presence for the given article. Find more information on<a href="https://help.altmetric.com/support/solutions/articles/6000233311-how-is-the-altmetric-attention-score-calculated" title="The Altmetric Attention Score and how the score is calculated"> the Altmetric Attention Score and how the score is calculated.</a></p></div></div></div></div></div></div><div class="article_header-meta-right"><div class="articleHeaderDropzone6" data-pb-dropzone="articleHeaderDropzone6"><div data-widget-def="UX3share" data-widget-id="787b5b92-0445-40f4-bdd2-9591d56f4a67" class="article_header-share share_label_visible">
        



        
        <script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script><script type="text/javascript" async="async" src="//s7.addthis.com/js/300/addthis_widget.js#pubid=xa-4faab26f2cff13a7"></script><div class="share"><div class="share_button"><span class="share__label">Share</span><a href="#" data-db-target-for="787b5b92-0445-40f4-bdd2-9591d56f4a67" data-db-switch="icon-close_thin" aria-label="share button" class="share__ctrl"><i aria-hidden="true" class="icon-Icon_Share"></i></a></div>



        
        <div class="achs-addto-mendeley"><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><input type="hidden" class="doi" value="10.1021/jm200939b" /></input><span class="achs-addto-mendeley_label achs-addto-mendeley_addToLabel">Add to</span><span class="achs-addto-mendeley_label achs-addto-mendeley_viewInLabel">View In</span><a title="Add to mendeley button" class="achs-addto-mendeley_button" tabindex="0"><i class="achs-addto-mendeley_icon icon-mendeley"></i><i class="achs-addto-mendeley_close icon-close"></i></a><div data-db-target-of="5423a74c-bbd8-47b1-9f43-99423ee72e5c" class="achs-addto-mendeley_list dropBlock__holder"><ul><li><a href="#" title="Add Full Text with Reference" class="achs-addto-mendeley_disabled-button add-full-document"><i class="icon-bookmark-o"></i><span>Add Full Text with Reference</span></a></li><li><a href="#" title="Add Description" class="achs-mendeley_button add-metadata-description"><i class="icon-mendeley"></i><span>Add Description</span></a></li></ul></div><a href="#" title="View in mendeley button" class="achs-addto-mendeley_viewin-button"><i class="icon-mendeley"></i></a><div class="achs_loader"><div class="achs_loader_dot"></div><div class="achs_loader_dot"></div><div class="achs_loader_dot"></div></div><input type="hidden" name="meta-data" value="{&quot;title&quot;:&quot;Discovery of Two Clinical Histamine H3 Receptor Antagonists: trans-N-Ethyl-3-fluoro-3-[3-fluoro-4-(pyrrolidinylmethyl)phenyl]cyclobutanecarboxamide (PF-03654746) and trans-3-Fluoro-3-[3-fluoro-4-(pyrrolidin-1-ylmethyl)phenyl]-N-(2-methylpropyl)cyclobutanecarboxamide (PF-03654764)&quot;,&quot;type&quot;:&quot;journal&quot;,&quot;authors&quot;:[{&quot;first_name&quot;:&quot;Travis&quot;,&quot;last_name&quot;:&quot;T. Wager&quot;},{&quot;first_name&quot;:&quot;Betty&quot;,&quot;last_name&quot;:&quot;A. Pettersen&quot;},{&quot;first_name&quot;:&quot;Anne&quot;,&quot;last_name&quot;:&quot;W. Schmidt&quot;},{&quot;first_name&quot;:&quot;Douglas&quot;,&quot;last_name&quot;:&quot;K. Spracklin&quot;},{&quot;first_name&quot;:&quot;Scot&quot;,&quot;last_name&quot;:&quot;Mente&quot;},{&quot;first_name&quot;:&quot;Todd&quot;,&quot;last_name&quot;:&quot;W. Butler&quot;},{&quot;first_name&quot;:&quot;Harry&quot;,&quot;last_name&quot;:&quot;Howard&quot;},{&quot;first_name&quot;:&quot;Daniel&quot;,&quot;last_name&quot;:&quot;J. Lettiere&quot;},{&quot;first_name&quot;:&quot;David&quot;,&quot;last_name&quot;:&quot;M. Rubitski&quot;},{&quot;first_name&quot;:&quot;Diane&quot;,&quot;last_name&quot;:&quot;F. Wong&quot;},{&quot;first_name&quot;:&quot;Frank&quot;,&quot;last_name&quot;:&quot;M. Nedza&quot;},{&quot;first_name&quot;:&quot;Frederick&quot;,&quot;last_name&quot;:&quot;R. Nelson&quot;},{&quot;first_name&quot;:&quot;Hans&quot;,&quot;last_name&quot;:&quot;Rollema&quot;},{&quot;first_name&quot;:&quot;Jeffrey&quot;,&quot;last_name&quot;:&quot;W. Raggon&quot;},{&quot;first_name&quot;:&quot;Jiri&quot;,&quot;last_name&quot;:&quot;Aubrecht&quot;},{&quot;first_name&quot;:&quot;Jody&quot;,&quot;last_name&quot;:&quot;K. Freeman&quot;},{&quot;first_name&quot;:&quot;John&quot;,&quot;last_name&quot;:&quot;M. Marcek&quot;},{&quot;first_name&quot;:&quot;Julie&quot;,&quot;last_name&quot;:&quot;Cianfrogna&quot;},{&quot;first_name&quot;:&quot;Karen&quot;,&quot;last_name&quot;:&quot;W. Cook&quot;},{&quot;first_name&quot;:&quot;Larry&quot;,&quot;last_name&quot;:&quot;C. James&quot;},{&quot;first_name&quot;:&quot;Linda&quot;,&quot;last_name&quot;:&quot;A. Chatman&quot;},{&quot;first_name&quot;:&quot;Philip&quot;,&quot;last_name&quot;:&quot;A. Iredale&quot;},{&quot;first_name&quot;:&quot;Michael&quot;,&quot;last_name&quot;:&quot;J. Banker&quot;},{&quot;first_name&quot;:&quot;Michael&quot;,&quot;last_name&quot;:&quot;L. Homiski&quot;},{&quot;first_name&quot;:&quot;Jennifer&quot;,&quot;last_name&quot;:&quot;B. Munzner&quot;},{&quot;first_name&quot;:&quot;Rama&quot;,&quot;last_name&quot;:&quot;Y. Chandrasekaran&quot;}],&quot;source&quot;:&quot;Journal of Medicinal Chemistry&quot;,&quot;year&quot;:&quot;2011&quot;,&quot;month&quot;:&quot;10&quot;,&quot;day&quot;:&quot;07&quot;,&quot;issue&quot;:&quot;21&quot;,&quot;volume&quot;:&quot;54&quot;,&quot;pages&quot;:&quot;7602-7620&quot;,&quot;identifiers&quot;:{&quot;doi&quot;:&quot;10.1021/jm200939b&quot;},&quot;abstract&quot;:&quot;The discovery of two histamine H3 antagonist clinical candidates is disclosed. The pathway to identification of the two clinical candidates, 6 (PF-03654746) and 7 (PF-03654764) required five hypothesis driven design cycles. The key to success in identifying these clinical candidates was the development of a compound design strategy that leveraged medicinal chemistry knowledge and traditional assays in conjunction with computational and in vitro safety tools. Overall, clinical compounds 6 and 7 exceeded conservative safety margins and possessed optimal pharmacological and pharmacokinetic profiles, thus achieving our initial goal of identifying compounds with fully aligned oral drug attributes, “best-in-class” molecules.&quot;}" class="meta-data"/></input><input type="hidden" name="mendeley-api-endpoint" value="https://api.mendeley.com/documents" class="mendeley-api-endpoint"/></input><input type="hidden" name="pub-access" value="full" class="pub-access"/></input><input type="hidden" name="library-url" value="https://www.mendeley.com/library/" class="library-url"/></input><input type="hidden" name="selected-share-option" class="selected-share-option"/></input></div>




        
        <div class="cit-download-dropdown"><span class="cit-download-dropdown_label">Export</span><a href="#" data-db-target-for="cit-download-dropdown_content" title="Download citation button" class="cit-download-dropdown_button"><span>RIS</span><i aria-hidden="true" aria-label="close" class="icon-close"></i></a><div data-db-target-of="cit-download-dropdown_content" class="cit-download-dropdown_content"><ul><li><a href="/action/downloadCitation?doi=10.1021%2Fjm200939b&amp;include=cit&amp;format=ris&amp;direct=true&amp;downloadFileName=jm200939b" title="Citation"><span>Citation</span></a></li><li><a href="/action/downloadCitation?doi=10.1021%2Fjm200939b&amp;include=abs&amp;format=ris&amp;direct=true&amp;downloadFileName=jm200939b" title="Citation and abstract"><span>Citation and abstract</span></a></li><li><a href="/action/downloadCitation?doi=10.1021%2Fjm200939b&amp;include=ref&amp;format=ris&amp;direct=true&amp;downloadFileName=jm200939b" title="Citation and references"><span>Citation and references</span></a></li><li><a href="/action/showCitFormats?doi=10.1021%2Fjm200939b&amp;include=cit&amp;format=ris&amp;direct=true&amp;downloadFileName=jm200939b&amp;href=/doi/10.1021/jm200939b" title="Cite This"><i class="icon-plus-square"></i><span>More Options</span></a></li></ul></div></div>
<div data-db-target-of="787b5b92-0445-40f4-bdd2-9591d56f4a67" id="787b5b92-0445-40f4-bdd2-9591d56f4a67_Pop" class="share__block dropBlock__holder fixed"><span class="sr-only">Share on</span><ul class="rlist w-slide--list addthis addthis_toolbox addthis_default_style addthis_32x32_style"><li><a role="link" class="addthis_button_facebook"><i aria-hidden="true" class="at-icon-wrapper icon-facebook"></i>Facebook</a></li><li><a role="link" class="addthis_button_twitter"><i aria-hidden="true" class="at-icon-wrapper icon-twitter"></i>Twitter</a></li><li><a role="link" class="addthis_button_wechat"><i aria-hidden="true" class="at-icon-wrapper icon-wechat"></i>Wechat</a></li><li><a role="link" class="addthis_button_linkedin"><i aria-hidden="true" class="at-icon-wrapper icon-linkedin"></i>Linked In</a></li><li><a role="link" class="addthis_button_reddit"><i aria-hidden="true" class="at-icon-wrapper icon-reddit"></i>Reddit</a></li></ul></div></div>

        </div></div></div></div><div class="article_header-footer"><div class="article_header-footer-left pull-left clearfix"><div class="article_header-links pull-left"><input class="pub-doi" type="hidden" name="pub-doi" value="10.1021/jm200939b" /></input><a href="/doi/pdf/10.1021/jm200939b" title="PDF" target="_blank" class="button_primary pdf-button"><i class="icon-file-pdf-o"></i><span>PDF (4 MB)
                            </span></a><a href="/servlet/linkout?suffix=s0&amp;dbid=16384&amp;doi=10.1021/jm200939b&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fid%3Ddoi%3A10.1021%252Fjm200939b%26sid%3Dliteratum%253Aachs%26pmid%3D21928839%26genre%3Darticle%26aulast%3DWager%26date%3D2011%26atitle%3DDiscovery%2Bof%2BTwo%2BClinical%2BHistamine%2BH3%2BReceptor%2BAntagonists%253A%2Btrans-N-Ethyl-3-fluoro-3-%255B3-fluoro-4-%2528pyrrolidinylmethyl%2529phenyl%255Dcyclobutanecarboxamide%2B%2528PF-03654746%2529%2Band%2Btrans-3-Fluoro-3-%255B3-fluoro-4-%2528pyrrolidin-1-ylmethyl%2529phenyl%255D-N-%25282-methylpropyl%2529cyclobutanecarboxamide%2B%2528PF-03654764%2529%26jtitle%3DJournal%2Bof%2BMedicinal%2BChemistry%26title%3DJournal%2Bof%2BMedicinal%2BChemistry%26volume%3D54%26issue%3D21%26spage%3D7602%26epage%3D7620%26issn%3D0022-2623" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a><div class="articleHeaderDropzone8" data-pb-dropzone="articleHeaderDropzone8"><div class="external-alerts-management"><input type="hidden" name="pub-type" value="article" class="pub-type"/></input><input type="hidden" name="is-enabled" value="true" class="is-enabled"/></input><input type="hidden" name="is-authenticated" value="false" class="is-authenticated"/></input><input type="hidden" name="pub-code" value="jmcmar" class="pub-code"/></input><input type="hidden" name="linkout-url" value="https://preferences.acspubs.org/journals" class="linkout-url"/></input><button data-toggle="modal" data-target="#ealertsModal" class="ealerts-toggle-btn hidden"></button><a class="button_primary_2 niHeader_getEAlerts jhHeader_sub_info"><i class="icon-send"></i><i class="icon-envelope"></i><i class="icon-check"></i><span class="ealerts-btn-text">Get e-Alerts</span><i aria-hidden="true" aria-label="close" class="icon-close"></i></a><div class="ux-modal-container"><div id="ealertsModal" style="display: none;" aria-live="polite" aria-atomic="true" class="modal"><div class="modal__dialog"><div class="modal__body"><iframe src="" class="ealerts-frame"></iframe></div></div></div></div><input type="hidden" id="ealertsModalSrc" value="https://preferences.acspubs.org/jmcmar?ifr=1"/></input></div></div></div><div class="article_header-suppInfo pull-left"><i class="icon-supporting-info"></i><span class="article_header-suppInfo-text">Supporting Info (1)</span><span class="article_header-suppInfo-arrow">»</span><a href="#" data-slide-target=".tab__pane-suppInfo" title="Supporting Information" class="article_header-suppInfo-link-mobile hidden-sm hidden-md hidden-lg w-slide__btn">Supporting Information
                </a><a href="#article_content-right" title="Supporting Information" data-scrollDuration="1000" class="article_header-suppInfo-link internalNav hidden-xs">Supporting Information
                </a></div></div><div class="article_header-footer-right"><div class="articleHeaderDropzone7" data-pb-dropzone="articleHeaderDropzone7"><div class="article_header-footer-right"><div class="article_header-taxonomy"><span>SUBJECTS:</span><ul class="rlist--inline loa"><li><a href="/action/doSearch?ConceptID=291171" title="Antagonists">Antagonists</a>,</li><li><a href="/action/doSearch?ConceptID=291350" title="Assays">Assays</a>,</li><li><a href="/action/doSearch?ConceptID=292464" title="Rodent models">Rodent models</a>,</li><li><a href="/action/doSearch?ConceptID=291697" title="Safety">Safety</a>,</li><li><a href="/action/doSearch?ConceptID=292186" title="Receptors">Receptors</a></li></ul></div></div></div></div></div></div><div class="article_header-right pull-left hidden-md hidden-sm hidden-xs"><div class="articleHeaderDropzone2" data-pb-dropzone="articleHeaderDropzone2"><div class="cover-image"><div class="cover-image__image"><a href="/toc/jmcmar/54/21" title="Go to Journal of Medicinal Chemistry "><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2011/jmcmar.2011.54.issue-21/jmcmar.2011.54.issue-21/production/jmcmar.2011.54.issue-21.largecover.jpg" alt="Go to Journal of Medicinal Chemistry "/></img></a></div></div>




        
        
<script>
 $(document).ready(function() {
   $('.article_header .external-alerts-management .niHeader_getEAlerts').each(function(){
	 var Tab = $(this).attr("href");
	   if(typeof Tab != undefined && Tab != false){
		 console.log("Testing Tab");
		 $(this).attr('href','#');
	   }
   });
 });
 $(document).on('click', '.article_header .external-alerts-management .niHeader_getEAlerts', function (e) {
	 //do something
	 if($(this).hasClass('registered')){
	  //send data to analytics for registered users
	      ga('send','event','Registered e-Alert','Article Page Click','jmcmar');
	  }else{
	     //send data to analytics for non-registered users
	      ga('send','event','Get e-Alert','Article Page Click','jmcmar');
	  }
  });
</script>





        
        <div class="pj-badge"></div>




        
        <div class="aJhp_link"></div>
<a href="/action/doUpdateAlertSettings?action=addJournal&amp;journalCode=jmcmar" class="button_primary_2"><i class="icon-send"></i><span>Get e-Alerts</span></a></div></div></div></div></div></div></div><div class="article_abstract"><div class="container container_scaled-down"><div class="row"><div class="col-xs-12"><h2 class="article_abstract-title" id="Abstract">Abstract</h2><div class="article_abstract-content hlFld-Abstract" id="abstractBox"><figure id="f_tgr1" data-index="0" class="article__inlineFigure article_abstract-img"><img class="inline-fig internalNav" src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2011/jmcmar.2011.54.issue-21/jm200939b/production/images/medium/jm-2011-00939b_0017.gif" alt="" id="tgr1" /></img><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2011/jmcmar.2011.54.issue-21/jm200939b/production/images/large/jm-2011-00939b_0017.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm200939b&amp;id=f_tgr1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><p class="articleBody_abstractText">The discovery of two histamine H<sub>3</sub> antagonist clinical candidates is disclosed. The pathway to identification of the two clinical candidates, <b>6</b> (PF-036547<u class="uu">46)</u> and <b>7</b> (PF-036547<u class="uu">64)</u> required five hypothesis driven design cycles. The key to success in identifying these clinical candidates was the development of a compound design strategy that leveraged medicinal chemistry knowledge and traditional assays in conjunction with computational and in vitro safety tools. Overall, clinical compounds <b>6</b> and <b>7</b> exceeded conservative safety margins and possessed optimal pharmacological and pharmacokinetic profiles, thus achieving our initial goal of identifying compounds with fully aligned oral drug attributes, “best-in-class” molecules.</p></div></div></div></div></div><div class="article_content"><ul class="tab-nav-shortcut"><li><i class="icon-image"></i></li><li><i class="icon-link"></i></li><li><i class="icon-supporting-info"></i></li></ul><div class="container container_scaled-down"><div class="row"><div class="col-xs-12"><div class="article_content-table hlFld-FullText"><div class="article_content-row"><div class="article_content-left"><div class="extra-info-sec articleNote"><h4><span>†</span> Author Contributions</h4><p class="last">T.T.W., B.A.P., and A.W.S. contributed to the writing of this manuscript.</p></div><div id="sec1" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i2">Introduction</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_84261" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_84261" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">Histamine receptors have been attractive and druggable targets for decades.<a onclick="showRef(event, 'ref1 ref2'); return false;" href="javascript:void(0);" class="ref ref1 ref2">(1, 2)</a> Histamine H<sub>1</sub> receptor antagonists, such as diphenhydramine and those that have limited central nervous system (CNS) exposure such as cetirizine and fexofenadine, are successful allergy medications. Histamine H<sub>2</sub> receptor antagonists such as ranitidine and famotidine have proved to be efficacious gastric ulcer treatments. While the histamine H<sub>3</sub> and H<sub>4</sub> receptors are also considered attractive and druggable targets, no marketed agents currently exist for these receptors. Preclinical activity is high, and early clinical candidates have been disclosed targeting histamine H<sub>3</sub> receptors.<a onclick="showRef(event, 'ref3 ref4'); return false;" href="javascript:void(0);" class="ref ref3 ref4">(3, 4)</a> Herein we describe the discovery of selective histamine H<sub>3</sub> receptor antagonists.</div><div class="NLM_p">Histamine has high affinity for H<sub>3</sub> receptors. The highest density of H<sub>3</sub> receptors is in the brain, primarily in prefrontal regions, where histamine seems to play a key role in a variety of centrally mediated functions including attention and learning/memory, as well as arousal and wakefulness.<a onclick="showRef(event, 'ref5 ref6'); return false;" href="javascript:void(0);" class="ref ref5 ref6">(5, 6)</a> Histamine levels oscillate over a 24 h period, with concentrations highest during the day and lowest at night. Furthermore, CNS-penetrant H<sub>1</sub> receptor antagonists induce marked sedation<a onclick="showRef(event, 'ref7'); return false;" href="javascript:void(0);" class="ref ref7">(7)</a> and impairment of cognitive performance, suggesting that histamine (HA) is involved in maintaining wakefulness and may promote enhanced attention and/or vigilance during the waking state. Some histamine H<sub>3</sub> receptors are inhibitory autoreceptors that regulate the synthesis and release of histamine (Figure <a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">1</a>A).<a onclick="showRef(event, 'ref8'); return false;" href="javascript:void(0);" class="ref ref8">(8)</a> Other H<sub>3</sub> receptors are heteroreceptors that regulate the release of neurotransmitters including dopamine (DA) and norepinephrine (NE), such that an H<sub>3</sub> receptor antagonist should increase levels of these other neurotransmitters in the synapse (Figure <a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">1</a>B).<a onclick="showRef(event, 'ref6 ref9'); return false;" href="javascript:void(0);" class="ref ref6 ref9">(6, 9)</a> However, not all H<sub>3</sub> receptor antagonists have the same effects on neurotransmitter release; for example, some H<sub>3</sub> antagonists increase DA and NE levels while others do not.<a onclick="showRef(event, 'ref10'); return false;" href="javascript:void(0);" class="ref ref10">(10)</a> In addition, H<sub>3</sub> receptors can regulate the release of acetylcholine (ACh), a neurotransmitter involved in cognition.<a onclick="showRef(event, 'ref9'); return false;" href="javascript:void(0);" class="ref ref9">(9)</a></div><div class="NLM_p">Collectively, the knowledge around histamine and H<sub>3</sub> receptors suggests that antagonism of the H<sub>3</sub> receptor is a potential therapeutic target for treatment of attention deficit hyperactivity disorder (ADHD), narcolepsy, Alzheimer’s disease (AD), and possibly other cognitive disorders. The cardinal symptoms of ADHD include impulsive behavior, hyperactivity, and inattention. Typically, the hyperactivity component seen in school-age children does not continue into adulthood, whereas the attention and impulsivity symptoms do persist. The psychostimulant methylphenidate, as well as other agents that successfully treat ADHD symptoms, elevates extracellular levels of dopamine and norepinephrine in the CNS. Recent microdialysis studies in rats show that methylphenidate also increases levels of histamine and acetylcholine.<a onclick="showRef(event, 'ref11 ref12'); return false;" href="javascript:void(0);" class="ref ref11 ref12">(11, 12)</a> Although psychostimulants are highly effective agents for treatment of patients with ADHD, there are several drawbacks: these agents produce decreased appetite, insomnia, upset stomach, and headache and additionally have abuse potential, leading to their classification as scheduled drugs. Atomoxetine, a norepinephrine reuptake inhibitor that is also approved to treat ADHD, acts by increasing extracellular levels of NE and DA, as well as HA and ACh, in prefrontal areas of the brain.<a onclick="showRef(event, 'ref11 ref12'); return false;" href="javascript:void(0);" class="ref ref11 ref12">(11, 12)</a> Although atomoxetine is not a scheduled agent, some safety liabilities have been reported and it bears a black box warning regarding liver toxicity.<a onclick="showRef(event, 'ref13 ref14'); return false;" href="javascript:void(0);" class="ref ref13 ref14">(13, 14)</a> Clearly, an unmet medical need exists in this area.</div><div class="NLM_p">Herein we describe the discovery of selective histamine H<sub>3</sub> receptor antagonists to treat CNS disorders. Our goal was to identify H<sub>3</sub> receptor antagonists that elevate HA and ACh levels in rat prefrontal cortex in vivo, possess a predicted pharmacokinetic (PK) profile consistent with q.d. or b.i.d. dosing in humans, and demonstrate a safety profile beyond standard margins in preclinical safety studies, as we were interested in considering a pediatric indication for ADHD. The work described here focuses less on in vitro potency, structure–activity relationships (SARs), and in vivo potency (typical medicinal chemistry benchmarks) and more on development of the strategy we used to identify safe and druglike molecules at the design stage, early in the drug discovery process.</div><figure id="fig1" data-index="1" class="article__inlineFigure"><h2 class="fig-label">Figure 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2011/jmcmar.2011.54.issue-21/jm200939b/production/images/medium/jm-2011-00939b_0001.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2011/jmcmar.2011.54.issue-21/jm200939b/production/images/large/jm-2011-00939b_0001.jpeg" id="gr1" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 1. (A) Histaminergic neuron. H<sub>3</sub> autoreceptor, endogenous histamine (HA), acts at presynaptic H<sub>3</sub> autoreceptors to reduce HA synthesis and release (a negative feedback loop). (B) Nonhistaminergic neuron. Blockade of the H<sub>3</sub> heteroreceptors should modulate the release of other neurotransmitters.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2011/jmcmar.2011.54.issue-21/jm200939b/production/images/large/jm-2011-00939b_0001.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm200939b&amp;id=fig1"><span>Download MS PowerPoint Slide</span></a></div></div></figure></div><div id="sec2" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i3">Results and Discussion</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_80216" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_80216" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div id="sec2_1" class="NLM_sec NLM_sec_level_2"><div id="ac_i4" class="anchor-spacer"></div><h3 class="article-section__title" id="_i4"> Initial HTS Screen and Analysis of Hits</h3><div class="NLM_p">The original H<sub>3</sub> hit <b>1</b> (Figure <a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">2</a>) was identified from a high-throughput binding screen and exhibited high affinity for human H<sub>3</sub> receptors (<i>K</i><sub>i</sub> = 1.3 nM). Structurally related hits (data not shown) were selective versus other biogenic amine receptors and had weak hERG inhibition as measured using a whole-cell voltage clamp technique (IC<sub>50</sub> > 5600 nM).<a onclick="showRef(event, 'ref15'); return false;" href="javascript:void(0);" class="ref ref15">(15)</a> By use of a high-throughput in vitro human liver microsome (HLM) assay and an in silico model of estimated microsomal free fraction (cf<sub>u,mic</sub>), the unbound microsomal intrinsic clearance (CL<sub>int,u</sub>) for <b>1</b> was determined to be unacceptably high (CL<sub>int,u</sub> = 219 mL min<sup>–1</sup> kg<sup>–1</sup>).<a onclick="showRef(event, 'ref16 ref17'); return false;" href="javascript:void(0);" class="ref ref16 ref17">(16, 17)</a> In addition to this rapid clearance, two other significant issues with <b>1</b> needed to be addressed. First, the compound had been reported as a curarizing (muscle-relaxant) agent,<a onclick="showRef(event, 'ref18'); return false;" href="javascript:void(0);" class="ref ref18">(18)</a> and second, the planar nature of the biphenyl motif could pose genetic safety issues. We were concerned with the potential long-term safety risks inherent in a linear rigid chemotype that could ultimately result in costly late-stage safety attrition (phase 3 or postmarketing).</div><div class="NLM_p">Exposure to polycyclic aromatic hydrocarbon compounds has been shown to increase genotoxic risk,<a onclick="showRef(event, 'ref19'); return false;" href="javascript:void(0);" class="ref ref19">(19)</a> and a crystal structure of nogalamycin in DNA revealed that bulky dumbbell-shaped molecules can intercalate between DNA base pairs.<a onclick="showRef(event, 'ref20'); return false;" href="javascript:void(0);" class="ref ref20">(20)</a> Further, dicationic amidine compounds have been reported to bind in the DNA minor groove.<a onclick="showRef(event, 'ref21'); return false;" href="javascript:void(0);" class="ref ref21">(21)</a> Thus, our primary concern was that the biaryldiamine template could act as a DNA-binding agent scaffold, producing genetic damage and increasing patients’ cancer risk. The initial in vitro micronucleus (IVMN) screening result was negative for <b>1</b>, but we remained apprehensive about idiosyncratic toxicity for this general chemotype. Further supporting our safety concerns, Hancock et al. reported positive findings in an IVMN assay for several biaryl H<sub>3</sub> receptor antagonists.<a onclick="showRef(event, 'ref22'); return false;" href="javascript:void(0);" class="ref ref22">(22)</a> To reduce the potential liability of the biaryl template, we searched for an aryl isostere that could mimic the distance between the two basic groups. We hypothesized that a cyclobutyl moiety might act as such an aryl ring isostere (Figure <a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">3</a>A). Molecular modeling supported this hypothesis: minimized structures of biaryl and arylcyclobutyl cores exhibited good overlap of the basic groups (Figure <a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">3</a>A).</div><figure id="fig2" data-index="2" class="article__inlineFigure"><h2 class="fig-label">Figure 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2011/jmcmar.2011.54.issue-21/jm200939b/production/images/medium/jm-2011-00939b_0002.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2011/jmcmar.2011.54.issue-21/jm200939b/production/images/large/jm-2011-00939b_0002.jpeg" id="gr2" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 2. H<sub>3</sub> receptor antagonist <b>1</b> emerged from a high-throughput screen (HTS). Subsequent to our identification of HTS hit <b>1</b>, it was reported in the literature by Morini et al.<a onclick="showRef(event, 'ref23'); return false;" href="javascript:void(0);" class="ref ref23">(23)</a></p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2011/jmcmar.2011.54.issue-21/jm200939b/production/images/large/jm-2011-00939b_0002.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm200939b&amp;id=fig2"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure id="fig3" data-index="3" class="article__inlineFigure"><h2 class="fig-label">Figure 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2011/jmcmar.2011.54.issue-21/jm200939b/production/images/medium/jm-2011-00939b_0003.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2011/jmcmar.2011.54.issue-21/jm200939b/production/images/large/jm-2011-00939b_0003.jpeg" id="gr3" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 3. (A) Isostere analysis of biaryl moiety vs cyclobutylaryl, where the black oval denotes motifs to be compared (isostere): molecular modeling and overlap of biaryl (gray) and cyclobutylaryl (green) compounds. The two nitrogen atoms maintain an approximately equal distance from each other in both molecules. (B) Same molecular overlap matched to surface of DNA structure (in blue, PDB code <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=302D">302D</a>). As designed, the cyclobutyl ring (green) is not a matched fit in the minor groove of DNA because of the bulkier cyclobutyl ring relative to the biaryl motif (gray).</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2011/jmcmar.2011.54.issue-21/jm200939b/production/images/large/jm-2011-00939b_0003.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm200939b&amp;id=fig3"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p last">In addition, we hypothesized that because of the three-dimensional shape (3D-volume) of the cyclobutyl-containing moiety, this moiety would be less likely to bind in the minor groove. Using the X-ray crystal structure of a known minor groove-binding drug (HOECHST 33258) bound to DNA as a template,<a onclick="showRef(event, 'ref24'); return false;" href="javascript:void(0);" class="ref ref24">(24)</a> we examined the overlay matched to the surface volume of DNA (Figure <a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">3</a>B). While the biaryl motif matches well, the cyclobutyl rotates in a manner that gives a far worse fit. Although the quality of fit was not quantified, we felt the synthetic chemistry investment was worth the risk to test these hypotheses. If one aryl group could be replaced with a cyclobutyl isostere, we could potentially accomplish two goals: (1) building a novel core and (2) increasing our odds of avoiding genetic toxicity.</div></div><div id="sec2_2" class="NLM_sec NLM_sec_level_2"><div id="ac_i5" class="anchor-spacer"></div><h3 class="article-section__title" id="_i5"> Design of the Initial Lead Compound (<b>2</b>)</h3><div class="NLM_p">To test whether replacing the biaryl moiety of the HTS hit <b>1</b> could be accomplished, an extensive set of dibasic cyclobutyl analogues was synthesized (see section <a class="ref internalNav" href="#sec4" aria-label="Chemistry">Chemistry</a> for synthesis). This synthetic effort yielded numerous compounds that maintained the potency attribute of the HTS hit <b>1</b>. Of the 286 dibasic cyclobutyl analogues synthesized, one compound (<b>2</b>) possessed the profile we sought for a potential drug candidate (Table <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">1</a>). Compound <b>2</b> had a high affinity for both the human and rat H<sub>3</sub> receptors (<i>K</i><sub>i</sub> of 2.2 and 7.7 nM, respectively) and demonstrated antagonist activity in adenylate cyclase assays in both human and rat cell lines expressing H<sub>3</sub>, with <i>K</i><sub>i</sub> of 0.89 and 3.5 nM, respectively. To assess selectivity, <b>2</b> was screened in a broad pharmacological panel, both in-house and externally (CEREP), and exhibited greater than 100-fold selectivity versus other biogenic amine receptors, enzymes, and transporters (see <a class="ref internalNav" href="#notes-1" aria-label="Supporting Information">Supporting Information</a>). In addition, <b>2</b> had a good early safety profile, as characterized by a lack of projected drug–drug interactions (DDI),<a onclick="showRef(event, 'ref25'); return false;" href="javascript:void(0);" class="ref ref25">(25)</a> extremely weak hERG inhibition (hERG IC<sub>50</sub> = 300 μM),<a onclick="showRef(event, 'ref15'); return false;" href="javascript:void(0);" class="ref ref15">(15)</a> and negative results in the BiolumAMES,<a onclick="showRef(event, 'ref26'); return false;" href="javascript:void(0);" class="ref ref26">(26)</a> in vitro micronucleus (IVMN), and human lymphocyte (HLA) assays.<a onclick="showRef(event, 'ref27'); return false;" href="javascript:void(0);" class="ref ref27">(27)</a> Finally, the pharmacokinetic profile of <b>2</b> was excellent, with low HLM clearance in vitro (CL<sub>int,u</sub>),<a onclick="showRef(event, 'ref16'); return false;" href="javascript:void(0);" class="ref ref16">(16)</a> high MDCK (Madin–Darby canine kidney) passive apparent permeability,<a onclick="showRef(event, 'ref28'); return false;" href="javascript:void(0);" class="ref ref28">(28)</a> and a low P-gp efflux ratio (ER) (see Table <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">1</a>).<a onclick="showRef(event, 'ref28'); return false;" href="javascript:void(0);" class="ref ref28">(28)</a> Thus, our goal of replacing one aryl ring with a cyclobutyl moiety while maintaining affinity for the H<sub>3</sub> receptor and minimizing the potential genetic toxicity was realized through the discovery of <b>2</b>.</div><div class="NLM_p">The central nervous system effect of <b>2</b> was demonstrated using the <i>R</i>-α-methylhistamine (RAMH) induced dipsogenia model.<a onclick="showRef(event, 'ref29 ref30'); return false;" href="javascript:void(0);" class="ref ref29 ref30">(29, 30)</a> Compound <b>2</b> dose-dependently blocked RAMH-induced water drinking in rats with a subcutaneous ID<sub>50</sub> of 0.78 mg/kg (<i>N</i> = 1 experiment). The free drug levels were calculated using plasma protein binding (<i>f</i><sub>u,p</sub>) measurements from a separate in vitro assay and determined to be 23.0 nM, approximately 3-fold higher than the <i>K</i><sub>i</sub> (rat H<sub>3</sub> binding <i>K</i><sub>i</sub> = 7.7 nM). This result (3-fold the rat H<sub>3</sub> binding <i>K</i><sub>i</sub>) is consistent with antagonist pharmacology requiring >75% receptor occupancy for efficacy.<a onclick="showRef(event, 'ref31'); return false;" href="javascript:void(0);" class="ref ref31">(31)</a> To allow comparisons between the safety profiles of lead compounds, this benchmark (3-fold <i>K</i><sub>i</sub>) is used throughout this manuscript as the projected clinically efficacious concentration (PCEC). One assumption made in this comparison was that all compounds freely cross the blood–brain barrier such that the ratio unbound brain (<i>C</i><sub>b,u</sub>)/unbound plasma (<i>C</i><sub>p,u</sub>) is equal to 1.</div><div class="NLM_table-wrap" id="tbl1"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 1. Selected Physicochemical Properties, in Vitro Characteristics, and Safety and ADME Data for <b>2</b></div></div></div><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2011/jmcmar.2011.54.issue-21/jm200939b/production/images/medium/jm-2011-00939b_0004.gif" alt="" id="fx6" /></img><div class="scrollable-table-wrap"><table class="table" border="0"><colgroup><col align="left" /></col><col align="left" /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center">parameter<a class="ref internalNav" href="#t1fn1" aria-label="a">a</a></th><th class="colsep0 rowsep0" align="center">value</th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">ClogP</td><td class="colsep0 rowsep0" align="left">3.6</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">ClogD<sub>7.4</sub></td><td class="colsep0 rowsep0" align="left">–0.2</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">MW</td><td class="colsep0 rowsep0" align="left">314</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">TPSA</td><td class="colsep0 rowsep0" align="left">15.7</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">p<i>K</i><sub>a</sub></td><td class="colsep0 rowsep0" align="left">9.8 and 7.7</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">H<sub>3</sub><i>K</i><sub>i</sub> functional antagonist (human)<a class="ref internalNav" href="#t1fn2" aria-label="b">b</a> (nM)</td><td class="colsep0 rowsep0" align="left">0.89</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">hERG IC<sub>50</sub> <a class="ref internalNav" href="#t1fn3" aria-label="c">c</a> (μM)</td><td class="colsep0 rowsep0" align="left">300</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">IVMN<a class="ref internalNav" href="#t1fn4" aria-label="d">d</a></td><td class="colsep0 rowsep0" align="left">negative</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">CL<sub>int,u</sub> <a class="ref internalNav" href="#t1fn5" aria-label="e">e</a>(mL min<sup>–1</sup> kg<sup>–1</sup>)</td><td class="colsep0 rowsep0" align="left"><10</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">MDCK AB<a class="ref internalNav" href="#t1fn6" aria-label="f">f</a>(cm/s)</td><td class="colsep0 rowsep0" align="left">>10 × 10<sup>–6</sup></td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">P-gp ER<a class="ref internalNav" href="#t1fn7" aria-label="g">g</a></td><td class="colsep0 rowsep0" align="left"><1</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">rat <i>f</i><sub>u,p</sub></td><td class="colsep0 rowsep0" align="left">0.72</td></tr></tbody></table></div><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t1fn1"><div class="footnote" id="t1fn1"><sup>a</sup><p class="last">Calculated physicochemical properties were obtained using standard commercial packages: Biobyte for ClogP calculations, ACD/Labs for ClogD at pH 7.4 and the most basic p<i>K</i><sub>a</sub>.</p></div><div class="footnote" id="t1fn2"><sup>b</sup><p class="last">Human functional assay measuring cAMP utilizing a reporter gene assay (β-lactamase) in HEK293 cells stably expressing human H<sub>3</sub> receptor. <i>K</i><sub>i</sub> is the geometric mean of five independent experiments.</p></div><div class="footnote" id="t1fn3"><sup>c</sup><p class="last">Blockade of the hERG potassium channel in HEK293 cells.<a onclick="showRef(event, 'ref15'); return false;" href="javascript:void(0);" class="ref ref15">(15)</a></p></div><div class="footnote" id="t1fn4"><sup>d</sup><p class="last">In vitro micronucleus assay.</p></div><div class="footnote" id="t1fn5"><sup>e</sup><p class="last">Human liver microsome unbound intrinsic clearance.</p></div><div class="footnote" id="t1fn6"><sup>f</sup><p class="last">MS-based quantification of apical → basolateral transfer rate of a test compound at 2 μM across contiguous monolayers of MDCK cells.</p></div><div class="footnote" id="t1fn7"><sup>g</sup><p class="last">Ratio of (basal → apical) to (apical → basal) transfer rate of a test compound at 2 μM across contiguous monolayers of MDR1-transfected MDCK cells.</p></div></div></div></div><div id="sec2_3" class="NLM_sec NLM_sec_level_2"><div id="ac_i7" class="anchor-spacer"></div><h3 class="article-section__title" id="_i7"> Phospholipidosis</h3><div class="NLM_p">Compound <b>2</b> met or exceeded our initial in vitro and in vivo efficacy criteria and was advanced into a 4-day oral dose study in rats (3/sex per dose) to assess safety. Several doses were tested in that study (5, 50, and 400 mg/kg). At 5 mg/kg (mean AUC of 1245 ± 659 ng·h/mL) there were no findings. At ≥50 mg/kg, phospholipidosis (kidney and lung) was seen (mean AUC of 17375 ± 6983 ng·h/mL), while mortality was observed at 400 mg/kg (mean <i>C</i><sub>max</sub> of 3918 ± 1280 ng/mL). Phospholipidosis was confirmed in the lung and kidney by electron microscopic examination, which revealed multilamellated membranous lysosomal inclusions commonly referred to as multilamellar bodies or MLBs (Figure <a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">4</a>A). These whorls are the hallmark of phospholipidosis (PL), a storage disorder resulting in excessive accumulation of phospholipids in lysosomes of the tissues. The risk associated with compound-induced PL was considered manageable provided that an acceptable therapeutic index (TI) existed and that the effect was reversible.<a onclick="showRef(event, 'ref32'); return false;" href="javascript:void(0);" class="ref ref32">(32)</a> On the basis of these findings, we embarked on an in vivo derisking strategy requiring longer exploratory toxicology studies (14 days in rat) that included an arm for reversibility of the PL finding (14-day washout period), as well as a toxicology study in a second species (dog). The next step with <b>2</b> was to conduct a 14-day study in rats (7 males/dose) to determine if the threshold for phospholipidosis decreased with increased duration of treatment (14 days versus 4 days). This 14-day study (5–30 mg/kg) indicated that the threshold for phospholipidosis did not decrease with longer treatment. In fact, no PL was observed at the highest tested dose (30 mg/kg) tested. The safety margin for phospholipidosis was large in rat, ≥588-fold PCEC (Table <a class="ref showTableEvent internalNav" data-ID="tbl11" href="#tbl11">11</a>, <a class="ref internalNav" href="#sec5" aria-label="Materials and Methods">Materials and Methods</a>). Although the safety profile from these rat studies was favorable, a concurrent 7-day study in dogs (3 dogs at 10 and 25 mg/kg) identified a new finding at all tested doses: cardiomyocyte vacuoles (CMV) were observed in heart tissue at low multiples of the PCEC (<17-fold, Table <a class="ref showTableEvent internalNav" data-ID="tbl11" href="#tbl11">11</a>). The CMV were specifically located in the cardiac papillary muscle and characterized as drug storage vacuoles (Figure <a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">4</a>B). This safety finding (CMV) was not manageable, as it had a low TI and no biomarker to guide clinical safety. The CMV safety findings observed in dogs precluded <b>2</b> from moving into regulatory toxicity studies.</div><figure id="fig4" data-index="4" class="article__inlineFigure"><h2 class="fig-label">Figure 4</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2011/jmcmar.2011.54.issue-21/jm200939b/production/images/medium/jm-2011-00939b_0005.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2011/jmcmar.2011.54.issue-21/jm200939b/production/images/large/jm-2011-00939b_0005.jpeg" id="gr4" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 4. (A) Electron microscopy image of rat lung, phospholipidosis “foamy macrophage” induced by <b>2</b> in drug-treated group at 400 mg/kg: multilamellated bodies (∗); <i>N</i> = nucleus; TEM 10000× magnification. (B) Electron microscopy image of drug storage. Cytoarchitecture of dog heart includes the presence of multiple cardiomyocyte vacuoles (CMV, ∗) induced by <b>2</b> within the cytoplasm of cardiomyocytes: ID = intercalated disk of cardiac muscle; G = glycogen; TEM 1000× magnification.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2011/jmcmar.2011.54.issue-21/jm200939b/production/images/large/jm-2011-00939b_0005.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm200939b&amp;id=fig4"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">In summary, while the initial design objective was achieved, two unexpected findings arose for the dibasic chemotype, both centered on safety (PL and CMV). Given the fact that our most advanced chemical matter attrited in later-stage safety studies, the discovery effort cycled back to the compound design stage and our initial strategy was re-evaluated. We asked ourselves the following question: “Was de-risking PL the ideal approach?” Our conclusion was “no”, that a better strategy, if possible, would be to design molecules that did not induce PL. We therefore set a conservative safety standard for compound progression: a compound would not advance if it caused PL in vivo at otherwise tolerated doses. It was hypothesized that moving to a more favorable physicochemical property space could avoid this safety finding.<a onclick="showRef(event, 'ref33 ref34'); return false;" href="javascript:void(0);" class="ref ref33 ref34">(33, 34)</a> To increase our odds of success, in addition to physicochemical property optimization, we also needed to develop a way to rank compounds according to their PL risk. Ideally, one would be able to evaluate PL at the design stage and then re-evaluate after synthesis. Rather than focusing on a single property, in silico model, or in vitro end point, we employed a multipronged design strategy (Figure <a data-tab="pane-pcw-Figures" href="#fig5" id="" class=" internalNav">5</a>). As part of this approach, we needed to prospectively incorporate medicinal chemistry knowledge around central nervous system (CNS) drugs into our design.<a onclick="showRef(event, 'ref34 ref35 ref36 ref37 ref38 ref39 ref40'); return false;" href="javascript:void(0);" class="ref ref34 ref35 ref36 ref37 ref38 ref39 ref40">(34-40)</a> First, at the design stage we worked toward optimizing physicochemical properties by lowering (a) lipophilicity, as assessed by calculated partition coefficient (ClogP), (b) distribution coefficient at pH 7.4 (ClogD), (c) molecular weight (MW), and (d) calculated p<i>K</i><sub>a</sub> of the most basic center. Simultaneously, we focused on developing and validating both an in silico PL model and an in vitro PL assay. Although we generated an in-house statistical PL model (not discussed herein), we chose to use the intuitive PL model described by Ploemen.<a onclick="showRef(event, 'ref41'); return false;" href="javascript:void(0);" class="ref ref41">(41)</a> Ploemen et al. reported that if the sum of the squares of the p<i>K</i><sub>a</sub> and ClogP values for a compound is greater than or equal to 90, then the compound is at higher risk of causing PL in vivo. Given the fact that H<sub>3</sub> is a biogenic amine receptor and our current hits possessed a basic amine, it was clear that lowering the p<i>K</i><sub>a</sub> was potentially the most direct way to bring the calculated value into a more desirable range. Indeed, the p<i>K</i><sub>a</sub> contribution value in Ploemen’s PL model accounted for the largest part of the sum of the squares (p<i>K</i><sub>a</sub> = 9.8, 9.8<sup>2</sup> = 96). A second factor we considered was that a dibasic compound may doubly impact the PL finding, which is not accounted for in Ploemen’s PL model. Thus, in addition to the in silico PL model, we examined an in vitro PL cell-based assay to serve as a surrogate for in vivo study and thus improve our odds of identifying a safe molecule. Generation of the in vitro PL values was accomplished using a method similar to that recently reported by Morelli et al.<a onclick="showRef(event, 'ref42'); return false;" href="javascript:void(0);" class="ref ref42">(42)</a> For the work describe herein, phospholipid accumulation was assessed in a transformed human liver epithelial (THLE) cell line and reported as a minimum effect dose (MED) value in μM, where lower MED values (see <a class="ref internalNav" href="#sec5" aria-label="Materials and Methods">Materials and Methods</a> for details) predict a greater risk of PL in vivo.</div><figure id="fig5" data-index="5" class="article__inlineFigure"><h2 class="fig-label">Figure 5</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2011/jmcmar.2011.54.issue-21/jm200939b/production/images/medium/jm-2011-00939b_0006.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2011/jmcmar.2011.54.issue-21/jm200939b/production/images/large/jm-2011-00939b_0006.jpeg" id="gr5" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 5. Development of a design strategy to remove safety liabilities. The two-pronged strategy uses prospective design (focusing on optimal physical properties) and the development and validation of an in vitro screening assay to identify PL liability at an early stage.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2011/jmcmar.2011.54.issue-21/jm200939b/production/images/large/jm-2011-00939b_0006.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm200939b&amp;id=fig5"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">In addition, we needed to understand the cause of CMV or, at a minimum, develop a strategy that would remove this safety liability. Parallel SAR efforts (data not discussed herein) allowed us to conclude that the CMV safety finding was not a direct result of antagonizing the H<sub>3</sub> receptor, as the evaluation of alternative chemotypes did not show this toxicity. Hjelle et al. reported that disobutamide was a potent inducer of clear cytoplasmic vacuoles in various tissues (Table <a class="ref showTableEvent internalNav" data-ID="tbl2" href="#tbl2">2</a>).<a onclick="showRef(event, 'ref43'); return false;" href="javascript:void(0);" class="ref ref43">(43)</a> The authors described disobutamide as a molecule that possessed a dibasic motif and they associated this structural feature with the observed toxicity. The clear cytoplasmic vacuoles described by Hjelle et al. seemed similar to those we observed, except that we observed them only in the cardiac papillary muscle. Their solution to the clear cytoplasmic vacuole problem was to remove or mask one of the basic amines (Table <a class="ref showTableEvent internalNav" data-ID="tbl2" href="#tbl2">2</a>). All this information suggested to us that elimination of the CMV safety finding might be accomplished by simply removing one basic center. It was crucial, of course, to demonstrate that potency, safety attributes, and the desired absorption, distribution, metabolism, and excretion (ADME) profiles could be retained in a monobasic molecule.</div><div class="NLM_table-wrap" id="tbl2"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 2. Safety Studies of Two Literature Compounds: Disobutamide and Bidisomide<a onclick="showRef(event, 'ref43 ref44'); return false;" href="javascript:void(0);" class="ref ref43 ref44">(43, 44)</a></div></div></div><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2011/jmcmar.2011.54.issue-21/jm200939b/production/images/medium/jm-2011-00939b_0007.gif" alt="" id="fx1" /></img><div></div></div></div><div id="sec2_4" class="NLM_sec NLM_sec_level_2"><div id="ac_i9" class="anchor-spacer"></div><h3 class="article-section__title" id="_i9"> Optimized Lead Compound <b>3</b></h3><div class="NLM_p">The overall compound design objective seemed simple enough: find a safe and well-tolerated H<sub>3</sub> receptor antagonist that would test the H<sub>3</sub> hypotheses in the clinic. For the next design cycle we employed the new design strategy highlighted above (Figure <a data-tab="pane-pcw-Figures" href="#fig5" id="" class=" internalNav">5</a>). The physicochemical properties of <b>2</b> that we considered optimal were its low MW (314 Da), moderate ClogP, low ClogD, and moderate to high basicity (p<i>K</i><sub>a</sub> of basic centers of 7.2 and 9.8). At the time of our initial work we tracked topological polar surface area (TPSA)<a onclick="showRef(event, 'ref45'); return false;" href="javascript:void(0);" class="ref ref45">(45)</a> and ClogP as a surrogate for volume of distribution (tissue distribution), which is thought to be a major factor contributing to in vivo PL.<a onclick="showRef(event, 'ref46'); return false;" href="javascript:void(0);" class="ref ref46">(46)</a> On the basis of a recent analysis by Hughes et al., this combination may have even more general utility as an early in vivo safety odds predictor.<a onclick="showRef(event, 'ref33'); return false;" href="javascript:void(0);" class="ref ref33">(33)</a> Topological polar surface area for <b>2</b> was undesirable (15 Å<sup>2</sup>) based on the cutoff (>75 Å<sup>2</sup>) provided by Hughes et al.<a onclick="showRef(event, 'ref33'); return false;" href="javascript:void(0);" class="ref ref33">(33)</a> These authors concluded that compounds possessed a greater safety risk when dual conditions ClogP > 3 and TPSA < 75 Å<sup>2</sup> were satisfied (odds of seeing an adverse event at a total plasma level of 10 μM test compound).<a onclick="showRef(event, 'ref33'); return false;" href="javascript:void(0);" class="ref ref33">(33)</a> We used <b>2</b> as a baseline for comparison and to benchmark progress for all later compounds. (Baseline values for <b>2</b> were the following: PL in silico value of 109 (19 higher than the target value 90) and in vitro PL MED = 37.5 μM, target value of ≥100 μM.) Employing this new design strategy, we set out to identify a compound with improved attributes.</div><div class="NLM_p">The next compound that we identified with a suitable profile was <b>3</b> (Table <a class="ref showTableEvent internalNav" data-ID="tbl3" href="#tbl3">3</a>). Monobasic compound <b>3</b> met all of our pharmacology and ADME criteria (Tables <a class="ref showTableEvent internalNav" data-ID="tbl7" href="#tbl7">7</a>–<a class="ref showTableEvent internalNav" data-ID="tbl10" href="#tbl10">10</a>) and most of our early safety targets. The physicochemical properties of <b>3</b> were similar to those of <b>2</b>, with the most notable improvement being removal of one of the basic amines. The in silico PL value increased to a less desirable value (112), driven by higher lipophilicity relative to <b>2</b> (ClogP of 3.6 → 4.0), but the in vitro PL value shifted upward toward a more favorable value (MED = 119 μM), meeting our target in this regard. Compound <b>3</b> was synthesized on scale (see <a class="ref internalNav" href="#sec4" aria-label="Chemistry">Chemistry</a>) and tested in a 14-day rat safety study (3/sex per dose). Given the potential risk of seeing PL in vivo, we elected to run three doses in this safety study (5, 50, 350 mg/kg).  Phospholipidosis was observed in multiple tissues (lung and liver) at ≥50 mg/kg (mean AUC 21,333 ± 7,146 ng·h/mL, day 1). As stated earlier, our compound selection criteria precluded compounds that exhibited PL in vivo, so this compound’s development was terminated (TI ≥ 7 PCEC; see Table <a class="ref showTableEvent internalNav" data-ID="tbl11" href="#tbl11">11</a>). The in silico PL model value (112 versus target 90) suggested an enhanced risk of PL in vivo, and this prediction was consistent with the 14-day safety study findings wherein PL was observed. We therefore placed more weight on this design parameter in subsequent work. On the other hand, the in vitro PL assay results had suggested a reduced risk of in vivo PL for <b>3</b> versus <b>2</b>, which was not observed. At this time we did not abandon the PL assay because we believed that there would still be benefit in rank-ordering compounds via an in vitro assay. Having established that a monobasic compound could provide a candidate profile, the next generation compound was also designed to be monobasic.<a onclick="showRef(event, 'ref43'); return false;" href="javascript:void(0);" class="ref ref43">(43)</a> Further, the use of both the in silico PL model and the in vitro PL assay was retained within the design strategy to better guide compound selection, and we anticipated allowing some flexibility in application of the PL models based on holistic assessment of scores. We felt that using hard cutoff values would restrict design space and perhaps cause undue hardship in the identification of a potent and safe H<sub>3</sub> receptor antagonist.</div><div class="NLM_table-wrap" id="tbl3"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 3. Monobasic Cyclobutylaryl H<sub>3</sub> Receptor Antagonist <b>3</b></div></div></div><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2011/jmcmar.2011.54.issue-21/jm200939b/production/images/medium/jm-2011-00939b_0008.gif" alt="" id="fx2" /></img><div class="scrollable-table-wrap"><table class="table" border="0"><colgroup><col align="left" /></col><col align="left" /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center">parameter<a class="ref internalNav" href="#t3fn1" aria-label="a">a</a></th><th class="colsep0 rowsep0" align="center">value</th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">ClogP</td><td class="colsep0 rowsep0" align="left">4.0</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">ClogD<sub>7.4</sub></td><td class="colsep0 rowsep0" align="left">0.8</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">MW</td><td class="colsep0 rowsep0" align="left">323</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">TPSA</td><td class="colsep0 rowsep0" align="left">38</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">p<i>K</i><sub>a</sub></td><td class="colsep0 rowsep0" align="left">9.8</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" colspan="2" align="center">Early PL Safety Assessment</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">in silico PL</td><td class="colsep0 rowsep0" align="left">112</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">PL MED<a class="ref internalNav" href="#t3fn2" aria-label="b">b</a> (μM)</td><td class="colsep0 rowsep0" align="left">119.5</td></tr></tbody></table></div><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t3fn1"><div class="footnote" id="t3fn1"><sup>a</sup><p class="last">Calculated physicochemical properties were obtained using standard commercial packages: Biobyte for ClogP calculations, ACD/Labs for ClogD at pH 7.4 and the most basic p<i>K</i><sub>a</sub>.</p></div><div class="footnote" id="t3fn2"><sup>b</sup><p class="last">Transformed human liver epithelial cellular phospholipidosis assay measuring phospholipid accumulation per cell. Compounds were classified as positive at the lowest dose for which the induction of phospholipid accumulation was 3-fold over background. MED value is the geometric mean of three independent experiments.</p></div></div></div></div><div id="sec2_5" class="NLM_sec NLM_sec_level_2"><div id="ac_i11" class="anchor-spacer"></div><h3 class="article-section__title" id="_i11"> Next Generation Lead Compound (<b>4</b>)</h3><div class="NLM_p">Earlier work from our laboratories (not described herein) suggested that substantially lowering the p<i>K</i><sub>a</sub> of the remaining basic amine (p<i>K</i><sub>a</sub> decreased from 9.8 to 7.6) resulted in a significant drop in affinity for the H<sub>3</sub> receptor. We therefore set out to identify a compound with only a moderate reduction in basicity (p<i>K</i><sub>a</sub> decreased to ∼9) that retained a high affinity for the H<sub>3</sub> receptor. From this effort, <b>4</b> was identified (see <a class="ref internalNav" href="#sec4" aria-label="Chemistry">Chemistry</a> for synthesis) as the next generation H<sub>3</sub> receptor antagonist (Table <a class="ref showTableEvent internalNav" data-ID="tbl4" href="#tbl4">4</a>). Compound <b>4</b> met our pharmacology and ADME criteria (Tables <a class="ref showTableEvent internalNav" data-ID="tbl7" href="#tbl7">7</a>–<a class="ref showTableEvent internalNav" data-ID="tbl10" href="#tbl10">10</a>) but now with an improved in silico PL value (98) and in vitro PL assay value (MED = 245 μM) relative to <b>2</b> and <b>3</b>. Although compound <b>4</b> did not meet the in silico PL target value of ≤90, the markedly increased in vitro PL value was encouraging. The physicochemical properties of <b>4</b> were desirable, with low MW, reduced ClogP, increased TPSA, and a reduction in the p<i>K</i><sub>a</sub> of the most basic center (Figure <a data-tab="pane-pcw-Figures" href="#fig6" id="" class=" internalNav">6</a>). The half log unit reduction in p<i>K</i><sub>a</sub> (from 9.8 to 9.3) relative to the parent compound (<b>2</b>) was achieved through incorporation of a halogen atom at the 2-position of the phenyl ring. Compound <b>4</b> was evaluated in a 14-day toxicology study in rats (6 males/dose) over a dose range of 10 to 300 mg/kg. All doses were well tolerated, and most importantly no PL was observed (mean AUC of ≤4444 ng·h/mL, day 1) (≥36 PCEC, Table <a class="ref showTableEvent internalNav" data-ID="tbl11" href="#tbl11">11</a>). These findings suggested that the improved design strategy (monobasic, moderate reduction of p<i>K</i><sub>a</sub>) was a viable approach for the identification of a PL-free compound and that the in vitro PL assay provided significant value. Notably, had we driven decisions using a sharp cutoff in the in silico PL value, we would not have made this compound (PL = 98). The successful completion of the 14-day toxicology study in rats justified further investment in compound <b>4</b>. A second species toxicology study, 7-day study in dogs (2/sex), was initiated at 50 mg/kg (mean AUC of 4777 ± 1970 ng·h/mL, day 1). This dose was lowered to 30 mg/kg on day 2 because of convulsions in 2 of 4 dogs following a single dose at 50 mg/kg (<i>C</i><sub>max</sub>of 3200–6200 ng/mL). The dose was maintained at 30 mg/kg for the rest of this study (mean AUC of 2911 ± 626 ng·h/mL, day 7). Given the fact that <b>4</b> was well-tolerated in the 14-day study in rats, we did not anticipate any problems in the 7-day study in dogs. However, testicular degeneration and CMV were observed at low multiples of the projected clinically efficacious concentration (<29 PCEC, Table <a class="ref showTableEvent internalNav" data-ID="tbl11" href="#tbl11">11</a>). The findings in the papillary region of the heart were similar to the CMV observed in dogs with <b>2</b> and precluded further development of this compound. On the basis of previous exploratory toxicology studies of monobasic compounds (data not shown), it was not clear why CMV were observed with this monobasic chemotype. One possible explanation was that hydrolysis of the amide yielded a dibasic metabolite that produced CMV in the 7-day dog safety study. While we had no direct evidence that metabolism of the amide in compound <b>4</b> yielded the free amine, the clinical use of <i>N-</i>acyl prodrugs of amines makes this a reasonable hypothesis.<a onclick="showRef(event, 'ref47'); return false;" href="javascript:void(0);" class="ref ref47">(47)</a> In any case, the identification of a compound without an in vivo PL safety liability was a major advancement. We attributed this success to a design strategy that leveraged our understanding of how physicochemical properties affect in vivo safety and appropriate utilization of in silico PL model values and in vitro PL assay data.</div><figure id="fig6" data-index="6" class="article__inlineFigure"><h2 class="fig-label">Figure 6</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2011/jmcmar.2011.54.issue-21/jm200939b/production/images/medium/jm-2011-00939b_0012.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2011/jmcmar.2011.54.issue-21/jm200939b/production/images/large/jm-2011-00939b_0012.jpeg" id="gr6" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 6. Path to the H<sub>3</sub> receptor antagonist clinical candidates. The red circles represent areas targeted for improvement, and the green circles represent improvements made to that molecule. The in silico phospholipidosis (PL) cutoff of ≤90 and the in vitro PL assay target of ≥100 μM were used to identify compounds with reduced risk of observing PL in vivo. Labels + (finding) and – (no findings) denote risk in in vitro micronucleus (IVMN) or findings for phospholipidosis (PL) and cardiomyocyte vacuoles (CMV) in an exploratory toxicology study (ETS).</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2011/jmcmar.2011.54.issue-21/jm200939b/production/images/large/jm-2011-00939b_0012.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm200939b&amp;id=fig6"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_table-wrap" id="tbl4"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 4. Monobasic H<sub>3</sub> Receptor Antagonist, <b>4</b> with Reduced p<i>K</i><sub>a</sub> Relative to Parent Compound <b>2</b></div></div></div><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2011/jmcmar.2011.54.issue-21/jm200939b/production/images/medium/jm-2011-00939b_0009.gif" alt="" id="fx3" /></img><div class="scrollable-table-wrap"><table class="table" border="0"><colgroup><col align="left" /></col><col align="left" /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center">parameter<a class="ref internalNav" href="#t4fn1" aria-label="a">a</a></th><th class="colsep0 rowsep0" align="center">value</th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">ClogP</td><td class="colsep0 rowsep0" align="left">3.3</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">ClogD<sub>7.4</sub></td><td class="colsep0 rowsep0" align="left">0.8</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">MW</td><td class="colsep0 rowsep0" align="left">335</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">TPSA</td><td class="colsep0 rowsep0" align="left">24</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">p<i>K</i><sub>a</sub></td><td class="colsep0 rowsep0" align="left">9.3</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" colspan="2" align="center">Early PL Safety Assessment</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">in silico PL</td><td class="colsep0 rowsep0" align="left">98</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">PL MED<a class="ref internalNav" href="#t4fn2" aria-label="b">b</a> (μM)</td><td class="colsep0 rowsep0" align="left">245.3</td></tr></tbody></table></div><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t4fn1"><div class="footnote" id="t4fn1"><sup>a</sup><p class="last">Calculated physicochemical properties were obtained using standard commercial packages: Biobyte for ClogP calculations, ACD/Labs for ClogD at pH 7.4 and the most basic p<i>K</i><sub>a</sub>.</p></div><div class="footnote" id="t4fn2"><sup>b</sup><p class="last">Transformed human liver epithelial cellular phospholipidosis assay measuring phospholipid accumulation per cell. Compounds were classified as positive at the lowest dose for which the induction of phospholipid accumulation was 3-fold over background. MED value is the geometric mean of three independent experiments.</p></div></div></div></div><div id="sec2_6" class="NLM_sec NLM_sec_level_2"><div id="ac_i13" class="anchor-spacer"></div><h3 class="article-section__title" id="_i13"> Addressing CMV. Lead Compound <b>5</b></h3><div class="NLM_p">The hypothesis that in vivo amide cleavage of <b>4</b> occurred and that the resulting metabolite was responsible for the CMV finding seemed plausible. In the next generation molecule, we therefore sought a compound that possessed all the desired attributes achieved with <b>4</b> but lacked the potential to generate a dibasic metabolite. This design strategy resulted in discovery of the potent H<sub>3</sub> receptor antagonist <b>5</b> (Table <a class="ref showTableEvent internalNav" data-ID="tbl5" href="#tbl5">5</a>). Structurally, <b>5</b> differs from <b>4</b> in two key features: first, the <i>exo</i>-amide is internalized, and second, the chlorine atom has been replaced by a fluorine. Metabolic cleavage of the <i>endo</i>-amide would provide a carboxylate moiety, avoiding the potential issues with a dibasic metabolite. We hypothesized that such a carboxylate metabolite would not cause CMV. The fluorine atom served the same purpose as the original chlorine atom (reduction of p<i>K</i><sub>a</sub>) but with the added benefit of reducing MW (335 → 318) and lipophilicity (ClogP = 3.3 → 2.6). Compound <b>5</b>’s pharmacology, ADME (Tables <a class="ref showTableEvent internalNav" data-ID="tbl7" href="#tbl7">7</a>–<a class="ref showTableEvent internalNav" data-ID="tbl10" href="#tbl10">10</a>) and early safety attributes were similar to those of <b>4</b>; in addition, it displayed a comparable in silico PL value (94) and in vitro PL assay value (MED = 300 μM). A 14-day toxicology study in rats (6 males/dose) was conducted with <b>5</b> over a dose range of 10–300 mg/kg, and no PL was observed (AUC up to 35600 ng·h/mL). Further, this compound was well tolerated up to a high multiple of the projected clinically efficacious concentration (≥371 PCEC, Table <a class="ref showTableEvent internalNav" data-ID="tbl11" href="#tbl11">11</a>). These data supported further development. A single-dose study in dogs (1/sex per dose at 10 and 50 mg/kg; 1 male dog/dose at 75 and 100 mg/kg) identified 50 mg/kg (<i>C</i><sub>max</sub>of 5875 ± 2227 ng/mL) as the maximum tolerated dose for a subsequent 7-day study. In this 7-day study in dogs (2/sex), the dose was lowered from 50 mg/kg (mean <i>C</i><sub>max</sub>of 12859 ± 4473 ng/mL, day 1) to 25 mg/kg on day 2 because of convulsions in 2 of 4 dogs at 50 mg/kg. The dose was maintained at 25 mg/kg (mean AUC of 10780 ± 1368 ng·h/mL, day 7 values) for the remainder of the study. Excellent drug exposure was achieved in this 7-day study, and there was no histological evidence of CMV (≥777 PCEC, Table <a class="ref showTableEvent internalNav" data-ID="tbl11" href="#tbl11">11</a>). The next-generation lead compound <b>5</b> therefore met all of our criteria to move forward into clinical development. The redesigned H<sub>3</sub> receptor antagonist (<i>endo</i>-amide) yielded a compound that not only retained the potency attributes of <b>4</b> but also improved the overall safety profile (no CMV). The continual refinement of the physicochemical properties, in silico PL value, and in vitro PL value, coupled with further compound design (<i>exo</i>- to <i>endo</i>-amide), resulted in retention of druglike attributes (potency, specificity, ADME, and safety alignment), yielding a compound that moved forward in the drug development process. Unfortunately, genetic toxicology screening revealed a positive signal in the IVMN.<a onclick="showRef(event, 'ref27'); return false;" href="javascript:void(0);" class="ref ref27">(27)</a> Follow-up testing indicated that the increased incidence of micronuclei resulted from an equal contribution of chromosome breakage and chromosome loss/gain. At this point we had the option to further characterize the risk of these findings and attempt to move <b>5</b> forward despite its genetic safety liability. In pursuit of a “best-in-class” molecule, however, we decided to further improve upon the profile of <b>5</b> and eliminate the genotoxic liability.</div><div class="NLM_table-wrap" id="tbl5"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 5. Monobasic H<sub>3</sub> Receptor Antagonist <b>5</b> with <i>endo</i>-Amide Replacing the <i>exo</i>-Amide of Compound <b>4</b></div></div></div><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2011/jmcmar.2011.54.issue-21/jm200939b/production/images/medium/jm-2011-00939b_0010.gif" alt="" id="fx4" /></img><div class="scrollable-table-wrap"><table class="table" border="0"><colgroup><col align="left" /></col><col align="left" /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center">parameter<a class="ref internalNav" href="#t5fn1" aria-label="a">a</a></th><th class="colsep0 rowsep0" align="center">value</th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">ClogP</td><td class="colsep0 rowsep0" align="left">2.6</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">ClogD<sub>7.4</sub></td><td class="colsep0 rowsep0" align="left">0.4</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">MW</td><td class="colsep0 rowsep0" align="left">318</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">TPSA</td><td class="colsep0 rowsep0" align="left">24</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">p<i>K</i><sub>a</sub></td><td class="colsep0 rowsep0" align="left">9.3</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" colspan="2" align="center">Early PL Safety Assessment</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">in silico PL</td><td class="colsep0 rowsep0" align="left">94</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">PL MED<a class="ref internalNav" href="#t5fn2" aria-label="a">a</a> (μM)</td><td class="colsep0 rowsep0" align="left">300.0</td></tr></tbody></table></div><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t5fn1"><div class="footnote" id="t5fn1"><sup>a</sup><p class="last">Calculated physicochemical properties were obtained using standard commercial packages: Biobyte for ClogP calculations, ACD/Labs for ClogD at pH 7.4 and the most basic p<i>K</i><sub>a</sub>.</p></div><div class="footnote" id="t5fn2"><sup>a</sup><p class="last">Transformed human liver epithelial cellular phospholipidosis assay measuring phospholipid accumulation per cell. Compounds were classified as positive at the lowest dose for which the induction of phospholipid accumulation was 3-fold over background. MED value is the geometric mean of three independent experiments.</p></div></div></div></div><div id="sec2_7" class="NLM_sec NLM_sec_level_2"><div id="ac_i15" class="anchor-spacer"></div><h3 class="article-section__title" id="_i15"> Final Drug Candidates <b>6</b> (PF-036547<u class="uu">46</u>) and <b>7</b> (PF-036547<u class="uu">64</u>).<a onclick="showRef(event, 'ref52'); return false;" href="javascript:void(0);" class="ref ref52">(52)</a></h3><div class="NLM_p">In the context of remaining true to our design strategy, we considered the possibility that an amplified electrostatic potential within the core of compound <b>5</b> might have a beneficial effect with respect to the IVMN liability. Our next design cycle focused on identifying where we could incorporate a fluorine atom without decreasing affinity for the H<sub>3</sub> receptor. We selected the cyclobutyl ring based on the assumption that the resulting compound would retain affinity for the H<sub>3</sub> receptor. The additional fluorine served two purposes: (1) to perturb any interactions with DNA that potentially existed with <b>5</b> and (2) to provide a long-range electron-withdrawing effect that should further reduce the p<i>K</i><sub>a</sub> of the basic amine. A second modification made in this template served to compensate for the molecular weight added by the second fluorine atom; we chose to remove the methyl on the amide nitrogen in the expectation that the reduction in molecular weight and increase in polarity (incorporation of one hydrogen bond donor) would provide the maximum benefit with respect to overall physicochemical properties and safety.<a onclick="showRef(event, 'ref33'); return false;" href="javascript:void(0);" class="ref ref33">(33)</a> Through these changes in this design cycle, we identified <b>6</b>, one of the clinical candidates (Table <a class="ref showTableEvent internalNav" data-ID="tbl6" href="#tbl6">6</a>). Overall, physicochemical properties were optimal from a CNS druglike perspective: ClogP (2.4), ClogD (0.03), MW (322), p<i>K</i><sub>a</sub> (9.2), and TPSA (32). These physicochemical property values are in line with the median values recently reported for a large set of marketed CNS drugs.<a onclick="showRef(event, 'ref34 ref48'); return false;" href="javascript:void(0);" class="ref ref34 ref48">(34, 48)</a> Lowering the ClogP and p<i>K</i><sub>a</sub> resulted in an improved in silico PL value (90), and the in vitro PL assay value remained high (MED = 300.0 μM). Compound <b>6</b> was negative in the BiolumAMES and IVMN assays, and the negative IVMN was confirmed in an exploratory cytogenetics assay.<a onclick="showRef(event, 'ref27'); return false;" href="javascript:void(0);" class="ref ref27">(27)</a> All data supported the continued development of <b>6</b>. In a 14-day study in rats (4 males/dose), all doses (30, 100, 300 mg/kg) were well tolerated (mean AUC of 189000 ng·h/mL at 300 mg/kg, day 14) and showed no evidence of PL. Treatment-related findings were limited to transient postdose salivation at ≥100 mg/kg and a slight decrease in food intake and body weight at 300 mg/kg (≥4181 PCEC, Table <a class="ref showTableEvent internalNav" data-ID="tbl11" href="#tbl11">11</a>). The only remaining hurdle was demonstration of safety in a second species. The 7-day study in dogs (2/sex) was initiated at 25 mg/kg. Because of convulsions observed on day 3, this dose was lowered on day 4 to 15 mg/kg. There were no treatment-related findings at 15 mg/kg (≥1248 PCEC, Table <a class="ref showTableEvent internalNav" data-ID="tbl11" href="#tbl11">11</a>). The continual refinement of physicochemical properties, in silico PL value, and in vitro PL value, all while focusing on alignment of drug attributes (potency, specificity, ADME, and safety profile) yielded a compound that moved forward into drug development; <b>6</b> has successfully completed regulatory toxicology studies and phase I studies including safety, tolerability, and proof of mechanism (POM) (results will be communicated separately). The drive for a best-in-class molecule resulted in the identification of an ideal molecule to broaden the scope of clinical testing. The profile of <b>6</b> makes it a practical tool to test not only the primary hypothesis around ADHD but several clinical hypotheses around antagonism of the histamine H<sub>3</sub> receptor, including the treatment of allergic rhinitis, narcolepsy, and Alzheimer’s disease (results will be communicated separately). For clinical study design details of <b>6</b>, see ClinicalTrial.gov (<a href="http://clinicaltrials.gov/ct2/results?term=pf-03654746" class="extLink">http://clinicaltrials.gov/ct2/results?term=pf-03654746</a>). To further increase our odds of identifying a drug, we continued to probe this highly desirable drug space in an effort to identify a second high-quality clinical candidate. The second clinical candidate, <b>7</b>, was discovered during follow-up work on the <b>6</b> template (Table <a class="ref showTableEvent internalNav" data-ID="tbl6" href="#tbl6">6</a>). Compound <b>7</b> also has full alignment of the desired attributes (potency, pharmacokinetics, and safety) and large safety multiples over the PCEC in both preclinical species profiled (Table <a class="ref showTableEvent internalNav" data-ID="tbl7" href="#tbl7">7</a>–<a class="ref showTableEvent internalNav" data-ID="tbl11" href="#tbl11">11</a>). While <b>6</b> and <b>7</b> are structurally similar, they differ in projected human pharmacokinetics, where <b>7</b> was projected to have a longer <i>T</i><sub>1/2</sub> (∼16 h), and in in vivo biological profiles (details to be described elsewhere). Further, <b>7</b> has successfully completed regulatory toxicology studies and phase I studies including safety and tolerability (results will be communicated separately). For clinical study design details of <b>7</b>, see ClinicalTrial.gov (<a href="http://clinicaltrials.gov/ct2/results?term=pf-03654764" class="extLink">http://clinicaltrials.gov/ct2/results?term=pf-03654764</a>).</div><div class="NLM_table-wrap" id="tbl6"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 6. Clinical H<sub>3</sub> Histamine Receptor Antagonists <b>6</b> and <b>7</b></div></div></div><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2011/jmcmar.2011.54.issue-21/jm200939b/production/images/medium/jm-2011-00939b_0011.gif" alt="" id="fx5" /></img><div class="scrollable-table-wrap"><table class="table" border="0"><colgroup><col align="left" /></col><col align="left" /></col><col align="left" /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center">parameter<a class="ref internalNav" href="#t6fn1" aria-label="a">a</a></th><th class="colsep0 rowsep0" align="center">value for <b>6</b></th><th class="colsep0 rowsep0" align="center">value for <b>7</b></th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">ClogP</td><td class="colsep0 rowsep0" align="left">2.4</td><td class="colsep0 rowsep0" align="left">3.4</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">ClogD<sub>7.4</sub></td><td class="colsep0 rowsep0" align="left">0.03</td><td class="colsep0 rowsep0" align="left">0.9</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">MW</td><td class="colsep0 rowsep0" align="left">322</td><td class="colsep0 rowsep0" align="left">350</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">TPSA</td><td class="colsep0 rowsep0" align="left">32</td><td class="colsep0 rowsep0" align="left">32</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">p<i>K</i><sub>a</sub></td><td class="colsep0 rowsep0" align="left">9.2</td><td class="colsep0 rowsep0" align="left">9.2</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" colspan="3" align="center">Early PL Safety Assessment</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">in silico PL</td><td class="colsep0 rowsep0" align="left">90</td><td class="colsep0 rowsep0" align="left">96</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">PL MED<a class="ref internalNav" href="#t6fn2" aria-label="a">a</a> (μM)</td><td class="colsep0 rowsep0" align="left">300.0</td><td class="colsep0 rowsep0" align="left">302.4</td></tr></tbody></table></div><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t6fn1"><div class="footnote" id="t6fn1"><sup>a</sup><p class="last">Calculated physicochemical properties were obtained using standard commercial packages: Biobyte for ClogP calculations, ACD/Labs for ClogD at pH 7.4 and the most basic p<i>K</i><sub>a</sub>.</p></div><div class="footnote" id="t6fn2"><sup>a</sup><p class="last">Transformed human liver epithelial cellular phospholipidosis assay measuring phospholipid accumulation per cell. Compounds were classified as positive at the lowest dose for which the induction of phospholipid accumulation was 3-fold over background. MED value is the geometric mean of three independent experiments.</p></div></div></div></div></div><div id="sec3" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i17">Conclusion</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_73017" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_73017" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">There are numerous obstacles along the drug discovery process, some of which slow and can even stop the development of a compound or drug target. Unexpected findings such as phospholipidosis, cardiomyocyte vacuoles, in vitro micronucleus, or unusual structure–activity relationships must be treated as information to be exploited in crafting the next design hypothesis. We have developed a design strategy that leverages medicinal chemistry knowledge, in conjunction with an in silico PL tool and an early in vitro safety PL assay, to identify increasingly safer H<sub>3</sub> receptor antagonists that possess fully aligned attributes (potency, pharmacokinetics, and safety). Critical to the success in identifying compounds free of PL was identifying compounds with PL MED > 200 μM and in silico PL of <98. Drug candidates <b>6</b> and <b>7</b> met or exceeded all of our design and biological screening criteria and effortlessly moved through both early safety studies and regulatory toxicology studies. The path to these clinical candidates was not a smooth one, but each step of the way generated additional knowledge that was applied in the next design cycle.</div><div id="sec3_1" class="NLM_sec NLM_sec_level_2"><div id="ac_i18" class="anchor-spacer"></div><h3 class="article-section__title" id="_i18"> In Vitro Pharmacology of Compounds</h3><div class="NLM_p">H<sub>3</sub> receptor binding affinities were determined by displacement of specific <sup>3</sup>H-<i>N</i>-α-methylhistamine binding to H<sub>3</sub> receptor binding sites in HEK-293 cells expressing full-length human or rat H<sub>3</sub> receptors. Clinical compounds <b>6</b> and <b>7</b> bound with high affinity to the human H<sub>3</sub> receptor and with lower affinity to the rat H<sub>3</sub> receptor (Table <a class="ref showTableEvent internalNav" data-ID="tbl7" href="#tbl7">7</a>), in addition to having >1000-fold selectivity versus other human histamine receptor subtypes (H<sub>1</sub>, H<sub>2</sub>, and H<sub>4</sub>). Compounds <b>6</b> and <b>7</b> displayed >1000-fold selectivity versus other G-protein-coupled receptors (GPCRs) and transporters.</div><div class="NLM_table-wrap" id="tbl7"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 7. In Vitro Receptor Binding Affinity</div></div></div><div class="scrollable-table-wrap"><table class="table" border="0"><colgroup><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center"> </th><th class="rowsep1 colsep0" colspan="2" align="center">human H<sub>3</sub></th><th class="rowsep1 colsep0" colspan="2" align="center">rat H<sub>3</sub></th><th class="colsep0 rowsep0" align="center"> </th></tr><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center">compd</th><th class="colsep0 rowsep0" align="center">p<i>K</i><sub>i</sub> ± SEM<a class="ref internalNav" href="#t7fn1" aria-label="a">a</a> (<i>K</i><sub>i</sub> in M)</th><th class="colsep0 rowsep0" align="center"><i>K</i><sub>i</sub> (nM)</th><th class="colsep0 rowsep0" align="center">p<i>K</i><sub>i</sub> ± SEM<a class="ref internalNav" href="#t7fn1" aria-label="a">a</a> (<i>K</i><sub>i</sub> in M)</th><th class="colsep0 rowsep0" align="center"><i>K</i><sub>i</sub> (nM)<a class="ref internalNav" href="#t7fn2" aria-label="b">b</a></th><th class="colsep0 rowsep0" align="center">species ratio</th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>1</b></td><td class="colsep0 rowsep0" align="left">8.88 ± 0.25</td><td class="colsep0 rowsep0" align="left">1.3</td><td class="colsep0 rowsep0" align="left">8.03 ± 0.07</td><td class="colsep0 rowsep0" align="left">9.3</td><td class="colsep0 rowsep0" align="left">7</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>2</b></td><td class="colsep0 rowsep0" align="left">8.66 ± 0.10</td><td class="colsep0 rowsep0" align="left">2.2</td><td class="colsep0 rowsep0" align="left">8.11 ± 0.05</td><td class="colsep0 rowsep0" align="left">7.7</td><td class="colsep0 rowsep0" align="left">3.5</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>3</b></td><td class="colsep0 rowsep0" align="left">8.06 ± 0.11</td><td class="colsep0 rowsep0" align="left">8.7</td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left">82</td><td class="colsep0 rowsep0" align="left">9.4</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>4</b></td><td class="colsep0 rowsep0" align="left">7.89 ± 0.06</td><td class="colsep0 rowsep0" align="left">14</td><td class="colsep0 rowsep0" align="left">6.81 ± 0.05</td><td class="colsep0 rowsep0" align="left">160</td><td class="colsep0 rowsep0" align="left">11</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>5</b></td><td class="colsep0 rowsep0" align="left">8.40 ± 0.09</td><td class="colsep0 rowsep0" align="left">4</td><td class="colsep0 rowsep0" align="left">7.22 ± 0.06</td><td class="colsep0 rowsep0" align="left">59</td><td class="colsep0 rowsep0" align="left">15</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>6</b></td><td class="colsep0 rowsep0" align="left">8.64 ± 0.09</td><td class="colsep0 rowsep0" align="left">2.3</td><td class="colsep0 rowsep0" align="left">7.43 ± 0.05</td><td class="colsep0 rowsep0" align="left">37</td><td class="colsep0 rowsep0" align="left">16</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>7</b></td><td class="colsep0 rowsep0" align="left">8.84 ± 0.08</td><td class="colsep0 rowsep0" align="left">1.4</td><td class="colsep0 rowsep0" align="left">7.73 ± 0.09</td><td class="colsep0 rowsep0" align="left">19</td><td class="colsep0 rowsep0" align="left">14</td></tr></tbody></table></div><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t7fn1"><div class="footnote" id="t7fn1"><sup>a</sup><p class="last">Data are expressed as geometric mean ± SEM (at least three determinations except for rat <i>K</i><sub>i</sub> of <b>3</b> which was <i>N</i> = 1).</p></div><div class="footnote" id="t7fn2"><sup>b</sup><p class="last">Rat <i>K</i><sub>i</sub> was determined in rat brain for compound <b>1</b>. All other compounds were tested in HEK-293 cells expressing rat H<sub>3</sub> receptor.</p></div></div></div><div class="NLM_p">Clinical candidates <b>6</b> and <b>7</b> displayed potent antagonist properties in functional assays measuring cAMP utilizing a reporter gene assay (β-lactamase) in HEK293 cells stably expressing full-length human or rat H<sub>3</sub> receptors (Table <a class="ref showTableEvent internalNav" data-ID="tbl8" href="#tbl8">8</a>). Results were consistent with the species differences observed in the binding assays.</div><div class="NLM_table-wrap" id="tbl8"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 8. Whole Cell Assay, H<sub>3</sub> Receptor cAMP, β-Lactamase Functional Affinity<a class="ref internalNav" href="#tbl8-fn1" aria-label="a">a</a></div></div></div><div class="scrollable-table-wrap"><table class="table" border="0"><colgroup><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center"> </th><th class="rowsep1 colsep0" colspan="2" align="center">human H<sub>3</sub></th><th class="rowsep1 colsep0" colspan="2" align="center">rat H<sub>3</sub></th><th class="colsep0 rowsep0" align="center"> </th></tr><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center">compd</th><th class="colsep0 rowsep0" align="center">p<i>K</i><sub>i</sub> ± SEM (<i>K</i><sub>i</sub> in M)</th><th class="colsep0 rowsep0" align="center"><i>K</i><sub>i</sub> (nM)</th><th class="colsep0 rowsep0" align="center">p<i>K</i><sub>i</sub> ± SEM (<i>K</i><sub>i</sub> in M)</th><th class="colsep0 rowsep0" align="center"><i>K</i><sub>i</sub> (nM)</th><th class="colsep0 rowsep0" align="center">species ratio</th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>2</b></td><td class="colsep0 rowsep0" align="left">9.05 ± 0.23</td><td class="colsep0 rowsep0" align="left">0.89</td><td class="colsep0 rowsep0" align="left">8.45 ± 0.07</td><td class="colsep0 rowsep0" align="left">3.5</td><td class="colsep0 rowsep0" align="left">3.7</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>3</b></td><td class="colsep0 rowsep0" align="left">7.93 ± 0.33</td><td class="colsep0 rowsep0" align="left">12.0</td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left">79</td><td class="colsep0 rowsep0" align="left">6.5</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>4</b></td><td class="colsep0 rowsep0" align="left">8.48 ± 0.08</td><td class="colsep0 rowsep0" align="left">3.3</td><td class="colsep0 rowsep0" align="left">7.68 ± 0.29</td><td class="colsep0 rowsep0" align="left">21</td><td class="colsep0 rowsep0" align="left">6.4</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>5</b></td><td class="colsep0 rowsep0" align="left">8.83 ± 0.12</td><td class="colsep0 rowsep0" align="left">1.5</td><td class="colsep0 rowsep0" align="left">7.69 ± 0.05</td><td class="colsep0 rowsep0" align="left">21</td><td class="colsep0 rowsep0" align="left">14</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>6</b></td><td class="colsep0 rowsep0" align="left">8.77 ± 0.10</td><td class="colsep0 rowsep0" align="left">1.7</td><td class="colsep0 rowsep0" align="left">8.05 ± 0.07</td><td class="colsep0 rowsep0" align="left">8.9</td><td class="colsep0 rowsep0" align="left">5.2</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>7</b></td><td class="colsep0 rowsep0" align="left">8.98 ± 0.09</td><td class="colsep0 rowsep0" align="left">1.2</td><td class="colsep0 rowsep0" align="left">8.10 ± 0.11</td><td class="colsep0 rowsep0" align="left">7.9</td><td class="colsep0 rowsep0" align="left">6.6</td></tr></tbody></table></div><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-tbl8-fn1"><div class="footnote" id="tbl8-fn1"><sup>a</sup><p class="last">Data are expressed as geometric mean ± SEM (at least three determinations except for compound <b>3</b>, which was tested only once in the rat functional assay).</p></div></div></div></div><div id="sec3_2" class="NLM_sec NLM_sec_level_2"><div id="ac_i21" class="anchor-spacer"></div><h3 class="article-section__title" id="_i21"> Pharmacokinetic (PK) Properties of Compound Set (<b>2</b>, <b>3</b>, <b>4</b>, <b>5</b>, <b>6</b>, and <b>7</b>)</h3><div class="NLM_p">Compounds <b>6</b> and <b>7</b> both possessed excellent ADME properties (Table <a class="ref showTableEvent internalNav" data-ID="tbl9" href="#tbl9">9</a>). Both compounds were well absorbed, as evidenced by both their in vitro properties (Caco-2 A → B, >38 × 10<sup>–6</sup> cm/s) and the results of in vivo studies suggesting complete absorption. The blood–brain barrier penetration was specifically tested with <b>6</b> (considered representative of the two), and the results indicated that the compound readily penetrated into the brain (brain/plasma ratio of 2.1), with no evidence for efflux mechanisms moderating its central disposition (MDR1 BA/AB = 1.1). In human hepatic microsomes, both compounds were metabolically stable (HLM <i>T</i><sub>1/2</sub> > 120 min) and were predicted to have low clearance (<5 mL min<sup>–1</sup> kg<sup>–1</sup>) in humans.</div><div class="NLM_table-wrap" id="tbl9"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 9. Pharmacokinetic (PK) Properties of Compound Set</div></div></div><div class="scrollable-table-wrap"><table class="table" border="0"><colgroup><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center">parameter</th><th class="colsep0 rowsep0" align="center">2</th><th class="colsep0 rowsep0" align="center"><b>3</b></th><th class="colsep0 rowsep0" align="center"><b>4</b></th><th class="colsep0 rowsep0" align="center"><b>5</b></th><th class="colsep0 rowsep0" align="center"><b>6</b></th><th class="colsep0 rowsep0" align="center"><b>7</b></th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">Caco-2 AB × 10<sup>–6</sup>(cm/s)<a class="ref internalNav" href="#t9fn1" aria-label="a">a</a></td><td class="colsep0 rowsep0" align="left">8.2</td><td class="colsep0 rowsep0" align="left">32.5</td><td class="colsep0 rowsep0" align="left">53.4</td><td class="colsep0 rowsep0" align="left">34.3</td><td class="colsep0 rowsep0" align="left">44.7</td><td class="colsep0 rowsep0" align="left">38.8</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">HLM <i>T</i><sub>1/2</sub>(min)<a class="ref internalNav" href="#t9fn2" aria-label="b">b</a></td><td class="colsep0 rowsep0" align="left">>120</td><td class="colsep0 rowsep0" align="left">>120</td><td class="colsep0 rowsep0" align="left">>120</td><td class="colsep0 rowsep0" align="left">>120</td><td class="colsep0 rowsep0" align="left">>120</td><td class="colsep0 rowsep0" align="left">>120</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">HLM CL<sub>h</sub>(mL min<sup>–1</sup> kg<sup>–1</sup>)<a class="ref internalNav" href="#t9fn3" aria-label="c">c</a></td><td class="colsep0 rowsep0" align="left"><8</td><td class="colsep0 rowsep0" align="left"><8</td><td class="colsep0 rowsep0" align="left"><8</td><td class="colsep0 rowsep0" align="left"><5</td><td class="colsep0 rowsep0" align="left"><5</td><td class="colsep0 rowsep0" align="left"><5</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">P-gp ER<a class="ref internalNav" href="#t9fn4" aria-label="d">d</a></td><td class="colsep0 rowsep0" align="left">0.95</td><td class="colsep0 rowsep0" align="left">0.90</td><td class="colsep0 rowsep0" align="left">1.27</td><td class="colsep0 rowsep0" align="left">1.29</td><td class="colsep0 rowsep0" align="left">1.1</td><td class="colsep0 rowsep0" align="left">0.96</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">plasma protein binding (<i>f</i><sub>u</sub>) (rat)</td><td class="colsep0 rowsep0" align="left">0.72</td><td class="colsep0 rowsep0" align="left">0.47</td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left">0.70</td><td class="colsep0 rowsep0" align="left">0.70</td><td class="colsep0 rowsep0" align="left">0.56</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">brain/plasma (rat) (1 h, sc)</td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left">2.1</td><td class="colsep0 rowsep0" align="left"> </td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><i>F</i> (rat) %</td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left">24.6</td><td class="colsep0 rowsep0" align="left">25.9</td><td class="colsep0 rowsep0" align="left">20.2</td></tr></tbody></table></div><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t9fn1"><div class="footnote" id="t9fn1"><sup>a</sup><p class="last">MS-based quantification of apical → basolateral transfer rate of a test compound at 2 μM across contiguous monolayers of Caco cells.</p></div><div class="footnote" id="t9fn2"><sup>b</sup><p class="last">Derived from human liver microsomes.</p></div><div class="footnote" id="t9fn3"><sup>c</sup><p class="last">Microsomal unbound intrinsic clearance using human liver microsomes and an in silico model estimate for <i>f</i><sub>u,mic</sub>.</p></div><div class="footnote" id="t9fn4"><sup>d</sup><p class="last">Ratio of (basal → apical) to (apical → basal) transfer rate of a test compound at 2 μM across contiguous monolayers of MDR1-transfected MDCK cells.</p></div></div></div></div></div><div id="sec4" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i23">Chemistry</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_33300" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_33300" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">The synthesis of the H<sub>3</sub> receptor antagonists <b>2</b> and <b>3</b> is outlined in Scheme <a class="ref internalNav" href="#sch1" aria-label="1">1</a>. The preparation of these lead compounds began with etherification of (3,3-dimethoxycyclobutyl)methanol<a onclick="showRef(event, 'ref49'); return false;" href="javascript:void(0);" class="ref ref49">(49)</a> using benzyl bromide and potassium <i>tert</i>-butoxide to afford the corresponding benzyl ether. Unmasking of the latent ketone was accomplished with aqueous <i>p</i>-toluenesulfonic acid, generating <b>8</b>. Lithium–halogen exchange was carried out on 1-(4-bromobenzyl)pyrrolidine via treatment with <i>n</i>-butyllithium; reaction with ketone <b>8</b> produced carbinol <b>9</b> as a mixture of cis and trans isomers. Access to cyclobutane <b>10</b>, as a mixture of isomers, was achieved by dehydroxylation of <b>9</b> with TFA and triethylsilane. Selective deprotection of the benzyl ether via palladium black catalyzed hydrogenolysis transformed <b>10</b> into alcohol <b>11</b>, which was converted to a mixture of the corresponding cis and trans tosylates <b>12a</b> and <b>12b</b>, respectively. At this stage, the isomers were separated by chromatography. When heated to 120 °C with morpholine in dimethylacetamide, <i>cis</i>-tosylate <b>12a</b> provided compound <b>2</b> in moderate yield. Detosylation of <i>trans</i>-tosylate <b>12b</b> was accomplished by heating with magnesium turnings in methanol to give alcohol <b>13</b>. S<sub>N</sub>Ar reaction of 2-chloropyrimidine with the potassium alkoxide of <b>13</b> generated pyrimidine <b>3</b> in good yield.</div><figure id="sch1" data-index="7" class="article__inlineFigure"><h2 class="fig-label">Scheme 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2011/jmcmar.2011.54.issue-21/jm200939b/production/images/medium/jm-2011-00939b_0013.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2011/jmcmar.2011.54.issue-21/jm200939b/production/images/large/jm-2011-00939b_0013.jpeg" id="gr7" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 1. Synthesis of Lead Compounds <b>2</b> and <b>3</b><sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2011/jmcmar.2011.54.issue-21/jm200939b/production/images/large/jm-2011-00939b_0013.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm200939b&amp;id=sch1"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions: (a) KO-<i>t</i>-Bu, benzyl bromide, THF, rt (69%); (b) <i>p</i>-TsOH (cat.), acetone/water, 65 °C (58%); (c) (i) 1-(4-bromobenzyl)pyrrolidine, <i>n</i>-BuLi, THF, −78 °C, (ii) <b>8</b>, THF, −78 °C (71%); (d) triethylsilane, TFA, 75 °C (taken on crude); (e) palladium black, 45 psi of H<sub>2</sub>, EtOH, rt (two steps, 79%); (f) <i>p</i>-toluenesulfonyl chloride, pyridine, CH<sub>2</sub>Cl<sub>2</sub>, 0 °C to rt (93%); (g) <b>12a</b>, morpholine, DMA, 120 °C (61%); (h) <b>12b</b>, Mg turnings, MeOH, rt (73%); (i) KO-<i>t</i>-Bu, THF, 2-chloropyrimidine, rt (89%).</p></p></figure><div class="NLM_p">The synthesis of <i>exo</i>-amide H<sub>3</sub> receptor antagonist <b>4</b> is depicted in Scheme <a class="ref internalNav" href="#sch2" aria-label="2">2</a>. Pyrrolidine amide <b>14</b> was prepared in excellent yield via coupling of 4-bromo-2-chlorobenzoic acid and pyrrolidine using propylphosphonic anhydride (T3P). Subsequent reduction of the amide with borane–THF yielded benzylic amine <b>15</b>. The conversion of <b>15</b> into <b>16</b> began with the selective bromine–metal exchange of <b>15</b> with <i>n</i>-BuLi at −78 °C. An amount of 2 equiv of this lithiated intermediate was added to 3-oxocyclobutanecarboxylic acid, and the resultant cyclobutanoic acid carbinol was treated in situ with methylamine and T3P to provide amide <b>16</b>. Dehydration with TFA afforded olefin <b>17</b>, which was directly hydrogenated using Wilkinson’s catalyst to predominantly yield <i>trans</i>-cyclobutylamide <b>18</b>. The trans selectivity is presumed to have arisen from a coordination effect between the carbonyl group of the amide and the metal of the Wilkinson’s catalyst, as suggested by Schultz and McCloskey for similar hydrogenations of amido-substituted cyclohexanes using Crabtree’s catalyst.<a onclick="showRef(event, 'ref50'); return false;" href="javascript:void(0);" class="ref ref50">(50)</a> Borane–THF reduction of amide <b>18</b> gave amine <b>19</b>, which was acetylated with acetic anhydride to afford H<sub>3</sub> receptor antagonist <b>4</b> in high yield.</div><figure id="sch2" data-index="8" class="article__inlineFigure"><h2 class="fig-label">Scheme 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2011/jmcmar.2011.54.issue-21/jm200939b/production/images/medium/jm-2011-00939b_0014.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2011/jmcmar.2011.54.issue-21/jm200939b/production/images/large/jm-2011-00939b_0014.jpeg" id="gr8" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 2. Synthesis of Lead Compound <b>4</b><sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2011/jmcmar.2011.54.issue-21/jm200939b/production/images/large/jm-2011-00939b_0014.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm200939b&amp;id=sch2"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions: (a) T3P, pyrrolidine, EtOAc, rt (96%); (b) BH<sub>3</sub>·THF, THF, rt (74%); (c) (i) <i>n</i>-BuLi, 3-oxocyclobutanecarboxylic acid, THF, −78 °C to rt; (ii) T3P, CH<sub>3</sub>NH<sub>2</sub>, rt (48%); (d) TFA, DCE, 75 °C (taken on crude); (e) Rh(Ph<sub>3</sub>P)<sub>3</sub>Cl, H<sub>2</sub> (45 psi), EtOH, 60 °C (two steps, 37%); (f) BH<sub>3</sub>·THF, THF, 70 °C (77%); (g) Ac<sub>2</sub>O, Et<sub>3</sub>N, CH<sub>2</sub>Cl<sub>2</sub>, 0 °C (>95%).</p></p></figure><div class="NLM_p">Synthesis of the <i>endo</i>-amide H<sub>3</sub> receptor antagonist <b>5</b> is described in Scheme <a class="ref internalNav" href="#sch3" aria-label="3">3</a>. Nucleophilic displacement of 4-bromo-2-fluorobenzyl bromide with pyrrolidine generated benzylic amine <b>20</b> in high yield. Selective lithiation of <b>20</b> using <i>n</i>-BuLi under cryogenic conditions and use of the optimized conditions described in Scheme <a class="ref internalNav" href="#sch2" aria-label="2">2</a> afforded carbinol <b>21</b>. Dehydration of <b>21</b> afforded cyclobutene <b>22</b>, which was not stable to column chromatography and was used without further purification. Reduction of the double bond was accomplished via hydrogenation; using 10% Pd/C as catalyst in the presence of hydrogen yielded the desired <i>cis-</i>cyclobutane <b>5</b> in good yield over two steps.</div><figure id="sch3" data-index="9" class="article__inlineFigure"><h2 class="fig-label">Scheme 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2011/jmcmar.2011.54.issue-21/jm200939b/production/images/medium/jm-2011-00939b_0015.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2011/jmcmar.2011.54.issue-21/jm200939b/production/images/large/jm-2011-00939b_0015.jpeg" id="gr9" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 3. Synthesis of Compound <b>5</b><sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2011/jmcmar.2011.54.issue-21/jm200939b/production/images/large/jm-2011-00939b_0015.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm200939b&amp;id=sch3"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions: (a) pyrrolidine, CH<sub>3</sub>CN, 10 °C to rt (90%); (b) (i) <i>n</i>-BuLi, 3-oxocyclobutanecarboxylic acid, THF, −78 °C, (ii) ethylmethylamine, T3P, EtOAc, rt (60%); (c) TFA, CH<sub>2</sub>Cl<sub>2</sub>, reflux (taken on crude); (d) 10% Pd/C, H<sub>2</sub> (45 psi), EtOH, rt (two steps, 71%).</p></p></figure><div class="NLM_p">The syntheses of the two clinical H<sub>3</sub> receptor antagonists, <b>6</b> and <b>7</b>, consisted of three linear steps from <b>20</b> (Scheme <a class="ref internalNav" href="#sch4" aria-label="4">4</a>) and leveraged a late coupling step to install diversity (ethyl or isobutyl). Overall, the synthesis was efficient, requiring only two reaction vessels to complete the process. In the first reaction vessel all the requisite carbons were installed. Aryl bromide <b>20</b> was lithiated and added to a precooled solution of 3-oxocyclobutanecarboxylic acid in THF. The resulting cyclobutanoic acid carbinol was converted to the requisite amide using the coupling reagent T3P and appropriate amine (ethyl or isobutyl) to yield carbinols <b>23</b> or <b>24</b>, respectively. Conversion of the alcohol group to a fluorine was accomplished using the fluorinating agent BAST (bis(2-methoxyethyl)aminosulfur trifluoride). Thus, reaction of carbinols <b>23</b> and <b>24</b> with BAST afforded <b>6</b> and <b>7</b>, respectively, with high trans selectivity. We hypothesize that the observed selectivity was imparted either through a stabilized carbocation or simply as a result of a steric interaction that caused the fluorinating reagent to approach the face opposite the carbonyl. Removal of the minor isomers was achieved by either preparative chromatography of the free base or recrystallization of the HCl salt.</div><div class="NLM_p">Through extensive salt evaluation, we discovered that the tosylate salt possessed optimal properties and this form of <b>6</b> was evaluated to determine its acceptability for tablet development. The material was determined to be a crystalline nonsolvated monotosylate salt with a melting onset temperature of 165 °C. Analysis of the moisture sorption isotherm at 25 °C, collected using the kinetic vacuum method, indicated that this solid-state form is nonhygroscopic. Compound <b>6</b> tosylate salt has a solubility of greater than 10 mg/mL in 0.1 M phosphate-buffered saline (final pH 7) and a solubility of 23.6 mg/mL in unbuffered water (final pH 3.8). The solubility in 0.1 M phosphate-buffered saline containing 0.5% sodium taurocholate/pamitoyloleoylphosphatidylcholine salts (final pH 6.5) was determined to be greater than 11 mg<sub>A</sub>/mL (active component). The apparent solubility of the <b>6</b> tosylate salt in simulated gastric fluid (pH 1) was greater than 15 mg/mL (active component). Overall, the high aqueous solubility of this compound in all simulated biological media suggests that the candidate would remain well solubilized in the gastrointestinal tract.</div><figure id="sch4" data-index="10" class="article__inlineFigure"><h2 class="fig-label">Scheme 4</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2011/jmcmar.2011.54.issue-21/jm200939b/production/images/medium/jm-2011-00939b_0016.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2011/jmcmar.2011.54.issue-21/jm200939b/production/images/large/jm-2011-00939b_0016.jpeg" id="gr10" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 4. Synthesis of Clinical Candidates <b>6</b> and <b>7</b><sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2011/jmcmar.2011.54.issue-21/jm200939b/production/images/large/jm-2011-00939b_0016.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm200939b&amp;id=sch4"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions: (a) (i) <i>n</i>-BuLi, 3-oxocyclobutanecarboxylic acid, THF, −78 °C, (ii) ethylamine or isobutylamine, T3P, EtOAc, rt (R = ethyl, 49%; R = isobutyl, 63%); (b) BAST, CH<sub>2</sub>Cl<sub>2</sub>, −78 °C (R = ethyl, 58%; R = isobutyl, 85%).</p></p></figure></div><div id="sec5" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i28">Materials and Methods</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_27438" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_27438" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div id="secz" class="NLM_sec NLM_sec_level_2"><div id="ac_i29" class="anchor-spacer"></div><h3 class="article-section__title" id="_i29"> Physicochemical Property Data</h3><div class="NLM_p last">This analysis included calculated lipophilicity (ClogP), calculated lipophilicity at pH 7.4 (ClogD), molecular weight (MW), topological polar surface area (TPSA), the number of hydrogen bond donors (HBD), and the calculated most basic center (p<i>K</i><sub>a</sub>). Calculated physicochemical properties were obtained using standard commercial packages: Biobyte for ClogP calculations and ACD/Labs for ClogD at pH 7.4 and the most basic p<i>K</i><sub>a</sub>. TPSA was calculated using the method developed by Ertl.<a onclick="showRef(event, 'ref51'); return false;" href="javascript:void(0);" class="ref ref51">(51)</a></div></div><div id="sec6_1" class="NLM_sec NLM_sec_level_2"><div id="ac_i30" class="anchor-spacer"></div><h3 class="article-section__title" id="_i30"> Chemistry. General Information</h3><div class="NLM_p last">All solvents and reagents were obtained from commercial sources and were used as received. All reactions were followed by TLC (TLC plates F254, Merck) or LCMS (liquid chromatography–mass spectrometry) analysis. Proton and <sup>13</sup>C NMR spectra were obtained using deuterated solvent on a Varian 300, 400, or 500 MHz instrument. All proton shifts are reported in δ units (ppm) downfield of TMS (tetramethylsilane) and were measured relative to the signals for chloroform (7.27 ppm) and methanol (3.31 ppm). All <sup>13</sup>C shifts are reported in δ units (ppm) relative to the signals for chloroform (77.0 ppm) and methanol (49.1 ppm) with <sup>1</sup>H decoupled observation. All coupling constants (<i>J</i>) are reported in hertz (Hz). NMR abbreviations are as follows: app, apparent; br, broadened; s, singlet; d, doublet; t, triplet; q, quartet; p, pentuplet; m, multiplet; dd, doublet of doublets; ddd, doublet of doublet of doublets; sept, septuplet. GCMS data were recorded on an HP 6890 GC system equipped with a 5973 mass selective detector (stationary phase, HP-1, fused silica, 12 m × 0.202 mm, 0.33 μm; temperature limits of −60 to 325 °C; ramp rate of 30 °C/min; solvent delay = of 0.4 min). Analytical analyses by Ultra performance liquid chromatography (UPLC) were performed on a Waters Acquity system with PDA detection (UV 210 nm) at 45 °C, flow rate of 0.5 mL/min, with a gradient of 95/5 buffer/acetonitrile (0–7.55 min), 10/90 buffer/acetonitrile (7.55–7.85 min), 95/5 buffer/acetonitrile (8.10–10.30 min) using the following columns and buffers: Waters BEH C8 column (2.1 mm × 100 mm, 1.7 μm) with 50 mM sodium perchlorate/0.1% phosphoric acid or 10 mM ammonium bicarbonate as buffer; Waters BEH RP C18 column (2.1 mm × 100 mm, 1.7 μm) or Waters HSS T3 (2.1 mm × 100 mm, 1.8 μm) column with 0.1% methanesulfonic acid buffer. All melting points are uncorrected. Elemental analyses were performed by QTI Development. Mass spectra were recorded on a Micromass ADM atmospheric pressure chemical ionization instrument (APCI). High resolution mass spectra were obtained on an Agilent LCMS TOF instrument equipped with a Zorbax Eclipse column (50 mm × 4.6 mm, 1.8 μm XDB-C18) using 0.1% aqueous formic acid as mobile phase A1 and acetonitrile containing 0.1% formic acid as mobile phase B1. Column chromatography was carried out on silica gel 60 (32–60 mesh, 60 Ǻ) or on prepacked Biotage columns. The purities of final compounds <b>2</b>–<b>7</b> as measured by UPLC and/or elemental analysis methods were found to be above 95%.</div></div><div id="sec6_2" class="NLM_sec NLM_sec_level_2"><div id="ac_i31" class="anchor-spacer"></div><h3 class="article-section__title" id="_i31"> 4-({<i>cis</i>-3-[4-(Pyrrolidin-1-ylmethyl)phenyl]cyclobutyl}methyl)morpholine (<b>2</b>)</h3><div class="NLM_p last">Morpholine (33.6 mL, 385 mmol) was added to <b>12a</b> (76.3 g, 191 mmol) in dimethylacetamide (DMA) (191 mL), and the mixture was heated at 120 °C for 1 h. The mixture was cooled to room temperature and concentrated. EtOAc and concentrated HCl (32 mL) were added. Solvents were removed in vacuo and two additional portions of EtOAc were added followed by reconcentration to help remove residual DMA. EtOAc (600 mL) was added to the resulting residue, and stirring was continued for 2 days. The solvent was decanted off, and the gummy residue was dissolved in 3:1 CHCl<sub>3</sub>/MeOH and basified with 15% aqueous NaOH. The organic layer was concentrated and purified by chromatography using a gradient of 3–50% MeOH in CH<sub>2</sub>Cl<sub>2</sub> containing 0.3% NH<sub>4</sub>OH, affording the title compound (36.8 g, 61%) as a solid. This was dissolved in EtOAc, treated with 1 N HCl in THF, and filtered to yield the HCl salt as a white solid. <sup>1</sup>H NMR (MeOH-<i>d</i><sub>4</sub>, 400 MHz) δ 7.42 (AB quartet, Δν<sub>AB</sub> = 50.7, <i>J</i><sub>AB</sub> = 8.3, 4H), 4.35 (s, 2H), 4.03 (dd, <i>J</i> = 12.9, 3.7, 2H), 3.84 (ddd, <i>J</i> = 13.3, 13.3, 1.7, 2H), 3.49–3.59 (m, 1H), 3.45 (br d, <i>J</i> = 12.0, 4H), 3.28 (d, <i>J</i> = 7.1, 2H), 3.13–3.22 (m, 4H), 2.77–2.87 (m, 1H), 2.61–2.68 (m, 2H), 2.10–2.22 (m, 2H), 1.96–2.05 (m, 4H). <sup>13</sup>C NMR (MeOH-<i>d</i><sub>4</sub>, 100 MHz) δ 146.7, 130.4, 128.8, 127.2, 63.8, 62.0, 57.7, 53.5, 51.9, 36.5, 34.6, 26.5, 22.6. HRMS <i>m</i>/<i>z</i>, calcd (M + 1) 315.2430, observed 315.2442.</div></div><div id="sec6_3" class="NLM_sec NLM_sec_level_2"><div id="ac_i32" class="anchor-spacer"></div><h3 class="article-section__title" id="_i32"> 2-({<i>trans</i>-3-[4-(Pyrrolidin-1-ylmethyl)phenyl]cyclobutyl}methoxy)pyrimidine (<b>3</b>)</h3><div class="NLM_p last">Potassium <i>tert</i>-butoxide (1.0 M in THF, 22.0 mL, 22.0 mmol) was added to a solution of <b>13</b> (3.6 g, 14.7 mmol) and 2-chloropyrimidine (1.85 g, 16.2 mmol) in THF (14 mL) to give a cloudy, dark pink mixture. After 10 min, saturated aqueous NH<sub>4</sub>Cl was added and the mixture was extracted with 3:1 CHCl<sub>3</sub>/<i>i</i>-PrOH. The organic layers were concentrated to give 5.2 g of the crude title compound. Chromatography using a gradient of 3–8% MeOH in CH<sub>2</sub>Cl<sub>2</sub> containing 0.2% NH<sub>4</sub>OH yielded the title compound (4.2 g, 89%) as a semisolid. The besylate salt was prepared in MeOH using 1 equiv of benzenesulfonic acid to yield 6.4 g of a light yellow solid. A portion of this material was recrystallized from water to provide an analytical sample. <sup>1</sup>H NMR (MeOH-<i>d</i><sub>4</sub>, 400 MHz) δ 8.58 (d, <i>J</i> = 4.6, 2H), 7.81–7.83 (m, 2H), 7.37–7.45 (m, 7H), 7.10 (t, <i>J</i> = 5.0, 1H), 4.56 (d, <i>J</i> = 7.1, 2H), 4.33 (s, 2H), 3.76 (tt, <i>J</i> = 8.6, 8.2 1H), 3.42–3.50 (m, 2H), 3.13–3.31 (m, 2H), 2.75–2.87 (m, 1H), 2.31–2.42 (m, 4H), 2.08–2.22 (m, 2H), 1.90–2.06 (m, 2H). <sup>13</sup>C NMR (MeOH-<i>d</i><sub>4</sub>, 100 MHz) δ 166.6, 160.9, 149.7, 146.5, 131.7, 131.4, 129.7, 129.5, 128.6, 127.1, 116.6, 72.1, 59.2, 54.9, 37.7, 32.2, 31.4, 23.9. HRMS <i>m</i>/<i>z</i>, calcd (M + 1) 324.2070, observed 324.2062.</div></div><div id="sec6_4" class="NLM_sec NLM_sec_level_2"><div id="ac_i33" class="anchor-spacer"></div><h3 class="article-section__title" id="_i33"> <i>N</i>-({<i>trans</i>-3-[3-Chloro-4-(pyrrolidin-1-ylmethyl)phenyl]cyclobutyl}methyl)-<i>N</i>-methylacetamide (<b>4</b>)</h3><div class="NLM_p last">Acetic anhydride (9.2 mL, 97 mmol) was added to a 0 °C solution of <b>19</b> (23.7 g, 81.2 mmol) and Et<sub>3</sub>N (22.6 mL, 162 mmol) in CH<sub>2</sub>Cl<sub>2</sub> (230 mL). After the mixture was stirred for 30 min, 1 N aqueous NaOH (200 mL) was added and the phases were separated. The aqueous phase was extracted twice with EtOAc, and the combined organics were dried over MgSO<sub>4</sub>, filtered, and concentrated to yield 29.2 g of crude product. Chromatography using a gradient of 5–20% MeOH in CH<sub>2</sub>Cl<sub>2</sub> containing 0.1% NH<sub>4</sub>OH yielded the title compound (27 g, 99%) as a colorless, viscous oil. This was dissolved in EtOAc (200 mL) and treated with 2 M HCl in Et<sub>2</sub>O (81.2 mL) to afford the mono-HCl salt of the title compound as a white solid (30.6 g, 99%). <sup>1</sup>H NMR (MeOH-<i>d</i><sub>4</sub>, 400 MHz) ∼1.5:1 mixture of rotamers, δ 7.70–7.73 (m, 1H), 7.50 and 7.46 (2 d, <i>J</i> = 1.7, 1H total), 7.40 and 7.36 (2 dd, <i>J</i> = 7.9, 1.5, 1H total), 4.57 (s, 2H), 3.70–3.82 (m, 3H), 3.53–3.60 (m, 2H), 3.24 (m, 2H), 3.24 and 3.14 (2 s, 3H total), 2.72–2.86 (m, 1H), 2.17–2.38 (m, 9H), 2.02–2.12 (m, 2H). <sup>13</sup>C NMR (MeOH-<i>d</i><sub>4</sub>, 100 MHz) δ 175.7, 175.4, 151.6, 151.5, 136.2, 134.3, 129.4, 129.3, 127.6, 127.5, 127.4, 127.3, 57.1, 55.9, 55.2, 54.7, 38.3, 37.2, 37.0, 36.0, 32.8, 32.6, 31.0, 30.4, 24.0, 20.2, 19.8. HRMS <i>m</i>/<i>z</i>, calcd (M + 1) 335.1884, observed 335.1880.</div></div><div id="sec6_5" class="NLM_sec NLM_sec_level_2"><div id="ac_i34" class="anchor-spacer"></div><h3 class="article-section__title" id="_i34"> <i>cis</i>-<i>N</i>-Ethyl-3-[3-fluoro-4-(pyrrolidin-1-ylmethyl)phenyl]-<i>N</i>-methylcyclobutanecarboxamide (<b>5</b>)</h3><div class="NLM_p last">Following the general procedure described for preparing olefin <b>17</b>, compound <b>21</b> (71.76 g, 214.6 mmol) yielded 182.0 g of crude olefin <b>22</b> as the TFA salt, <i>N</i>-ethyl-3-[3-fluoro-4-(pyrrolidin-1-ylmethyl)phenyl]-<i>N</i>-methylcyclobut-2-ene-1-carboxamide, as a brown oil. This was dissolved in EtOH (1.5 L) and hydrogenated (∼45 psi) with 10% Pd/C (10 g) at room temperature for 1.5 h. After filtration and concentration, the resulting oil was dissolved in EtOAc (500 mL), washed with a solution of K<sub>2</sub>CO<sub>3</sub> (60 g) in water (400 mL), then with brine (200 mL), and dried over MgSO<sub>4</sub>. Filtration and concentration afforded 66.26 g of an orange oil, which was purified by chromatography, flushing first with CH<sub>2</sub>Cl<sub>2</sub> and then eluting with 5% MeOH in CH<sub>2</sub>Cl<sub>2</sub> to yield 41.75 g (58%) of pure title compound and 9.98 g (14%) of ∼85–90% pure material. The cleaner material (41.75 g, 131.1 mmol) was dissolved in EtOAc (1 L); 2 N HCl in Et<sub>2</sub>O (80 mL, 160 mmol) was added over ∼1 min with vigorous stirring. After 30 min, the light orange precipitate was collected, rinsed with EtOAc, and dried to yield the corresponding HCl salt of <b>5</b> (36.15 g). A portion was recrystallized from MeOH/EtOAc to provide an analytical sample as a white solid, mp 196–196.5 °C. <sup>1</sup>H NMR (300 MHz, CDCl<sub>3</sub>) ∼1:1 mixture of rotamers, δ 12.69 (br s, 1H), 7.79 (t, <i>J</i> = 7.9, 1H), 7.07–7.00 (m, 2H), 4.20 (d, <i>J</i> = 5.4, 2H), 3.57–3.64 (m, 2H), 3.47–3.53 (m, 2H), 3.16–3.30 (m, 2H), 2.91 and 2.88 (2 s, 3H total), 2.79–2.85 (m, 2H), 2.50–2.60 (m, 2H), 2.34–2.46 (m, 2H), 2.14–2.26 (m, 2H), 1.95 −2.06 (m, 2H), 1.14 and 1.07 (2 t, <i>J</i> = 7.1, 3H total). <sup>13</sup>C NMR (100 MHz, CDCl<sub>3</sub>) δ (mixture of rotamers) 173.3, 162.7, 160.2, 150.6, 150.5, 133.6, 133.6, 124.0, 124.0, 114.4, 114.3, 114.0, 113.8, 52.6, 49.9, 49.9, 44.1, 42.7, 35.3, 34.3, 33.5, 32.8, 32.4, 23.2, 14.1, 12.4. HRMS <i>m</i>/<i>z</i>, calcd (M + 1) 319.2180, observed 319.2188. Anal. Calcd for C<sub>19</sub>H<sub>27</sub>FN<sub>2</sub>O·HCl: C, 64.30; H, 7.95; N, 7.89. Found: C, 64.36; H, 8.02; N, 7.97.</div></div><div id="sec6_6" class="NLM_sec NLM_sec_level_2"><div id="ac_i35" class="anchor-spacer"></div><h3 class="article-section__title" id="_i35"> <i>trans</i>-<i>N</i>-Ethyl-3-fluoro-3-[3-fluoro-4-(pyrrolidin-1-ylmethyl)phenyl]cyclobutanecarboxamide (<b>6</b>)</h3><div class="NLM_p last">A solution of <b>23</b> (48.7 g, 152.0 mmol) in CH<sub>2</sub>Cl<sub>2</sub> (450 mL) was added over 50 min down the reaction flask walls to a −78 °C solution of bis(2-methoxyethyl)aminosulfur trifluoride (BAST) (42.0 mL, 227.8 mmol) in CH<sub>2</sub>Cl<sub>2</sub> (375 mL). After 2.5 h at −78 °C, the cooling bath was removed and the mixture was stirred for 16 h at room temperature. With stirring, aqueous NaHCO<sub>3</sub> was carefully added in portions until all foaming subsided. Solid K<sub>2</sub>CO<sub>3</sub> was then added to ensure that the pH was >8. The phases were separated, and the aqueous phase was extracted with additional CH<sub>2</sub>Cl<sub>2</sub> (2 × 100 mL). The organic phases were combined, dried over MgSO<sub>4</sub>, filtered, and concentrated to yield a dark orange-brown oil (50.2 g). This crude material was purified by chromatography, eluting with EtOAc and 10% MeOH/EtOAc to yield 28.21 g (58%) of the title compound. The monotosylate salt of <b>6</b> was prepared by addition of a solution of <i>p</i>-toluenesulfonic acid (2.50 g, 13.14 mmol) in EtOAc (70 mL) to a stirring solution of the free base (4.18 g, 13.0 mmol) in EtOAc (35 mL). The resulting mixture was stirred for an additional hour. The white precipitate was filtered, rinsed with EtOAc, and air-dried to afford 6.32 g of the tosylate salt of <b>6</b>. This material was dissolved in MeOH, filtered to remove particulates, and reconcentrated. The resulting solid was dissolved in ∼12–14 mL of MeOH with gentle heating. EtOAc (75 mL) was added over 20 min, and then the mixture was stirred for 1 h at room temperature. The solid was filtered, rinsed with EtOAc, and air-dried to yield the monotosylate salt of <b>6</b> (5.59 g) as a white, crystalline powder. <sup>1</sup>H NMR (CDCl<sub>3</sub>) δ 7.71 (d, <i>J</i> = 8.3, 2H), 7.65 (t, <i>J</i> = 7.9, 1H), 7.28–7.22 (m, 2H), 7.15 (d, <i>J</i> = 7.9, 2H), 6.52 (br s, 1H), 4.28 (d, <i>J</i> = 5.4, 2H), 3.68–3.37 (m, 2H), 3.33–3.18 (m, 3H), 2.97–2.88 (m, 2H), 2.84–2.57 (m, 4H), 2.32 (s, 3H), 2.27–1.96 (m, 4H), 1.07 (t, <i>J</i> = 7.3, 3H). <sup>13</sup>C NMR (CDCl<sub>3</sub>) δ 173.5, 161.0 (dd, <i>J</i><sub>C–F</sub> = 248.9, 1.5), 147.0 (dd, <i>J</i><sub>C–F</sub> = 23.6, 7.4), 142.0, 140.1, 133.3 (d, <i>J</i><sub>C–F</sub> = 3.0), 128.8, 125.8, 121.5 (dd, <i>J</i><sub>C–F</sub> = 8.8, 3.7), 116.1 (dd, <i>J</i><sub>C–F</sub> = 14.7, 1.5), 112.6 (dd, <i>J</i><sub>C–F</sub> = 23.6, 8.8), 96.4 (dd, <i>J</i><sub>C–F</sub> = 197.6, 2.2), 53.2, 50.4 (d, <i>J</i><sub>C–F</sub> = 2.9), 38.6 (d, <i>J</i><sub>C–F</sub> = 24.3), 34.4, 32.4, 22.7, 21.3, 14.7. Anal. Calcd for C<sub>18</sub>H<sub>24</sub>F<sub>2</sub>N<sub>2</sub>O·C<sub>7</sub>H<sub>8</sub>O<sub>3</sub>S: C, 60.71; H, 6.52; N, 5.66; F, 7.68; S, 6.48. Found: C, 60.55; H, 6.40; N, 5.58; F, 7.67; S, 6.68. HRMS <i>m</i>/<i>z</i>, calcd (M + 1) 323.1929, observed 323.1934.</div></div><div id="sec6_7" class="NLM_sec NLM_sec_level_2"><div id="ac_i36" class="anchor-spacer"></div><h3 class="article-section__title" id="_i36"> <i>trans</i>-3-Fluoro-3-[3-fluoro-4-(pyrrolidin-1-ylmethyl)phenyl]-<i>N</i>-(2-methylpropyl)cyclobutanecarboxamide (<b>7</b>)</h3><div class="NLM_p last">The free base of this material was prepared in 85% yield as a waxy orange solid following the general procedure described for compound <b>6</b> and substituting <b>24</b> for <b>23</b>. The free base <b>7</b> (13.8 g, 79.0 mmol) was dissolved in EtOAc (250 mL) and treated with <i>p</i>-toluenesulfonic acid (15.2 g, 79.9 mmol) in EtOAc (150 mL). The resulting solution was stirred overnight, and the white precipitate was collected and dried under nitrogen purge to yield 16.5 g of the monotosylate salt. The salt was dissolved in a mixture of MeOH (20 mL) and EtOAc (40 mL) by application of heat. Following filtration through a nylon filter, EtOAc (250 mL) was added to the filtrate over ∼40 min. After the mixture was stirred for an additional hour, the resulting white solid was collected and dried under nitrogen purge. This recrystallization procedure was repeated twice to afford 12.2 g of the tosylate salt of <b>7</b> as a solid. <sup>1</sup>H NMR (300 MHz, CDCl<sub>3</sub>) δ 11.36 (br s, 1H), 7.79–7.74 (m, 3H), 7.32–7.28 (m, 2H), 7.19 (d, <i>J</i> = 7.9, 2H), 5.78 (br s, 1H), 4.32 (d, <i>J</i> = 5.4, 2H), 3.79–3.73 (m, 2H), 3.29 (tt, <i>J</i> = 8.7, 8.3, 1H), 3.09 (dd, <i>J</i> = 7.1, 6.3, 2H), 2.93–2.66 (m, 6H), 2.36 (s, 3H), 2.24–2.18 (m, 2H), 2.08–2.02 (m, 2H), 1.76 (sept, <i>J</i> = 6.7, 1H), 0.89 (d, <i>J</i> = 6.6, 6H). <sup>13</sup>C NMR (100 MHz, CDCl<sub>3</sub>) δ 174.0, 161.3 (d, <i>J</i><sub>C–F</sub> = 248.0), 147.4 (dd, <i>J</i><sub>C–F</sub> = 24.1, 7.5), 142.5, 140.3, 133.3 (d, <i>J</i><sub>C–F</sub> = 3.0), 128.8, 125.8, 121.5 (dd, <i>J</i><sub>C–F</sub> = 9.0, 4.5), 116.1 (d, <i>J</i><sub>C–F</sub> = 13.5), 112.3 (dd, <i>J</i><sub>C–F</sub> = 24.1, 9.0), 96.7 (d, <i>J</i><sub>C–F</sub> = 196.9), 53.4, 50.0 (d, <i>J</i><sub>C–F</sub> = 3.0), 46.9, 38.6 (d, <i>J</i><sub>C–F</sub> = 25.6), 32.5, 28.4, 22.7, 21.2, 20.0. Anal. Calcd for C<sub>20</sub>H<sub>28</sub>F<sub>2</sub>N<sub>2</sub>O·C<sub>7</sub>H<sub>8</sub>O<sub>3</sub>S: C, 62.05; H, 6.94; N, 5.36; F, 7.27; S, 6.14. Found: C, 61.85; H, 7.03; N, 5.32; F, 7.21; S, 6.34. HRMS <i>m</i>/<i>z</i>, calcd (M + 1) 351.2242, observed 351.2236.</div></div><div id="sec6_8" class="NLM_sec NLM_sec_level_2"><div id="ac_i37" class="anchor-spacer"></div><h3 class="article-section__title" id="_i37"> {[(3,3-Dimethoxycyclobutyl)methoxy]methyl}benzene (<b>8a</b>)</h3><div class="NLM_p last"><i>t-</i>BuOK (1 M in THF, 163 mL, 163 mmol) was added at room temperature to a solution of (3,3-dimethoxycyclobutyl)methanol<a onclick="showRef(event, 'ref50'); return false;" href="javascript:void(0);" class="ref ref50">(50)</a> (11.9 g, 81.5 mmol) in THF (100 mL). The mixture was stirred for 30 min. Benzyl bromide (10.2 mL, 85.6 mmol) was added, and the stirring was continued for an additional 30 min. Water and CH<sub>2</sub>Cl<sub>2</sub> were added, and the organic layer was separated, dried over MgSO<sub>4</sub>, filtered, and concentrated. Chromatography using a gradient of 100% hexanes to 5% EtOAc/hexanes furnished the desired product as a colorless oil (13.2 g, 69%). <sup>1</sup>H NMR (CDCl<sub>3</sub>, 400 MHz) δ 7.36–7.25 (m, 5H), 4.52 (s, 2H), 3.48 (d, <i>J</i> = 7.0, 2H), 3.16 (s, 3H), 3.12 (s, 3H), 2.44–2.26 (m, 3H), 1.90–1.84 (m, 2H). <sup>13</sup>C NMR (CDCl<sub>3</sub>, 100 MHz) δ 138.8, 128.6, 127.9, 127.8, 101.1, 74.7, 73.2, 48.6, 48.4, 34.9, 24.9. MS (APCI) <i>m</i>/<i>z</i> = 205.3 (M – OCH<sub>3</sub>).</div></div><div id="sec6_9" class="NLM_sec NLM_sec_level_2"><div id="ac_i38" class="anchor-spacer"></div><h3 class="article-section__title" id="_i38"> 3-[(Benzyloxy)methyl]cyclobutanone (<b>8</b>)</h3><div class="NLM_p last"><i>p-</i>Toluenesulfonic acid monohydrate (2.1 g, 11 mmol) was added to a solution of <b>8a</b> (13.0 g, 55.1 mmol) in acetone/water (3:1, 200 mL). After heating for 45 min at 65 °C, the mixture was cooled to room temperature and concentrated. The residue was dissolved in EtOAc, washed with 5% aqueous NaOH, dried over MgSO<sub>4</sub>, filtered, and concentrated. Chromatography using 10% EtOAc/hexanes yielded the title compound as a colorless oil (6.0 g, 58%). <sup>1</sup>H NMR (CDCl<sub>3</sub>, 400 MHz) δ 7.28–7.38 (m, 5H), 4.56 (s, 2H), 3.59 (d, <i>J</i> = 6.3, 2H), 3.88–3.18 (m, 2H), 2.84–2.92 (m, 2H), 2.64–2.75 (m, 1H). <sup>13</sup>C NMR (CDCl<sub>3</sub>, 100 MHz) δ 207.6, 138.3, 128.7, 127.9, 127.8, 73.4, 73.1, 50.2, 23.9. GCMS <i>m</i>/<i>z</i> = 190 (M<sup>+</sup>).</div></div><div id="sec6_10" class="NLM_sec NLM_sec_level_2"><div id="ac_i39" class="anchor-spacer"></div><h3 class="article-section__title" id="_i39"> 3-[(Benzyloxy)methyl]-1-[4-(pyrrolidin-1-ylmethyl)phenyl]cyclobutanol (<b>9</b>)</h3><div class="NLM_p last"><i>n</i>-BuLi (2.5 M in hexane, 3.2 mL, 8.0 mmol) was slowly added to a −78 °C solution of 1-(4-bromobenzyl)pyrrolidine (1.9 g, 7.9 mmol) in THF (13 mL). After 30 min, a −78 °C solution of <b>8</b> (1.0 g, 5.3 mmol) in THF (1 mL) was added via cannula and the resulting solution was stirred at −78 °C for 30 min. The reaction was quenched with saturated aqueous NH<sub>4</sub>Cl and diluted with EtOAc. The organics were dried over MgSO<sub>4</sub>, filtered, and concentrated. Chromatography using a gradient of 2% MeOH/CH<sub>2</sub>Cl<sub>2</sub> containing 0.1% NH<sub>4</sub>OH to 30% MeOH/CH<sub>2</sub>Cl<sub>2</sub> containing 0.1% NH<sub>4</sub>OH afforded the title compound (1.3 g, 71%) as a colorless oil. GCMS analysis indicated a ∼3:1 mixture of isomers, presumed to be cis and trans. <sup>1</sup>H NMR (CDCl<sub>3</sub>, 400 MHz) δ 7.28–7.47 (m, 9H), 4.61 and 4.52 (singlets, 2H total), 3.46–3.62 (m, 4H), 2.75–2.97 (m, 2H), 2.48–2.53 (m, 4H), 2.22–2.47 (m, 4H), 1.75–1.82 (m, 4H). MS (APCI) <i>m</i>/<i>z</i> = 352.4 (M + 1).</div></div><div id="sec6_11" class="NLM_sec NLM_sec_level_2"><div id="ac_i40" class="anchor-spacer"></div><h3 class="article-section__title" id="_i40"> 1-(4-{3-[(Benzyloxy)methyl]cyclobutyl}benzyl)pyrrolidine (<b>10</b>)</h3><div class="NLM_p last">Triethylsilane (49.0 mL, 308 mmol) and TFA (47 mL, 620 mmol) were added to <b>9</b> (21.6 g, 61.5 mmol) and the resulting biphasic mixture was heated at 75 °C for 1 h, cooled to room temperature and concentrated. This material was used without purification in the next step. For characterization, a portion of the crude material was dissolved in EtOAc and washed with 1 N aqueous NaOH, dried over MgSO<sub>4</sub>, filtered and concentrated. Chromatography using EtOAc and 10% MeOH/EtOAc gave a ∼1:1 mixture of <i>cis and trans</i> isomers of the title compound as a colorless oil. <sup>1</sup>H NMR (CDCl<sub>3</sub>, 400 MHz) δ 7.14–7.40 (m, 9H), 4.59 and 4.54 (singlets, 2H total), 3.65 and 3.47 (doublets, <i>J</i> = 7.2 and 6.3, 2H total), 3.60 (singlet, 1H), 3.59 (singlet, 1H), 3.55–3.61 and 3.36–3.43 (multiplets, 1H total), 2.45–2.65 (overlapping multiplets, 6H total), 2.20–2.34 and 1.86–1.94 (multiplets, 3H total), 1.75–1.82 (m, 4H). MS (APCI) <i>m</i>/<i>z</i> = 336.4 (M + 1).</div></div><div id="sec6_12" class="NLM_sec NLM_sec_level_2"><div id="ac_i41" class="anchor-spacer"></div><h3 class="article-section__title" id="_i41"> {3-[4-(Pyrrolidin-1-ylmethyl)phenyl]cyclobutyl}methanol (<b>11</b>)</h3><div class="NLM_p last">A sample of 20% palladium black (4.0 g) was added to a stirring solution of crude <b>10</b> (61.5 mmol) in EtOH (250 mL). This mixture was hydrogenated at 45 psi for 1 h, filtered through Celite, and concentrated. The residue was dissolved in CH<sub>2</sub>Cl<sub>2</sub> and washed with saturated aqueous NaHCO<sub>3</sub>. The aqueous layer was extracted with 3:1 CHCl<sub>3</sub>/<i>i-</i>PrOH, and the combined organic layers were dried over MgSO<sub>4</sub>, filtered, and concentrated. Chromatography with a gradient of 2–20% MeOH/CH<sub>2</sub>Cl<sub>2</sub> containing 0.2% NH<sub>4</sub>OH provided the desired product as the TFA salt. This was dissolved in 3:1 CHCl<sub>3</sub>/<i>i-</i>PrOH and washed with aqueous K<sub>2</sub>CO<sub>3</sub>. Removal of solvent yielded the title compound (11.9 g, 79%, colorless oil) as a mixture of cis and trans isomers, which was used without further separation. <sup>1</sup>H NMR (CDCl<sub>3</sub>, 400 MHz) δ 7.20–7.24 (m, 2H), 7.09–7.14 (m, 2H), 5.69 (br s, 1H), 3.76 and 3.75 (singlets, 2H total), 3.24–3.65 (overlapping doublets and multiplets, 3H total), 2.70–2.77 (m, 4H), 2.30–2.43 (m, 2H), 1.73–1.85 and 2.08–2.16 (overlapping multiplets, 7H total). MS (APCI) <i>m</i>/<i>z</i> = 246.3 (M + 1).</div></div><div id="sec6_13" class="NLM_sec NLM_sec_level_2"><div id="ac_i42" class="anchor-spacer"></div><h3 class="article-section__title" id="_i42"> {<i>cis</i>-3-[4-(Pyrrolidin-1-ylmethyl)phenyl]cyclobutyl}methyl 4-Methylbenzenesulfonate (<b>12a</b>) and {<i>trans</i>-3-[4-(Pyrrolidin-1-ylmethyl)phenyl]cyclobutyl}methyl 4-Methylbenzenesulfonate (<b>12b</b>)</h3><div class="NLM_p"><i>p</i>-Toluenesulfonyl chloride (<i>p-</i>TsCl) (49.9 g, 262 mmol) was added to a 0 °C solution of <b>11</b> (53.5 g, 218.4 mmol) and pyridine (88.3 mL, 1.09 mol) in CH<sub>2</sub>Cl<sub>2</sub> (250 mL). After 30 min, an additional portion of <i>p-</i>TsCl (10.0 g, 52.5 mmol) was added, and the mixture was stirred overnight at room temperature. The mixture was concentrated to near dryness. Water, CH<sub>2</sub>Cl<sub>2</sub>, and solid NaHCO<sub>3</sub> and K<sub>2</sub>CO<sub>3</sub> were added, and the mixture was stirred for 90 min to consume excess <i>p-</i>TsCl. The organic layer was separated, dried over MgSO<sub>4</sub>, filtered, and concentrated. The resulting oil (110 g) was purified by chromatography using a gradient of 2–5% MeOH in CH<sub>2</sub>Cl<sub>2</sub> to provide a 1:2 mixture of cis and trans isomers of the product (57 g, 66%) as a brown gum. The isomers were separated by preparative HPLC (Chiralpak AD column, eluting with 85/15 heptane/EtOH with 0.1% diethylamine modifier) to afford the following compounds.</div><div class="NLM_p"><b>12a</b> (cis isomer): colorless gum. <sup>1</sup>H NMR (CDCl<sub>3</sub>, 400 MHz) δ 7.79 (d, <i>J</i> = 8.3, 2H), 7.32 (d, <i>J</i> = 7.9, 2H), 7.24 (d, <i>J</i> = 7.9, 2H), 7.08 (d, <i>J</i> = 7.9, 2H), 3.99 (d, <i>J</i> = 6.2, 2H), 3.57 (s, 2H), 3.31–3.40 (m, 1H), 2.53–2.63 (m, 1H), 2.46–2.50 (m, 4H), 2.42 (s, 3H), 2.36–2.41 (m, 2H), 1.78–1.87 (m, 2H), 1.72–1.77 (m, 4H). <sup>13</sup>C NMR (CDCl<sub>3</sub>, 100 MHz) δ 144.4, 143.1, 136.9, 132.8, 129.6, 128.5, 127.5, 125.8, 73.6, 60.0, 53.8, 35.3, 31.9, 29.7, 23.1, 21.3. MS (APCI) <i>m</i>/<i>z</i> = 400.3 (M + 1).</div><div class="NLM_p last"><b>12b</b> (trans isomer): colorless gum. <sup>1</sup>H NMR (CDCl<sub>3</sub>, 400 MHz) δ 7.84 (d, <i>J</i> = 8.1, 2H), 7.37 (d, <i>J</i> = 7.8, 2H), 7.26 (d, <i>J</i> = 8.2, 2H), 7.13 (d, <i>J</i> = 8.2, 2H), 4.19 (d, <i>J</i> = 7.4, 2H), 3.59 (s, 2H), 3.49–3.57 (m, 1H), 2.57–2.65 (m, 1H), 2.49–2.52 (m, 4H), 2.47 (s, 3H), 2.23–2.31 (m, 2H), 2.14–2.21 (m, 2H), 1.76–1.80 (m, 4H). <sup>13</sup>C NMR (CDCl<sub>3</sub>, 100 MHz) δ 144.7, 143.9, 137.0, 133.2, 129.8, 128.9, 127.9, 126.1, 73.6, 60.3, 54.1, 35.9, 30.6, 29.9, 23.4, 21.6. MS (APCI) <i>m</i>/<i>z</i> = 400.3 (M + 1).</div></div><div id="sec6_14" class="NLM_sec NLM_sec_level_2"><div id="ac_i43" class="anchor-spacer"></div><h3 class="article-section__title" id="_i43"> {<i>trans</i>-3-[4-(Pyrrolidin-1-ylmethyl)phenyl]cyclobutyl}methanol (<b>13</b>)</h3><div class="NLM_p last">Magnesium turnings (4.87 g, 201 mmol) and <b>12b</b> (8.0 g, 20 mmol) in MeOH (160 mL) were stirred for 4 h to give a milky mixture. Aqueous NaOH (15%) was added, and the mixture was extracted with 3:1 CHCl<sub>3</sub>/<i>i</i>-PrOH. The organic phase was dried over MgSO<sub>4</sub>, filtered, and concentrated to yield the title compound (3.6 g, 73%) as a colorless oil. This material was used without further purification. <sup>1</sup>H NMR (CDCl<sub>3</sub>, 400 MHz) δ 7.28 (d, <i>J</i> = 8.0, 2H), 7.19 (d, <i>J</i> = 8.0, 2H), 3.73 (d, <i>J</i> = 7.4, 2H), 3.60 (s, 2H), 3.52–3.58 (m, 1H), 3.47 (br s, 1H), 2.49–2.56 (m, 4H), 2.41–2.49 (m, 1H), 2.16–2.29 (m, 4H), 1.70–1.81 (m, 4H). <sup>13</sup>C NMR (CDCl<sub>3</sub>, 100 MHz) δ 144.9, 136.2, 128.9, 126.1, 66.2, 60.2, 53.9, 36.3, 32.8, 31.0, 23.2. MS (APCI) <i>m</i>/<i>z</i> = 246.4 (M + 1).</div></div><div id="sec6_15" class="NLM_sec NLM_sec_level_2"><div id="ac_i44" class="anchor-spacer"></div><h3 class="article-section__title" id="_i44"> (4-Bromo-2-chlorophenyl)(pyrrolidin-1-yl)methanone (<b>14</b>)</h3><div class="NLM_p last">T3P (48.6 g, 153 mmol, 50 wt % in EtOAc) was added to a mixture of 4-bromo-2-chlorobenzoic acid (30 g, 130 mmol), triethylamine (25.8 g, 255 mmol), and pyrrolidine (18 g, 255 mmol) in EtOAc (1.5 L). After 1 h, 1 N aqueous NaOH (200 mL) was added and the mixture was stirred for 10 min. The layers were separated, and the aqueous phase was extracted with EtOAc (2 × 500 mL). The combined organic extracts were dried over MgSO<sub>4</sub>, filtered, and concentrated to provide a viscous oil. Chromatography using a gradient of 50–80% EtOAc in hexanes yielded the title compound as a light yellow, viscous oil (35.4 g, 96%). <sup>1</sup>H NMR (CDCl<sub>3</sub>, 400 MHz) δ 7.56 (d, <i>J</i> = 1.7, 1H), 7.43 (dd, <i>J</i> = 8.3, 1.7, 1H), 7.17 (d, <i>J</i> = 8.3, 1H), 3.63 (br app t, <i>J</i> = 6.6, 2H), 3.17 (br app t, <i>J</i> = 6.6, 2H), 2.00–1.84 (m, 4H). <sup>13</sup>C NMR (CDCl<sub>3,</sub> 100 MHz) δ 166.0, 136.6, 132.6, 131.3, 130.7, 128.9, 123.3, 48.0, 45.8, 26.1, 24.7. MS (APCI) <i>m</i>/<i>z</i> = 287.9 (M + 1).</div></div><div id="sec6_16" class="NLM_sec NLM_sec_level_2"><div id="ac_i45" class="anchor-spacer"></div><h3 class="article-section__title" id="_i45"> 1-(4-Bromo-2-chlorobenzyl)pyrrolidine (<b>15</b>)</h3><div class="NLM_p last">Borane–THF complex (1.0 M in THF, 367 mL, 367 mmol) was added dropwise to a solution of <b>14</b> (35.3 g, 122 mmol) in THF (120 mL), and the resulting mixture was stirred at room temperature for 21 h. The reaction was quenched with MeOH (120 mL), and the mixture was heated to 80 °C for 18 h. The mixture was cooled to room temperature and concentrated and the resulting residue was purified by chromatography using 50% EtOAc in hexanes to yield the title compound as a colorless, viscous oil (24.4 g, 74%). <sup>1</sup>H NMR (CDCl<sub>3,</sub> 400 MHz) δ 7.47 (br s, 1H), 7.38–7.33 (m, 2H), 3.66 (s, 2H), 2.58–2.54 (m, 4H), 1.80–1.76 (m, 4H). <sup>13</sup>C NMR (CDCl<sub>3</sub>,100 MHz) δ 136.4, 134.8, 132.0, 131.9, 130.0, 120.7, 56.6, 54.4, 23.8. MS (APCI) <i>m</i>/<i>z</i> = 275.8 (M + 1).</div></div><div id="sec6_17" class="NLM_sec NLM_sec_level_2"><div id="ac_i46" class="anchor-spacer"></div><h3 class="article-section__title" id="_i46"> 3-[3-Chloro-4-(pyrrolidin-1-ylmethyl)phenyl]-3-hydroxy-<i>N</i>-methylcyclobutanecarboxamide (<b>16</b>)</h3><div class="NLM_p last"><i>n</i>-Butyllithium (2.5 M in hexanes, 135 mL, 0.335 mol) was added down the reaction flask walls over 25 min to a −78 °C solution of <b>15</b> (92.0 g, 0.335 mol) in THF (400 mL). After the mixture was stirred at −78 °C for 1 h, a −78 °C solution of 3-oxocyclobutanecarboxylic acid (19.0 g, 167.5 mmol) in THF (400 mL) was cannulated into the reaction mixture over 15 min. The resulting dark orange solution was slowly warmed to room temperature over 16 h. To the crude solution of the intermediate 3-[3-chloro-4-(pyrrolidin-1-ylmethyl)phenyl]-3-hydroxycyclobutanecarboxylic acid were added methylamine (2.0 M in THF, 167 mL, 334 mmol) and T3P (50 wt % solution in EtOAc, 128 mL, 201 mmol). The resulting reaction mixture was stirred at room temperature for 1 h. Then 1 N aqueous NaOH (575 mL) and EtOAc (400 mL) were added and the layers were separated. The aqueous layer was subjected to EtOAc extraction (2 × 500 mL), and the combined organic layers were dried over MgSO<sub>4</sub>, filtered, and concentrated. Chromatography with a gradient of 5–15% MeOH in CH<sub>2</sub>Cl<sub>2</sub> containing 0.25% NH<sub>4</sub>OH provided the title compound (25.9 g, 48%). <sup>1</sup>H NMR (CDCl<sub>3</sub>, 400 MHz) δ 7.46–7.48 (m, 2H), 7.34 (dd, <i>J</i> = 7.9, 1.7, 1H), 6.03–6.11 (br m, 1H), 5.77 (br s, 1H), 3.76 (s, 2H), 2.85 (d, <i>J</i> = 4.9, 3H), 2.73–2.86 (m, 3H), 2.56–2.63 (m, 4H), 2.47–2.54 (m, 2H), 1.76–1.84 (m, 4H). <sup>13</sup>C NMR (CDCl<sub>3</sub>, 100 MHz) δ 177.3, 145.8, 135.1, 133.8, 130.6, 126.1, 123.3, 74.1, 56.5, 54.1, 40.8, 33.1, 26.6, 23.5. MS (APCI) <i>m</i>/<i>z</i> = 323.1 (M + 1).</div></div><div id="sec6_18" class="NLM_sec NLM_sec_level_2"><div id="ac_i47" class="anchor-spacer"></div><h3 class="article-section__title" id="_i47"> <i>trans</i>-3-[3-Chloro-4-(pyrrolidin-1-ylmethyl)phenyl]-<i>N</i>-methylcyclobutanecarboxamide (<b>18</b>)</h3><div class="NLM_p last">TFA (48 mL) was added to a solution of <b>16</b> (10.0 g, 31.4 mmol) in DCE (202 mL), and the resulting mixture was heated at 75 °C for 18 h and concentrated. The crude TFA salt of 3-[3-chloro-4-(pyrrolidin-1-ylmethyl)phenyl]-<i>N</i>-methylcyclobut-2-ene-1-carboxamide (<b>17</b>) thus obtained was redissolved in EtOH (130 mL) and hydrogenated (45 psi) at 60 °C in the presence of chlorotris(triphenylphosphine)rhodium(I) (Wilkinson’s catalyst, 1.5 g). After 2 h, the mixture was cooled and concentrated. The residue was redissolved in 1 N aqueous HCl (100 mL) and washed twice with EtOAc (2 × 100 mL). The aqueous layer was then made basic with 1 N aqueous NaOH (100 mL) and extracted with EtOAc (2 × 500 mL). The combined organic phases were dried over MgSO<sub>4</sub>, filtered, and concentrated. Chromatography with a gradient of 5–15% MeOH in CH<sub>2</sub>Cl<sub>2</sub> containing 0.25% NH<sub>4</sub>OH gave a mixture of cis and trans isomers of the title compound (4.6 g, 48% yield). These isomers were separated by preparative chromatography on a Chiralcel OD (10 cm × 50 cm) column using heptane/<i>i</i>-PrOH (90/10) to yield the pure trans (3.6 g) and cis (0.52 g) isomers. <i>trans</i>-3-[3-Chloro-4-(pyrrolidin-1-ylmethyl)phenyl]-<i>N</i>-methylcyclobutanecarboxamide (<b>18</b>): <sup>1</sup>H NMR (CDCl<sub>3</sub>, 400 MHz) δ 7.39 (d, <i>J</i> = 7.8, 1H), 7.22 (d, <i>J</i> = 1.6, 1H), 7.09 (dd, <i>J</i> = 7.8, 1.2, 1H), 5.58 (br s, 1H), 3.69–3.77 (singlet at 3.72 (2H) overlapping multiplet (1H), 3H total), 2.94–3.00 (m, 1H), 2.86 (d, <i>J</i> = 5.1, 3H), 2.65–2.72 (m, 2H), 2.55–2.60 (m, 4H), 2.31–2.38 (m, 2H), 1.75–1.83 (m, 4H). <sup>13</sup>C NMR (CDCl<sub>3</sub>, 100 MHz) δ 175.8, 145.7, 134.4, 133.8, 130.6, 127.1, 124.7, 56.7, 54.2, 36.2, 36.1, 31.9, 26.4, 23.5. MS (APCI) <i>m</i>/<i>z</i> = 307.4 (M + 1).</div></div><div id="sec6_19" class="NLM_sec NLM_sec_level_2"><div id="ac_i48" class="anchor-spacer"></div><h3 class="article-section__title" id="_i48"> 1-{<i>trans</i>-3-[3-Chloro-4-(pyrrolidin-1-ylmethyl)phenyl]cyclobutyl}-<i>N</i>-methylmethanamine (<b>19</b>)</h3><div class="NLM_p last">BH<sub>3</sub>–THF complex (1.0 M in THF, 319 mL, 319 mmol) was added to a solution of <b>18</b> (32.5 g, 106.2 mmol) in THF (516 mL), and the resulting solution was heated at 70 °C for 16 h. MeOH was added to quench the excess borane, and the heating was continued for another 16 h. The reaction mixture was cooled to room temperature and concentrated to yield a viscous oil which was redissolved in EtOAc (500 mL) and extracted into 6 N HCl (260 mL). The acidic aqueous phase was basified with 15% aqueous NaOH (500 mL) and extracted with EtOAc (2 × 750 mL). The extracts were dried over MgSO<sub>4</sub>, filtered, and concentrated to yield 30.3 g of crude product. Chromatography with a gradient of 5–100% MeOH in CH<sub>2</sub>Cl<sub>2</sub> containing 0.25% NH<sub>4</sub>OH afforded the title compound (23.7 g, 77% yield) as a colorless viscous oil. <sup>1</sup>H NMR (CDCl<sub>3</sub>, 400 MHz) δ 7.39 (d, <i>J</i> = 7.9, 1H), 7.23 (d, <i>J</i> = 1.7, 1H), 7.10 (dd, <i>J</i> = 7.9, 1.7, 1H), 3.73 (s, 2H), 3.55 (tt, <i>J</i> = 8.3, 8.2, 1H), 2.79 (d, <i>J</i> = 7.5, 2H), 2.56–2.61 (m, 4H), 2.48 (s, 3H) overlapping 2.44–2.51 (m, 1H), 2.21–2.31 (m, 2H), 2.12–2.18 (m, 2H), 1.76–1.83 (m, 4H). <sup>13</sup>C NMR (CDCl<sub>3</sub>, 100 MHz) δ 146.5, 134.1, 133.7, 130.5, 127.2, 124.7, 57.3, 56.7, 54.2, 36.6, 36.2, 32.4, 30.9, 23.5. MS (APCI) <i>m</i>/<i>z</i> = 293.2 (M + 1).</div></div><div id="sec6_20" class="NLM_sec NLM_sec_level_2"><div id="ac_i49" class="anchor-spacer"></div><h3 class="article-section__title" id="_i49"> <i>N</i>-({<i>trans</i>-3-[3-Chloro-4-(pyrrolidin-1-ylmethyl)phenyl]cyclobutyl}methyl)-<i>N</i>-methylacetamide (<b>4</b>)</h3><div class="NLM_p last">Acetic anhydride (9.2 mL, 97 mmol) was added to a 0 °C solution of <b>19</b> (23.7 g, 81.2 mmol) and Et<sub>3</sub>N (22.6 mL, 162 mmol) in CH<sub>2</sub>Cl<sub>2</sub> (230 mL). After the mixture was stirred for 30 min, 1 N aqueous NaOH (200 mL) was added and the phases were separated. The aqueous phase was extracted twice with EtOAc, and the combined organics were dried over MgSO<sub>4</sub>, filtered, and concentrated to yield 29.2 g of crude product. Chromatography using a gradient of 5–20% MeOH in CH<sub>2</sub>Cl<sub>2</sub> containing 0.1% NH<sub>4</sub>OH yielded the title compound (27 g, 99%) as a colorless, viscous oil. This was dissolved in EtOAc (200 mL) and treated with 2 M HCl in Et<sub>2</sub>O (81.2 mL) to afford the mono-HCl salt of the title compound as a white solid (30.6 g, 99%). <sup>1</sup>H NMR (MeOH-<i>d</i><sub>4</sub>, 400 MHz) ∼1.5:1 mixture of rotamers, δ 7.70–7.73 (m, 1H), 7.50 and 7.46 (2 d, <i>J</i> = 1.7, 1H total), 7.40 and 7.36 (2 dd, <i>J</i> = 7.9, 1.5, 1H total), 4.57 (s, 2H), 3.70–3.82 (m, 3H), 3.53–3.60 (m, 2H), 3.24 (m, 2H), 3.24 and 3.14 (2 s, 3H total), 2.72–2.86 (m, 1H), 2.17–2.38 (m, 9H), 2.02–2.12 (m, 2H). <sup>13</sup>C NMR (MeOH-<i>d</i><sub>4</sub>, 100 MHz) δ 175.7, 175.4, 151.6, 151.5, 136.2, 134.3, 129.4, 129.3, 127.6, 127.5, 127.4, 127.3, 57.1, 55.9, 55.2, 54.7, 38.3, 37.2, 37.0, 36.0, 32.8, 32.6, 31.0, 30.4, 24.0, 20.2, 19.8. HRMS <i>m</i>/<i>z</i>, calcd (M + 1) 335.1884, observed 335.1880.</div></div><div id="sec6_21" class="NLM_sec NLM_sec_level_2"><div id="ac_i50" class="anchor-spacer"></div><h3 class="article-section__title" id="_i50"> 1-(4-Bromo-2-fluorobenzyl)pyrrolidine (<b>20</b>)</h3><div class="NLM_p last">4-Bromo-2-fluorobenzyl bromide (375 g, 1.40 mol) was added in six portions to a 10 °C solution of pyrrolidine (363 g, 426 mL, 5.10 mol) in CH<sub>3</sub>CN (2.75 L) while maintaining the temperature below 20 °C. After the mixture was stirred at room temperature for 4 h, the mixture was concentrated, water (500 mL) and saturated aqueous Na<sub>2</sub>CO<sub>3</sub> (2 L) were added, and the mixture was extracted with CH<sub>2</sub>Cl<sub>2</sub> (3 × 700 mL). The extracts were dried over Na<sub>2</sub>SO<sub>4</sub>, filtered, and concentrated, and the resulting light yellow oil was purified by vacuum distillation (∼1 mm, bp 125 °C) to yield the title compound (324.5 g, 90%) as a colorless oil. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 7.19–7.31 (m, 3H), 3.60 (d, <i>J</i> = 1.7, 2H), 2.48–2.52 (m, 4H), 1.74–1.77 (m, 4H). <sup>13</sup>C NMR (CDCl<sub>3</sub>, 100 MHz) δ 160.8 (d, <i>J</i><sub>C–F</sub> = 250), 132.3 (d, <i>J</i><sub>C–F</sub> = 6.0), 127.1 (d, <i>J</i><sub>C–F</sub> = 3.7), 125.3 (d, <i>J</i><sub>C–F</sub> = 14.7), 120.6 (d, <i>J</i><sub>C–F</sub> = 9.6), 118.7 (d, <i>J</i><sub>C–F</sub> = 25.7), 53.9, 52.2 (d, <i>J</i><sub>C–F</sub> = 1.5), 23.4. MS (APCI) <i>m</i>/<i>z</i> = 258.5 (M + 1).</div></div><div id="sec6_22" class="NLM_sec NLM_sec_level_2"><div id="ac_i51" class="anchor-spacer"></div><h3 class="article-section__title" id="_i51"> <i>N</i>-Ethyl-3-[3-fluoro-4-(pyrrolidin-1-ylmethyl)phenyl]-3-hydroxy-<i>N</i>-methylcyclobutanecarboxamide (<b>21</b>)</h3><div class="NLM_p last">This material was prepared as a waxy orange solid in 60% yield following the general procedure described for preparation of compound <b>16</b>, by using <b>20</b> and substituting ethylmethylamine for methylamine. <sup>1</sup>H NMR (300 MHz, CDCl<sub>3</sub>) ∼1:1 mixture of rotamers, δ 7.38 (t, <i>J</i> = 7.7, 1H), 7.18–7.25 (m, 2H), 5.10 and 4.84 (2 overlapping br s, 1H total), 3.68 (s, 2H), 3.48 and 3.33 (2 q, <i>J</i> = 7.2, 2H total), 3.13–3.23 (m, 1H), 3.00 and 2.97 (2 s, 3H total), 2.80–2.86 (m, 2H), 2.53–2.60 (m, 6H), 1.76–1.80 (m, 4H), 1.12–1.19 (m, 3H). <sup>13</sup>C NMR (CDCl<sub>3</sub>, 100 MHz) ∼1:1 mixture of rotamers, δ 175.9, 175.4, 162.3, 159.8, 146.9, 146.8, 131.3, 131.2, 124.6, 124.4, 120.4, 120.3, 112.3, 112.0, 73.9, 73.9, 73.7, 73.7, 53.9, 52.5, 52.4, 44.7, 43.0, 41.0, 40.8, 34.7, 33.5, 28.9, 28.3, 23.4, 14.0, 12.2. MS (APCI) <i>m</i>/<i>z</i> = 335.5 (M + 1).</div></div><div id="sec6_23" class="NLM_sec NLM_sec_level_2"><div id="ac_i52" class="anchor-spacer"></div><h3 class="article-section__title" id="_i52"> <i>cis</i>-<i>N</i>-Ethyl-3-[3-fluoro-4-(pyrrolidin-1-ylmethyl)phenyl]-3-hydroxycyclobutanecarboxamide (<b>23</b>)</h3><div class="NLM_p last">This material was prepared as a waxy orange solid in 49% yield from <b>20</b> following the general procedure described for compound <b>16</b> and substituting ethylamine for methylamine. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 7.36 (t, <i>J</i> = 7.9, 1H), 7.14–7.22 (m, 2H), 6.01 (br s, 1H), 5.77 (br s, 1H), 3.66 (d, <i>J</i> = 1.3, 2H), 3.28–3.35 (m, 2H), 2.71–2.82 (m, 3H), 2.47–2.55 (m, 6H), 1.74–1.79 (m, 4H), 1.15 (t, <i>J</i> = 7.3, 3H). <sup>13</sup>C NMR (CDCl<sub>3</sub>,100 MHz) δ 176.5, 161.0 (d, <i>J</i><sub>C–F</sub> = 245.9), 146.8 (d, <i>J</i><sub>C–F</sub> = 7.4), 131.3 (d, <i>J</i><sub>C–F</sub> = 5.2), 124.1 (d, <i>J</i><sub>C–F</sub> = 15.5), 120.3 (d, <i>J</i><sub>C–F</sub> = 2.9), 112.0 (d, <i>J</i><sub>C–F</sub> = 22.8), 74.0 (d, <i>J</i><sub>C–F</sub> = 1.5), 53.8, 52.3 (d, <i>J</i><sub>C–F</sub> = 1.5), 40.9, 34.7, 33.2, 23.4, 14.7. MS (APCI) <i>m</i>/<i>z</i> = 321.3 (M + 1).</div></div><div id="sec6_24" class="NLM_sec NLM_sec_level_2"><div id="ac_i53" class="anchor-spacer"></div><h3 class="article-section__title" id="_i53"> <i>cis</i>-3-[3-Fluoro-4-(pyrrolidin-1-ylmethyl)phenyl]-3-hydroxy-<i>N</i>-(2-methylpropyl)cyclobutanecarboxamide (<b>24</b>)</h3><div class="NLM_p last">This material was prepared in 63% yield as a waxy orange solid from <b>20</b> following the general procedure described for compound <b>16</b> and substituting isobutylamine for methylamine. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 7.46 (t, <i>J</i> = 7.9, 1H), 7.18–7.24 (m, 2H), 6.10 (br s, 1H), 3.79 (s, 2H), 3.12 (t, <i>J</i> = 6.4, 2H), 2.77–2.83 (m, 3H), 2.62–2.70 (m, 4H), 2.45–2.55 (m, 2H), 1.75–1.86 (m, 4H), 0.87–0.99 [d at 0.92 (<i>J</i> = 6.6, 6H) overlapping m (1H)]. <sup>13</sup>C NMR (CDCl<sub>3</sub>,100 MHz) δ 176.8, 161.0 (d, <i>J</i><sub>C–F</sub> = 245.9), 147.6 (d, <i>J</i><sub>C–F</sub> = 7.9), 131.7 (d, <i>J</i><sub>C–F</sub> = 4.4), 122.5 (d, <i>J</i><sub>C–F</sub> = 15.4), 120.6 (d, <i>J</i><sub>C–F</sub> = 4.7), 112.2 (d, <i>J</i><sub>C–F</sub> = 23.5), 74.1 (d, <i>J</i><sub>C–F</sub> = 1.5), 53.6, 51.9 (br s), 47.2, 41.0, 33.3, 28.5, 23.3, 20.0. MS (APCI) <i>m</i>/<i>z</i> = 349.4 (M + 1).</div></div><div id="sec6_24_1" class="NLM_sec NLM_sec_level_2"><div id="ac_i54" class="anchor-spacer"></div><h3 class="article-section__title" id="_i54"> H<sub>3</sub> Receptor Binding Protocol</h3><div class="NLM_p last">Cell paste was homogenized in 50 mM Tris-HCl buffer (pH 7.4 at 4 °C) containing 2.0 mM MgCl<sub>2</sub> using a Polytron at medium speed and spun in a centrifuge at 40000<i>g</i> for 10 min. The supernatant was discarded and the pellet suspended in 50 mM Tris-HCl buffer (pH 7.4 at 25 °C) containing 2 mM MgCl<sub>2</sub>. Incubations were initiated by the addition of tissue homogenate to 96-well plates containing test drugs and radioligand (1.0 nM <sup>3</sup>H-<i>N</i>-α-methylhistamine). Nonspecific binding was determined by radioligand binding in the presence of a saturating concentration of ciproxifan (10 μM). After a 60 min incubation at room temperature, assay samples were rapidly filtered through Whatman GF/B filters that had been presoaked and dried in 0.5% polyethylenimine and rinsed with ice-cold 50 mM Tris-HCl buffer (pH 7.7 at 4 °C). Membrane-bound <sup>3</sup>H-<i>N-</i>α-methylhistamine levels were determined by liquid scintillation counting of the filters in BetaScint on a Betaplate scintillation counter. The IC<sub>50</sub> (concentration at which 50% inhibition of specific binding occurs) was calculated by linear regression of the concentration–response data (logit transformation of the percent inhibition versus log of the concentration). <i>K</i><sub>i</sub> values were calculated based on the Cheng–Prusoff equation, <i>K</i><sub>i</sub> = IC<sub>50</sub>/(1 + (<i>L</i>/<i>K</i><sub>d</sub>)), where <i>L</i> is the concentration of the radioligand used in the experiment and the <i>K</i><sub>d</sub> is the dissociation constant for the radioligand (determined previously by saturation analysis). Geometric mean values are expressed as p<i>K</i><sub>i</sub> ± SEM.</div></div><div id="sec6_24_2" class="NLM_sec NLM_sec_level_2"><div id="ac_i55" class="anchor-spacer"></div><h3 class="article-section__title" id="_i55"> H<sub>3</sub> cAMP Assay Protocol</h3><div id="sec6_24_2_1" class="NLM_sec NLM_sec_level_3"><div id="ac_i56" class="anchor-spacer"></div><h4 class="article-section__title" id="_i56"> Cell Preparation</h4><div class="NLM_p last">HEK 293 cells stably expressing the human or rat histamine H<sub>3</sub> receptor and cAMP response element β-lactamase reporter gene were maintained in minimal essential media supplemented with 10% (v/v) fetal bovine serum, 2 mM glutamine, 0.1 mM nonessential amino acids, 1 mM sodium pyruvate, 25 mM HEPES, 300 μg/mL Geneticin, and 50 μg/mL Zeocin at 37 °C and 5% CO<sub>2</sub>. Cells were harvested at 70–80% confluence and washed. A suspension of cells was added to each well of a 384-well, black clear-bottom poly-<span class="smallcaps smallerCapital">d</span>-lysine coated plate such that each well received 25 000 cells (in 75 μL). Plates were incubated at 37 °C/5% CO<sub>2</sub> overnight.</div></div><div id="sec6_24_2_2" class="NLM_sec NLM_sec_level_3"><div id="ac_i57" class="anchor-spacer"></div><h4 class="article-section__title" id="_i57"> cAMP Assay</h4><div class="NLM_p last">Following overnight incubation of the assay plate in a 37 °C/5% CO<sub>2</sub> incubator, 12.5 μL of compound dilutions and maximum and minimum controls were added to the assay plate 10 min prior to addition of 12.5 μL of forskolin or 12.5 μL of forskolin/imetit. An amount of 25 μL of phosphate-buffered saline was added to the blank wells. Plates were incubated for 4.5 h in a 37 °C/5% CO<sub>2</sub> incubator. Following the 4.5 h incubation, 50 μL of MEM + 10 μL of dye solution [loading dye solution was prepared at 6× final concentration: 6 μL of solution A (1 mM CCF4-AM in dry dimethylsulfoxide) was added to 60 μL of solution B (100 mg/mL Pluronic-F127 surfactant in dimethylsulfoxide and 0.1% acetic acid); the resulting solution was vortexed and added to 940 μL of solution C (24% w/w PEG 400, 18% TR-40 by volume in water)] was added to each well and the assay plates were incubated for 90–120 min at room temperature and kept in the dark. The assay plates were then read using a Tecan SpectraFluor plate reader, with an excitation wavelength of 405 nm and emission wavelengths at 450 and 530 nm.</div></div><div id="sec6_24_2_3" class="NLM_sec NLM_sec_level_3"><div id="ac_i58" class="anchor-spacer"></div><h4 class="article-section__title" id="_i58"> Data Analysis</h4><div class="NLM_p last">Unconstrained sigmoidal curve fitting was used to estimate an IC<sub>50</sub> using GraphPad Prism. The <i>K</i><sub>i</sub> values were calculated from the IC<sub>50</sub> according to the Cheng–Prusoff equation <i>K</i><sub>i</sub> = (IC<sub>50</sub>)/(1 + ([C]/EC<sub>50</sub>)), where [C] is the concentration of the agonist (1 nM final imetit) used in the experiment and the EC<sub>50</sub> value is the EC<sub>50</sub> for the imetit determined in each experiment.</div></div></div><div id="sec6_24_3" class="NLM_sec NLM_sec_level_2"><div id="ac_i59" class="anchor-spacer"></div><h3 class="article-section__title" id="_i59"> Phospholipidosis Assay Protocol</h3><div id="sec6_24_3_1" class="NLM_sec NLM_sec_level_3"><div id="ac_i60" class="anchor-spacer"></div><h4 class="article-section__title" id="_i60"> Phospholipidosis Assay</h4><div class="NLM_p">Transformed human liver epithelial cells (THLE) were purchased from American Type Culture Collection. Cells were kept in culture in bronchial epithelial growth media (Lonza) supplemented with 5 ng/mL human epidermal growth factor and 70 ng/mL phosphoethanolamine. All cell culture flasks and plates were precoated with bronchial epithelial basal medium supplemented with 0.01 mg/mL human fibronectin, 0.01 mg/mL BSA and 0.03 mg/mL collagen. Cells were maintained at 37 °C under 3.5% CO<sub>2</sub>. Cells in logarithmic growth phase were seeded at a density of 1 × 10<sup>4</sup> per well in 96-well microplates. Test articles and the positive control, amiodarone (Sigma), were diluted in DMSO to 30 mM. Serial dilutions of all 30 mM stock concentrations were carried out in microplates, and 2 μL of each concentration was transferred from the compound dilution plate to a new microplate. A fluorophore-labeled phospholipid, <i>N</i>-(7-nitrobenz-2-oxa-1,3-diazol-4-yl)-1,2-dihexadecanoyl-<i>sn</i>-glycero-3-phosphoethanolamine, triethylammonium salt (NBD-PE Invitrogen, CA, U.S.) was diluted with ethanol (1 mL) and sonicated for 10 min. The dye was then transferred into 250 mL of THLE medium and sonicated for an additional 30 min. The dye-supplemented medium was then filtered through a Millipore 22 μm filter flask, and 200 μL aliquots were added to each well of the intermediate plates containing 2 μL of the test article and control dilutions to achieve final concentrations of 300, 100, 30, 10, 3, and 1 μM test article or control.</div><div class="NLM_p">At 24 hours after cell plating, the medium in each microplate was removed and compound dilutions in NBD-PE supplemented medium were added. Plates were returned to the incubator under the same conditions. At 24 hours after dosing, the medium was removed and cells were washed twice with 100 μL of PBS. Following the wash, nucleic acid stain Hoechst 33342, diluted 1:1000 in PBS, was added and plates were incubated for 30 min at room temperature. Following incubation, cells were washed twice with 100 μL of PBS. A final volume of 100 μL of PBS was added, and plates were covered and left overnight at room temperature. The microplates were scanned in a Cellomics ArrayScan for quantitation of uptake of both Hoechst 33342, to identify cell nuclei, and NBD-PE, to determine phospholipid accumulation per cell. Compounds were classified as positive at the lowest dose for which the induction of phospholipid accumulation was 3-fold over background (Table <a class="ref showTableEvent internalNav" data-ID="tbl10" href="#tbl10">10</a>).</div><div class="NLM_table-wrap" id="tbl10"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 10. In Vitro PL Values for H<sub>3</sub> Antagonists</div></div></div><div class="scrollable-table-wrap"><table class="table" border="0"><colgroup><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center">compd</th><th class="colsep0 rowsep0" align="center">mean (μM)<a class="ref internalNav" href="#t10fn1" aria-label="a">a</a></th><th class="colsep0 rowsep0" align="center">standard deviation (μM)</th><th class="colsep0 rowsep0" align="center">lower<a class="ref internalNav" href="#t10fn2" aria-label="b">b</a> (μM)</th><th class="colsep0 rowsep0" align="center">upper<a class="ref internalNav" href="#t10fn2" aria-label="b">b</a> (μM)</th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>1</b></td><td class="colsep0 rowsep0" align="left">17.6</td><td class="colsep0 rowsep0" align="left">11.2</td><td class="colsep0 rowsep0" align="left">9.3</td><td class="colsep0 rowsep0" align="left">25.9</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>2</b></td><td class="colsep0 rowsep0" align="left">37.5</td><td class="colsep0 rowsep0" align="left">24.6</td><td class="colsep0 rowsep0" align="left">19.3</td><td class="colsep0 rowsep0" align="left">55.7</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>3</b></td><td class="colsep0 rowsep0" align="left">119.5</td><td class="colsep0 rowsep0" align="left">73.9</td><td class="colsep0 rowsep0" align="left">64.8</td><td class="colsep0 rowsep0" align="left">174.2</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>4</b></td><td class="colsep0 rowsep0" align="left">245.3</td><td class="colsep0 rowsep0" align="left">135.9</td><td class="colsep0 rowsep0" align="left">144.5</td><td class="colsep0 rowsep0" align="left">346.0</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>5</b></td><td class="colsep0 rowsep0" align="left">300.0</td><td class="colsep0 rowsep0" align="left">0.01</td><td class="colsep0 rowsep0" align="left">300.01</td><td class="colsep0 rowsep0" align="left">300.03</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>6</b></td><td class="colsep0 rowsep0" align="left">300.0</td><td class="colsep0 rowsep0" align="left">0.3</td><td class="colsep0 rowsep0" align="left">299.8</td><td class="colsep0 rowsep0" align="left">300.2</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>7</b></td><td class="colsep0 rowsep0" align="left">302.4</td><td class="colsep0 rowsep0" align="left">91.4</td><td class="colsep0 rowsep0" align="left">234.7</td><td class="colsep0 rowsep0" align="left">370.1</td></tr></tbody></table></div><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t10fn1"><div class="footnote" id="t10fn1"><sup>a</sup><p class="last">At least three determinations.</p></div><div class="footnote" id="t10fn2"><sup>b</sup><p class="last">95% confidence limits.</p></div></div></div></div></div><div id="sec6_24_4" class="NLM_sec NLM_sec_level_2"><div id="ac_i62" class="anchor-spacer"></div><h3 class="article-section__title" id="_i62"> Safety Studies</h3><div id="sec6_24_4_1" class="NLM_sec NLM_sec_level_3"><div id="ac_i63" class="anchor-spacer"></div><h4 class="article-section__title" id="_i63"> In Vivo Toleration Studies</h4><div class="NLM_p">In vivo toleration studies up to 2 weeks in duration were completed in Sprague–Dawley rats and beagle dogs. Drug formulations were prepared in 0.5% methylcellulose and administered at a dosage volume of 10 mL/kg in rats and 1 mL/kg in dogs. Monitored end points in these studies included clinical signs (daily), food intake (daily), body weight (daily), clinical pathology (hematology, serum chemistry, urinalysis; end of study), vital signs (heart rate, respiratory rate; dogs, predose and postdose at about <i>T</i><sub>max</sub> at end of study), electrocardiogram (dogs, predose and postdose at about <i>T</i><sub>max</sub> at end of study), plasma drug levels (day 1 and end of study; 4–5 time points on each sampling day), and gross/histopathology (end of dosing phase in repeat dose studies).</div><div class="NLM_p">All procedures performed on these animals were in accordance with regulations and established guidelines and were reviewed and approved by an Institutional Animal Care and Use Committee or through an ethical review process. Convulsions in dogs were either self-limiting or required intervention with a standard anticonvulsant. Exposure and estimated safety margins derived from ETS in rats (14-day) and in dogs (single dose and 7-day) and are summarized in Table <a class="ref showTableEvent internalNav" data-ID="tbl11" href="#tbl11">11</a>.</div><div class="NLM_table-wrap" id="tbl11"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 11. In Vivo Assessment of H<sub>3</sub> Antagonist Lead Compounds and Clinical Candidates</div></div></div><div class="scrollable-table-wrap"><table class="table" border="0"><colgroup><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center">compd</th><th class="colsep0 rowsep0" align="center">maximum tolerated dose (mg/kg)</th><th class="colsep0 rowsep0" align="center">study duration (days)</th><th class="colsep0 rowsep0" align="center">human protein binding (hf<sub>u</sub>)</th><th class="colsep0 rowsep0" align="center">projected human PCEC, <i>C</i><sub>p</sub>, nM<a class="ref internalNav" href="#t11fn1" aria-label="a">a</a></th><th class="colsep0 rowsep0" align="center">species <i>C</i><sub>max</sub>, (ng/mL)<a class="ref internalNav" href="#t11fn2" aria-label="b">b</a></th><th class="colsep0 rowsep0" align="center">species <i>C</i><sub>max</sub>, (nM)<a class="ref internalNav" href="#t11fn3" aria-label="c">c</a></th><th class="colsep0 rowsep0" align="center">species AUC<sub>(0–24)</sub>(ng·h/mL)</th><th class="colsep0 rowsep0" align="center">safety margin × PCEC<a class="ref internalNav" href="#t11fn4" aria-label="d">d</a></th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" colspan="9" align="center">Rat Exploratory Toxicology Studies<a class="ref internalNav" href="#t11fn5" aria-label="e">e</a></td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>2</b></td><td class="colsep0 rowsep0" align="left">≥5</td><td class="colsep0 rowsep0" align="left">4</td><td class="colsep0 rowsep0" align="left">0.78</td><td class="colsep0 rowsep0" align="left">8.5</td><td class="colsep0 rowsep0" align="left">95 ± 100</td><td class="colsep0 rowsep0" align="left">302</td><td class="colsep0 rowsep0" align="left">1245 ± 659</td><td class="colsep0 rowsep0" align="left">≥35</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>2</b></td><td class="colsep0 rowsep0" align="left">≥30</td><td class="colsep0 rowsep0" align="left">14</td><td class="colsep0 rowsep0" align="left">0.78</td><td class="colsep0 rowsep0" align="left">8.5</td><td class="colsep0 rowsep0" align="left">1573 ± 189</td><td class="colsep0 rowsep0" align="left">5002</td><td class="colsep0 rowsep0" align="left">15513 ± 1451</td><td class="colsep0 rowsep0" align="left">≥588</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>3</b></td><td class="colsep0 rowsep0" align="left">≥5</td><td class="colsep0 rowsep0" align="left">14</td><td class="colsep0 rowsep0" align="left">0.44</td><td class="colsep0 rowsep0" align="left">59.3</td><td class="colsep0 rowsep0" align="left">130 ± 141</td><td class="colsep0 rowsep0" align="left">402</td><td class="colsep0 rowsep0" align="left">1278 ± 260</td><td class="colsep0 rowsep0" align="left">≥7</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>4</b></td><td class="colsep0 rowsep0" align="left">≥300</td><td class="colsep0 rowsep0" align="left">14</td><td class="colsep0 rowsep0" align="left">0.24</td><td class="colsep0 rowsep0" align="left">175</td><td class="colsep0 rowsep0" align="left">2107 ± 803</td><td class="colsep0 rowsep0" align="left">6292</td><td class="colsep0 rowsep0" align="left">4444<a class="ref internalNav" href="#t11fn3" aria-label="c">c</a></td><td class="colsep0 rowsep0" align="left">≥36</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>5</b></td><td class="colsep0 rowsep0" align="left">≥100</td><td class="colsep0 rowsep0" align="left">14</td><td class="colsep0 rowsep0" align="left">0.57</td><td class="colsep0 rowsep0" align="left">21</td><td class="colsep0 rowsep0" align="left">2482<a class="ref internalNav" href="#t11fn3" aria-label="c">c</a></td><td class="colsep0 rowsep0" align="left">7794</td><td class="colsep0 rowsep0" align="left">12700<a class="ref internalNav" href="#t11fn3" aria-label="c">c</a></td><td class="colsep0 rowsep0" align="left">≥371</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>6</b></td><td class="colsep0 rowsep0" align="left">≥300</td><td class="colsep0 rowsep0" align="left">14</td><td class="colsep0 rowsep0" align="left">0.66</td><td class="colsep0 rowsep0" align="left">10.4</td><td class="colsep0 rowsep0" align="left">14020 ± 2087</td><td class="colsep0 rowsep0" align="left">43486</td><td class="colsep0 rowsep0" align="left">189000<a class="ref internalNav" href="#t11fn3" aria-label="c">c</a></td><td class="colsep0 rowsep0" align="left">≥4181</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>7</b></td><td class="colsep0 rowsep0" align="left">≥300</td><td class="colsep0 rowsep0" align="left">14</td><td class="colsep0 rowsep0" align="left">0.34</td><td class="colsep0 rowsep0" align="left">12.3</td><td class="colsep0 rowsep0" align="left">8057 ± 3083</td><td class="colsep0 rowsep0" align="left">22990</td><td class="colsep0 rowsep0" align="left">67400<a class="ref internalNav" href="#t11fn6" aria-label="f">f</a></td><td class="colsep0 rowsep0" align="left">≥1869</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" colspan="9" align="center">Dog Exploratory Toxicology Studies<a class="ref internalNav" href="#t11fn7" aria-label="g">g</a></td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>2</b></td><td class="colsep0 rowsep0" align="left"><10</td><td class="colsep0 rowsep0" align="left">7</td><td class="colsep0 rowsep0" align="left">0.78</td><td class="colsep0 rowsep0" align="left">8.5</td><td class="colsep0 rowsep0" align="left">46.7 ± 0.9</td><td class="colsep0 rowsep0" align="left">148.5</td><td class="colsep0 rowsep0" align="left">740 ± 167</td><td class="colsep0 rowsep0" align="left"><17</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>3</b></td><td class="colsep0 rowsep0" align="left">ND<a class="ref internalNav" href="#t11fn8" aria-label="h">h</a></td><td class="colsep0 rowsep0" align="left">ND<a class="ref internalNav" href="#t11fn8" aria-label="h">h</a></td><td class="colsep0 rowsep0" align="left">0.44</td><td class="colsep0 rowsep0" align="left">59.3</td><td class="colsep0 rowsep0" align="left">ND<a class="ref internalNav" href="#t11fn8" aria-label="h">h</a></td><td class="colsep0 rowsep0" align="left">ND<a class="ref internalNav" href="#t11fn8" aria-label="h">h</a></td><td class="colsep0 rowsep0" align="left">ND<a class="ref internalNav" href="#t11fn8" aria-label="h">h</a></td><td class="colsep0 rowsep0" align="left">ND<a class="ref internalNav" href="#t11fn8" aria-label="h">h</a></td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>4</b></td><td class="colsep0 rowsep0" align="left"><30</td><td class="colsep0 rowsep0" align="left">7</td><td class="colsep0 rowsep0" align="left">0.24</td><td class="colsep0 rowsep0" align="left">175</td><td class="colsep0 rowsep0" align="left">1717 ± 295</td><td class="colsep0 rowsep0" align="left">5127</td><td class="colsep0 rowsep0" align="left">2911 ± 626</td><td class="colsep0 rowsep0" align="left"><29</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>5</b></td><td class="colsep0 rowsep0" align="left">≥25</td><td class="colsep0 rowsep0" align="left">7</td><td class="colsep0 rowsep0" align="left">0.57</td><td class="colsep0 rowsep0" align="left">21</td><td class="colsep0 rowsep0" align="left">5197 ± 635</td><td class="colsep0 rowsep0" align="left">16320</td><td class="colsep0 rowsep0" align="left">10780 ± 1368</td><td class="colsep0 rowsep0" align="left">≥777</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>6</b></td><td class="colsep0 rowsep0" align="left">≥15</td><td class="colsep0 rowsep0" align="left">7</td><td class="colsep0 rowsep0" align="left">0.66</td><td class="colsep0 rowsep0" align="left">10.4</td><td class="colsep0 rowsep0" align="left">4185 ± 1762</td><td class="colsep0 rowsep0" align="left">12980</td><td class="colsep0 rowsep0" align="left">18910 ± 10775</td><td class="colsep0 rowsep0" align="left">≥1248</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>7</b></td><td class="colsep0 rowsep0" align="left">≥15</td><td class="colsep0 rowsep0" align="left">7</td><td class="colsep0 rowsep0" align="left">0.34</td><td class="colsep0 rowsep0" align="left">12.3</td><td class="colsep0 rowsep0" align="left">6302 ± 1370</td><td class="colsep0 rowsep0" align="left">17982</td><td class="colsep0 rowsep0" align="left">18175 ± 222</td><td class="colsep0 rowsep0" align="left">≥1462</td></tr></tbody></table></div><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t11fn1"><div class="footnote" id="t11fn1"><sup>a</sup><p class="last">Human projected clinical efficacious concentration (PCEC) was calculated (3 × human H<sub>3</sub> binding <i>K</i><sub>i</sub>) and converted to total plasma concentration (<i>C</i><sub>p</sub>) using measured human plasma protein binding (hf<sub>u</sub>).</p></div><div class="footnote" id="t11fn2"><sup>b</sup><p class="last"><i>T</i><sub>max</sub> ≈ 0.5–1 h postdose.</p></div><div class="footnote" id="t11fn3"><sup>c</sup><p class="last">Mean value.</p></div><div class="footnote" id="t11fn4"><sup>d</sup><p class="last">Average multiples over the projected clinical efficacious concentrations in the species examined at <i>C</i><sub>max</sub> of maximum tolerated dose (corrected for species differences in plasma protein binding).</p></div><div class="footnote" id="t11fn5"><sup>e</sup><p class="last">Rat oral exploratory toxicology study (ETS) study.</p></div><div class="footnote" id="t11fn6"><sup>f</sup><p class="last">Day 1 value.</p></div><div class="footnote" id="t11fn7"><sup>g</sup><p class="last">Dog oral 7 day ETS.</p></div><div class="footnote" id="t11fn8"><sup>h</sup><p class="last">ND = not determined.</p></div></div></div></div></div></div><div class="NLM_back"><div class="article_supporting-info" id="notes-1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i66"><a href="/doi/suppl/10.1021/jm200939b">Supporting Information</a></h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_70810" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_70810" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><p class="last">Cerep profile of lead compounds and spectral data for intermediates and final compounds. This material is available free of charge via the Internet at <a href="http://pubs.acs.org" class="extLink">http://pubs.acs.org</a>.</p><div class="supInfoBoxOnFTP "><div class="sup-info-attachments"><ul><li><a class="suppl-anchor" href="/doi/suppl/10.1021/jm200939b/suppl_file/jm200939b_si_001.pdf">jm200939b_si_001.pdf (2.59 MB)</a></li></ul></div></div></div><div class="testing" data-doi="10.1021/jm200939b" data-url="https://widgets.figshare.com/static/figshare.js" id="figshare-widget"></div><div class="TermsAndConditionsDropzone3" data-pb-dropzone="TermsAndConditionsDropzone3"><div data-widget-def="UX3HTMLWidget" data-widget-id="85b54935-30e9-4058-a6d2-0b40fb754a85" class="mb-4">
        



        
            <h2 class="">
                Terms & Conditions
            </h2>
        
        <p>Most electronic Supporting Information files are available without a subscription to ACS Web Editions. Such files may be downloaded by article for research use (if there is a public use license linked to the relevant article, that license may permit other uses). Permission may be obtained from ACS for other uses through requests via the RightsLink permission system: <a href="/page/copyright/permissions.html" title="RightsLink">http://pubs.acs.org/page/copyright/permissions.html</a>.</p>

        </div></div><div class="authorInformationSection"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="authorInformationSection">Author Information</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_01531" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_01531" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><ul><li><span class="author-information-subsection-header">Corresponding Author</span><ul><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Travis T. Wager</span> - <span class="hlFld-Affiliation affiliation">Groton Laboratories, Pfizer Worldwide Research and Development, 558 Eastern Point Road, Groton, Connecticut 06340-5159, United States</span>; 
    <span class="author-email">
                Email: <a href="/cdn-cgi/l/email-protection#a2d6d0c3d4cbd18cd68cd5c3c5c7d0e2d2c4cbd8c7d08cc1cdcf"><span class="__cf_email__" data-cfemail="b7c3c5d6c1dec499c399c0d6d0d2c5f7c7d1decdd2c599d4d8da">[email protected]</span></a></span></div></li></ul></li><li><span class="author-information-subsection-header">Authors</span><ul><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Betty A. Pettersen</span> - <span class="hlFld-Affiliation affiliation">Groton Laboratories, Pfizer Worldwide Research and Development, 558 Eastern Point Road, Groton, Connecticut 06340-5159, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Anne W. Schmidt</span> - <span class="hlFld-Affiliation affiliation">Groton Laboratories, Pfizer Worldwide Research and Development, 558 Eastern Point Road, Groton, Connecticut 06340-5159, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Douglas K. Spracklin</span> - <span class="hlFld-Affiliation affiliation">Groton Laboratories, Pfizer Worldwide Research and Development, 558 Eastern Point Road, Groton, Connecticut 06340-5159, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Scot Mente</span> - <span class="hlFld-Affiliation affiliation">Groton Laboratories, Pfizer Worldwide Research and Development, 558 Eastern Point Road, Groton, Connecticut 06340-5159, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Todd W. Butler</span> - <span class="hlFld-Affiliation affiliation">Groton Laboratories, Pfizer Worldwide Research and Development, 558 Eastern Point Road, Groton, Connecticut 06340-5159, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Harry Howard</span> - <span class="hlFld-Affiliation affiliation">Groton Laboratories, Pfizer Worldwide Research and Development, 558 Eastern Point Road, Groton, Connecticut 06340-5159, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Daniel J. Lettiere</span> - <span class="hlFld-Affiliation affiliation">Groton Laboratories, Pfizer Worldwide Research and Development, 558 Eastern Point Road, Groton, Connecticut 06340-5159, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">David M. Rubitski</span> - <span class="hlFld-Affiliation affiliation">Groton Laboratories, Pfizer Worldwide Research and Development, 558 Eastern Point Road, Groton, Connecticut 06340-5159, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Diane F. Wong</span> - <span class="hlFld-Affiliation affiliation">Groton Laboratories, Pfizer Worldwide Research and Development, 558 Eastern Point Road, Groton, Connecticut 06340-5159, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Frank M. Nedza</span> - <span class="hlFld-Affiliation affiliation">Groton Laboratories, Pfizer Worldwide Research and Development, 558 Eastern Point Road, Groton, Connecticut 06340-5159, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Frederick R. Nelson</span> - <span class="hlFld-Affiliation affiliation">Groton Laboratories, Pfizer Worldwide Research and Development, 558 Eastern Point Road, Groton, Connecticut 06340-5159, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Hans Rollema</span> - <span class="hlFld-Affiliation affiliation">Groton Laboratories, Pfizer Worldwide Research and Development, 558 Eastern Point Road, Groton, Connecticut 06340-5159, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Jeffrey W. Raggon</span> - <span class="hlFld-Affiliation affiliation">Groton Laboratories, Pfizer Worldwide Research and Development, 558 Eastern Point Road, Groton, Connecticut 06340-5159, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Jiri Aubrecht</span> - <span class="hlFld-Affiliation affiliation">Groton Laboratories, Pfizer Worldwide Research and Development, 558 Eastern Point Road, Groton, Connecticut 06340-5159, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Jody K. Freeman</span> - <span class="hlFld-Affiliation affiliation">Groton Laboratories, Pfizer Worldwide Research and Development, 558 Eastern Point Road, Groton, Connecticut 06340-5159, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">John M. Marcek</span> - <span class="hlFld-Affiliation affiliation">Groton Laboratories, Pfizer Worldwide Research and Development, 558 Eastern Point Road, Groton, Connecticut 06340-5159, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Julie Cianfrogna</span> - <span class="hlFld-Affiliation affiliation">Groton Laboratories, Pfizer Worldwide Research and Development, 558 Eastern Point Road, Groton, Connecticut 06340-5159, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Karen W. Cook</span> - <span class="hlFld-Affiliation affiliation">Groton Laboratories, Pfizer Worldwide Research and Development, 558 Eastern Point Road, Groton, Connecticut 06340-5159, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Larry C. James</span> - <span class="hlFld-Affiliation affiliation">Groton Laboratories, Pfizer Worldwide Research and Development, 558 Eastern Point Road, Groton, Connecticut 06340-5159, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Linda A. Chatman</span> - <span class="hlFld-Affiliation affiliation">Groton Laboratories, Pfizer Worldwide Research and Development, 558 Eastern Point Road, Groton, Connecticut 06340-5159, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Philip A. Iredale</span> - <span class="hlFld-Affiliation affiliation">Groton Laboratories, Pfizer Worldwide Research and Development, 558 Eastern Point Road, Groton, Connecticut 06340-5159, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Michael J. Banker</span> - <span class="hlFld-Affiliation affiliation">Groton Laboratories, Pfizer Worldwide Research and Development, 558 Eastern Point Road, Groton, Connecticut 06340-5159, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Michael L. Homiski</span> - <span class="hlFld-Affiliation affiliation">Groton Laboratories, Pfizer Worldwide Research and Development, 558 Eastern Point Road, Groton, Connecticut 06340-5159, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Jennifer B. Munzner</span> - <span class="hlFld-Affiliation affiliation">Groton Laboratories, Pfizer Worldwide Research and Development, 558 Eastern Point Road, Groton, Connecticut 06340-5159, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Rama Y. Chandrasekaran</span> - <span class="hlFld-Affiliation affiliation">Groton Laboratories, Pfizer Worldwide Research and Development, 558 Eastern Point Road, Groton, Connecticut 06340-5159, United States</span></div></li></ul></li><li></li><li></li><li></li></ul></div><div class="ack"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i65">Acknowledgment</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_75605" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_75605" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><p class="last">The authors thank Joe Brady, Christopher O’Donnell, and Anabella Villalobos for helpful discussions; Ana Cobani, Elaine Greer, Stephen Anderson, and Margaret Landis for salt form and formulation evaluations; Daniel Virtue and Robert DePianta, Jr., Benjamin Hritzko, Chris Wood, Christopher Foti, Justin Ringling, Chris Caldwel, Marina Shalaeva, and Randy Smith for compound purifications, analytical assessments, and property measurements; James Candee and Jon Bordner for X-ray powder and single crystal crystallography support; Chester J. Siok, Darcy G. Izzarelli, Elizabeth E. Rubitski, David E. Johnson, Francis J. Sweeney, Holly D. Soares, Leslie K. Chambers, Bernard Fermini, Michelle A. Vanase-Frawley, Mihaly Hajos, Patricia A. Seymour, Weldon E. Horner, and William E. Hoffmann for providing in vitro selectivity and in vivo and biomarker data for the team; Bishop Wlodecki, Mark Elliot, Stanton McHardy, and Vinod Parikh for helpful discussions during the hunt for the best-in-class molecule; and Katherine Brighty for her insightful comments on this manuscript.</p></div><div id="" class="NLM_sec NLM_sec_level_1"><div id="ac_i67" class="anchor-spacer"></div><h2 class="article-section__title section__title" id="_i67"> </h2><div class="NLM_p last"><table summary="" class="NLM_def-list" id="dl1"><div id="ac_i68" class="anchor-spacer"></div><h2 class="article-section__title section__title" id="_i68"> Abbreviations Used</h2><tr><td class="NLM_term">ACh</td><td class="NLM_def"><p class="first last">acetylcholine</p></td></tr><tr><td class="NLM_term">AD</td><td class="NLM_def"><p class="first last">Alzheimer’s disease</p></td></tr><tr><td class="NLM_term">ADHD</td><td class="NLM_def"><p class="first last">attention deficit hyperactivity disorder</p></td></tr><tr><td class="NLM_term">ADME</td><td class="NLM_def"><p class="first last">absorption, distribution, metabolism, and excretion</p></td></tr><tr><td class="NLM_term">cAMP</td><td class="NLM_def"><p class="first last">cyclic adenosine monophosphate</p></td></tr><tr><td class="NLM_term">CMV</td><td class="NLM_def"><p class="first last">cardiomyocyte vacuoles</p></td></tr><tr><td class="NLM_term">CNS</td><td class="NLM_def"><p class="first last">central nervous system</p></td></tr><tr><td class="NLM_term">DA</td><td class="NLM_def"><p class="first last">dopamine</p></td></tr><tr><td class="NLM_term">DCE</td><td class="NLM_def"><p class="first last">dichloroethane</p></td></tr><tr><td class="NLM_term">DDI</td><td class="NLM_def"><p class="first last">drug–drug interactions</p></td></tr><tr><td class="NLM_term">DMA</td><td class="NLM_def"><p class="first last">dimethylacetamide</p></td></tr><tr><td class="NLM_term">DME</td><td class="NLM_def"><p class="first last">1,2-dimethoxyethane</p></td></tr><tr><td class="NLM_term">DMF</td><td class="NLM_def"><p class="first last">dimethylformamide</p></td></tr><tr><td class="NLM_term">ER</td><td class="NLM_def"><p class="first last">efflux ratio</p></td></tr><tr><td class="NLM_term">EtOAc</td><td class="NLM_def"><p class="first last">ethyl acetate</p></td></tr><tr><td class="NLM_term">ETS</td><td class="NLM_def"><p class="first last">exploratory toxicology study</p></td></tr><tr><td class="NLM_term">GPCR</td><td class="NLM_def"><p class="first last">G-protein-coupled receptor</p></td></tr><tr><td class="NLM_term">HA</td><td class="NLM_def"><p class="first last">histamine</p></td></tr><tr><td class="NLM_term">HBD</td><td class="NLM_def"><p class="first last">hydrogen bond donor</p></td></tr><tr><td class="NLM_term">hERG</td><td class="NLM_def"><p class="first last">human ether-a-go-go-related gene</p></td></tr><tr><td class="NLM_term">HLA</td><td class="NLM_def"><p class="first last">human lymphocyte assay</p></td></tr><tr><td class="NLM_term">HLM</td><td class="NLM_def"><p class="first last">human liver microsome</p></td></tr><tr><td class="NLM_term">HTS</td><td class="NLM_def"><p class="first last">high-throughput screening</p></td></tr><tr><td class="NLM_term">IVMN</td><td class="NLM_def"><p class="first last">in vitro micronucleus</p></td></tr><tr><td class="NLM_term">MDCK</td><td class="NLM_def"><p class="first last">Madin–Darby canine kidney</p></td></tr><tr><td class="NLM_term">MDR</td><td class="NLM_def"><p class="first last">multidrug resistance</p></td></tr><tr><td class="NLM_term">MED</td><td class="NLM_def"><p class="first last">minimally effective dose</p></td></tr><tr><td class="NLM_term">MW</td><td class="NLM_def"><p class="first last">molecular weight</p></td></tr><tr><td class="NLM_term">nAChR</td><td class="NLM_def"><p class="first last">nicotinic acetylcholine receptor</p></td></tr><tr><td class="NLM_term">NaOH</td><td class="NLM_def"><p class="first last">sodium hydroxide</p></td></tr><tr><td class="NLM_term">NE</td><td class="NLM_def"><p class="first last">norepinephrine</p></td></tr><tr><td class="NLM_term">PCEC</td><td class="NLM_def"><p class="first last">projected clinically effective concentration</p></td></tr><tr><td class="NLM_term">P-gp</td><td class="NLM_def"><p class="first last">P-glycoprotein</p></td></tr><tr><td class="NLM_term">PK</td><td class="NLM_def"><p class="first last">pharmacokinetic</p></td></tr><tr><td class="NLM_term">PL</td><td class="NLM_def"><p class="first last">phospholipidosis</p></td></tr><tr><td class="NLM_term">RAMH</td><td class="NLM_def"><p class="first last"><i>R</i>-α-methylhistamine</p></td></tr><tr><td class="NLM_term">RLM</td><td class="NLM_def"><p class="first last">rat liver microsome</p></td></tr><tr><td class="NLM_term">rt</td><td class="NLM_def"><p class="first last">room temperature</p></td></tr><tr><td class="NLM_term">SAR</td><td class="NLM_def"><p class="first last">structure–activity relationship</p></td></tr><tr><td class="NLM_term">sc</td><td class="NLM_def"><p class="first last">subcutaneous</p></td></tr><tr><td class="NLM_term"><i>t</i>-BuOK</td><td class="NLM_def"><p class="first last">potassium <i>tert</i>-butoxide</p></td></tr><tr><td class="NLM_term">TEA</td><td class="NLM_def"><p class="first last">triethylamine</p></td></tr><tr><td class="NLM_term">T3P</td><td class="NLM_def"><p class="first last">propylphosphonic anhydride</p></td></tr><tr><td class="NLM_term">TEM</td><td class="NLM_def"><p class="first last">transmission electron microscope</p></td></tr><tr><td class="NLM_term">TFA</td><td class="NLM_def"><p class="first last">trifluoroacetic acid</p></td></tr><tr><td class="NLM_term">THF</td><td class="NLM_def"><p class="first last">tetrahydrofuran</p></td></tr><tr><td class="NLM_term">THLE</td><td class="NLM_def"><p class="first last">transformed human liver epithelial</p></td></tr><tr><td class="NLM_term">TI</td><td class="NLM_def"><p class="first last">therapeutic index</p></td></tr><tr><td class="NLM_term">TPSA</td><td class="NLM_def"><p class="first last">topological polar surface area</p></td></tr></table></div></div><div class="refs-header-label"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i69">References</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_24416" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_24416" class="dropBlock__holder"></div></div></div></div></div><hr /></hr></div><p class="references-count">
            This article references 52 other publications.
        </p><ol id="references" class="useLabel"><li id="ref1"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref1'); return false;" data-citation="" class="refNumLink">1</a></strong><div class="NLM_citation" id="cit1"><span><span class="NLM_contrib-group">Ash, A. S. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schild, H. O.</span><span> </span><span class="NLM_article-title">Receptors mediating some actions of histamine</span> <span class="citation_source-journal">Br. J. Pharmacol. Chemother.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1966</span><span class="NLM_x">, </span> <span class="NLM_volume">27</span><span class="NLM_x">, </span> <span class="NLM_fpage">427</span><span class="NLM_x">–</span> <span class="NLM_lpage">439</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=16&amp;doi=10.1021%2Fjm200939b&amp;key=10.1111%2Fj.1476-5381.1966.tb01674.x" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=8&amp;doi=10.1021%2Fjm200939b&amp;key=4381779" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=32&amp;doi=10.1021%2Fjm200939b&amp;key=1%3ACAS%3A528%3ADyaF28Xks1yit7k%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=27&publication_year=1966&pages=427-439&author=A.+S.+F.+Ashauthor=H.+O.+Schild&title=Receptors+mediating+some+actions+of+histamine"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit1R"><div class="casContent"><span class="casTitleNuber">1</span><div class="casTitle"><span class="NLM_cas:atitle">Receptors mediating some action of histamine</span></div><div class="casAuthors">Ash, A. S. F.; Schild, J. O.</div><div class="citationInfo"><span class="NLM_cas:title">British Journal of Pharmacology and Chemotherapy</span>
        (<span class="NLM_cas:date">1966</span>),
    <span class="NLM_cas:volume">27</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">427-39</span>CODEN:
                <span class="NLM_cas:coden">BJPCAL</span>;
        ISSN:<span class="NLM_cas:issn">0366-0826</span>.
    </div><div class="casAbstract">The characteristics of some histamine receptors were investigated by comparing the relative activities of several histamine analogs.  Three prepns. were used: the perfused rat stomach for gastric secretory action; the isolated rat uterus, stimulated with carbachol, for smooth muscle inhibitory action; and the isolated guinea pig ileum for smooth muscle stimulatory action.  N-Methylhistamine, N-benzylhistamine, N,N-diethylhistamine,β-chloroethylimidazole, β-3,5-pyrazolethylamine, β-2- and β-4-pyridylethylamine, and β-phenylethylamine stimulated rat gastric acid secretion and inhibited rat uterus.  The mode of action of β-chloroethylimidazole differed from that of histamine.  There was a marked correlation between the relative activities of the other compds. on the two prepns.  The receptors for isoprenaline inrat uterus were differentiated from those for histamine by means of the β-blocking drugs dichloroisoprenaline and pronethalol.  On guinea pig ileum, substitution of the terminal amino group of histamine by Me had little effect on activity, but substitution by larger groups or modification of the ring markedly diminished activity.  β-4-Pyridylethylamine, as well as compds. more closely related to histamine, had an affinity for histamine receptors in guinea pig ileum.  The symbol H1 is suggested for receptors which are specifically antagonized by low concns. of antihistamine drugs.  No specific antagonists were found for the actions of histamine on rat uterus and stomach.  These actions are therefore unlikely to be mediated by H1 receptors.  The relative activities of several histamine analogs support the differentiation of histamine receptors into at least two classes.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoQA5V9HgMkJbVg90H21EOLACvtfcHk0lhc_98Ck37Iug"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaF28Xks1yit7k%253D&md5=36ca8d52720ac9ec43e1f2aec38b6b72</span></div><a href="/servlet/linkout?suffix=cit1&amp;dbid=16384&amp;doi=10.1111%2Fj.1476-5381.1966.tb01674.x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Fj.1476-5381.1966.tb01674.x%26sid%3Dliteratum%253Aachs%26aulast%3DAsh%26aufirst%3DA.%2BS.%2BF.%26aulast%3DSchild%26aufirst%3DH.%2BO.%26atitle%3DReceptors%2520mediating%2520some%2520actions%2520of%2520histamine%26jtitle%3DBr.%2520J.%2520Pharmacol.%2520Chemother.%26date%3D1966%26volume%3D27%26spage%3D427%26epage%3D439" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref2"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref2'); return false;" data-citation="" class="refNumLink">2</a></strong><div class="NLM_citation" id="cit2"><span><span class="NLM_contrib-group">Black, J. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Duncan, W. A. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Durant, C. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ganellin, C. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Parsons, E. M.</span><span> </span><span class="NLM_article-title">Definition and antagonism of histamine H<sub>2</sub>-receptors</span> <span class="citation_source-journal">Nature</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1972</span><span class="NLM_x">, </span> <span class="NLM_volume">236</span><span class="NLM_x">, </span> <span class="NLM_fpage">385</span><span class="NLM_x">–</span> <span class="NLM_lpage">390</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=16&amp;doi=10.1021%2Fjm200939b&amp;key=10.1038%2F236385a0" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=8&amp;doi=10.1021%2Fjm200939b&amp;key=4401751" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=32&amp;doi=10.1021%2Fjm200939b&amp;key=1%3ACAS%3A528%3ADyaE38XksVehsLc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=236&publication_year=1972&pages=385-390&author=J.+W.+Blackauthor=W.+A.+M.+Duncanauthor=C.+J.+Durantauthor=C.+R.+Ganellinauthor=E.+M.+Parsons&title=Definition+and+antagonism+of+histamine+H2-receptors"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit2R"><div class="casContent"><span class="casTitleNuber">2</span><div class="casTitle"><span class="NLM_cas:atitle">Definition and antagonism of histamine H2-receptors</span></div><div class="casAuthors">Black, J. W.; Duncan, W. A. M.; Durant, C. J.; Ganellin, C. R.; Parsons, E. M.</div><div class="citationInfo"><span class="NLM_cas:title">Nature (London, United Kingdom)</span>
        (<span class="NLM_cas:date">1972</span>),
    <span class="NLM_cas:volume">236</span>
        (<span class="NLM_cas:issue">5347</span>),
    <span class="NLM_cas:pages">385-90</span>CODEN:
                <span class="NLM_cas:coden">NATUAS</span>;
        ISSN:<span class="NLM_cas:issn">0028-0836</span>.
    </div><div class="casAbstract">Burimamide (I) [34970-69-9] competitively antagonized the effects of histamine (II) [51-45-6] in a dose-related manner in guinea pig atria and rat uterus; both of these tissues contain H2-receptors which are classified on the basis of II reactivity not responsive to antagonism by mepyramine [91-84-9].  I did not antagonize the β-receptor stimulant isoprenaline in guinea pig atrium or rat uterus.  I caused a slight noncompetitive inhibition of II-induced contraction in the guinea pig ileum, a tissue known to contain H1-receptors which are susceptible to antagonism by mepyramine.  I inhibited II- and pentagastrin (III) [5534-95-2]-induced, but not vagally-stimulated, gastric acid secretion in rats.  The 50% effective dose (ED50) of I for inhibition of max. II-stimulated gastric secretion in cats was 2.3 .tim. 10-5 moles/kg and for max. III-stimulated secretion was 1.6 .tim. 10-5 moles/kg.  In dogs, an ED50 of 1.9 .tim. 10-5 moles I/kg was found for inhibition of max. stimulation by II; results were similar for III-stimulated or food-stimulated secretion.  In humans, an infusion of 3 .tim. 10-1 g I hr decreased max. III-stimulated gastric acid secretion by 80% after 90 min.; results were similar with II-induced gastric secretion.  In cats, 3 .tim. 10-6 moles I/kg/min for 30 min blocked the hypotensive effect of 2 .tim. 10-8 - 2 .tim. 10-7 moles II/kg.  With 2 .tim. 10-9 moles II/kg, the hypotensive action was only partially blocked by 1 .tim. 10-2g mepyramine/kg; the resistant part of the hypotensive effect could be antagonized completely by 3 .tim. 10-7 moles I/kg/30 min.  The cardiovascular effects of II therefore involve both H1 and H2 receptors.  I is now defined as an antagonist of H2 receptors.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGptoDdXVcvFCrVg90H21EOLACvtfcHk0lhc_98Ck37Iug"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaE38XksVehsLc%253D&md5=90eb7d2efdd4383433a3acb92ebc2044</span></div><a href="/servlet/linkout?suffix=cit2&amp;dbid=16384&amp;doi=10.1038%2F236385a0&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252F236385a0%26sid%3Dliteratum%253Aachs%26aulast%3DBlack%26aufirst%3DJ.%2BW.%26aulast%3DDuncan%26aufirst%3DW.%2BA.%2BM.%26aulast%3DDurant%26aufirst%3DC.%2BJ.%26aulast%3DGanellin%26aufirst%3DC.%2BR.%26aulast%3DParsons%26aufirst%3DE.%2BM.%26atitle%3DDefinition%2520and%2520antagonism%2520of%2520histamine%2520H2-receptors%26jtitle%3DNature%26date%3D1972%26volume%3D236%26spage%3D385%26epage%3D390" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref3"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref3'); return false;" data-citation="" class="refNumLink">3</a></strong><div class="NLM_citation" id="cit3"><span><span class="NLM_contrib-group">Celanire, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wijtmans, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Talaga, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Leurs, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">de Esch, I. J. P.</span><span> </span><span class="NLM_article-title">Keynote review: histamine H<sub>3</sub> receptor antagonists reach out for the clinic</span> <span class="citation_source-journal">Drug Discovery Today</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">10</span><span class="NLM_x">, </span> <span class="NLM_fpage">1613</span><span class="NLM_x">–</span> <span class="NLM_lpage">1627</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=10&publication_year=2005&pages=1613-1627&author=S.+Celanireauthor=M.+Wijtmansauthor=P.+Talagaauthor=R.+Leursauthor=I.+J.+P.+de+Esch&title=Keynote+review%3A+histamine+H3+receptor+antagonists+reach+out+for+the+clinic"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit3&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DCelanire%26aufirst%3DS.%26aulast%3DWijtmans%26aufirst%3DM.%26aulast%3DTalaga%26aufirst%3DP.%26aulast%3DLeurs%26aufirst%3DR.%26aulast%3Dde%2BEsch%26aufirst%3DI.%2BJ.%2BP.%26atitle%3DKeynote%2520review%253A%2520histamine%2520H3%2520receptor%2520antagonists%2520reach%2520out%2520for%2520the%2520clinic%26jtitle%3DDrug%2520Discovery%2520Today%26date%3D2005%26volume%3D10%26spage%3D1613%26epage%3D1627" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref4"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref4'); return false;" data-citation="" class="refNumLink">4</a></strong><div class="NLM_citation" id="cit4"><span><span class="NLM_contrib-group">Łażewska, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kieć-Kononowicz, K.</span><span> </span><span class="NLM_article-title">Recent advances in histamine H<sub>3</sub> receptor antagonists/inverse agonists</span> <span class="citation_source-journal">Expert Opin. Ther. Pat.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">20</span><span class="NLM_x">, </span> <span class="NLM_fpage">1147</span><span class="NLM_x">–</span> <span class="NLM_lpage">1169</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=16&amp;doi=10.1021%2Fjm200939b&amp;key=10.1517%2F13543776.2010.509346" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=8&amp;doi=10.1021%2Fjm200939b&amp;key=20716022" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=32&amp;doi=10.1021%2Fjm200939b&amp;key=1%3ACAS%3A528%3ADC%252BC3cXhtVCntLnE" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=20&publication_year=2010&pages=1147-1169&author=D.+%C5%81a%C5%BCewskaauthor=K.+Kie%C4%87-Kononowicz&title=Recent+advances+in+histamine+H3+receptor+antagonists%2Finverse+agonists"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit4R"><div class="casContent"><span class="casTitleNuber">4</span><div class="casTitle"><span class="NLM_cas:atitle">Recent advances in histamine H3 receptor antagonists/inverse agonists</span></div><div class="casAuthors">Lazewska, Dorota; Kiec-Kononowicz, Katarzyna</div><div class="citationInfo"><span class="NLM_cas:title">Expert Opinion on Therapeutic Patents</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">20</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">1147-1169</span>CODEN:
                <span class="NLM_cas:coden">EOTPEG</span>;
        ISSN:<span class="NLM_cas:issn">1354-3776</span>.
    
            (<span class="NLM_cas:orgname">Informa Healthcare</span>)
        </div><div class="casAbstract">A review.  Importance of the field: Histamine H3 receptor (H3R) antagonists/inverse agonists can be therapeutically useful in the treatment of various CNS, metabolic syndrome and allergic disorders, and constitute an attractive target in the search for new drugs.  However, several drug candidates have been rejected because of unwanted effects.  There is, therefore, a strong need to develop new H3R ligands.  Areas covered in this review: A review was conducted of recent advances in the search for H3R antagonists/inverse agonists as reflected by patent applications/patents over the last 3 years.  What the reader will gain: A total of around 100 patent applications/patents along with selected peer-reviewed publications are surveyed.  These involve antagonists/inverse agonists of H3R, which the authors have divided into five groups.  The above-mentioned compds. were evaluated for their potential utility in the treatment of narcolepsy, attention deficit hyperactivity disorder, epilepsy, Alzheimer's disease, schizophrenia, obesity and neuropathic pain.  Take home message: Several H3R antagonists/inverse agonists appear to be promising drug candidates, including at least 15 compds. undergoing evaluation in clin. development.  Esp. interesting is pitolisant, which is progressing through to Phase III clin. trials.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqRVSNfy6q5wrVg90H21EOLACvtfcHk0ljZkvCF3GCdaQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXhtVCntLnE&md5=033312a9f907c9b0b7d6652977b3cbc5</span></div><a href="/servlet/linkout?suffix=cit4&amp;dbid=16384&amp;doi=10.1517%2F13543776.2010.509346&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1517%252F13543776.2010.509346%26sid%3Dliteratum%253Aachs%26aulast%3D%25C5%2581a%25C5%25BCewska%26aufirst%3DD.%26aulast%3DKie%25C4%2587-Kononowicz%26aufirst%3DK.%26atitle%3DRecent%2520advances%2520in%2520histamine%2520H3%2520receptor%2520antagonists%252Finverse%2520agonists%26jtitle%3DExpert%2520Opin.%2520Ther.%2520Pat.%26date%3D2010%26volume%3D20%26spage%3D1147%26epage%3D1169" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref5"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref5'); return false;" data-citation="" class="refNumLink">5</a></strong><div class="NLM_citation" id="cit5"><span><span class="NLM_contrib-group">Passani, M. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lin, J.-S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hancock, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Crochet, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Blandina, P.</span><span> </span><span class="NLM_article-title">The histamine H<sub>3</sub> receptor as a novel therapeutic target for cognitive and sleep disorders</span> <span class="citation_source-journal">Trends Pharmacol. Sci.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">25</span><span class="NLM_x">, </span> <span class="NLM_fpage">618</span><span class="NLM_x">–</span> <span class="NLM_lpage">625</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=25&publication_year=2004&pages=618-625&author=M.+B.+Passaniauthor=J.-S.+Linauthor=A.+Hancockauthor=S.+Crochetauthor=P.+Blandina&title=The+histamine+H3+receptor+as+a+novel+therapeutic+target+for+cognitive+and+sleep+disorders"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit5&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DPassani%26aufirst%3DM.%2BB.%26aulast%3DLin%26aufirst%3DJ.-S.%26aulast%3DHancock%26aufirst%3DA.%26aulast%3DCrochet%26aufirst%3DS.%26aulast%3DBlandina%26aufirst%3DP.%26atitle%3DThe%2520histamine%2520H3%2520receptor%2520as%2520a%2520novel%2520therapeutic%2520target%2520for%2520cognitive%2520and%2520sleep%2520disorders%26jtitle%3DTrends%2520Pharmacol.%2520Sci.%26date%3D2004%26volume%3D25%26spage%3D618%26epage%3D625" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref6"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref6'); return false;" data-citation="" class="refNumLink">6</a></strong><div class="NLM_citation" id="cit6"><span><span class="NLM_contrib-group">Barbier, A. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bradbury, M. J.</span><span> </span><span class="NLM_article-title">Histaminergic control of sleep–wake cycles: recent therapeutic advances for sleep and wake disorders</span> <span class="citation_source-journal">CNS Neurol. Disord.: Drug Targets</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">6</span><span class="NLM_x">, </span> <span class="NLM_fpage">31</span><span class="NLM_x">–</span> <span class="NLM_lpage">43</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=16&amp;doi=10.1021%2Fjm200939b&amp;key=10.2174%2F187152707779940790" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=8&amp;doi=10.1021%2Fjm200939b&amp;key=17305552" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=32&amp;doi=10.1021%2Fjm200939b&amp;key=1%3ACAS%3A528%3ADC%252BD2sXis1alsbk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=2007&pages=31-43&author=A.+J.+Barbierauthor=M.+J.+Bradbury&title=Histaminergic+control+of+sleep%E2%80%93wake+cycles%3A+recent+therapeutic+advances+for+sleep+and+wake+disorders"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit6R"><div class="casContent"><span class="casTitleNuber">6</span><div class="casTitle"><span class="NLM_cas:atitle">Histaminergic control of sleep-wake cycles: recent therapeutic advances for sleep and wake disorders</span></div><div class="casAuthors">Barbier, A. J.; Bradbury, M. J.</div><div class="citationInfo"><span class="NLM_cas:title">CNS & Neurological Disorders: Drug Targets</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">6</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">31-43</span>CODEN:
                <span class="NLM_cas:coden">CNDDA3</span>;
        ISSN:<span class="NLM_cas:issn">1871-5273</span>.
    
            (<span class="NLM_cas:orgname">Bentham Science Publishers Ltd.</span>)
        </div><div class="casAbstract">A review.  The role of histaminergic neurotransmission in the promotion of waking has been extensively studied in preclin. species.  Appreciation for the role of histamine continues to expand with increasing understanding of the interaction of histamine within the broad network of neuromodulators that regulate sleep and wake.  The effects of histamine on waking are transduced through the H1 and the H3 receptors in the central nervous system.  Brain penetrant over-the-counter antihistamines comprised of antagonist actions at H1 receptors as well as varying degrees of antimuscarinic properties are marketed as sleep aids, based on their well-known daytime drowsiness side effects.  The data supporting their use as sedatives, however, are not consistent.  H3 receptors are presynaptic receptors that limit histamine release as well as that of monoamine neurotransmitters thought to participate in the maintenance of waking.  In this review, we discuss the existing studies on various antihistamines and antagonists of the H1 receptor in the regulation of sleep in preclin. studies, normal subjects and in subjects with sleep disorders.  In addn., we review the current data available on the use of ligands at H3 receptors for the modulation of sleep and wake.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpcdA_sS0bH2LVg90H21EOLACvtfcHk0ljZkvCF3GCdaQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXis1alsbk%253D&md5=ab8fd3a7b40ee363db2882471ca68d06</span></div><a href="/servlet/linkout?suffix=cit6&amp;dbid=16384&amp;doi=10.2174%2F187152707779940790&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2174%252F187152707779940790%26sid%3Dliteratum%253Aachs%26aulast%3DBarbier%26aufirst%3DA.%2BJ.%26aulast%3DBradbury%26aufirst%3DM.%2BJ.%26atitle%3DHistaminergic%2520control%2520of%2520sleep%25E2%2580%2593wake%2520cycles%253A%2520recent%2520therapeutic%2520advances%2520for%2520sleep%2520and%2520wake%2520disorders%26jtitle%3DCNS%2520Neurol.%2520Disord.%253A%2520Drug%2520Targets%26date%3D2007%26volume%3D6%26spage%3D31%26epage%3D43" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref7"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref7'); return false;" data-citation="" class="refNumLink">7</a></strong><div class="NLM_citation" id="cit7"><span><span class="NLM_contrib-group">Levander, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Haegermark, O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Staahle, M.</span><span> </span><span class="NLM_article-title">Peripheral antihistamine and central sedative effects of three H<sub>1</sub>-receptor antagonists</span> <span class="citation_source-journal">Eur. J. Clin. Pharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1985</span><span class="NLM_x">, </span> <span class="NLM_volume">28</span><span class="NLM_x">, </span> <span class="NLM_fpage">523</span><span class="NLM_x">–</span> <span class="NLM_lpage">529</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=28&publication_year=1985&pages=523-529&author=S.+Levanderauthor=O.+Haegermarkauthor=M.+Staahle&title=Peripheral+antihistamine+and+central+sedative+effects+of+three+H1-receptor+antagonists"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit7&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DLevander%26aufirst%3DS.%26aulast%3DHaegermark%26aufirst%3DO.%26aulast%3DStaahle%26aufirst%3DM.%26atitle%3DPeripheral%2520antihistamine%2520and%2520central%2520sedative%2520effects%2520of%2520three%2520H1-receptor%2520antagonists%26jtitle%3DEur.%2520J.%2520Clin.%2520Pharmacol.%26date%3D1985%26volume%3D28%26spage%3D523%26epage%3D529" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref8"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref8'); return false;" data-citation="" class="refNumLink">8</a></strong><div class="NLM_citation" id="cit8"><span><span class="NLM_contrib-group">Arrang, J. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Garbarg, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schwartz, J. C.</span><span> </span><span class="NLM_article-title">Autoinhibition of brain histamine release mediated by a novel class (H<sub>3</sub>) of histamine receptor</span> <span class="citation_source-journal">Nature</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1983</span><span class="NLM_x">, </span> <span class="NLM_volume">302</span><span class="NLM_x">, </span> <span class="NLM_fpage">832</span><span class="NLM_x">–</span> <span class="NLM_lpage">837</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=302&publication_year=1983&pages=832-837&author=J.+M.+Arrangauthor=M.+Garbargauthor=J.+C.+Schwartz&title=Autoinhibition+of+brain+histamine+release+mediated+by+a+novel+class+%28H3%29+of+histamine+receptor"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit8&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DArrang%26aufirst%3DJ.%2BM.%26aulast%3DGarbarg%26aufirst%3DM.%26aulast%3DSchwartz%26aufirst%3DJ.%2BC.%26atitle%3DAutoinhibition%2520of%2520brain%2520histamine%2520release%2520mediated%2520by%2520a%2520novel%2520class%2520%2528H3%2529%2520of%2520histamine%2520receptor%26jtitle%3DNature%26date%3D1983%26volume%3D302%26spage%3D832%26epage%3D837" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref9"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref9'); return false;" data-citation="" class="refNumLink">9</a></strong><div class="NLM_citation" id="cit9"><span><span class="NLM_contrib-group">Brown, R. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stevens, D. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Haas, H. L.</span><span> </span><span class="NLM_article-title">The physiology of brain histamine</span> <span class="citation_source-journal">Prog. Neurobiol. (Oxford, U. K.)</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2001</span><span class="NLM_x">, </span> <span class="NLM_volume">63</span><span class="NLM_x">, </span> <span class="NLM_fpage">637</span><span class="NLM_x">–</span> <span class="NLM_lpage">672</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=16&amp;doi=10.1021%2Fjm200939b&amp;key=10.1016%2FS0301-0082%2800%2900039-3" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=8&amp;doi=10.1021%2Fjm200939b&amp;key=11164999" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=32&amp;doi=10.1021%2Fjm200939b&amp;key=1%3ACAS%3A528%3ADC%252BD3MXntlOktg%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=63&publication_year=2001&pages=637-672&author=R.+E.+Brownauthor=D.+R.+Stevensauthor=H.+L.+Haas&title=The+physiology+of+brain+histamine"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit9R"><div class="casContent"><span class="casTitleNuber">9</span><div class="casTitle"><span class="NLM_cas:atitle">The physiology of brain histamine</span></div><div class="casAuthors">Brown, R. E.; Stevens, D. R.; Haas, H. L.</div><div class="citationInfo"><span class="NLM_cas:title">Progress in Neurobiology (Oxford, United Kingdom)</span>
        (<span class="NLM_cas:date">2001</span>),
    <span class="NLM_cas:volume">63</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">637-672</span>CODEN:
                <span class="NLM_cas:coden">PGNBA5</span>;
        ISSN:<span class="NLM_cas:issn">0301-0082</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Science Ltd.</span>)
        </div><div class="casAbstract">A review, with ∼375 refs.  Histamine-releasing neurons are located exclusively in the TM of the hypothalamus, from where they project to practically all brain regions, with ventral areas (hypothalamus, basal forebrain, amygdala) receiving a particularly strong innervation.  The intrinsic electrophysiol. properties of TM neurons (slow spontaneous firing, broad action potentials, deep afterhyperpolarizations, etc.) are extremely similar to other aminergic neurons.  Their firing rate varies across the sleep-wake cycle, being highest during waking and lowest during rapid-eye movement sleep.  In contrast to other aminergic neurons somatodendritic autoreceptors (H3) do not activate an inwardly rectifying potassium channel but instead control firing by inhibiting voltage-dependent calcium channels.  Histamine release is enhanced under extreme conditions such as dehydration or hypoglycemia or by a variety of stressors.  Histamine activates four types of receptors.  H1 receptors are mainly postsynaptically located and are coupled pos. to phospholipase C. High densities are found esp. in the hypothalamus and other limbic regions.  Activation of these receptors causes large depolarizations via blockade of a leak potassium conductance, activation of a non-specific cation channel or activation of a sodium-calcium exchanger.  H2 receptors are also mainly postsynaptically located and are coupled pos. to adenylyl cyclase.  High densities are found in hippocampus, amygdala and basal ganglia.  Activation of these receptors also leads to mainly excitatory effects through blockade of calcium-dependent potassium channels and modulation of the hyperpolarization-activated cation channel.  H3 receptors are exclusively presynaptically located and are neg. coupled to adenylyl cyclase.  High densities are found in the basal ganglia.  These receptors mediated presynaptic inhibition of histamine release and the release of other neurotransmitters, most likely via inhibition of presynaptic calcium channels.  Finally, histamine modulates the glutamate NMDA receptor via an action at the polyamine binding site.  The central histamine system is involved in many central nervous system functions: arousal; anxiety; activation of the sympathetic nervous system; the stress-related release of hormones from the pituitary and of central aminergic neurotransmitters; antinociception; water retention and suppression of eating.  A role for the neuronal histamine system as a danger response system is proposed.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGojnBKJrphchrVg90H21EOLACvtfcHk0liGo2JaPRviOg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3MXntlOktg%253D%253D&md5=7d9e9c1c91cf00ebe5d5212fc6cb883c</span></div><a href="/servlet/linkout?suffix=cit9&amp;dbid=16384&amp;doi=10.1016%2FS0301-0082%2800%2900039-3&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0301-0082%252800%252900039-3%26sid%3Dliteratum%253Aachs%26aulast%3DBrown%26aufirst%3DR.%2BE.%26aulast%3DStevens%26aufirst%3DD.%2BR.%26aulast%3DHaas%26aufirst%3DH.%2BL.%26atitle%3DThe%2520physiology%2520of%2520brain%2520histamine%26jtitle%3DProg.%2520Neurobiol.%2520%2528Oxford%252C%2520U.%2520K.%2529%26date%3D2001%26volume%3D63%26spage%3D637%26epage%3D672" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref10"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref10'); return false;" data-citation="" class="refNumLink">10</a></strong><div class="NLM_citation" id="cit10"><span><span class="NLM_contrib-group">Esbenshade, T. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Browman, K. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bitner, R. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Strakhova, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cowart, M. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brioni, J. D.</span><span> </span><span class="NLM_article-title">The histamine H<sub>3</sub> receptor: an attractive target for the treatment of cognitive disorders</span> <span class="citation_source-journal">Br. J. Pharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">154</span><span class="NLM_x">, </span> <span class="NLM_fpage">1166</span><span class="NLM_x">–</span> <span class="NLM_lpage">1181</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=16&amp;doi=10.1021%2Fjm200939b&amp;key=10.1038%2Fbjp.2008.147" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=8&amp;doi=10.1021%2Fjm200939b&amp;key=18469850" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=32&amp;doi=10.1021%2Fjm200939b&amp;key=1%3ACAS%3A528%3ADC%252BD1cXosVCjtL4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=154&publication_year=2008&pages=1166-1181&author=T.+A.+Esbenshadeauthor=K.+E.+Browmanauthor=R.+S.+Bitnerauthor=M.+Strakhovaauthor=M.+D.+Cowartauthor=J.+D.+Brioni&title=The+histamine+H3+receptor%3A+an+attractive+target+for+the+treatment+of+cognitive+disorders"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit10R"><div class="casContent"><span class="casTitleNuber">10</span><div class="casTitle"><span class="NLM_cas:atitle">The histamine H3 receptor: an attractive target for the treatment of cognitive disorders</span></div><div class="casAuthors">Esbenshade, T. A.; Browman, K. E.; Bitner, R. S.; Strakhova, M.; Cowart, M. D.; Brioni, J. D.</div><div class="citationInfo"><span class="NLM_cas:title">British Journal of Pharmacology</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">154</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">1166-1181</span>CODEN:
                <span class="NLM_cas:coden">BJPCBM</span>;
        ISSN:<span class="NLM_cas:issn">0007-1188</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A review.  The histamine H3 receptor, first described in 1983 as a histamine autoreceptor and later shown to also function as a heteroreceptor that regulates the release of other neurotransmitters, has been the focus of research by numerous labs. as it represents an attractive drug target for a no. of indications including cognition.  The purpose of this review is to acquaint the reader with the current understanding of H3 receptor localization and function as a modulator of neurotransmitter release and its effects on cognitive processes, as well as to provide an update on selected H3 antagonists in various states of preclin. and clin. advancement.  Blockade of centrally localized H3 receptors by selective H3 receptor antagonists has been shown to enhance the release of neurotransmitters such as histamine, ACh, dopamine and norepinephrine, among others, which play important roles in cognitive processes.  The cognitive-enhancing effects of H3 antagonists across multiple cognitive domains in a wide no. of preclin. cognition models also bolster confidence in this therapeutic approach for the treatment of attention deficit hyperactivity disorder, Alzheimer's disease and schizophrenia.  However, although a no. of clin. studies examg. the efficacy of H3 receptor antagonists for a variety of cognitive disorders are currently underway, no clin. proof of concept for an H3 receptor antagonist has been reported to date.  The discovery of effective H3 antagonists as therapeutic agents for the novel treatment of cognitive disorders will only be accomplished through continued research efforts that further our insights into the functions of the H3 receptor.  British Journal of Pharmacol. (2008) 154, 1166-1181; doi:10.1038/bjp.2008.147; published online 12 May 2008.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr2N2Dg3cdZfrVg90H21EOLACvtfcHk0liGo2JaPRviOg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXosVCjtL4%253D&md5=05bcda7b1140e9d16b4ca4072902d925</span></div><a href="/servlet/linkout?suffix=cit10&amp;dbid=16384&amp;doi=10.1038%2Fbjp.2008.147&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fbjp.2008.147%26sid%3Dliteratum%253Aachs%26aulast%3DEsbenshade%26aufirst%3DT.%2BA.%26aulast%3DBrowman%26aufirst%3DK.%2BE.%26aulast%3DBitner%26aufirst%3DR.%2BS.%26aulast%3DStrakhova%26aufirst%3DM.%26aulast%3DCowart%26aufirst%3DM.%2BD.%26aulast%3DBrioni%26aufirst%3DJ.%2BD.%26atitle%3DThe%2520histamine%2520H3%2520receptor%253A%2520an%2520attractive%2520target%2520for%2520the%2520treatment%2520of%2520cognitive%2520disorders%26jtitle%3DBr.%2520J.%2520Pharmacol.%26date%3D2008%26volume%3D154%26spage%3D1166%26epage%3D1181" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref11"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref11'); return false;" data-citation="" class="refNumLink">11</a></strong><div class="NLM_citation" id="cit11"><span><span class="NLM_contrib-group">Tzavara, E. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bymaster, F. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Overshiner, C. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Davis, R. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Perry, K. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wolff, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McKinzie, D. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Witkin, J. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nomikos, G. G.</span><span> </span><span class="NLM_article-title">Procholinergic and memory enhancing properties of the selective norepinephrine uptake inhibitor atomoxetine</span> <span class="citation_source-journal">Mol. Psychiatry</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">11</span><span class="NLM_x">, </span> <span class="NLM_fpage">187</span><span class="NLM_x">–</span> <span class="NLM_lpage">195</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=16&amp;doi=10.1021%2Fjm200939b&amp;key=10.1038%2Fsj.mp.4001763" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=8&amp;doi=10.1021%2Fjm200939b&amp;key=16231039" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=32&amp;doi=10.1021%2Fjm200939b&amp;key=1%3ACAS%3A528%3ADC%252BD28XnsV2mtA%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=11&publication_year=2006&pages=187-195&author=E.+T.+Tzavaraauthor=F.+P.+Bymasterauthor=C.+D.+Overshinerauthor=R.+J.+Davisauthor=K.+W.+Perryauthor=M.+Wolffauthor=D.+L.+McKinzieauthor=J.+M.+Witkinauthor=G.+G.+Nomikos&title=Procholinergic+and+memory+enhancing+properties+of+the+selective+norepinephrine+uptake+inhibitor+atomoxetine"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit11R"><div class="casContent"><span class="casTitleNuber">11</span><div class="casTitle"><span class="NLM_cas:atitle">Procholinergic and memory enhancing properties of the selective norepinephrine uptake inhibitor atomoxetine</span></div><div class="casAuthors">Tzavara, E. T.; Bymaster, F. P.; Overshiner, C. D.; Davis, R. J.; Perry, K. W.; Wolff, M.; McKinzie, D. L.; Witkin, J. M.; Nomikos, G. G.</div><div class="citationInfo"><span class="NLM_cas:title">Molecular Psychiatry</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">11</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">187-195</span>CODEN:
                <span class="NLM_cas:coden">MOPSFQ</span>;
        ISSN:<span class="NLM_cas:issn">1359-4184</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">Atomoxetine has been approved by the FDA as the first new drug in 30 years for the treatment of attention deficit/hyperactivity disorder (ADHD).  As a selective norepinephrine uptake inhibitor and a nonstimulant, atomoxetine has a different mechanism of action from the stimulant drugs used up to now for the treatment of ADHD.  Since brain acetylcholine (ACh) has been assocd. with memory, attention and motivation, processes dysregulated in ADHD, we investigated the effects of atomoxetine on cholinergic neurotransmission.  We showed here that, in rats, atomoxetine (0.3-3 mg/kg, i.p.), - increases in vivo extracellular levels of ACh in cortical but not subcortical brain regions.  The marked increase of cortical ACh induced by atomoxetine was dependent upon norepinephrine α-1 and/or dopamine D1 receptor activation.  We obsd. similar increases in cortical and hippocampal ACh release with methylphenidate (1 and 3 mg/kg, i.p.) - currently the most commonly prescribed medication for the treatment of ADHD - and with the norepinephrine uptake inhibitor reboxetine (3-30 mg/kg, i.p.).  Since drugs that increase cholinergic neurotransmission are used in the treatment of cognitive dysfunction and dementias, we also investigated the effects of atomoxetine on memory tasks.  We showed that, consistent with its cortical procholinergic and catecholamine-enhancing profile, atomoxetine (1-3 mg/kg, p.o.) significantly ameliorated performance in the object recognition test and the radial arm-maze test.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp_B1VE6vP6MbVg90H21EOLACvtfcHk0liGo2JaPRviOg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28XnsV2mtA%253D%253D&md5=afa062abf68eb50e31afd533d27a1c10</span></div><a href="/servlet/linkout?suffix=cit11&amp;dbid=16384&amp;doi=10.1038%2Fsj.mp.4001763&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fsj.mp.4001763%26sid%3Dliteratum%253Aachs%26aulast%3DTzavara%26aufirst%3DE.%2BT.%26aulast%3DBymaster%26aufirst%3DF.%2BP.%26aulast%3DOvershiner%26aufirst%3DC.%2BD.%26aulast%3DDavis%26aufirst%3DR.%2BJ.%26aulast%3DPerry%26aufirst%3DK.%2BW.%26aulast%3DWolff%26aufirst%3DM.%26aulast%3DMcKinzie%26aufirst%3DD.%2BL.%26aulast%3DWitkin%26aufirst%3DJ.%2BM.%26aulast%3DNomikos%26aufirst%3DG.%2BG.%26atitle%3DProcholinergic%2520and%2520memory%2520enhancing%2520properties%2520of%2520the%2520selective%2520norepinephrine%2520uptake%2520inhibitor%2520atomoxetine%26jtitle%3DMol.%2520Psychiatry%26date%3D2006%26volume%3D11%26spage%3D187%26epage%3D195" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref12"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref12'); return false;" data-citation="" class="refNumLink">12</a></strong><div class="NLM_citation" id="cit12"><span><span class="NLM_contrib-group">Horner, W. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Johnson, D. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schmidt, A. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rollema, H.</span><span> </span><span class="NLM_article-title">Methylphenidate and atomoxetine increase histamine release in rat prefrontal cortex</span> <span class="citation_source-journal">Eur. J. Pharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">558</span><span class="NLM_x">, </span> <span class="NLM_fpage">96</span><span class="NLM_x">–</span> <span class="NLM_lpage">97</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=16&amp;doi=10.1021%2Fjm200939b&amp;key=10.1016%2Fj.ejphar.2006.11.048" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=8&amp;doi=10.1021%2Fjm200939b&amp;key=17198700" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=32&amp;doi=10.1021%2Fjm200939b&amp;key=1%3ACAS%3A528%3ADC%252BD2sXhvVGnsr0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=558&publication_year=2007&pages=96-97&author=W.+E.+Hornerauthor=D.+E.+Johnsonauthor=A.+W.+Schmidtauthor=H.+Rollema&title=Methylphenidate+and+atomoxetine+increase+histamine+release+in+rat+prefrontal+cortex"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit12R"><div class="casContent"><span class="casTitleNuber">12</span><div class="casTitle"><span class="NLM_cas:atitle">Methylphenidate and atomoxetine increase histamine release in rat prefrontal cortex</span></div><div class="casAuthors">Horner, Weldon E.; Johnson, David E.; Schmidt, Anne W.; Rollema, Hans</div><div class="citationInfo"><span class="NLM_cas:title">European Journal of Pharmacology</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">558</span>
        (<span class="NLM_cas:issue">1-3</span>),
    <span class="NLM_cas:pages">96-97</span>CODEN:
                <span class="NLM_cas:coden">EJPHAZ</span>;
        ISSN:<span class="NLM_cas:issn">0014-2999</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">Using microdialysis in rat prefrontal cortex, we found that 1 mg/kg of the stimulant methylphenidate and the non-stimulant atomoxetine, two widely used treatments for Attention Deficit/Hyperactivity Disorder (ADHD), produce robust increases in the extracellular levels of histamine, which plays a key role in attention, learning and memory.  While the clin. response to ADHD drugs is typically attributed to modulation of norepinephrine and dopamine, this finding suggests enhanced histamine release may contribute to their efficacy as ADHD treatments.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr4UinWVjCBJLVg90H21EOLACvtfcHk0lgGFh-pgsdiIA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXhvVGnsr0%253D&md5=a3112bec5974a993095d38e8c8eb5f5c</span></div><a href="/servlet/linkout?suffix=cit12&amp;dbid=16384&amp;doi=10.1016%2Fj.ejphar.2006.11.048&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.ejphar.2006.11.048%26sid%3Dliteratum%253Aachs%26aulast%3DHorner%26aufirst%3DW.%2BE.%26aulast%3DJohnson%26aufirst%3DD.%2BE.%26aulast%3DSchmidt%26aufirst%3DA.%2BW.%26aulast%3DRollema%26aufirst%3DH.%26atitle%3DMethylphenidate%2520and%2520atomoxetine%2520increase%2520histamine%2520release%2520in%2520rat%2520prefrontal%2520cortex%26jtitle%3DEur.%2520J.%2520Pharmacol.%26date%3D2007%26volume%3D558%26spage%3D96%26epage%3D97" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref13"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref13'); return false;" data-citation="" class="refNumLink">13</a></strong><div class="NLM_citation" id="cit13"><span>FDA. Atomoxetine (Marketed as Strattera) Information,<span class="NLM_x"> </span><span class="NLM_year">2005</span>. <a href="http://www.fda.gov/Drugs/DrugSafety/PostmarketDrugSafetyInformationforPatientsandProviders/ucm107912.htm" class="extLink">http://www.fda.gov/Drugs/DrugSafety/PostmarketDrugSafetyInformationforPatientsandProviders/ucm107912.htm</a></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=FDA.+Atomoxetine+%28Marketed+as+Strattera%29+Information%2C+2005.+http%3A%2F%2Fwww.fda.gov%2FDrugs%2FDrugSafety%2FPostmarketDrugSafetyInformationforPatientsandProviders%2Fucm107912.htm"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit13&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dweb%26sid%3Dliteratum%253Aachs%26date%3D2005" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref14"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref14'); return false;" data-citation="" class="refNumLink">14</a></strong><div class="NLM_citation" id="cit14"><span><span class="NLM_contrib-group">Wernicke, J. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kratochvil, C. J.</span><span> </span><span class="NLM_article-title">Safety profile of atomoxetine in the treatment of children and adolescents with ADHD</span> <span class="citation_source-journal">J. Clin. Psychiatry</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2002</span><span class="NLM_x">, </span> <span class="NLM_volume">63</span><span class="NLM_x"> (</span><span class="NLM_issue">Suppl. 12</span><span class="NLM_x">) </span> <span class="NLM_fpage">50</span><span class="NLM_x">–</span> <span class="NLM_lpage">55</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=8&amp;doi=10.1021%2Fjm200939b&amp;key=12562062" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=32&amp;doi=10.1021%2Fjm200939b&amp;key=1%3ACAS%3A528%3ADC%252BD3sXit1Oi" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=63&publication_year=2002&pages=50-55&issue=Suppl.+12&author=J.+F.+Wernickeauthor=C.+J.+Kratochvil&title=Safety+profile+of+atomoxetine+in+the+treatment+of+children+and+adolescents+with+ADHD"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit14R"><div class="casContent"><span class="casTitleNuber">14</span><div class="casTitle"><span class="NLM_cas:atitle">Safety profile of atomoxetine in the treatment of children and adolescents with ADHD</span></div><div class="casAuthors">Wernicke, J. F.; Kratochvil, Christopher J.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Clinical Psychiatry</span>
        (<span class="NLM_cas:date">2002</span>),
    <span class="NLM_cas:volume">63</span>
        (<span class="NLM_cas:issue">Suppl. 12</span>),
    <span class="NLM_cas:pages">50-55</span>CODEN:
                <span class="NLM_cas:coden">JCLPDE</span>;
        ISSN:<span class="NLM_cas:issn">0160-6689</span>.
    
            (<span class="NLM_cas:orgname">Physicians Postgraduate Press, Inc.</span>)
        </div><div class="casAbstract">A review.  Atomoxetine is a selective norepinephrine reuptake inhibitor that is being developed for the treatment of attention-deficit/hyperactivity disorder (ADHD).  Atomoxetine will be the first nonstimulant medication approved by the U.S.  Food and Drug Administration (FDA) for the treatment of ADHD.  Throughout the testing phases, more than 2000 children and adolescents have been exposed to atomoxetine in clin. trials, with both the no. of exposures and the length of exposure time increasing.  Serious adverse events have not been clearly assocd. with the drug, and there have been few discontinuations due to adverse events.  The most common drug-related event reported in trials has been decreased appetite and an initial period of wt. loss followed by an apparently normal rate of wt. gain.  These events tend to appear early in the course of treatment with atomoxetine and then decline.  Atomoxetine has also been assocd. with mild increases in blood pressure and pulse that plateau during treatment and resolve upon discontinuation.  There have been no effects seen on the QT interval, and the cytochrome P 450 2D6 metab. of patients seems to have little effect on safety or tolerability of the drug.  This article will review the data from completed and ongoing clin. trials available at the time the New Drug Application was submitted to the FDA.  Described are serious adverse events, discontinuations, and treatment-emergent adverse events.  Specifically, cardiac effects and effects on wt., height, and metab. that are related to treatment of ADHD with atomoxetine in children and adolescents are discussed.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpUejL3GHHM2bVg90H21EOLACvtfcHk0lgGFh-pgsdiIA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3sXit1Oi&md5=9fe9b3296c1ae0363f1e42b23222a526</span></div><a href="/servlet/linkout?suffix=cit14&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DWernicke%26aufirst%3DJ.%2BF.%26aulast%3DKratochvil%26aufirst%3DC.%2BJ.%26atitle%3DSafety%2520profile%2520of%2520atomoxetine%2520in%2520the%2520treatment%2520of%2520children%2520and%2520adolescents%2520with%2520ADHD%26jtitle%3DJ.%2520Clin.%2520Psychiatry%26date%3D2002%26volume%3D63%26issue%3DSuppl.%252012%26spage%3D50%26epage%3D55" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref15"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref15'); return false;" data-citation="" class="refNumLink">15</a></strong><div class="NLM_citation" id="cit15"><span><span class="NLM_contrib-group">Fermini, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fossa, A. A.</span><span> </span><span class="NLM_article-title">The impact of drug-induced QT interval prolongation on drug discovery and development</span> <span class="citation_source-journal">Nat. Rev. Drug Discovery</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">2</span><span class="NLM_x">, </span> <span class="NLM_fpage">439</span><span class="NLM_x">–</span> <span class="NLM_lpage">447</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=2&publication_year=2003&pages=439-447&author=B.+Ferminiauthor=A.+A.+Fossa&title=The+impact+of+drug-induced+QT+interval+prolongation+on+drug+discovery+and+development"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit15&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DFermini%26aufirst%3DB.%26aulast%3DFossa%26aufirst%3DA.%2BA.%26atitle%3DThe%2520impact%2520of%2520drug-induced%2520QT%2520interval%2520prolongation%2520on%2520drug%2520discovery%2520and%2520development%26jtitle%3DNat.%2520Rev.%2520Drug%2520Discovery%26date%3D2003%26volume%3D2%26spage%3D439%26epage%3D447" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref16"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref16'); return false;" data-citation="" class="refNumLink">16</a></strong><div class="NLM_citation" id="cit16"><span><span class="NLM_contrib-group">Hosea, N. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Collard, W. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cole, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Maurer, T. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fang, R. X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jones, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kakar, S. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nakai, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Smith, B. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Webster, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Beaumont, K.</span><span> </span><span class="NLM_article-title">Prediction of human pharmacokinetics from preclinical information: comparative accuracy of quantitative prediction approaches</span> <span class="citation_source-journal">J. Clin. Pharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">49</span><span class="NLM_x">, </span> <span class="NLM_fpage">513</span><span class="NLM_x">–</span> <span class="NLM_lpage">533</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=16&amp;doi=10.1021%2Fjm200939b&amp;key=10.1177%2F0091270009333209" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=8&amp;doi=10.1021%2Fjm200939b&amp;key=19299532" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=32&amp;doi=10.1021%2Fjm200939b&amp;key=1%3ACAS%3A528%3ADC%252BD1MXlsFWmu74%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=49&publication_year=2009&pages=513-533&author=N.+A.+Hoseaauthor=W.+T.+Collardauthor=S.+Coleauthor=T.+S.+Maurerauthor=R.+X.+Fangauthor=H.+Jonesauthor=S.+M.+Kakarauthor=Y.+Nakaiauthor=B.+J.+Smithauthor=R.+Websterauthor=K.+Beaumont&title=Prediction+of+human+pharmacokinetics+from+preclinical+information%3A+comparative+accuracy+of+quantitative+prediction+approaches"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit16R"><div class="casContent"><span class="casTitleNuber">16</span><div class="casTitle"><span class="NLM_cas:atitle">Prediction of human pharmacokinetics from preclinical information: comparative accuracy of quantitative prediction approaches</span></div><div class="casAuthors">Hosea, Natilie A.; Collard, Wendy T.; Cole, Susan; Maurer, Tristan S.; Fang, Rick X.; Jones, Hannah; Kakar, Shefali M.; Nakai, Yasuhiro; Smith, Bill J.; Webster, Rob; Beaumont, Kevin</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Clinical Pharmacology</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">49</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">513-533</span>CODEN:
                <span class="NLM_cas:coden">JCPCBR</span>;
        ISSN:<span class="NLM_cas:issn">0091-2700</span>.
    
            (<span class="NLM_cas:orgname">Sage Publications</span>)
        </div><div class="casAbstract">A review.  Quant. prediction of human pharmacokinetics is crit. in assessing the viability of drug candidates and in detg. first-in-human dosing.  Numerous prediction methodologies, incorporating both in vitro and preclin. in vivo data, have been developed in recent years, each with advantages and disadvantages.  However, the lack of a comprehensive data set, both preclin. and clin., has limited efforts to evaluate the optimal strategy (or strategies) that results in quant. predictions of human pharmacokinetics.  To address this issue, the authors conducted a retrospective anal. using 50 proprietary compds. for which in vitro, preclin. pharmacokinetic data and oral single-dose human pharmacokinetic data were available.  Five predictive strategies, involving either allometry or use of unbound intrinsic clearance from microsomes or hepatocytes, were then compared for their ability to predict human oral clearance, half-life through predictions of systemic clearance, vol. of distribution, and bioavailability.  Use of a single-species scaling approach with rat, dog, or monkey was as accurate as or more accurate than using multiple-species allometry.  For those compds. cleared almost exclusively by P 450-mediated pathways, scaling from human liver microsomes was as predictive as single-species scaling of clearance based on data from rat, dog, or monkey.  These data suggest that use of predictive methods involving either single-species in vivo data or in vitro human liver microsomes can quant. predict human in vivo pharmacokinetics and suggest the possibility of streamlining the predictive methodol. through use of a single species or use only of human in vitro microsomal prepns.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrg67HcwS4O4LVg90H21EOLACvtfcHk0lh1UnmYOT546g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXlsFWmu74%253D&md5=a0941d53fe43392f8fb1562ee546705e</span></div><a href="/servlet/linkout?suffix=cit16&amp;dbid=16384&amp;doi=10.1177%2F0091270009333209&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1177%252F0091270009333209%26sid%3Dliteratum%253Aachs%26aulast%3DHosea%26aufirst%3DN.%2BA.%26aulast%3DCollard%26aufirst%3DW.%2BT.%26aulast%3DCole%26aufirst%3DS.%26aulast%3DMaurer%26aufirst%3DT.%2BS.%26aulast%3DFang%26aufirst%3DR.%2BX.%26aulast%3DJones%26aufirst%3DH.%26aulast%3DKakar%26aufirst%3DS.%2BM.%26aulast%3DNakai%26aufirst%3DY.%26aulast%3DSmith%26aufirst%3DB.%2BJ.%26aulast%3DWebster%26aufirst%3DR.%26aulast%3DBeaumont%26aufirst%3DK.%26atitle%3DPrediction%2520of%2520human%2520pharmacokinetics%2520from%2520preclinical%2520information%253A%2520comparative%2520accuracy%2520of%2520quantitative%2520prediction%2520approaches%26jtitle%3DJ.%2520Clin.%2520Pharmacol.%26date%3D2009%26volume%3D49%26spage%3D513%26epage%3D533" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref17"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref17'); return false;" data-citation="" class="refNumLink">17</a></strong><div class="NLM_citation" id="cit17"><span><span class="NLM_contrib-group">Gao, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yao, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mathieu, H. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Maurer, T. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Troutman, M. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Scott, D. O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ruggeri, R. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lin, J.</span><span> </span><span class="NLM_article-title">In silico modeling of nonspecific binding to human liver microsomes</span> <span class="citation_source-journal">Drug Metab. Dispos.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">36</span><span class="NLM_x">, </span> <span class="NLM_fpage">2130</span><span class="NLM_x">–</span> <span class="NLM_lpage">2135</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=36&publication_year=2008&pages=2130-2135&author=H.+Gaoauthor=L.+Yaoauthor=H.+W.+Mathieuauthor=Y.+Zhangauthor=T.+S.+Maurerauthor=M.+D.+Troutmanauthor=D.+O.+Scottauthor=R.+B.+Ruggeriauthor=J.+Lin&title=In+silico+modeling+of+nonspecific+binding+to+human+liver+microsomes"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit17&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DGao%26aufirst%3DH.%26aulast%3DYao%26aufirst%3DL.%26aulast%3DMathieu%26aufirst%3DH.%2BW.%26aulast%3DZhang%26aufirst%3DY.%26aulast%3DMaurer%26aufirst%3DT.%2BS.%26aulast%3DTroutman%26aufirst%3DM.%2BD.%26aulast%3DScott%26aufirst%3DD.%2BO.%26aulast%3DRuggeri%26aufirst%3DR.%2BB.%26aulast%3DLin%26aufirst%3DJ.%26atitle%3DIn%2520silico%2520modeling%2520of%2520nonspecific%2520binding%2520to%2520human%2520liver%2520microsomes%26jtitle%3DDrug%2520Metab.%2520Dispos.%26date%3D2008%26volume%3D36%26spage%3D2130%26epage%3D2135" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref18"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref18'); return false;" data-citation="" class="refNumLink">18</a></strong><div class="NLM_citation" id="cit18"><span><span class="NLM_contrib-group">Walker, J.</span><span> </span><span class="NLM_article-title">Some new curarizing agents</span> <span class="citation_source-journal">J. Chem. Soc.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1950</span><span class="NLM_x">, </span> <span class="NLM_fpage">193</span><span class="NLM_x">–</span> <span class="NLM_lpage">197</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=1950&pages=193-197&author=J.+Walker&title=Some+new+curarizing+agents"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit18&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DWalker%26aufirst%3DJ.%26atitle%3DSome%2520new%2520curarizing%2520agents%26jtitle%3DJ.%2520Chem.%2520Soc.%26date%3D1950%26spage%3D193%26epage%3D197" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref19"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref19'); return false;" data-citation="" class="refNumLink">19</a></strong><div class="NLM_citation" id="cit19"><span><span class="NLM_contrib-group">Sasaki, J. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Arey, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Eastmond, D. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Parks, K. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Grosovsky, A. J.</span><span> </span><span class="NLM_article-title">Genotoxicity induced in human lymphoblasts by atmospheric reaction products of naphthalene and phenanthrene</span> <span class="citation_source-journal">Mutat. Res., Genet. Toxicol. Environ. Mutagen.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1997</span><span class="NLM_x">, </span> <span class="NLM_volume">393</span><span class="NLM_x">, </span> <span class="NLM_fpage">23</span><span class="NLM_x">–</span> <span class="NLM_lpage">35</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=393&publication_year=1997&pages=23-35&author=J.+C.+Sasakiauthor=J.+Areyauthor=D.+A.+Eastmondauthor=K.+K.+Parksauthor=A.+J.+Grosovsky&title=Genotoxicity+induced+in+human+lymphoblasts+by+atmospheric+reaction+products+of+naphthalene+and+phenanthrene"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit19&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DSasaki%26aufirst%3DJ.%2BC.%26aulast%3DArey%26aufirst%3DJ.%26aulast%3DEastmond%26aufirst%3DD.%2BA.%26aulast%3DParks%26aufirst%3DK.%2BK.%26aulast%3DGrosovsky%26aufirst%3DA.%2BJ.%26atitle%3DGenotoxicity%2520induced%2520in%2520human%2520lymphoblasts%2520by%2520atmospheric%2520reaction%2520products%2520of%2520naphthalene%2520and%2520phenanthrene%26jtitle%3DMutat.%2520Res.%252C%2520Genet.%2520Toxicol.%2520Environ.%2520Mutagen.%26date%3D1997%26volume%3D393%26spage%3D23%26epage%3D35" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref20"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref20'); return false;" data-citation="" class="refNumLink">20</a></strong><div class="NLM_citation" id="cit20"><span><span class="NLM_contrib-group">Smith, C. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Davies, G. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dodson, E. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Moore, M. H.</span><span> </span><span class="NLM_article-title">DNA–nogalamycin interactions: the crystal structure of d(TGATCA) complexed with nogalamycin</span> <span class="citation_source-journal">Biochemistry</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1995</span><span class="NLM_x">, </span> <span class="NLM_volume">34</span><span class="NLM_x">, </span> <span class="NLM_fpage">415</span><span class="NLM_x">–</span> <span class="NLM_lpage">425</span></span><div class="citationLinks">[<a href="/doi/10.1021/bi00002a005" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=34&publication_year=1995&pages=415-425&author=C.+K.+Smithauthor=G.+J.+Daviesauthor=E.+J.+Dodsonauthor=M.+H.+Moore&title=DNA%E2%80%93nogalamycin+interactions%3A+the+crystal+structure+of+d%28TGATCA%29+complexed+with+nogalamycin"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit20&amp;dbid=16384&amp;doi=10.1021%2Fbi00002a005&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fbi00002a005%26sid%3Dliteratum%253Aachs%26aulast%3DSmith%26aufirst%3DC.%2BK.%26aulast%3DDavies%26aufirst%3DG.%2BJ.%26aulast%3DDodson%26aufirst%3DE.%2BJ.%26aulast%3DMoore%26aufirst%3DM.%2BH.%26atitle%3DDNA%25E2%2580%2593nogalamycin%2520interactions%253A%2520the%2520crystal%2520structure%2520of%2520d%2528TGATCA%2529%2520complexed%2520with%2520nogalamycin%26jtitle%3DBiochemistry%26date%3D1995%26volume%3D34%26spage%3D415%26epage%3D425" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref21"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref21'); return false;" data-citation="" class="refNumLink">21</a></strong><div class="NLM_citation" id="cit21"><span><span class="NLM_contrib-group">Feigon, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Denny, W. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Leupin, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kearns, D. R.</span><span> </span><span class="NLM_article-title">Interactions of antitumor drugs with natural DNA: proton NMR study of binding mode and kinetics</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1984</span><span class="NLM_x">, </span> <span class="NLM_volume">27</span><span class="NLM_x">, </span> <span class="NLM_fpage">450</span><span class="NLM_x">–</span> <span class="NLM_lpage">465</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm00370a007" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=27&publication_year=1984&pages=450-465&author=J.+Feigonauthor=W.+A.+Dennyauthor=W.+Leupinauthor=D.+R.+Kearns&title=Interactions+of+antitumor+drugs+with+natural+DNA%3A+proton+NMR+study+of+binding+mode+and+kinetics"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit21&amp;dbid=16384&amp;doi=10.1021%2Fjm00370a007&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm00370a007%26sid%3Dliteratum%253Aachs%26aulast%3DFeigon%26aufirst%3DJ.%26aulast%3DDenny%26aufirst%3DW.%2BA.%26aulast%3DLeupin%26aufirst%3DW.%26aulast%3DKearns%26aufirst%3DD.%2BR.%26atitle%3DInteractions%2520of%2520antitumor%2520drugs%2520with%2520natural%2520DNA%253A%2520proton%2520NMR%2520study%2520of%2520binding%2520mode%2520and%2520kinetics%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D1984%26volume%3D27%26spage%3D450%26epage%3D465" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref22"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref22'); return false;" data-citation="" class="refNumLink">22</a></strong><div class="NLM_citation" id="cit22"><span><span class="NLM_contrib-group">Hancock, A. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Diehl, M. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Faghih, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bush, E. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Krueger, K. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Krishna, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Miller, T. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wilcox, D. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nguyen, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pratt, J. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cowart, M. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Esbenshade, T. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jacobson, P. B.</span><span> </span><span class="NLM_article-title">In vitro optimization of structure activity relationships of analogues of A-331440 combining radioligand receptor binding assays and micronucleus assays of potential antiobesity histamine H<sub>3</sub> receptor antagonists</span> <span class="citation_source-journal">Basic Clin. Pharmacol. Toxicol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">95</span><span class="NLM_x">, </span> <span class="NLM_fpage">144</span><span class="NLM_x">–</span> <span class="NLM_lpage">152</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=16&amp;doi=10.1021%2Fjm200939b&amp;key=10.1111%2Fj.1742-7843.2004.950307.x" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=8&amp;doi=10.1021%2Fjm200939b&amp;key=15447739" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=32&amp;doi=10.1021%2Fjm200939b&amp;key=1%3ACAS%3A528%3ADC%252BD2cXosFyiu7o%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=95&publication_year=2004&pages=144-152&author=A.+A.+Hancockauthor=M.+S.+Diehlauthor=R.+Faghihauthor=E.+N.+Bushauthor=K.+M.+Kruegerauthor=G.+Krishnaauthor=T.+R.+Millerauthor=D.+M.+Wilcoxauthor=P.+Nguyenauthor=J.+K.+Prattauthor=M.+D.+Cowartauthor=T.+A.+Esbenshadeauthor=P.+B.+Jacobson&title=In+vitro+optimization+of+structure+activity+relationships+of+analogues+of+A-331440+combining+radioligand+receptor+binding+assays+and+micronucleus+assays+of+potential+antiobesity+histamine+H3+receptor+antagonists"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit22R"><div class="casContent"><span class="casTitleNuber">22</span><div class="casTitle"><span class="NLM_cas:atitle">In vitro optimization of structure activity relationships of analogs of A-331440 combining radioligand receptor binding assays and micronucleus assays of potential antiobesity histamine H3 receptor antagonists</span></div><div class="casAuthors">Hancock, Arthur A.; Diehl, Marilyn S.; Faghih, Ramin; Bush, Eugene N.; Krueger, Kathleen M.; Krishna, Gopala; Miller, Thomas R.; Wilcox, Denise M.; Nguyen, Phong; Pratt, John K.; Cowart, Marlon D.; Eshenshade, Timothy A.; Jacobson, Peer B.</div><div class="citationInfo"><span class="NLM_cas:title">Basic & Clinical Pharmacology & Toxicology</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">95</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">144-152</span>CODEN:
                <span class="NLM_cas:coden">BCPTBO</span>;
        ISSN:<span class="NLM_cas:issn">1742-7835</span>.
    
            (<span class="NLM_cas:orgname">Blackwell Publishing Ltd.</span>)
        </div><div class="casAbstract">A-331440 {4'-[3-(3(R)-(dimethylamino)-pyrrolidin-1-yl)-propoxy]-biphenyl-4-carbonitrile}, a potent and selective antagonist of histamine H3 receptors, yielded pos. results in an in vitro micronucleus assay, predictive of genotoxicity in vivo.  Because this compd. has highly favorable properties and potential as an antiobesity agent, new compds. of this general chem. class were sought that would retain or improve upon the high potency and selectivity of A-331440 for H3 receptors, but would lack the potential for genotoxicity obtained with that compd.  Our working hypothesis was that the biphenyl rings in A-331440 might contribute to interactions with DNA and thereby predispose toward genotoxicity.  Toward this end, several analogs were prepd., with substituents introduced onto the biaryl ring to alter the orientation, electronegativity, and polarity of this moiety, and were tested for their radioligand binding potency and selectivity and their propensity to induce genotoxicity in the in vitro micronucleus assay.  Using this strategy, novel compds. were discovered that retained or improved upon the potency and selectivity of A-331440 for H3 receptors and were devoid of genotoxicity in vitro.  Of these, the simple mono- and di-fluorinated analogs (A-417022 [4'-{3-[(3R)-3-(dimethylamino)-1-pyrrolidinyl]propoxy}-3'-fluoro-1,1'-biphenyl-4-carbonitrile] and A-423579 [4'-{3-[(3R)-3-(dimethylamino)-1-pyrrolidinyl]-propoxy}-3',5'-difluoro-1,1'-biphenyl-4-carbonitrile] resp.) were found to bind to H3 receptors at least as potently as A-331440, while lacking genotoxicity in the micronucleus assay.  The reason of the lack of genotoxicity of the fluorinated analogs is unclear, but is esp. noteworthy in light of the general principle that fluorine and hydrogen are very similar in size.  Therefore, these fluorinated analogs of A-331440 represented the most potent and potentially safest compds. for further evaluation as antiobesity leads.  Preliminary findings with one of these examples, A-417022, in a mouse model of obesity are presented.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqsB-CdUg04qLVg90H21EOLACvtfcHk0ljQGz6VyTywHA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXosFyiu7o%253D&md5=dd639fa35ed75d531d83b6fc8f662087</span></div><a href="/servlet/linkout?suffix=cit22&amp;dbid=16384&amp;doi=10.1111%2Fj.1742-7843.2004.950307.x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Fj.1742-7843.2004.950307.x%26sid%3Dliteratum%253Aachs%26aulast%3DHancock%26aufirst%3DA.%2BA.%26aulast%3DDiehl%26aufirst%3DM.%2BS.%26aulast%3DFaghih%26aufirst%3DR.%26aulast%3DBush%26aufirst%3DE.%2BN.%26aulast%3DKrueger%26aufirst%3DK.%2BM.%26aulast%3DKrishna%26aufirst%3DG.%26aulast%3DMiller%26aufirst%3DT.%2BR.%26aulast%3DWilcox%26aufirst%3DD.%2BM.%26aulast%3DNguyen%26aufirst%3DP.%26aulast%3DPratt%26aufirst%3DJ.%2BK.%26aulast%3DCowart%26aufirst%3DM.%2BD.%26aulast%3DEsbenshade%26aufirst%3DT.%2BA.%26aulast%3DJacobson%26aufirst%3DP.%2BB.%26atitle%3DIn%2520vitro%2520optimization%2520of%2520structure%2520activity%2520relationships%2520of%2520analogues%2520of%2520A-331440%2520combining%2520radioligand%2520receptor%2520binding%2520assays%2520and%2520micronucleus%2520assays%2520of%2520potential%2520antiobesity%2520histamine%2520H3%2520receptor%2520antagonists%26jtitle%3DBasic%2520Clin.%2520Pharmacol.%2520Toxicol.%26date%3D2004%26volume%3D95%26spage%3D144%26epage%3D152" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref23"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref23'); return false;" data-citation="" class="refNumLink">23</a></strong><div class="NLM_citation" id="cit23"><span><span class="NLM_contrib-group">Morini, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Comini, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rivara, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rivara, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lorenzi, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bordi, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mor, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Flammini, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bertoni, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ballabeni, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Barocelli, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Plazzi, P. V.</span><span> </span><span class="NLM_article-title">Dibasic non-imidazole histamine H<sub>3</sub> receptor antagonists with a rigid biphenyl scaffold</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">16</span><span class="NLM_x">, </span> <span class="NLM_fpage">4063</span><span class="NLM_x">–</span> <span class="NLM_lpage">4067</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=16&publication_year=2006&pages=4063-4067&author=G.+Moriniauthor=M.+Cominiauthor=M.+Rivaraauthor=S.+Rivaraauthor=S.+Lorenziauthor=F.+Bordiauthor=M.+Morauthor=L.+Flamminiauthor=S.+Bertoniauthor=V.+Ballabeniauthor=E.+Barocelliauthor=P.+V.+Plazzi&title=Dibasic+non-imidazole+histamine+H3+receptor+antagonists+with+a+rigid+biphenyl+scaffold"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit23&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DMorini%26aufirst%3DG.%26aulast%3DComini%26aufirst%3DM.%26aulast%3DRivara%26aufirst%3DM.%26aulast%3DRivara%26aufirst%3DS.%26aulast%3DLorenzi%26aufirst%3DS.%26aulast%3DBordi%26aufirst%3DF.%26aulast%3DMor%26aufirst%3DM.%26aulast%3DFlammini%26aufirst%3DL.%26aulast%3DBertoni%26aufirst%3DS.%26aulast%3DBallabeni%26aufirst%3DV.%26aulast%3DBarocelli%26aufirst%3DE.%26aulast%3DPlazzi%26aufirst%3DP.%2BV.%26atitle%3DDibasic%2520non-imidazole%2520histamine%2520H3%2520receptor%2520antagonists%2520with%2520a%2520rigid%2520biphenyl%2520scaffold%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2006%26volume%3D16%26spage%3D4063%26epage%3D4067" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref24"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref24'); return false;" data-citation="" class="refNumLink">24</a></strong><div class="NLM_citation" id="cit24"><span><span class="NLM_contrib-group">Clark, G. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Squire, C. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gray, E. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Leupin, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Neidle, S.</span><span> </span><span class="NLM_article-title">Designer DNA-binding drugs: the crystal structure of a meta-hydroxy analogue of Hoechst 33258 bound to d(CGCGAATTCGCG)<sub>2</sub></span> <span class="citation_source-journal">Nucleic Acids Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1996</span><span class="NLM_x">, </span> <span class="NLM_volume">24</span><span class="NLM_x">, </span> <span class="NLM_fpage">4882</span><span class="NLM_x">–</span> <span class="NLM_lpage">4889</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=24&publication_year=1996&pages=4882-4889&author=G.+R.+Clarkauthor=C.+J.+Squireauthor=E.+J.+Grayauthor=W.+Leupinauthor=S.+Neidle&title=Designer+DNA-binding+drugs%3A+the+crystal+structure+of+a+meta-hydroxy+analogue+of+Hoechst+33258+bound+to+d%28CGCGAATTCGCG%292"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit24&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DClark%26aufirst%3DG.%2BR.%26aulast%3DSquire%26aufirst%3DC.%2BJ.%26aulast%3DGray%26aufirst%3DE.%2BJ.%26aulast%3DLeupin%26aufirst%3DW.%26aulast%3DNeidle%26aufirst%3DS.%26atitle%3DDesigner%2520DNA-binding%2520drugs%253A%2520the%2520crystal%2520structure%2520of%2520a%2520meta-hydroxy%2520analogue%2520of%2520Hoechst%252033258%2520bound%2520to%2520d%2528CGCGAATTCGCG%25292%26jtitle%3DNucleic%2520Acids%2520Res.%26date%3D1996%26volume%3D24%26spage%3D4882%26epage%3D4889" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref25"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref25'); return false;" data-citation="" class="refNumLink">25</a></strong><div class="NLM_citation" id="cit25"><span><span class="NLM_contrib-group">Miller, V. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stresser, D. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Blanchard, A. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Turner, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Crespi, C. L.</span><span> </span><span class="NLM_article-title">Fluorometric high-throughput screening for inhibitors of cytochrome P450</span> <span class="citation_source-journal">Ann. N.Y. Acad. Sci.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2000</span><span class="NLM_x">, </span> <span class="NLM_volume">919</span><span class="NLM_x">, </span> <span class="NLM_fpage">26</span><span class="NLM_x">–</span> <span class="NLM_lpage">32</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=919&publication_year=2000&pages=26-32&author=V.+P.+Millerauthor=D.+M.+Stresserauthor=A.+P.+Blanchardauthor=S.+Turnerauthor=C.+L.+Crespi&title=Fluorometric+high-throughput+screening+for+inhibitors+of+cytochrome+P450"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit25&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DMiller%26aufirst%3DV.%2BP.%26aulast%3DStresser%26aufirst%3DD.%2BM.%26aulast%3DBlanchard%26aufirst%3DA.%2BP.%26aulast%3DTurner%26aufirst%3DS.%26aulast%3DCrespi%26aufirst%3DC.%2BL.%26atitle%3DFluorometric%2520high-throughput%2520screening%2520for%2520inhibitors%2520of%2520cytochrome%2520P450%26jtitle%3DAnn.%2520N.Y.%2520Acad.%2520Sci.%26date%3D2000%26volume%3D919%26spage%3D26%26epage%3D32" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref26"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref26'); return false;" data-citation="" class="refNumLink">26</a></strong><div class="NLM_citation" id="cit26"><span><span class="NLM_contrib-group">Aubrecht, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Osowski, J. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Persaud, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cheung, J. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ackerman, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lopes, S. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ku, W. W.</span><span> </span><span class="NLM_article-title">Bioluminescent Salmonella reverse mutation assay: a screen for detecting mutagenicity with high throughput attributes</span> <span class="citation_source-journal">Mutagenesis</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">22</span><span class="NLM_x">, </span> <span class="NLM_fpage">335</span><span class="NLM_x">–</span> <span class="NLM_lpage">342</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=22&publication_year=2007&pages=335-342&author=J.+Aubrechtauthor=J.+J.+Osowskiauthor=P.+Persaudauthor=J.+R.+Cheungauthor=J.+Ackermanauthor=S.+H.+Lopesauthor=W.+W.+Ku&title=Bioluminescent+Salmonella+reverse+mutation+assay%3A+a+screen+for+detecting+mutagenicity+with+high+throughput+attributes"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit26&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DAubrecht%26aufirst%3DJ.%26aulast%3DOsowski%26aufirst%3DJ.%2BJ.%26aulast%3DPersaud%26aufirst%3DP.%26aulast%3DCheung%26aufirst%3DJ.%2BR.%26aulast%3DAckerman%26aufirst%3DJ.%26aulast%3DLopes%26aufirst%3DS.%2BH.%26aulast%3DKu%26aufirst%3DW.%2BW.%26atitle%3DBioluminescent%2520Salmonella%2520reverse%2520mutation%2520assay%253A%2520a%2520screen%2520for%2520detecting%2520mutagenicity%2520with%2520high%2520throughput%2520attributes%26jtitle%3DMutagenesis%26date%3D2007%26volume%3D22%26spage%3D335%26epage%3D342" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref27"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref27'); return false;" data-citation="" class="refNumLink">27</a></strong><div class="NLM_citation" id="cit27"><span><span class="NLM_contrib-group">Homiski, M. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Muehlbauer, P. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dobo, K. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schuler, M. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Aubrecht, J.</span><span> </span><span class="NLM_article-title">Concordance analysis of an in vitro micronucleus screening assay and the regulatory chromosome aberration assay using pharmaceutical drug candidates</span> <span class="citation_source-journal">Environ. Mol. Mutagen.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">51</span><span class="NLM_x">, </span> <span class="NLM_fpage">39</span><span class="NLM_x">–</span> <span class="NLM_lpage">47</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=51&publication_year=2010&pages=39-47&author=M.+L.+Homiskiauthor=P.+A.+Muehlbauerauthor=K.+L.+Doboauthor=M.+J.+Schulerauthor=J.+Aubrecht&title=Concordance+analysis+of+an+in+vitro+micronucleus+screening+assay+and+the+regulatory+chromosome+aberration+assay+using+pharmaceutical+drug+candidates"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit27&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DHomiski%26aufirst%3DM.%2BL.%26aulast%3DMuehlbauer%26aufirst%3DP.%2BA.%26aulast%3DDobo%26aufirst%3DK.%2BL.%26aulast%3DSchuler%26aufirst%3DM.%2BJ.%26aulast%3DAubrecht%26aufirst%3DJ.%26atitle%3DConcordance%2520analysis%2520of%2520an%2520in%2520vitro%2520micronucleus%2520screening%2520assay%2520and%2520the%2520regulatory%2520chromosome%2520aberration%2520assay%2520using%2520pharmaceutical%2520drug%2520candidates%26jtitle%3DEnviron.%2520Mol.%2520Mutagen.%26date%3D2010%26volume%3D51%26spage%3D39%26epage%3D47" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref28"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref28'); return false;" data-citation="" class="refNumLink">28</a></strong><div class="NLM_citation" id="cit28"><span><span class="NLM_contrib-group">Feng, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mills, J. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Davidson, R. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mireles, R. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Janiszewski, J. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Troutman, M. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">de Morais, S. M.</span><span> </span><span class="NLM_article-title">In vitro P-glycoprotein assays to predict the in vivo interactions of P-glycoprotein with drugs in the central nervous system</span> <span class="citation_source-journal">Drug Metab. Dispos.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">36</span><span class="NLM_x">, </span> <span class="NLM_fpage">268</span><span class="NLM_x">–</span> <span class="NLM_lpage">275</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=16&amp;doi=10.1021%2Fjm200939b&amp;key=10.1124%2Fdmd.107.017434" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=8&amp;doi=10.1021%2Fjm200939b&amp;key=17962372" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=32&amp;doi=10.1021%2Fjm200939b&amp;key=1%3ACAS%3A528%3ADC%252BD1cXht1yktbc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=36&publication_year=2008&pages=268-275&author=B.+Fengauthor=J.+B.+Millsauthor=R.+E.+Davidsonauthor=R.+J.+Mirelesauthor=J.+S.+Janiszewskiauthor=M.+D.+Troutmanauthor=S.+M.+de+Morais&title=In+vitro+P-glycoprotein+assays+to+predict+the+in+vivo+interactions+of+P-glycoprotein+with+drugs+in+the+central+nervous+system"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit28R"><div class="casContent"><span class="casTitleNuber">28</span><div class="casTitle"><span class="NLM_cas:atitle">In vitro P-glycoprotein assays to predict the in vivo interactions of P-glycoprotein with drugs in the central nervous system</span></div><div class="casAuthors">Feng, Bo; Mills, Jessica B.; Davidson, Ralph E.; Mireles, Rouchelle J.; Janiszewski, John S.; Troutman, Matthew D.; de Morais, Sonia M.</div><div class="citationInfo"><span class="NLM_cas:title">Drug Metabolism and Disposition</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">36</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">268-275</span>CODEN:
                <span class="NLM_cas:coden">DMDSAI</span>;
        ISSN:<span class="NLM_cas:issn">0090-9556</span>.
    
            (<span class="NLM_cas:orgname">American Society for Pharmacology and Experimental Therapeutics</span>)
        </div><div class="casAbstract">Thirty-one structurally diverse marketed central nervous system (CNS)-active drugs, one active metabolite, and seven non-CNS-active compds. were tested in three P-glycoprotein (P-gp) in vitro assays: transwell assays using MDCK, human MDR1-MDCK, and mouse Mdr1a-MDCK cells, ATPase, and calcein AM inhibition.  Addnl., the permeability for these compds. was measured in two in vitro models: parallel artificial membrane permeation assay and apical-to-basolateral apparent permeability in MDCK.  The exposure of the same set of compds. in brain and plasma was measured in P-gp knockout (KO) and wild-type (WT) mice after s.c. administration.  One drug and its metabolite, risperidone and 9-hydroxyrisperidone, of the 32 CNS compds., and 6 of the 7 non-CNS drugs were detd. to have pos. efflux using ratio of ratios in MDR1-MDCK vs. MDCK transwell assays.  Data from transwell studies correlated well with the brain-to-plasma area under the curve ratios between P-gp KO and WT mice for the 32 CNS compds.  In addn., 3300 Pfizer compds. were tested in MDR1-MDCK and Mdr1a-MDCK transwell assays, with a good correlation (R2 = 0.92) between the efflux ratios in human MDR1-MDCK and mouse Mdr1a-MDCK cells.  Permeability data showed that the majority of the 32 CNS compds. have moderate to high passive permeability.  This work has demonstrated that in vitro transporter assays help in understanding the role of P-gp-mediated efflux activity in detg. the disposition of CNS drugs in vivo, and the transwell assay is a valuable in vitro assay to evaluate human P-gp interaction with compds. for assessing brain penetration of new chem. entities to treat CNS disorders.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqsQyRSOySyGLVg90H21EOLACvtfcHk0lje3Hw2iOsodg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXht1yktbc%253D&md5=bbf8b6969bd6d6b3d741b6ef9e7853f3</span></div><a href="/servlet/linkout?suffix=cit28&amp;dbid=16384&amp;doi=10.1124%2Fdmd.107.017434&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1124%252Fdmd.107.017434%26sid%3Dliteratum%253Aachs%26aulast%3DFeng%26aufirst%3DB.%26aulast%3DMills%26aufirst%3DJ.%2BB.%26aulast%3DDavidson%26aufirst%3DR.%2BE.%26aulast%3DMireles%26aufirst%3DR.%2BJ.%26aulast%3DJaniszewski%26aufirst%3DJ.%2BS.%26aulast%3DTroutman%26aufirst%3DM.%2BD.%26aulast%3Dde%2BMorais%26aufirst%3DS.%2BM.%26atitle%3DIn%2520vitro%2520P-glycoprotein%2520assays%2520to%2520predict%2520the%2520in%2520vivo%2520interactions%2520of%2520P-glycoprotein%2520with%2520drugs%2520in%2520the%2520central%2520nervous%2520system%26jtitle%3DDrug%2520Metab.%2520Dispos.%26date%3D2008%26volume%3D36%26spage%3D268%26epage%3D275" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref29"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref29'); return false;" data-citation="" class="refNumLink">29</a></strong><div class="NLM_citation" id="cit29"><span><span class="NLM_contrib-group">Fox, G. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pan, J. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Esbenshade, T. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bitner, R. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nikkel, A. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Miller, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kang, C. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bennani, Y. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Black, L. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Faghih, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hancock, A. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Decker, M. W.</span><span> </span><span class="NLM_article-title">Differential in vivo effects of H<sub>3</sub> receptor ligands in a new mouse dipsogenia model</span> <span class="citation_source-journal">Pharmacol., Biochem. Behav.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2002</span><span class="NLM_x">, </span> <span class="NLM_volume">72</span><span class="NLM_x">, </span> <span class="NLM_fpage">741</span><span class="NLM_x">–</span> <span class="NLM_lpage">750</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref29/cit29&amp;dbid=16&amp;doi=10.1021%2Fjm200939b&amp;key=10.1016%2FS0091-3057%2802%2900745-1" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref29/cit29&amp;dbid=8&amp;doi=10.1021%2Fjm200939b&amp;key=12175472" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref29/cit29&amp;dbid=32&amp;doi=10.1021%2Fjm200939b&amp;key=1%3ACAS%3A528%3ADC%252BD38Xjt1Sksbg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=72&publication_year=2002&pages=741-750&author=G.+B.+Foxauthor=J.+B.+Panauthor=T.+A.+Esbenshadeauthor=R.+S.+Bitnerauthor=A.+L.+Nikkelauthor=T.+Millerauthor=C.+H.+Kangauthor=Y.+L.+Bennaniauthor=L.+A.+Blackauthor=R.+Faghihauthor=A.+A.+Hancockauthor=M.+W.+Decker&title=Differential+in+vivo+effects+of+H3+receptor+ligands+in+a+new+mouse+dipsogenia+model"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit29R"><div class="casContent"><span class="casTitleNuber">29</span><div class="casTitle"><span class="NLM_cas:atitle">Differential in vivo effects of H3 receptor ligands in a new mouse dipsogenia model</span></div><div class="casAuthors">Fox, Gerard B.; Pan, Jia Bao; Esbenshade, Timothy A.; Bitner, R. Scott; Nikkel, Arthur L.; Miller, Tom; Kang, Chae Hee; Bennani, Youssef L.; Black, Lawrence A.; Faghih, Ramin; Hancock, Arthur A.; Decker, Michael W.</div><div class="citationInfo"><span class="NLM_cas:title">Pharmacology, Biochemistry and Behavior</span>
        (<span class="NLM_cas:date">2002</span>),
    <span class="NLM_cas:volume">72</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">741-750</span>CODEN:
                <span class="NLM_cas:coden">PBBHAU</span>;
        ISSN:<span class="NLM_cas:issn">0091-3057</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Science Inc.</span>)
        </div><div class="casAbstract">The selective H3 receptor agonist (R)-α-methylhistamine [(R)-α-MeHA] stimulates drinking in the adult rat.  In the present study, we investigated the role of the H3 receptor in mediating this behavior in a new dipsogenia model using the CD-1 mouse.  In addn., the putative inverse agonists ciproxifan, thioperamide and clobenpropit; the reported antagonist (1R,2R)-4-[2-(5,5-dimethylhex-1-ynyl)cyclopropyl]imidazole (GT-2331); and the putative neutral antagonist/weak partial agonist proxyfan were evaluated for possible differences in pharmacol. activity in this new model.  Water intake increased over baseline in a dose-related manner following i.p. administration of 80, 160 or 240 μmol/kg (R)-α-MeHA, but this effect was dependent on age (P30<P60<P80=P120).  [3H]-N-α-methylhistamine binding studies showed no change in H3 receptor d. for the whole mouse brain at these ages.  All subsequent studies employed P80 mice dosed with 240 μmol/kg (R)-α-MeHA.  Ciproxifan (0.001-30 μmol/kg), thioperamide (0.01-10 μmol/kg), clobenpropit (0.1-30 μmol/kg) and GT-2331 (0.03-10 μmol/kg) attenuated drinking dose-dependently, blocking the response completely at the highest doses in each case.  In contrast, proxyfan (0.001-10 μmol/kg) only partially attenuated drinking elicited by (R)-α-MeHA: coadministration of proxyfan and ciproxifan resulted in an attenuation of ciproxifan's effects.  This new dipsogenia model provides the first in vivo behavioral evidence for possible pharmacol. differences between three putative H3 receptor inverse agonists, GT-2331 and proxyfan.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrtc-PysOlv_7Vg90H21EOLACvtfcHk0ljem7P3N4ldLw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD38Xjt1Sksbg%253D&md5=74c56dfbae7a6bdbf7bf7bc166ef8807</span></div><a href="/servlet/linkout?suffix=cit29&amp;dbid=16384&amp;doi=10.1016%2FS0091-3057%2802%2900745-1&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0091-3057%252802%252900745-1%26sid%3Dliteratum%253Aachs%26aulast%3DFox%26aufirst%3DG.%2BB.%26aulast%3DPan%26aufirst%3DJ.%2BB.%26aulast%3DEsbenshade%26aufirst%3DT.%2BA.%26aulast%3DBitner%26aufirst%3DR.%2BS.%26aulast%3DNikkel%26aufirst%3DA.%2BL.%26aulast%3DMiller%26aufirst%3DT.%26aulast%3DKang%26aufirst%3DC.%2BH.%26aulast%3DBennani%26aufirst%3DY.%2BL.%26aulast%3DBlack%26aufirst%3DL.%2BA.%26aulast%3DFaghih%26aufirst%3DR.%26aulast%3DHancock%26aufirst%3DA.%2BA.%26aulast%3DDecker%26aufirst%3DM.%2BW.%26atitle%3DDifferential%2520in%2520vivo%2520effects%2520of%2520H3%2520receptor%2520ligands%2520in%2520a%2520new%2520mouse%2520dipsogenia%2520model%26jtitle%3DPharmacol.%252C%2520Biochem.%2520Behav.%26date%3D2002%26volume%3D72%26spage%3D741%26epage%3D750" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref30"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref30'); return false;" data-citation="" class="refNumLink">30</a></strong><div class="NLM_citation" id="cit30"><span><span class="NLM_contrib-group">McLeod, R. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rizzo, C. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">West, R. E.,  Jr.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Aslanian, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McCormick, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bryant, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hsieh, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Korfmacher, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mingo, G. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Varty, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Williams, S. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shih, N.-Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Egan, R. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hey, J. A.</span><span> </span><span class="NLM_article-title">Pharmacological characterization of the novel histamine H<sub>3</sub>-receptor antagonist <i>N</i>-(3,5-dichlorophenyl)-<i>N′</i>-[[4-(1<i>H</i>-imidazol-4-ylmethyl)phenyl]-methyl]-urea (SCH 79687)</span> <span class="citation_source-journal">J. Pharmacol. Exp. Ther.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">305</span><span class="NLM_x">, </span> <span class="NLM_fpage">1037</span><span class="NLM_x">–</span> <span class="NLM_lpage">1044</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=16&amp;doi=10.1021%2Fjm200939b&amp;key=10.1124%2Fjpet.103.049254" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=8&amp;doi=10.1021%2Fjm200939b&amp;key=12649305" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=32&amp;doi=10.1021%2Fjm200939b&amp;key=1%3ACAS%3A528%3ADC%252BD3sXkt1Snsbc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=305&publication_year=2003&pages=1037-1044&author=R.+L.+McLeodauthor=C.+A.+Rizzoauthor=R.+E.+Westauthor=R.+Aslanianauthor=K.+McCormickauthor=M.+Bryantauthor=Y.+Hsiehauthor=W.+Korfmacherauthor=G.+G.+Mingoauthor=L.+Vartyauthor=S.+M.+Williamsauthor=N.-Y.+Shihauthor=R.+W.+Eganauthor=J.+A.+Hey&title=Pharmacological+characterization+of+the+novel+histamine+H3-receptor+antagonist+N-%283%2C5-dichlorophenyl%29-N%E2%80%B2-%5B%5B4-%281H-imidazol-4-ylmethyl%29phenyl%5D-methyl%5D-urea+%28SCH+79687%29"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit30R"><div class="casContent"><span class="casTitleNuber">30</span><div class="casTitle"><span class="NLM_cas:atitle">Pharmacological characterization of the novel histamine H3-receptor antagonist N-(3,5-dichlorophenyl)-N'-[[4-(1H-imidazol-4-ylmethyl)phenyl]methyl]urea (SCH 79687)</span></div><div class="casAuthors">McLeod, Robbie L.; Rizzo, Charlie A.; West, Robert E., Jr.; Aslanian, Robert; McCormick, Kevin; Bryant, Matthew; Hsieh, Yunsheng; Korfmacher, Walter; Mingo, Garfield G.; Varty, Loriann; Williams, Shirley M.; Shih, Neng-Yang; Egan, Robert W.; Hey, John A.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Pharmacology and Experimental Therapeutics</span>
        (<span class="NLM_cas:date">2003</span>),
    <span class="NLM_cas:volume">305</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">1037-1044</span>CODEN:
                <span class="NLM_cas:coden">JPETAB</span>;
        ISSN:<span class="NLM_cas:issn">0022-3565</span>.
    
            (<span class="NLM_cas:orgname">American Society for Pharmacology and Experimental Therapeutics</span>)
        </div><div class="casAbstract">We present the pharmacol. and pharmacokinetic profiles of a novel histamine H3 receptor antagonist SCH 79687.  The H3-receptor binding Ki values for SCH 79687 were 1.9 and 13 nM in the rat and guinea pig (GP), resp.  The Kj values for SCH 79687 at histamine H1 and H2 receptors were greater than 1 μM.  SCH 79687 showed a 41- and 82-fold binding selectivity for the H3 receptor over α2A-adrenoceptors and imidazoline I2, and >500-fold H3 selectivity compared with over 60 addnl. receptors.  The pA2 value for SCH 79687 in the GP ileum elec. field-stimulated (EFS) contraction was 9.6±0.3.  Similar H3 antagonist activity was obsd. in the EFS cryopreserved and fresh tissue isolated human saphenous vein (HSV) assays (pKb = 9.4±0.3 and 10.1±0.4).  SCH 79687 (30 nM) did not block clonidine-induced inhibition of EFS-induced contractions in HSV.  SCH 79687 (ED50 = 0.3 mg/kg i.v.) attenuated (R)-α-methylhistamine inhibition of sympathetic hypertensive responses in the GP.  At the time of activity evaluation, the GP plasma SCH 79687 concn. was 25 ng/mL at the dose of 0.3 mg/kg i.v.  In feline nasal studies, combined administration of SCH 79687 (3 mg/kg i.v.) and the H1-antagonist loratadine (3 mg/kg i.v.), at individual doses that do not produce decongestion, inhibited the compd. 48/80-induced congestion by 47%.  The α-adrenergic agonist phenylpropanolamine (PPA; 1 mg/kg i.v.) also attenuated compd. 48/80 nasal responses by 42%.  Unlike the H3/H1 combination that did not affect blood pressure (BP), PPA (1 mg/kg i.v.) significantly increased BP compared with control animals by a max. of 31 mm Hg.  Orally, SCH 79687 (10 mg/kg) plus loratadine (10 mg/kg) also produced decongestion without effects on BP.  In pharmacokinetic studies, oral dosing with SCH 79687 in the rat (10 mg/kg) and monkey (3 mg/kg) achieved plasma Cmax and area under the curve values greater than 1.5 and 12.1 μg · h/mL, resp.  SCH 79687 is an orally active H3 antagonist with a good pharmacokinetic profile that, in combination with an H1 antagonist, demonstrates decongestant efficacy comparable with oral sympathomimetic decongestants but without hypertensive liabilities.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrhbbuVnZwB77Vg90H21EOLACvtfcHk0ljem7P3N4ldLw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3sXkt1Snsbc%253D&md5=79cfdefeca31c9ad658be8cc0d591084</span></div><a href="/servlet/linkout?suffix=cit30&amp;dbid=16384&amp;doi=10.1124%2Fjpet.103.049254&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1124%252Fjpet.103.049254%26sid%3Dliteratum%253Aachs%26aulast%3DMcLeod%26aufirst%3DR.%2BL.%26aulast%3DRizzo%26aufirst%3DC.%2BA.%26aulast%3DWest%26aufirst%3DR.%2BE.%26aulast%3DAslanian%26aufirst%3DR.%26aulast%3DMcCormick%26aufirst%3DK.%26aulast%3DBryant%26aufirst%3DM.%26aulast%3DHsieh%26aufirst%3DY.%26aulast%3DKorfmacher%26aufirst%3DW.%26aulast%3DMingo%26aufirst%3DG.%2BG.%26aulast%3DVarty%26aufirst%3DL.%26aulast%3DWilliams%26aufirst%3DS.%2BM.%26aulast%3DShih%26aufirst%3DN.-Y.%26aulast%3DEgan%26aufirst%3DR.%2BW.%26aulast%3DHey%26aufirst%3DJ.%2BA.%26atitle%3DPharmacological%2520characterization%2520of%2520the%2520novel%2520histamine%2520H3-receptor%2520antagonist%2520N-%25283%252C5-dichlorophenyl%2529-N%25E2%2580%25B2-%255B%255B4-%25281H-imidazol-4-ylmethyl%2529phenyl%255D-methyl%255D-urea%2520%2528SCH%252079687%2529%26jtitle%3DJ.%2520Pharmacol.%2520Exp.%2520Ther.%26date%3D2003%26volume%3D305%26spage%3D1037%26epage%3D1044" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref31"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref31'); return false;" data-citation="" class="refNumLink">31</a></strong><div class="NLM_citation" id="cit31"><span><span class="NLM_contrib-group">Smith, D. A.; van de Waterbeemd, H.; Walker, D. K.</span> <span class="citation_source-book">Pharmacokinetics and Metabolism in Drug Design</span>, <span class="NLM_edition">2</span>nd ed.; <span class="NLM_publisher-name">Wiley-VCH Verlag GmbH & Co. KGaA</span>: <span class="NLM_publisher-loc">New York</span>,<span class="NLM_x"> </span><span class="NLM_year">2006</span><span class="NLM_x">; </span>pp  <span class="NLM_fpage">19</span><span class="NLM_x">–</span> <span class="NLM_lpage">37</span>.</span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref31/cit31&amp;dbid=16&amp;doi=10.1021%2Fjm200939b&amp;key=10.1002%2F3527608222.ch2" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2006&pages=19-37&author=D.+A.+Smith&author=H.+van+de+Waterbeemd&author=D.+K.+Walker&title=Pharmacokinetics+and+Metabolism+in+Drug+Design"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit31&amp;dbid=16384&amp;doi=10.1002%2F3527608222.ch2&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dbook%26id%3Ddoi%3A10.1002%252F3527608222.ch2%26sid%3Dliteratum%253Aachs%26aulast%3DSmith%26aufirst%3DD.%2BA.%26btitle%3DPharmacokinetics%2520and%2520Metabolism%2520in%2520Drug%2520Design%26pub%3DWiley-VCH%2520Verlag%2520GmbH%2520%2526%2520Co.%2520KGaA%26date%3D2006%26spage%3D19%26epage%3D37" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref32"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref32'); return false;" data-citation="" class="refNumLink">32</a></strong><div class="NLM_citation" id="cit32"><span><span class="NLM_contrib-group">Price, D. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Blagg, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jones, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Greene, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wager, T.</span><span> </span><span class="NLM_article-title">Physicochemical drug properties associated with in vivo toxicological outcomes: a review</span> <span class="citation_source-journal">Expert Opin. Drug Metab. Toxicol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">5</span><span class="NLM_x">, </span> <span class="NLM_fpage">921</span><span class="NLM_x">–</span> <span class="NLM_lpage">931</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref32/cit32&amp;dbid=16&amp;doi=10.1021%2Fjm200939b&amp;key=10.1517%2F17425250903042318" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref32/cit32&amp;dbid=8&amp;doi=10.1021%2Fjm200939b&amp;key=19519283" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref32/cit32&amp;dbid=32&amp;doi=10.1021%2Fjm200939b&amp;key=1%3ACAS%3A528%3ADC%252BD1MXovVCjtb0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=5&publication_year=2009&pages=921-931&author=D.+A.+Priceauthor=J.+Blaggauthor=L.+Jonesauthor=N.+Greeneauthor=T.+Wager&title=Physicochemical+drug+properties+associated+with+in+vivo+toxicological+outcomes%3A+a+review"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit32R"><div class="casContent"><span class="casTitleNuber">32</span><div class="casTitle"><span class="NLM_cas:atitle">Physicochemical drug properties associated with in vivo toxicological outcomes: a review</span></div><div class="casAuthors">Price, David A.; Blagg, Julian; Jones, Lyn; Greene, Nigel; Wager, Travis</div><div class="citationInfo"><span class="NLM_cas:title">Expert Opinion on Drug Metabolism & Toxicology</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">5</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">921-931</span>CODEN:
                <span class="NLM_cas:coden">EODMAP</span>;
        ISSN:<span class="NLM_cas:issn">1742-5255</span>.
    
            (<span class="NLM_cas:orgname">Informa Healthcare</span>)
        </div><div class="casAbstract">A review.  The genesis of any toxicol. or safety outcome is multifactorial and complex; for this reason, it can be difficult for drug discovery projects to factor the avoidance of toxicity outcomes into their target design.  A focus on readily measurable parameters from high-throughput in vitro assays (e.g., primary potency, clearance) is easier to handle and have become the mainstays of drug discovery projects.  However, the fundamental origins of adverse safety or toxicity findings can be considered as deriving from four parameters, all of which are in the control of the drug designer.  These can be described as primary pharmacol., off target pharmacol., the presence of a defined structural fragment that can be assocd. with adverse outcomes and the overall physicochem. properties of the mol. that may predispose it to adverse outcomes.  In the drug discovery community, there has been recognition for many years of the influence of physicochem. drug properties (in particular lipophilicity) on the toxicol. profile of compds., and recent research is now beginning to quantify that risk in a probabilistic sense.  This review focuses on the overall properties of classes of mols. that are assocd. with an increased probability of adverse outcomes in in vivo studies.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpU8kwwUsaFIrVg90H21EOLACvtfcHk0ljJQPq0DMN98A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXovVCjtb0%253D&md5=bd1cca3634afda14de2f8aa115d7d55e</span></div><a href="/servlet/linkout?suffix=cit32&amp;dbid=16384&amp;doi=10.1517%2F17425250903042318&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1517%252F17425250903042318%26sid%3Dliteratum%253Aachs%26aulast%3DPrice%26aufirst%3DD.%2BA.%26aulast%3DBlagg%26aufirst%3DJ.%26aulast%3DJones%26aufirst%3DL.%26aulast%3DGreene%26aufirst%3DN.%26aulast%3DWager%26aufirst%3DT.%26atitle%3DPhysicochemical%2520drug%2520properties%2520associated%2520with%2520in%2520vivo%2520toxicological%2520outcomes%253A%2520a%2520review%26jtitle%3DExpert%2520Opin.%2520Drug%2520Metab.%2520Toxicol.%26date%3D2009%26volume%3D5%26spage%3D921%26epage%3D931" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref33"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref33'); return false;" data-citation="" class="refNumLink">33</a></strong><div class="NLM_citation" id="cit33"><span><span class="NLM_contrib-group">Hughes, J. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Blagg, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Price, D. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bailey, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">DeCrescenzo, G. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Devraj, R. V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ellsworth, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fobian, Y. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gibbs, M. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gilles, R. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Greene, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Huang, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Krieger-Burke, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Loesel, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wager, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Whiteley, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, Y.</span><span> </span><span class="NLM_article-title">Physiochemical drug properties associated with in vivo toxicological outcomes</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">18</span><span class="NLM_x">, </span> <span class="NLM_fpage">4872</span><span class="NLM_x">–</span> <span class="NLM_lpage">4875</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref33/cit33&amp;dbid=16&amp;doi=10.1021%2Fjm200939b&amp;key=10.1016%2Fj.bmcl.2008.07.071" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref33/cit33&amp;dbid=8&amp;doi=10.1021%2Fjm200939b&amp;key=18691886" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref33/cit33&amp;dbid=32&amp;doi=10.1021%2Fjm200939b&amp;key=1%3ACAS%3A528%3ADC%252BD1cXhtVOnsbjE" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=18&publication_year=2008&pages=4872-4875&author=J.+D.+Hughesauthor=J.+Blaggauthor=D.+A.+Priceauthor=S.+Baileyauthor=G.+A.+DeCrescenzoauthor=R.+V.+Devrajauthor=E.+Ellsworthauthor=Y.+M.+Fobianauthor=M.+E.+Gibbsauthor=R.+W.+Gillesauthor=N.+Greeneauthor=E.+Huangauthor=T.+Krieger-Burkeauthor=J.+Loeselauthor=T.+Wagerauthor=L.+Whiteleyauthor=Y.+Zhang&title=Physiochemical+drug+properties+associated+with+in+vivo+toxicological+outcomes"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit33R"><div class="casContent"><span class="casTitleNuber">33</span><div class="casTitle"><span class="NLM_cas:atitle">Physiochemical drug properties associated with in vivo toxicological outcomes</span></div><div class="casAuthors">Hughes, Jason D.; Blagg, Julian; Price, David A.; Bailey, Simon; DeCrescenzo, Gary A.; Devraj, Rajesh V.; Ellsworth, Edmund; Fobian, Yvette M.; Gibbs, Michael E.; Gilles, Richard W.; Greene, Nigel; Huang, Enoch; Krieger-Burke, Teresa; Loesel, Jens; Wager, Travis; Whiteley, Larry; Zhang, Yao</div><div class="citationInfo"><span class="NLM_cas:title">Bioorganic & Medicinal Chemistry Letters</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">18</span>
        (<span class="NLM_cas:issue">17</span>),
    <span class="NLM_cas:pages">4872-4875</span>CODEN:
                <span class="NLM_cas:coden">BMCLE8</span>;
        ISSN:<span class="NLM_cas:issn">0960-894X</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ltd.</span>)
        </div><div class="casAbstract">Relationships between physicochem. drug properties and toxicity were inferred from a data set consisting of animal in vivo toleration (IVT) studies on 245 preclin. Pfizer compds.; an increased likelihood of toxic events was found for less polar, more lipophilic compds.  This trend held across a wide range of types of toxicity and across a broad swath of chem. space.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrPMmGEpVF0mbVg90H21EOLACvtfcHk0ljJQPq0DMN98A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXhtVOnsbjE&md5=80ea5ced359112a363f38b3545cd7646</span></div><a href="/servlet/linkout?suffix=cit33&amp;dbid=16384&amp;doi=10.1016%2Fj.bmcl.2008.07.071&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmcl.2008.07.071%26sid%3Dliteratum%253Aachs%26aulast%3DHughes%26aufirst%3DJ.%2BD.%26aulast%3DBlagg%26aufirst%3DJ.%26aulast%3DPrice%26aufirst%3DD.%2BA.%26aulast%3DBailey%26aufirst%3DS.%26aulast%3DDeCrescenzo%26aufirst%3DG.%2BA.%26aulast%3DDevraj%26aufirst%3DR.%2BV.%26aulast%3DEllsworth%26aufirst%3DE.%26aulast%3DFobian%26aufirst%3DY.%2BM.%26aulast%3DGibbs%26aufirst%3DM.%2BE.%26aulast%3DGilles%26aufirst%3DR.%2BW.%26aulast%3DGreene%26aufirst%3DN.%26aulast%3DHuang%26aufirst%3DE.%26aulast%3DKrieger-Burke%26aufirst%3DT.%26aulast%3DLoesel%26aufirst%3DJ.%26aulast%3DWager%26aufirst%3DT.%26aulast%3DWhiteley%26aufirst%3DL.%26aulast%3DZhang%26aufirst%3DY.%26atitle%3DPhysiochemical%2520drug%2520properties%2520associated%2520with%2520in%2520vivo%2520toxicological%2520outcomes%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2008%26volume%3D18%26spage%3D4872%26epage%3D4875" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref34"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref34'); return false;" data-citation="" class="refNumLink">34</a></strong><div class="NLM_citation" id="cit34"><span><span class="NLM_contrib-group">Wager, T. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chandrasekaran, R. Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hou, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Troutman, M. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Verhoest, P. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Villalobos, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Will, Y.</span><span> </span><span class="NLM_article-title">Defining desirable central nervous system drug space through the alignment of molecular properties, in vitro ADME, and safety attributes</span> <span class="citation_source-journal">ACS Chem. Neurosci.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">1</span><span class="NLM_x">, </span> <span class="NLM_fpage">420</span><span class="NLM_x">–</span> <span class="NLM_lpage">434</span></span><div class="citationLinks">[<a href="/doi/10.1021/cn100007x" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref34/cit34&amp;dbid=32&amp;doi=10.1021%2Fjm200939b&amp;key=1%3ACAS%3A528%3ADC%252BC3cXjvVaqtbk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=1&publication_year=2010&pages=420-434&author=T.+T.+Wagerauthor=R.+Y.+Chandrasekaranauthor=X.+Houauthor=M.+D.+Troutmanauthor=P.+R.+Verhoestauthor=A.+Villalobosauthor=Y.+Will&title=Defining+desirable+central+nervous+system+drug+space+through+the+alignment+of+molecular+properties%2C+in+vitro+ADME%2C+and+safety+attributes"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit34R"><div class="casContent"><span class="casTitleNuber">34</span><div class="casTitle"><span class="NLM_cas:atitle">Defining Desirable Central Nervous System Drug Space through the Alignment of Molecular Properties, in Vitro ADME, and Safety Attributes</span></div><div class="casAuthors">Wager, Travis T.; Chandrasekaran, Ramalakshmi Y.; Hou, Xinjun; Troutman, Matthew D.; Verhoest, Patrick R.; Villalobos, Anabella; Will, Yvonne</div><div class="citationInfo"><span class="NLM_cas:title">ACS Chemical Neuroscience</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">1</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">420-434</span>CODEN:
                <span class="NLM_cas:coden">ACNCDM</span>;
        ISSN:<span class="NLM_cas:issn">1948-7193</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">As part of our effort to increase survival of drug candidates and to move our medicinal chem. design to higher probability space for success in the Neuroscience therapeutic area, we embarked on a detailed study of the property space for a collection of central nervous system (CNS) mols.  We carried out a thorough anal. of properties for 119 marketed CNS drugs and a set of 108 Pfizer CNS candidates.  In particular, we focused on understanding the relationships between physicochem. properties, in vitro ADME (absorption, distribution, metab., and elimination) attributes, primary pharmacol. binding efficiencies, and in vitro safety data for these two sets of compds.  This scholarship provides guidance for the design of CNS mols. in a property space with increased probability of success and may lead to the identification of druglike candidates with favorable safety profiles that can successfully test hypotheses in the clinic.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqvEMBo2f34BrVg90H21EOLACvtfcHk0ljJQPq0DMN98A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXjvVaqtbk%253D&md5=85716be86290fd85e93c6b8d5621683c</span></div><a href="/servlet/linkout?suffix=cit34&amp;dbid=16384&amp;doi=10.1021%2Fcn100007x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fcn100007x%26sid%3Dliteratum%253Aachs%26aulast%3DWager%26aufirst%3DT.%2BT.%26aulast%3DChandrasekaran%26aufirst%3DR.%2BY.%26aulast%3DHou%26aufirst%3DX.%26aulast%3DTroutman%26aufirst%3DM.%2BD.%26aulast%3DVerhoest%26aufirst%3DP.%2BR.%26aulast%3DVillalobos%26aufirst%3DA.%26aulast%3DWill%26aufirst%3DY.%26atitle%3DDefining%2520desirable%2520central%2520nervous%2520system%2520drug%2520space%2520through%2520the%2520alignment%2520of%2520molecular%2520properties%252C%2520in%2520vitro%2520ADME%252C%2520and%2520safety%2520attributes%26jtitle%3DACS%2520Chem.%2520Neurosci.%26date%3D2010%26volume%3D1%26spage%3D420%26epage%3D434" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref35"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref35'); return false;" data-citation="" class="refNumLink">35</a></strong><div class="NLM_citation" id="cit35"><span><span class="NLM_contrib-group">Wenlock, M. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Austin, R. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Barton, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Davis, A. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Leeson, P. D.</span><span> </span><span class="NLM_article-title">A comparison of physiochemical property profiles of development and marketed oral drugs</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">46</span><span class="NLM_x">, </span> <span class="NLM_fpage">1250</span><span class="NLM_x">–</span> <span class="NLM_lpage">1256</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm021053p" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref35/cit35&amp;dbid=32&amp;doi=10.1021%2Fjm200939b&amp;key=1%3ACAS%3A528%3ADC%252BD3sXhslSlsbY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=46&publication_year=2003&pages=1250-1256&author=M.+C.+Wenlockauthor=R.+P.+Austinauthor=P.+Bartonauthor=A.+M.+Davisauthor=P.+D.+Leeson&title=A+comparison+of+physiochemical+property+profiles+of+development+and+marketed+oral+drugs"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit35R"><div class="casContent"><span class="casTitleNuber">35</span><div class="casTitle"><span class="NLM_cas:atitle">A Comparison of Physiochemical Property Profiles of Development and Marketed Oral Drugs</span></div><div class="casAuthors">Wenlock, Mark C.; Austin, Rupert P.; Barton, Patrick; Davis, Andrew M.; Leeson, Paul D.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2003</span>),
    <span class="NLM_cas:volume">46</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">1250-1256</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">The process of drug discovery applies rigorous selection pressures.  Marketed oral drugs will generally possess favorable physiochem. properties with respect to absorption, metab., distribution, and clearance.  This paper describes a study in which the distributions of physiochem. properties of oral drugs in different phases of clin. development are compared to those already marketed.  The aim is to identify the trends in physiochem. properties that favor a drug's successful passage through clin. development and on to the market.  Two libraries were created, one of current development oral drugs and one of marketed oral drugs.  Statistical anal. of the two showed that the mean mol. wt. of orally administered drugs in development decreases on passing through each of the different clin. phases and gradually converges toward the mean mol. wt. of marketed oral drugs.  It is also clear that the most lipophilic compds. are being discontinued from development.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoF0PksUFJq0bVg90H21EOLACvtfcHk0ljqRslHz2W04A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3sXhslSlsbY%253D&md5=b9809c803a61ec99a1b4171e97952452</span></div><a href="/servlet/linkout?suffix=cit35&amp;dbid=16384&amp;doi=10.1021%2Fjm021053p&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm021053p%26sid%3Dliteratum%253Aachs%26aulast%3DWenlock%26aufirst%3DM.%2BC.%26aulast%3DAustin%26aufirst%3DR.%2BP.%26aulast%3DBarton%26aufirst%3DP.%26aulast%3DDavis%26aufirst%3DA.%2BM.%26aulast%3DLeeson%26aufirst%3DP.%2BD.%26atitle%3DA%2520comparison%2520of%2520physiochemical%2520property%2520profiles%2520of%2520development%2520and%2520marketed%2520oral%2520drugs%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2003%26volume%3D46%26spage%3D1250%26epage%3D1256" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref36"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref36'); return false;" data-citation="" class="refNumLink">36</a></strong><div class="NLM_citation" id="cit36"><span><span class="NLM_contrib-group">Veber, D. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Johnson, S. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cheng, H.-Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Smith, B. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ward, K. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kopple, K. D.</span><span> </span><span class="NLM_article-title">Molecular properties that influence the oral bioavailability of drug candidates</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2002</span><span class="NLM_x">, </span> <span class="NLM_volume">45</span><span class="NLM_x">, </span> <span class="NLM_fpage">2615</span><span class="NLM_x">–</span> <span class="NLM_lpage">2623</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm020017n" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref36/cit36&amp;dbid=32&amp;doi=10.1021%2Fjm200939b&amp;key=1%3ACAS%3A528%3ADC%252BD38XjsFCmt7g%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=45&publication_year=2002&pages=2615-2623&author=D.+F.+Veberauthor=S.+R.+Johnsonauthor=H.-Y.+Chengauthor=B.+R.+Smithauthor=K.+W.+Wardauthor=K.+D.+Kopple&title=Molecular+properties+that+influence+the+oral+bioavailability+of+drug+candidates"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit36R"><div class="casContent"><span class="casTitleNuber">36</span><div class="casTitle"><span class="NLM_cas:atitle">Molecular Properties That Influence the Oral Bioavailability of Drug Candidates</span></div><div class="casAuthors">Veber, Daniel F.; Johnson, Stephen R.; Cheng, Hung-Yuan; Smith, Brian R.; Ward, Keith W.; Kopple, Kenneth D.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2002</span>),
    <span class="NLM_cas:volume">45</span>
        (<span class="NLM_cas:issue">12</span>),
    <span class="NLM_cas:pages">2615-2623</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Oral bioavailability measurements in rats for over 1100 drug candidates studied at Smith-Kline Beecham Pharmaceuticals (now Glaxo Smith-Kline) have allowed us to analyze the relative importance of mol. properties considered to influence that drug property.  Reduced mol. flexibility, as measured by the no. of rotatable bonds, and low polar surface area or total hydrogen bond count (sum of donors and acceptors) are found to be important predictors of good oral bioavailability, independent of mol. wt.  That on av. both the no. of rotatable bonds and polar surface area or hydrogen bond count tend to increase with mol. wt. may in part explain the success of the mol. wt. parameter in predicting oral bioavailability.  The commonly applied mol. wt. cutoff at 500 does not itself significantly sep. compds. with poor oral bioavailability from those with acceptable values in this extensive data set.  Our observations suggest that compds. which meet only the 2 criteria of (1) 10 or fewer rotatable bonds and (2) polar surface area ≤140 Å2 (or 12 or fewer H-bond donors and acceptors) will have a high probability of good oral bioavailability in the rat.  Data sets for the artificial membrane permeation rate and for clearance in the rat were also examd.  Reduced polar surface area correlates better with increased permeation rate than does lipophilicity (C log P), and increased rotatable bond count has a neg. effect on the permeation rate.  A threshold permeation rate is a prerequisite of oral bioavailability.  The rotatable bond count does not correlate with the data examd. here for the in vivo clearance rate in the rat.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr3JtJEkO7yVLVg90H21EOLACvtfcHk0ljqRslHz2W04A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD38XjsFCmt7g%253D&md5=eaad26ed6a259de82ad65a8834fc397d</span></div><a href="/servlet/linkout?suffix=cit36&amp;dbid=16384&amp;doi=10.1021%2Fjm020017n&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm020017n%26sid%3Dliteratum%253Aachs%26aulast%3DVeber%26aufirst%3DD.%2BF.%26aulast%3DJohnson%26aufirst%3DS.%2BR.%26aulast%3DCheng%26aufirst%3DH.-Y.%26aulast%3DSmith%26aufirst%3DB.%2BR.%26aulast%3DWard%26aufirst%3DK.%2BW.%26aulast%3DKopple%26aufirst%3DK.%2BD.%26atitle%3DMolecular%2520properties%2520that%2520influence%2520the%2520oral%2520bioavailability%2520of%2520drug%2520candidates%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2002%26volume%3D45%26spage%3D2615%26epage%3D2623" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref37"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref37'); return false;" data-citation="" class="refNumLink">37</a></strong><div class="NLM_citation" id="cit37"><span><span class="NLM_contrib-group">Proudfoot, J. R.</span><span> </span><span class="NLM_article-title">The evolution of synthetic oral drug properties</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">15</span><span class="NLM_x">, </span> <span class="NLM_fpage">1087</span><span class="NLM_x">–</span> <span class="NLM_lpage">1090</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref37/cit37&amp;dbid=16&amp;doi=10.1021%2Fjm200939b&amp;key=10.1016%2Fj.bmcl.2004.12.024" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref37/cit37&amp;dbid=8&amp;doi=10.1021%2Fjm200939b&amp;key=15686918" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref37/cit37&amp;dbid=32&amp;doi=10.1021%2Fjm200939b&amp;key=1%3ACAS%3A528%3ADC%252BD2MXos1Cmsw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=15&publication_year=2005&pages=1087-1090&author=J.+R.+Proudfoot&title=The+evolution+of+synthetic+oral+drug+properties"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit37R"><div class="casContent"><span class="casTitleNuber">37</span><div class="casTitle"><span class="NLM_cas:atitle">The evolution of synthetic oral drug properties</span></div><div class="casAuthors">Proudfoot, John R.</div><div class="citationInfo"><span class="NLM_cas:title">Bioorganic & Medicinal Chemistry Letters</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">15</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">1087-1090</span>CODEN:
                <span class="NLM_cas:coden">BMCLE8</span>;
        ISSN:<span class="NLM_cas:issn">0960-894X</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">A review.  An anal. of the properties of 1791 synthetic, oral drugs approved and/or marketed since 1937 demonstrates that the median mol. wt. of oral drugs has increased substantially over the past 60 years.  Fewer than 5% of approved/marketed oral drugs have more than 4-H bond donors and just 2% have MW > 500 and >3 H-bond donors.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqJrtZI0e95g7Vg90H21EOLACvtfcHk0ljqRslHz2W04A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXos1Cmsw%253D%253D&md5=f393b9b972482a471185c4de545bfc75</span></div><a href="/servlet/linkout?suffix=cit37&amp;dbid=16384&amp;doi=10.1016%2Fj.bmcl.2004.12.024&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmcl.2004.12.024%26sid%3Dliteratum%253Aachs%26aulast%3DProudfoot%26aufirst%3DJ.%2BR.%26atitle%3DThe%2520evolution%2520of%2520synthetic%2520oral%2520drug%2520properties%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2005%26volume%3D15%26spage%3D1087%26epage%3D1090" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref38"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref38'); return false;" data-citation="" class="refNumLink">38</a></strong><div class="NLM_citation" id="cit38"><span><span class="NLM_contrib-group">Pajouhesh, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lenz, G. R.</span><span> </span><span class="NLM_article-title">Medicinal chemical properties of successful central nervous system drugs</span> <span class="citation_source-journal">NeuroRx</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">2</span><span class="NLM_x">, </span> <span class="NLM_fpage">541</span><span class="NLM_x">–</span> <span class="NLM_lpage">553</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref38/cit38&amp;dbid=16&amp;doi=10.1021%2Fjm200939b&amp;key=10.1602%2Fneurorx.2.4.541" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref38/cit38&amp;dbid=8&amp;doi=10.1021%2Fjm200939b&amp;key=16489364" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref38/cit38&amp;dbid=32&amp;doi=10.1021%2Fjm200939b&amp;key=1%3ACAS%3A280%3ADC%252BD28%252FpvVKqsg%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=2&publication_year=2005&pages=541-553&author=H.+Pajouheshauthor=G.+R.+Lenz&title=Medicinal+chemical+properties+of+successful+central+nervous+system+drugs"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit38R"><div class="casContent"><span class="casTitleNuber">38</span><div class="casTitle"><span class="NLM_cas:atitle">Medicinal chemical properties of successful central nervous system drugs</span></div><div class="casAuthors">Pajouhesh Hassan; Lenz George R</div><div class="citationInfo"><span class="NLM_cas:title">NeuroRx : the journal of the American Society for Experimental NeuroTherapeutics</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">2</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">541-53</span>
        ISSN:<span class="NLM_cas:issn">1545-5343</span>.
    </div><div class="casAbstract">Fundamental physiochemical features of CNS drugs are related to their ability to penetrate the blood-brain barrier affinity and exhibit CNS activity.  Factors relevant to the success of CNS drugs are reviewed.  CNS drugs show values of molecular weight, lipophilicity, and hydrogen bond donor and acceptor that in general have a smaller range than general therapeutics.  Pharmacokinetic properties can be manipulated by the medicinal chemist to a significant extent.  The solubility, permeability, metabolic stability, protein binding, and human ether-ago-go-related gene inhibition of CNS compounds need to be optimized simultaneously with potency, selectivity, and other biological parameters.  The balance between optimizing the physiochemical and pharmacokinetic properties to make the best compromises in properties is critical for designing new drugs likely to penetrate the blood brain barrier and affect relevant biological systems.  This review is intended as a guide to designing CNS therapeutic agents with better drug-like properties.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcT_ncsy3yuEinl8icjszYl0fW6udTcc2eYxKxjnicnDurntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BD28%252FpvVKqsg%253D%253D&md5=0815084e2d107b9243b785d0782dfc3a</span></div><a href="/servlet/linkout?suffix=cit38&amp;dbid=16384&amp;doi=10.1602%2Fneurorx.2.4.541&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1602%252Fneurorx.2.4.541%26sid%3Dliteratum%253Aachs%26aulast%3DPajouhesh%26aufirst%3DH.%26aulast%3DLenz%26aufirst%3DG.%2BR.%26atitle%3DMedicinal%2520chemical%2520properties%2520of%2520successful%2520central%2520nervous%2520system%2520drugs%26jtitle%3DNeuroRx%26date%3D2005%26volume%3D2%26spage%3D541%26epage%3D553" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref39"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref39'); return false;" data-citation="" class="refNumLink">39</a></strong><div class="NLM_citation" id="cit39"><span><span class="NLM_contrib-group">Lipinski, C. A.</span><span> </span><span class="NLM_article-title">Filtering in drug discovery</span> <span class="citation_source-journal">Annu. Rep. Comput. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">1</span><span class="NLM_x">, </span> <span class="NLM_fpage">155</span><span class="NLM_x">–</span> <span class="NLM_lpage">168</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref39/cit39&amp;dbid=16&amp;doi=10.1021%2Fjm200939b&amp;key=10.1016%2FS1574-1400%2805%2901011-X" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref39/cit39&amp;dbid=32&amp;doi=10.1021%2Fjm200939b&amp;key=1%3ACAS%3A528%3ADC%252BD2MXmsV2ksbg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=1&publication_year=2005&pages=155-168&author=C.+A.+Lipinski&title=Filtering+in+drug+discovery"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit39R"><div class="casContent"><span class="casTitleNuber">39</span><div class="casTitle"><span class="NLM_cas:atitle">Filtering in drug discovery</span></div><div class="casAuthors">Lipinski, Christopher A.</div><div class="citationInfo"><span class="NLM_cas:title">Annual Reports in Computational Chemistry</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">1</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">155-168</span>CODEN:
                <span class="NLM_cas:coden">ARCCC3</span>;
        ISSN:<span class="NLM_cas:issn">1574-1400</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">A review focuses on recent advances in filtering in drug discovery.  Filtering is used in a global broad sense to include exclusionary as well as inclusionary criteria and encompasses several topics related to the discovery of drugs.  Such topics include computational definitions of drug-likeness, pos. filters for drug-like activity, lead-likeness as a concept, oral activity filters, central nervous system drug filters, intestinal permeability filters, drug metab. parameter filters, promiscuous compd. filters, and agrochem. filters.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrIvJpIrP50ZLVg90H21EOLACvtfcHk0ljjh4wLY-MZzQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXmsV2ksbg%253D&md5=94a637b4ce6077b2d896c4111eb42c72</span></div><a href="/servlet/linkout?suffix=cit39&amp;dbid=16384&amp;doi=10.1016%2FS1574-1400%2805%2901011-X&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS1574-1400%252805%252901011-X%26sid%3Dliteratum%253Aachs%26aulast%3DLipinski%26aufirst%3DC.%2BA.%26atitle%3DFiltering%2520in%2520drug%2520discovery%26jtitle%3DAnnu.%2520Rep.%2520Comput.%2520Chem.%26date%3D2005%26volume%3D1%26spage%3D155%26epage%3D168" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref40"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref40'); return false;" data-citation="" class="refNumLink">40</a></strong><div class="NLM_citation" id="cit40"><span><span class="NLM_contrib-group">Hitchcock, S. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pennington, L. D.</span><span> </span><span class="NLM_article-title">Structure–brain exposure relationships</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">49</span><span class="NLM_x">, </span> <span class="NLM_fpage">7559</span><span class="NLM_x">–</span> <span class="NLM_lpage">7583</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm060642i" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=49&publication_year=2006&pages=7559-7583&author=S.+A.+Hitchcockauthor=L.+D.+Pennington&title=Structure%E2%80%93brain+exposure+relationships"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit40&amp;dbid=16384&amp;doi=10.1021%2Fjm060642i&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm060642i%26sid%3Dliteratum%253Aachs%26aulast%3DHitchcock%26aufirst%3DS.%2BA.%26aulast%3DPennington%26aufirst%3DL.%2BD.%26atitle%3DStructure%25E2%2580%2593brain%2520exposure%2520relationships%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2006%26volume%3D49%26spage%3D7559%26epage%3D7583" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref41"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref41'); return false;" data-citation="" class="refNumLink">41</a></strong><div class="NLM_citation" id="cit41"><span><span class="NLM_contrib-group">Ploemen, J.-P. H. T. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kelder, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hafmans, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">van de Sandt, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">van Burgsteden, J. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Salemink, P. J. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">van Esch, E.</span><span> </span><span class="NLM_article-title">Use of physicochemical calculation of pKa and CLogP to predict phospholipidosis-inducing potential: a case study with structurally related piperazines</span> <span class="citation_source-journal">Exp. Toxicol. Pathol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">55</span><span class="NLM_x">, </span> <span class="NLM_fpage">347</span><span class="NLM_x">–</span> <span class="NLM_lpage">355</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref41/cit41&amp;dbid=8&amp;doi=10.1021%2Fjm200939b&amp;key=15088636" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref41/cit41&amp;dbid=32&amp;doi=10.1021%2Fjm200939b&amp;key=1%3ACAS%3A528%3ADC%252BD2cXksFGltL0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=55&publication_year=2004&pages=347-355&author=J.-P.+H.+T.+M.+Ploemenauthor=J.+Kelderauthor=T.+Hafmansauthor=H.+van+de+Sandtauthor=J.+A.+van+Burgstedenauthor=P.+J.+M.+Saleminkauthor=E.+van+Esch&title=Use+of+physicochemical+calculation+of+pKa+and+CLogP+to+predict+phospholipidosis-inducing+potential%3A+a+case+study+with+structurally+related+piperazines"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit41R"><div class="casContent"><span class="casTitleNuber">41</span><div class="casTitle"><span class="NLM_cas:atitle">Use of physicochemical calculation of pKa and CLogP to predict phospholipidosis-inducing potential: a case study with structurally related piperazines</span></div><div class="casAuthors">Ploemen, Jan-Peter H. T. M.; Kelder, Jan; Hafmans, Theo; van de Sandt, Han; van Burgsteden, Johan A.; Salemink, Paul J. M.; van Esch, Eric</div><div class="citationInfo"><span class="NLM_cas:title">Experimental and Toxicologic Pathology</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">55</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">347-355</span>CODEN:
                <span class="NLM_cas:coden">ETPAEK</span>;
        ISSN:<span class="NLM_cas:issn">0940-2993</span>.
    
            (<span class="NLM_cas:orgname">Elsevier GmbH</span>)
        </div><div class="casAbstract">Several cationic amphiphilic compds. are known to induce phospholipidosis, a condition primarily characterized by excessive accumulation of phospholipids in different cell types, giving the affected cells a finely foamy appearance.  Excessive storage of lamellar membranous intralysosomal inclusion bodies is the hallmark for phospholipidosis on the electron microscopic level.  In case of alveolar phospholipidosis, foamy macrophages accumulate within the alveolar spaces of the lung.  Based on such findings in a one-year toxicity study with gepirone in rats, we studied the mol. properties of this compd. and compds. suspected of being phospholipidosis inducers by means of physicochem. calcns.  Physicochem. mol. calcns. of mol. wt., ClogP (partition coeff. octanol/water), logD at pH 7.4, and pKa were performed, for the cationic amphiphilic compds. chlorpromazine, amiodarone, imipramine, propranolol and fluoxetine, and for the structurally related compds. 1-phenylpiperazine (1-PHP), gepirone (and its major metabolites, 3-OH-gepirone and 1-pyrimidinylpiperazine [1-PP]), and buspirone.  ClogP and calcd. pKa cluster differently for the amphiphilic drugs compared to the chem. series of piperazines.  In line with this anal., lamellar inclusion bodies were found in an in vitro validation expt. in the human monoblastoid cell line U-937, incubated for 96 h at 10 μg/mL with cationic amphiphilic drugs (amiodarone, imipramine, or propranolol).  No such lamellar inclusion bodies were seen for any of the compds. from the chem. series of piperazines including gepirone and its metabolites.  The data presented support the use of simple physicochem. calcns. of ClogP and pKa to discriminate rapidly between compds. suspected of being phospholipidosis inducers.  Finally, the discriminative power of these physicochem. ClogP and pKa calcns. to predict phospholipidosis-inducing potential was further validated by extension of the set of compds.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo-qnA3_zghvbVg90H21EOLACvtfcHk0ljjh4wLY-MZzQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXksFGltL0%253D&md5=caf5e68d3d5356dfef1cc29dbaf5ca87</span></div><a href="/servlet/linkout?suffix=cit41&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DPloemen%26aufirst%3DJ.-P.%2BH.%2BT.%2BM.%26aulast%3DKelder%26aufirst%3DJ.%26aulast%3DHafmans%26aufirst%3DT.%26aulast%3Dvan%2Bde%2BSandt%26aufirst%3DH.%26aulast%3Dvan%2BBurgsteden%26aufirst%3DJ.%2BA.%26aulast%3DSalemink%26aufirst%3DP.%2BJ.%2BM.%26aulast%3Dvan%2BEsch%26aufirst%3DE.%26atitle%3DUse%2520of%2520physicochemical%2520calculation%2520of%2520pKa%2520and%2520CLogP%2520to%2520predict%2520phospholipidosis-inducing%2520potential%253A%2520a%2520case%2520study%2520with%2520structurally%2520related%2520piperazines%26jtitle%3DExp.%2520Toxicol.%2520Pathol.%26date%3D2004%26volume%3D55%26spage%3D347%26epage%3D355" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref42"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref42'); return false;" data-citation="" class="refNumLink">42</a></strong><div class="NLM_citation" id="cit42"><span><span class="NLM_contrib-group">Morelli, J. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Buehrle, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pognan, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Barone, L. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fieles, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ciaccio, P. J.</span><span> </span><span class="NLM_article-title">Validation of an in vitro screen for phospholipidosis using a high-content biology platform</span> <span class="citation_source-journal">Cell Biol. Toxicol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">22</span><span class="NLM_x">, </span> <span class="NLM_fpage">15</span><span class="NLM_x">–</span> <span class="NLM_lpage">27</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref42/cit42&amp;dbid=16&amp;doi=10.1021%2Fjm200939b&amp;key=10.1007%2Fs10565-006-0176-z" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref42/cit42&amp;dbid=8&amp;doi=10.1021%2Fjm200939b&amp;key=16463016" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref42/cit42&amp;dbid=32&amp;doi=10.1021%2Fjm200939b&amp;key=1%3ACAS%3A528%3ADC%252BD28XhtFWmur4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=22&publication_year=2006&pages=15-27&author=J.+K.+Morelliauthor=M.+Buehrleauthor=F.+Pognanauthor=L.+R.+Baroneauthor=W.+Fielesauthor=P.+J.+Ciaccio&title=Validation+of+an+in+vitro+screen+for+phospholipidosis+using+a+high-content+biology+platform"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit42R"><div class="casContent"><span class="casTitleNuber">42</span><div class="casTitle"><span class="NLM_cas:atitle">Validation of an in vitro screen for phospholipidosis using a high-content biology platform</span></div><div class="casAuthors">Morelli, J. K.; Buehrle, M.; Pognan, F.; Barone, L. R.; Fieles, W.; Ciaccio, P. J.</div><div class="citationInfo"><span class="NLM_cas:title">Cell Biology and Toxicology</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">22</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">15-27</span>CODEN:
                <span class="NLM_cas:coden">CBTOE2</span>;
        ISSN:<span class="NLM_cas:issn">0742-2091</span>.
    
            (<span class="NLM_cas:orgname">Springer</span>)
        </div><div class="casAbstract">Several cationic amphiphilic drugs cause local or systemic phospholipidosis (PLD) after chronic exposure in preclin. species.  PLD is characterized by the accumulation of drug, phospholipid, and concentric lamellar bodies in cellular lysosomes.  The authors have developed a fluorescence-based in vitro screen that is predictive of PLD using the Cellomics ArrayScan high-content screening platform, which captures and analyzes images from 96-well cell culture microtiter plates using multichannel fluorescence microscopy.  I-13.35 adherent mouse spleen macrophage cells were cultured with drug and a fluorescently tagged phospholipid, N-(7-nitrobenz-2-oxa-1,3-diazol-4-yl)-1,2-dihexadecanoyl-sn-glycero-3-phosphoethanolamine (NBD-PE).  Drug concns. were used in a range from 1 to 100 μmol/L.  After 24 h incubations, the cells were fixed with formalin.  NBD-PE uptake was quantified in controls and treated cells.  Nuclei were identified by Hoechst 33258 staining and dead cells were identified using ethidium homodimer-2 incorporation.  Thus, confounding accumulation of NBD-PE due to cytotoxicity that produces false-pos. results at high concns. was eliminated from quantitation by ethidium staining and employing cell gating (dead cell rejection).  The assay was found to be both sensitive and selective in that 26 of 28 pos., phospholipidogenic controls and 8 of 8 neg., nonphospholipidogenic controls were correctly called.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo5jzENAdqu-rVg90H21EOLACvtfcHk0ljjh4wLY-MZzQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28XhtFWmur4%253D&md5=8492308f1a1e0970baf602304fbd1f44</span></div><a href="/servlet/linkout?suffix=cit42&amp;dbid=16384&amp;doi=10.1007%2Fs10565-006-0176-z&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252Fs10565-006-0176-z%26sid%3Dliteratum%253Aachs%26aulast%3DMorelli%26aufirst%3DJ.%2BK.%26aulast%3DBuehrle%26aufirst%3DM.%26aulast%3DPognan%26aufirst%3DF.%26aulast%3DBarone%26aufirst%3DL.%2BR.%26aulast%3DFieles%26aufirst%3DW.%26aulast%3DCiaccio%26aufirst%3DP.%2BJ.%26atitle%3DValidation%2520of%2520an%2520in%2520vitro%2520screen%2520for%2520phospholipidosis%2520using%2520a%2520high-content%2520biology%2520platform%26jtitle%3DCell%2520Biol.%2520Toxicol.%26date%3D2006%26volume%3D22%26spage%3D15%26epage%3D27" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref43"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref43'); return false;" data-citation="" class="refNumLink">43</a></strong><div class="NLM_citation" id="cit43"><span><span class="NLM_contrib-group">Hjelle, J. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ruben, Z.</span><span> </span><span class="NLM_article-title">Investigations in intracellular drug storage: localization of disobutamide in lysosomal and nonlysosomal vesicles</span> <span class="citation_source-journal">Toxicol. Appl. Pharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1989</span><span class="NLM_x">, </span> <span class="NLM_volume">101</span><span class="NLM_x">, </span> <span class="NLM_fpage">70</span><span class="NLM_x">–</span> <span class="NLM_lpage">82</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref43/cit43&amp;dbid=16&amp;doi=10.1021%2Fjm200939b&amp;key=10.1016%2F0041-008X%2889%2990213-5" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref43/cit43&amp;dbid=8&amp;doi=10.1021%2Fjm200939b&amp;key=2799819" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref43/cit43&amp;dbid=32&amp;doi=10.1021%2Fjm200939b&amp;key=1%3ACAS%3A528%3ADyaL1MXmtVyltLc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=101&publication_year=1989&pages=70-82&author=J.+T.+Hjelleauthor=Z.+Ruben&title=Investigations+in+intracellular+drug+storage%3A+localization+of+disobutamide+in+lysosomal+and+nonlysosomal+vesicles"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit43R"><div class="casContent"><span class="casTitleNuber">43</span><div class="casTitle"><span class="NLM_cas:atitle">Investigations in intracellular drug storage:  localization of disobutamide in lysosomal and nonlysosomal vesicles</span></div><div class="casAuthors">Hjelle, J. Thomas; Ruben, Zadok</div><div class="citationInfo"><span class="NLM_cas:title">Toxicology and Applied Pharmacology</span>
        (<span class="NLM_cas:date">1989</span>),
    <span class="NLM_cas:volume">101</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">70-82</span>CODEN:
                <span class="NLM_cas:coden">TXAPA9</span>;
        ISSN:<span class="NLM_cas:issn">0041-008X</span>.
    </div><div class="casAbstract">In the investigation of the dynamic nature of intracellular drug-induced storage disorder assocd. with clear cytoplasmic vacuoles (CCV), rat urinary bladder carcinoma cells (RBT CC-8) were cultured with [14C]disobutamide.  Cell monolayers were then harvested and anal. cell fractionation techniques were employed to examine the assocn. of disobutamide with the various subcellular fractions.  Disobutamide distributed in 2 modes: as a free, organelle-independent fraction and as a light membrane-assocd. fraction that overlapped with markers for the plasma membrane, endoplasmic reticulum, and lysosomes.  The similarity in buoyant densities of these organelles derived from RBT CC-8 cells precluded resoln. of these structures by isopycnic centrifugation.  In addnl. expts., disobutamide was incubated in vitro with a suspension of isolated rabbit renal proximal tubules.  In these cells, anal. fractionation showed that the drug localized predominantly to lysosomes and to a sep. light membrane fraction that was clearly resolved from the markers for the endoplasmic reticulum, brush border, mitochondria, and peroxisomes; this fraction overlapped with the most buoyant aspects of the Golgi app. and basolateral plasma membrane.  The buoyant d. of this disobutamide-assocd. nonlysosomal fraction was 1.11 g/mL.  Electron microscopy of the disobutamide-exposed tubules showed a substantial formation of apical vesicles, esp. small, smooth-surfaced vesicles, typical of the endocytic app.  From these findings and based on the physicochem. properties of the cationic moiety of disobutamide, its is concluded that the drug localizes in lysosomal and nonlysosomal acidic vesicles.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrPyjOyPDTslrVg90H21EOLACvtfcHk0liAxBOoQ1ZaUQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaL1MXmtVyltLc%253D&md5=8897fa2728c7adb4364ed6b655592f71</span></div><a href="/servlet/linkout?suffix=cit43&amp;dbid=16384&amp;doi=10.1016%2F0041-008X%2889%2990213-5&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252F0041-008X%252889%252990213-5%26sid%3Dliteratum%253Aachs%26aulast%3DHjelle%26aufirst%3DJ.%2BT.%26aulast%3DRuben%26aufirst%3DZ.%26atitle%3DInvestigations%2520in%2520intracellular%2520drug%2520storage%253A%2520localization%2520of%2520disobutamide%2520in%2520lysosomal%2520and%2520nonlysosomal%2520vesicles%26jtitle%3DToxicol.%2520Appl.%2520Pharmacol.%26date%3D1989%26volume%3D101%26spage%3D70%26epage%3D82" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref44"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref44'); return false;" data-citation="" class="refNumLink">44</a></strong><div class="NLM_citation" id="cit44"><span><span class="NLM_contrib-group">Rorig, K. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ruben, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Anderson, S. N.</span><span> </span><span class="NLM_article-title">Structural determinants of cationic amphiphilic amines which induce clear cytoplasmic vacuoles in cultured cells</span> <span class="citation_source-journal">Proc. Soc. Exp. Biol. Med.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1987</span><span class="NLM_x">, </span> <span class="NLM_volume">184</span><span class="NLM_x">, </span> <span class="NLM_fpage">165</span><span class="NLM_x">–</span> <span class="NLM_lpage">171</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref44/cit44&amp;dbid=16&amp;doi=10.1021%2Fjm200939b&amp;key=10.3181%2F00379727-184-42462" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref44/cit44&amp;dbid=8&amp;doi=10.1021%2Fjm200939b&amp;key=3809171" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref44/cit44&amp;dbid=32&amp;doi=10.1021%2Fjm200939b&amp;key=1%3ACAS%3A528%3ADyaL2sXhsVyqtLY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=184&publication_year=1987&pages=165-171&author=K.+J.+Rorigauthor=Z.+Rubenauthor=S.+N.+Anderson&title=Structural+determinants+of+cationic+amphiphilic+amines+which+induce+clear+cytoplasmic+vacuoles+in+cultured+cells"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit44R"><div class="casContent"><span class="casTitleNuber">44</span><div class="casTitle"><span class="NLM_cas:atitle">Structural determinants of cationic amphiphilic amines which induce clear cytoplasmic vacuoles in cultured cells</span></div><div class="casAuthors">Rorig, Kurt J.; Ruben, Zadok; Anderson, Steven N.</div><div class="citationInfo"><span class="NLM_cas:title">Proceedings of the Society for Experimental Biology and Medicine</span>
        (<span class="NLM_cas:date">1987</span>),
    <span class="NLM_cas:volume">184</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">165-71</span>CODEN:
                <span class="NLM_cas:coden">PSEBAA</span>;
        ISSN:<span class="NLM_cas:issn">0037-9727</span>.
    </div><div class="casAbstract">To delineate the structural determinants of amines that induce clear cytoplasmic vacuoles (CCV), cultured rat urinary bladder carcinoma and rabbit aorta muscle cells were exposed to numerous cationic drugs and chems. and examd. by phase light microscopy.  The cationic moiety of these cationic amphiphilic amines (CAA) was responsible for the induction of CCV.  The very potent inducers were compds. that had 2 strongly basic amine (cationic) centers.  The bistertiary amines were particularly potent inducers.  Aliph. diamines of minimal lipophilicity induced CCV, thus showing that an amphiphilic structural feature, though present in many CAA drugs, is not necessary for CCV induction.  The distance between the 2 cationic centers was irrelevant to the induction of CCV.  Apparently, CCV are a manifestation of intracellular (e.g., intralysosomal) drug storage.  These structural delineations will be useful in future drug design and for further understanding of drug-cell interactions.  Based on these findings, an antiarrhythmic CAA was synthesized which did not induce CCV.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq8_MXsnvupRLVg90H21EOLACvtfcHk0liAxBOoQ1ZaUQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaL2sXhsVyqtLY%253D&md5=90aba7e3fd9de52d94e7323f5a2800f2</span></div><a href="/servlet/linkout?suffix=cit44&amp;dbid=16384&amp;doi=10.3181%2F00379727-184-42462&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.3181%252F00379727-184-42462%26sid%3Dliteratum%253Aachs%26aulast%3DRorig%26aufirst%3DK.%2BJ.%26aulast%3DRuben%26aufirst%3DZ.%26aulast%3DAnderson%26aufirst%3DS.%2BN.%26atitle%3DStructural%2520determinants%2520of%2520cationic%2520amphiphilic%2520amines%2520which%2520induce%2520clear%2520cytoplasmic%2520vacuoles%2520in%2520cultured%2520cells%26jtitle%3DProc.%2520Soc.%2520Exp.%2520Biol.%2520Med.%26date%3D1987%26volume%3D184%26spage%3D165%26epage%3D171" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref45"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref45'); return false;" data-citation="" class="refNumLink">45</a></strong><div class="NLM_citation" id="cit45"><span><span class="NLM_contrib-group">Ertl, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rohde, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Selzer, P.</span><span> </span><span class="NLM_article-title">Fast calculation of molecular polar surface area as a sum of fragment-based contributions and its application to the prediction of drug transport properties</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2000</span><span class="NLM_x">, </span> <span class="NLM_volume">43</span><span class="NLM_x">, </span> <span class="NLM_fpage">3714</span><span class="NLM_x">–</span> <span class="NLM_lpage">3717</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm000942e" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref45/cit45&amp;dbid=32&amp;doi=10.1021%2Fjm200939b&amp;key=1%3ACAS%3A528%3ADC%252BD3cXmsFeitb4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=43&publication_year=2000&pages=3714-3717&author=P.+Ertlauthor=B.+Rohdeauthor=P.+Selzer&title=Fast+calculation+of+molecular+polar+surface+area+as+a+sum+of+fragment-based+contributions+and+its+application+to+the+prediction+of+drug+transport+properties"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit45R"><div class="casContent"><span class="casTitleNuber">45</span><div class="casTitle"><span class="NLM_cas:atitle">Fast Calculation of Molecular Polar Surface Area as a Sum of Fragment-Based Contributions and Its Application to the Prediction of Drug Transport Properties</span></div><div class="casAuthors">Ertl, Peter; Rohde, Bernhard; Selzer, Paul</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2000</span>),
    <span class="NLM_cas:volume">43</span>
        (<span class="NLM_cas:issue">20</span>),
    <span class="NLM_cas:pages">3714-3717</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Mol. polar surface area (PSA), i.e., surface belonging to polar atoms, is a descriptor that was shown to correlate well with passive mol. transport through membranes and, therefore, allows prediction of transport properties of drugs.  The calcn. of PSA, however, is rather time-consuming because of the necessity to generate a reasonable 3D mol. geometry and the calcn. of the surface itself.  A new approach for the calcn. of the PSA is presented here, based on the summation of tabulated surface contributions of polar fragments.  The method, termed topol. PSA (TPSA), provides results which are practically identical with the 3D PSA (the correlation coeff. between 3D PSA and fragment-based TPSA for 34 810 mols. from the World Drug Index is 0.99), while the computation speed is 2-3 orders of magnitude faster.  The new methodol. may, therefore, be used for fast bioavailability screening of virtual libraries having millions of mols.  This article describes the new methodol. and shows the results of validation studies based on sets of published absorption data, including intestinal absorption, Caco-2 monolayer penetration, and blood-brain barrier penetration.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrhP6Qncx_h6LVg90H21EOLACvtfcHk0liAxBOoQ1ZaUQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3cXmsFeitb4%253D&md5=23ae4e7708bd8ddeb4a24ad160a29bd6</span></div><a href="/servlet/linkout?suffix=cit45&amp;dbid=16384&amp;doi=10.1021%2Fjm000942e&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm000942e%26sid%3Dliteratum%253Aachs%26aulast%3DErtl%26aufirst%3DP.%26aulast%3DRohde%26aufirst%3DB.%26aulast%3DSelzer%26aufirst%3DP.%26atitle%3DFast%2520calculation%2520of%2520molecular%2520polar%2520surface%2520area%2520as%2520a%2520sum%2520of%2520fragment-based%2520contributions%2520and%2520its%2520application%2520to%2520the%2520prediction%2520of%2520drug%2520transport%2520properties%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2000%26volume%3D43%26spage%3D3714%26epage%3D3717" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref46"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref46'); return false;" data-citation="" class="refNumLink">46</a></strong><div class="NLM_citation" id="cit46"><span><span class="NLM_contrib-group">Hanumegowda, U. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wenke, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Regueiro-Ren, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yordanova, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Corradi, J. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Adams, S. P.</span><span> </span><span class="NLM_article-title">Phospholipidosis as a function of basicity, lipophilicity, and volume of distribution of compounds</span> <span class="citation_source-journal">Chem. Res. Toxicol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">23</span><span class="NLM_x">, </span> <span class="NLM_fpage">749</span><span class="NLM_x">–</span> <span class="NLM_lpage">755</span></span><div class="citationLinks">[<a href="/doi/10.1021/tx9003825" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref46/cit46&amp;dbid=32&amp;doi=10.1021%2Fjm200939b&amp;key=1%3ACAS%3A528%3ADC%252BC3cXktVeqtLw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=23&publication_year=2010&pages=749-755&author=U.+M.+Hanumegowdaauthor=G.+Wenkeauthor=A.+Regueiro-Renauthor=R.+Yordanovaauthor=J.+P.+Corradiauthor=S.+P.+Adams&title=Phospholipidosis+as+a+function+of+basicity%2C+lipophilicity%2C+and+volume+of+distribution+of+compounds"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit46R"><div class="casContent"><span class="casTitleNuber">46</span><div class="casTitle"><span class="NLM_cas:atitle">Phospholipidosis as a Function of Basicity, Lipophilicity, and Volume of Distribution of Compounds</span></div><div class="casAuthors">Hanumegowda, Umesh M.; Wenke, Gottfried; Regueiro-Ren, Alicia; Yordanova, Roumyana; Corradi, John P.; Adams, Stephen P.</div><div class="citationInfo"><span class="NLM_cas:title">Chemical Research in Toxicology</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">23</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">749-755</span>CODEN:
                <span class="NLM_cas:coden">CRTOEC</span>;
        ISSN:<span class="NLM_cas:issn">0893-228X</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Drug-induced phospholipidosis (PLD) is an adaptive histol. alteration that is seen with various marketed drugs and often encountered during drug development.  Various in silico and in vitro cell-based methods have been developed to predict the PLD-inducing potential of compds.  These methods rely on the inherent physicochem. properties of the mol. and, as such, tend to overpredict compds. as PLD inducers.  Recognizing that the distribution of compds. into tissues or tissue accumulation is likely a key factor in PLD induction, in addn. to key physicochem. properties, we developed a model to predict PLD in vivo using the measures of basicity (pKa), lipophilicity (ClogP), and vol. of distribution (Vd).  Using sets of PLD inducers and noninducers, we demonstrate improved concordance with this method.  Furthermore, we propose a screening paradigm that includes a combination of various methods to predict the in vivo PLD-inducing potential of compds., which may be esp. useful in lead identification and optimization processes in drug discovery.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrJNq2nVkAysrVg90H21EOLACvtfcHk0lhWos1PfV9G5w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXktVeqtLw%253D&md5=471380f65644ba0db549660acf6b4d8d</span></div><a href="/servlet/linkout?suffix=cit46&amp;dbid=16384&amp;doi=10.1021%2Ftx9003825&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Ftx9003825%26sid%3Dliteratum%253Aachs%26aulast%3DHanumegowda%26aufirst%3DU.%2BM.%26aulast%3DWenke%26aufirst%3DG.%26aulast%3DRegueiro-Ren%26aufirst%3DA.%26aulast%3DYordanova%26aufirst%3DR.%26aulast%3DCorradi%26aufirst%3DJ.%2BP.%26aulast%3DAdams%26aufirst%3DS.%2BP.%26atitle%3DPhospholipidosis%2520as%2520a%2520function%2520of%2520basicity%252C%2520lipophilicity%252C%2520and%2520volume%2520of%2520distribution%2520of%2520compounds%26jtitle%3DChem.%2520Res.%2520Toxicol.%26date%3D2010%26volume%3D23%26spage%3D749%26epage%3D755" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref47"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref47'); return false;" data-citation="" class="refNumLink">47</a></strong><div class="NLM_citation" id="cit47"><span><span class="NLM_contrib-group">Simplício, A. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Clancy, J. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gilmer, J. F.</span><span> </span><span class="NLM_article-title">Prodrugs for amines</span> <span class="citation_source-journal">Molecules</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">13</span><span class="NLM_x">, </span> <span class="NLM_fpage">519</span><span class="NLM_x">–</span> <span class="NLM_lpage">547</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref47/cit47&amp;dbid=16&amp;doi=10.1021%2Fjm200939b&amp;key=10.3390%2Fmolecules13030519" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref47/cit47&amp;dbid=8&amp;doi=10.1021%2Fjm200939b&amp;key=18463563" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref47/cit47&amp;dbid=32&amp;doi=10.1021%2Fjm200939b&amp;key=1%3ACAS%3A280%3ADC%252BD1czgtFSqtQ%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=13&publication_year=2008&pages=519-547&author=A.+L.+Simpl%C3%ADcioauthor=J.+M.+Clancyauthor=J.+F.+Gilmer&title=Prodrugs+for+amines"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit47R"><div class="casContent"><span class="casTitleNuber">47</span><div class="casTitle"><span class="NLM_cas:atitle">Prodrugs for amines</span></div><div class="casAuthors">Simplicio Ana L; Clancy John M; Gilmer John F</div><div class="citationInfo"><span class="NLM_cas:title">Molecules (Basel, Switzerland)</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">13</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">519-47</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">The purpose of this work is to review the published strategies for the production of prodrugs of amines.  The review is divided in two main groups of approaches: those that rely on enzymatic activation and those that take advantage of physiological chemical conditions for release of the drugs.  A compilation of the most important approaches is presented in the form of a table, where the main advantages and disadvantages of each strategy are also referred.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcQqXISolqenaDdblLE_E9PWfW6udTcc2eYuC-rWINAzmLntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BD1czgtFSqtQ%253D%253D&md5=ebdca0c3524c2de9c015d2a152777027</span></div><a href="/servlet/linkout?suffix=cit47&amp;dbid=16384&amp;doi=10.3390%2Fmolecules13030519&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.3390%252Fmolecules13030519%26sid%3Dliteratum%253Aachs%26aulast%3DSimpl%25C3%25ADcio%26aufirst%3DA.%2BL.%26aulast%3DClancy%26aufirst%3DJ.%2BM.%26aulast%3DGilmer%26aufirst%3DJ.%2BF.%26atitle%3DProdrugs%2520for%2520amines%26jtitle%3DMolecules%26date%3D2008%26volume%3D13%26spage%3D519%26epage%3D547" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref48"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref48'); return false;" data-citation="" class="refNumLink">48</a></strong><div class="NLM_citation" id="cit48"><span><span class="NLM_contrib-group">Wager, T. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hou, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Verhoest, P. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Villalobos, A.</span><span> </span><span class="NLM_article-title">Moving beyond rules: the development of a central nervous system multiparameter optimization (CNS MPO) approach to enable alignment of druglike properties</span> <span class="citation_source-journal">ACS Chem. Neurosci.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">1</span><span class="NLM_x">, </span> <span class="NLM_fpage">435</span><span class="NLM_x">–</span> <span class="NLM_lpage">449</span></span><div class="citationLinks">[<a href="/doi/10.1021/cn100008c" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref48/cit48&amp;dbid=32&amp;doi=10.1021%2Fjm200939b&amp;key=1%3ACAS%3A528%3ADC%252BC3cXjvVejtr8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=1&publication_year=2010&pages=435-449&author=T.+T.+Wagerauthor=X.+Houauthor=P.+R.+Verhoestauthor=A.+Villalobos&title=Moving+beyond+rules%3A+the+development+of+a+central+nervous+system+multiparameter+optimization+%28CNS+MPO%29+approach+to+enable+alignment+of+druglike+properties"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit48R"><div class="casContent"><span class="casTitleNuber">48</span><div class="casTitle"><span class="NLM_cas:atitle">Moving beyond Rules: The Development of a Central Nervous System Multiparameter Optimization (CNS MPO) Approach To Enable Alignment of Druglike Properties</span></div><div class="casAuthors">Wager, Travis T.; Hou, Xinjun; Verhoest, Patrick R.; Villalobos, Anabella</div><div class="citationInfo"><span class="NLM_cas:title">ACS Chemical Neuroscience</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">1</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">435-449</span>CODEN:
                <span class="NLM_cas:coden">ACNCDM</span>;
        ISSN:<span class="NLM_cas:issn">1948-7193</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">The interplay among commonly used physicochem. properties in drug design was examd. and utilized to create a prospective design tool focused on the alignment of key druglike attributes.  Using a set of six physicochem. parameters ((a) lipophilicity, calcd. partition coeff. (ClogP); (b) calcd. distribution coeff. at pH = 7.4 (ClogD); (c) mol. wt. (MW); (d) topol. polar surface area (TPSA); (e) no. of hydrogen bond donors (HBD); (f) most basic center (pKa)), a druglikeness central nervous system multiparameter optimization (CNS MPO) algorithm was built and applied to a set of marketed CNS drugs (N = 119) and Pfizer CNS candidates (N = 108), as well as to a large diversity set of Pfizer proprietary compds. (N = 11 303).  The novel CNS MPO algorithm showed that 74% of marketed CNS drugs displayed a high CNS MPO score (MPO desirability score ≥ 4, using a scale of 0-6), in comparison to 60% of the Pfizer CNS candidates.  This anal. suggests that this algorithm could potentially be used to identify compds. with a higher probability of successfully testing hypotheses in the clinic.  In addn., a relationship between an increasing CNS MPO score and alignment of key in vitro attributes of drug discovery (favorable permeability, P-glycoprotein (P-gp) efflux, metabolic stability, and safety) was seen in the marketed CNS drug set, the Pfizer candidate set, and the Pfizer proprietary diversity set.  The CNS MPO scoring function offers advantages over hard cutoffs or utilization of single parameters to optimize structure-activity relationships (SAR) by expanding medicinal chem. design space through a holistic assessment approach.  Based on six physicochem. properties commonly used by medicinal chemists, the CNS MPO function may be used prospectively at the design stage to accelerate the identification of compds. with increased probability of success.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqB3Mvkgm_X5bVg90H21EOLACvtfcHk0lhWos1PfV9G5w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXjvVejtr8%253D&md5=e94998f65a420be6ee4dec4a987cb983</span></div><a href="/servlet/linkout?suffix=cit48&amp;dbid=16384&amp;doi=10.1021%2Fcn100008c&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fcn100008c%26sid%3Dliteratum%253Aachs%26aulast%3DWager%26aufirst%3DT.%2BT.%26aulast%3DHou%26aufirst%3DX.%26aulast%3DVerhoest%26aufirst%3DP.%2BR.%26aulast%3DVillalobos%26aufirst%3DA.%26atitle%3DMoving%2520beyond%2520rules%253A%2520the%2520development%2520of%2520a%2520central%2520nervous%2520system%2520multiparameter%2520optimization%2520%2528CNS%2520MPO%2529%2520approach%2520to%2520enable%2520alignment%2520of%2520druglike%2520properties%26jtitle%3DACS%2520Chem.%2520Neurosci.%26date%3D2010%26volume%3D1%26spage%3D435%26epage%3D449" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref49"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref49'); return false;" data-citation="" class="refNumLink">49</a></strong><div class="NLM_citation" id="cit49"><span><span class="NLM_contrib-group">Stevens, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">De Kimpe, N.</span><span> </span><span class="NLM_article-title">A new entry into 2-azabicyclo[2.1.1]hexanes via 3-(chloromethyl)cyclobutanone</span> <span class="citation_source-journal">J. Org. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1996</span><span class="NLM_x">, </span> <span class="NLM_volume">61</span><span class="NLM_x">, </span> <span class="NLM_fpage">2174</span><span class="NLM_x">–</span> <span class="NLM_lpage">2178</span></span><div class="citationLinks">[<a href="/doi/10.1021/jo951865b" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=61&publication_year=1996&pages=2174-2178&author=C.+Stevensauthor=N.+De+Kimpe&title=A+new+entry+into+2-azabicyclo%5B2.1.1%5Dhexanes+via+3-%28chloromethyl%29cyclobutanone"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit49&amp;dbid=16384&amp;doi=10.1021%2Fjo951865b&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjo951865b%26sid%3Dliteratum%253Aachs%26aulast%3DStevens%26aufirst%3DC.%26aulast%3DDe%2BKimpe%26aufirst%3DN.%26atitle%3DA%2520new%2520entry%2520into%25202-azabicyclo%255B2.1.1%255Dhexanes%2520via%25203-%2528chloromethyl%2529cyclobutanone%26jtitle%3DJ.%2520Org.%2520Chem.%26date%3D1996%26volume%3D61%26spage%3D2174%26epage%3D2178" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref50"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref50'); return false;" data-citation="" class="refNumLink">50</a></strong><div class="NLM_citation" id="cit50"><span><span class="NLM_contrib-group">Schultz, A. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McCloskey, P. J.</span><span> </span><span class="NLM_article-title">Carboxamide and carbalkoxy group directed stereoselective iridium-catalyzed homogeneous olefin hydrogenations</span> <span class="citation_source-journal">J. Org. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1985</span><span class="NLM_x">, </span> <span class="NLM_volume">50</span><span class="NLM_x">, </span> <span class="NLM_fpage">5905</span><span class="NLM_x">–</span> <span class="NLM_lpage">5907</span></span><div class="citationLinks">[<a href="/doi/10.1021/jo00350a105" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=50&publication_year=1985&pages=5905-5907&author=A.+G.+Schultzauthor=P.+J.+McCloskey&title=Carboxamide+and+carbalkoxy+group+directed+stereoselective+iridium-catalyzed+homogeneous+olefin+hydrogenations"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit50&amp;dbid=16384&amp;doi=10.1021%2Fjo00350a105&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjo00350a105%26sid%3Dliteratum%253Aachs%26aulast%3DSchultz%26aufirst%3DA.%2BG.%26aulast%3DMcCloskey%26aufirst%3DP.%2BJ.%26atitle%3DCarboxamide%2520and%2520carbalkoxy%2520group%2520directed%2520stereoselective%2520iridium-catalyzed%2520homogeneous%2520olefin%2520hydrogenations%26jtitle%3DJ.%2520Org.%2520Chem.%26date%3D1985%26volume%3D50%26spage%3D5905%26epage%3D5907" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref51"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref51'); return false;" data-citation="" class="refNumLink">51</a></strong><div class="NLM_citation" id="cit51"><span><span class="NLM_contrib-group">Ertl, P.</span><span> </span><span class="NLM_article-title">Polar surface area</span> <span class="citation_source-journal">Methods Princ. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">37</span><span class="NLM_x">, </span> <span class="NLM_fpage">111</span><span class="NLM_x">–</span> <span class="NLM_lpage">126</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref51/cit51&amp;dbid=32&amp;doi=10.1021%2Fjm200939b&amp;key=1%3ACAS%3A528%3ADC%252BD1cXmtFyjurs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=37&publication_year=2008&pages=111-126&author=P.+Ertl&title=Polar+surface+area"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit51R"><div class="casContent"><span class="casTitleNuber">51</span><div class="casTitle"><span class="NLM_cas:atitle">Polar surface area</span></div><div class="casAuthors">Ertl, Peter</div><div class="citationInfo"><span class="NLM_cas:title">Methods and Principles in Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">37</span>
        (<span class="NLM_cas:issue">Molecular Drug Properties</span>),
    <span class="NLM_cas:pages">111-126</span>CODEN:
                <span class="NLM_cas:coden">MPMCE3</span>;
        ISSN:<span class="NLM_cas:issn">1432-4636</span>.
    
            (<span class="NLM_cas:orgname">Wiley-VCH Verlag GmbH & Co. KGaA</span>)
        </div><div class="casAbstract">A review on the application of polar surface area (PSA) for prediction of drug transport properties and in virtual screening, calcn. of PSA, and correlation of PSA with other mol. descriptors.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq1fbBsoe-2AbVg90H21EOLACvtfcHk0ljftQXsTjgX1g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXmtFyjurs%253D&md5=bb6de7704ffc98d18d1d6de9c1590755</span></div><a href="/servlet/linkout?suffix=cit51&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DErtl%26aufirst%3DP.%26atitle%3DPolar%2520surface%2520area%26jtitle%3DMethods%2520Princ.%2520Med.%2520Chem.%26date%3D2008%26volume%3D37%26spage%3D111%26epage%3D126" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref52"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref52'); return false;" data-citation="" class="refNumLink">52</a></strong><div class="NLM_citation" id="cit52"><span><span class="NLM_contrib-group">Wager, T. T.; Chandrasekaran, R. Y.; Butler, T. W.</span><span> </span><span class="NLM_article-title">Preparation of Pyrrolidinylmethylphenylcyclobutanecarboxamides as Histamine H3 Receptor Antagonists</span>. PCT Int. Appl. WO2007049123,<span class="NLM_x"> </span><span class="NLM_year">2007</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2007&author=T.+T.+Wager&author=R.+Y.+Chandrasekaran&author=T.+W.+Butler&title=Preparation+of+Pyrrolidinylmethylphenylcyclobutanecarboxamides+as+Histamine+H3+Receptor+Antagonists"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit52&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DWager%26aufirst%3DT.%2BT.%26atitle%3DPreparation%2520of%2520Pyrrolidinylmethylphenylcyclobutanecarboxamides%2520as%2520Histamine%2520H3%2520Receptor%2520Antagonists%26date%3D2007" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li></ol></div><script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script><script type="text/javascript">window.refViewer={'ref1':['cit1'],'ref2':['cit2'],'ref3':['cit3'],'ref4':['cit4'],'ref5':['cit5'],'ref6':['cit6'],'ref7':['cit7'],'ref8':['cit8'],'ref9':['cit9'],'ref10':['cit10'],'ref11':['cit11'],'ref12':['cit12'],'ref13':['cit13'],'ref14':['cit14'],'ref15':['cit15'],'ref16':['cit16'],'ref17':['cit17'],'ref18':['cit18'],'ref19':['cit19'],'ref20':['cit20'],'ref21':['cit21'],'ref22':['cit22'],'ref23':['cit23'],'ref24':['cit24'],'ref25':['cit25'],'ref26':['cit26'],'ref27':['cit27'],'ref28':['cit28'],'ref29':['cit29'],'ref30':['cit30'],'ref31':['cit31'],'ref32':['cit32'],'ref33':['cit33'],'ref34':['cit34'],'ref35':['cit35'],'ref36':['cit36'],'ref37':['cit37'],'ref38':['cit38'],'ref39':['cit39'],'ref40':['cit40'],'ref41':['cit41'],'ref42':['cit42'],'ref43':['cit43'],'ref44':['cit44'],'ref45':['cit45'],'ref46':['cit46'],'ref47':['cit47'],'ref48':['cit48'],'ref49':['cit49'],'ref50':['cit50'],'ref51':['cit51'],'ref52':['cit52']}</script><div class="articleCitedByDropzone" data-pb-dropzone="articleCitedByDropzone"><div class="cited-by"><div class="article_content-header cited-content_header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="citeThis">Cited By</h2></div></div></div><hr/></hr><div class="cited-by__content"><div class="cited-content hlFld-Abstract"><p>This article is cited by 52 publications.</p><ol class="cited-content_cbyCitation"><li><span class="cited-content_cbyCitation_article-contributors">Kevin Nguyen, Helen A. Clement, Louise Bernier, Jotham W. Coe, William Farrell, Christopher J. Helal, Matthew R. Reese, Neal W. Sach, Jack C. Lee, <span class="NLM_string-name hlFld-ContribAuthor">Dennis G. Hall</span>. </span><span class="cited-content_cbyCitation_article-title">Catalytic Enantioselective Synthesis of a cis-β-Boronyl Cyclobutylcarboxyester Scaffold and Its Highly Diastereoselective Nickel/Photoredox Dual-Catalyzed Csp3–Csp2 Cross-Coupling to Access Elusive trans-β-Aryl/Heteroaryl Cyclobutylcarboxyesters. </span><span class="cited-content_cbyCitation_journal-name">ACS Catalysis</span><span> <strong>2021,</strong> <em>11 </em>
                                    (1)
                                     , 404-413. <a href="https://doi.org/10.1021/acscatal.0c04520" title="DOI URL">https://doi.org/10.1021/acscatal.0c04520</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acscatal.0c04520&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facscatal.0c04520%26sid%3Dliteratum%253Aachs%26jtitle%3DACS%2520Catalysis%26atitle%3DCatalytic%252BEnantioselective%252BSynthesis%252Bof%252Ba%252Bcis-%2525CE%2525B2-Boronyl%252BCyclobutylcarboxyester%252BScaffold%252Band%252BIts%252BHighly%252BDiastereoselective%252BNickel%25252FPhotoredox%252BDual-Catalyzed%252BCsp3%2525E2%252580%252593Csp2%252BCross-Coupling%252Bto%252BAccess%252BElusive%252Btrans-%2525CE%2525B2-Aryl%25252FHeteroaryl%252BCyclobutylcarboxyesters%26aulast%3DNguyen%26aufirst%3DKevin%26date%3D2021%26date%3D2020%26date%3D2020%26date%3D2020%26date%3D19102020%26date%3D05122020%26date%3D21122020%26volume%3D11%26issue%3D1%26spage%3D404%26epage%3D413" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">Taeho Kang, Tuğçe G. Erbay, Kane L. Xu, Gary M. Gallego, Alexander Burtea, Sajiv K. Nair, Ryan L. Patman, Ru Zhou, Scott C. Sutton, Indrawan J. McAlpine, Peng Liu, <span class="NLM_string-name hlFld-ContribAuthor">Keary M. Engle</span>. </span><span class="cited-content_cbyCitation_article-title">Multifaceted Substrate–Ligand Interactions Promote the Copper-Catalyzed Hydroboration of Benzylidenecyclobutanes and Related Compounds. </span><span class="cited-content_cbyCitation_journal-name">ACS Catalysis</span><span> <strong>2020,</strong> <em>10 </em>
                                    (21)
                                     , 13075-13083. <a href="https://doi.org/10.1021/acscatal.0c03622" title="DOI URL">https://doi.org/10.1021/acscatal.0c03622</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acscatal.0c03622&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facscatal.0c03622%26sid%3Dliteratum%253Aachs%26jtitle%3DACS%2520Catalysis%26atitle%3DMultifaceted%252BSubstrate%2525E2%252580%252593Ligand%252BInteractions%252BPromote%252Bthe%252BCopper-Catalyzed%252BHydroboration%252Bof%252BBenzylidenecyclobutanes%252Band%252BRelated%252BCompounds%26aulast%3DKang%26aufirst%3DTaeho%26date%3D2020%26date%3D2020%26date%3D2020%26date%3D2020%26date%3D19082020%26date%3D05102020%26date%3D27102020%26volume%3D10%26issue%3D21%26spage%3D13075%26epage%3D13083" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">Steven H. Bennett, Alexander Fawcett, Elliott H. Denton, Tobias Biberger, Valerio Fasano, Nils Winter, <span class="NLM_string-name hlFld-ContribAuthor">Varinder K. Aggarwal</span>. </span><span class="cited-content_cbyCitation_article-title">Difunctionalization of C–C σ-Bonds Enabled by the Reaction of Bicyclo[1.1.0]butyl Boronate Complexes with Electrophiles: Reaction Development, Scope, and Stereochemical Origins. </span><span class="cited-content_cbyCitation_journal-name">Journal of the American Chemical Society</span><span> <strong>2020,</strong> <em>142 </em>
                                    (39)
                                     , 16766-16775. <a href="https://doi.org/10.1021/jacs.0c07357" title="DOI URL">https://doi.org/10.1021/jacs.0c07357</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/jacs.0c07357&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Fjacs.0c07357%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520the%2520American%2520Chemical%2520Society%26atitle%3DDifunctionalization%252Bof%252BC%2525E2%252580%252593C%252B%2525CF%252583-Bonds%252BEnabled%252Bby%252Bthe%252BReaction%252Bof%252BBicyclo%25255B1.1.0%25255Dbutyl%252BBoronate%252BComplexes%252Bwith%252BElectrophiles%25253A%252BReaction%252BDevelopment%25252C%252BScope%25252C%252Band%252BStereochemical%252BOrigins%26aulast%3DBennett%26aufirst%3DSteven%2BH.%26date%3D2020%26date%3D2020%26date%3D2020%26date%3D08072020%26date%3D18092020%26date%3D04092020%26volume%3D142%26issue%3D39%26spage%3D16766%26epage%3D16775" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">Mahesh
M. Parsutkar, Vinayak Vishnu Pagar, <span class="NLM_string-name hlFld-ContribAuthor">T. V. RajanBabu</span>. </span><span class="cited-content_cbyCitation_article-title">Catalytic Enantioselective Synthesis of Cyclobutenes from Alkynes and Alkenyl Derivatives. </span><span class="cited-content_cbyCitation_journal-name">Journal of the American Chemical Society</span><span> <strong>2019,</strong> <em>141 </em>
                                    (38)
                                     , 15367-15377. <a href="https://doi.org/10.1021/jacs.9b07885" title="DOI URL">https://doi.org/10.1021/jacs.9b07885</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/jacs.9b07885&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Fjacs.9b07885%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520the%2520American%2520Chemical%2520Society%26atitle%3DCatalytic%252BEnantioselective%252BSynthesis%252Bof%252BCyclobutenes%252Bfrom%252BAlkynes%252Band%252BAlkenyl%252BDerivatives%26aulast%3DParsutkar%26aufirst%3DMahesh%2BM.%26date%3D2019%26date%3D2019%26date%3D2019%26date%3D23072019%26date%3D12092019%26date%3D02092019%26volume%3D141%26issue%3D38%26spage%3D15367%26epage%3D15377" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">Ramakrishna Nirogi, Anil Shinde, Abdul Rasheed Mohammed, Rajesh Kumar Badange, Veena Reballi, Thrinath Reddy Bandyala, Sangram Keshari Saraf, Kumar Bojja, Sravanthi Manchineella, Pramod Kumar Achanta, Kiran Kumar Kandukuri, Ramkumar Subramanian, Vijay Benade, Raghava Choudary Palacharla, Pradeep Jayarajan, Santoshkumar Pandey, <span class="NLM_string-name hlFld-ContribAuthor">Venkat Jasti</span>. </span><span class="cited-content_cbyCitation_article-title">Discovery and Development of N-[4-(1-Cyclobutylpiperidin-4-yloxy)phenyl]-2-(morpholin-4-yl)acetamide Dihydrochloride (SUVN-G3031): A Novel, Potent, Selective, and Orally Active Histamine H3 Receptor Inverse Agonist with Robust Wake-Promoting Activity. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2019,</strong> <em>62 </em>
                                    (3)
                                     , 1203-1217. <a href="https://doi.org/10.1021/acs.jmedchem.8b01280" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.8b01280</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.8b01280&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jmedchem.8b01280%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DDiscovery%252Band%252BDevelopment%252Bof%252BN-%25255B4-%2525281-Cyclobutylpiperidin-4-yloxy%252529phenyl%25255D-2-%252528morpholin-4-yl%252529acetamide%252BDihydrochloride%252B%252528SUVN-G3031%252529%25253A%252BA%252BNovel%25252C%252BPotent%25252C%252BSelective%25252C%252Band%252BOrally%252BActive%252BHistamine%252BH3%252BReceptor%252BInverse%252BAgonist%252Bwith%252BRobust%252BWake-Promoting%252BActivity%26aulast%3DNirogi%26aufirst%3DRamakrishna%26date%3D2019%26date%3D2019%26date%3D2018%26date%3D13082018%26date%3D25012019%26date%3D10012019%26volume%3D62%26issue%3D3%26spage%3D1203%26epage%3D1217" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">Prantik Maity, V. V. Ramana Reddy, Jayaraj Mohan, Satish Korapati, Harishkumar Narayana, Nagesh Cherupally, Sathishkumar Chandrasekaran, Ravikumar Ramachandran, Chris Sfouggatakis, Martin D. Eastgate, Eric M. Simmons, <span class="NLM_string-name hlFld-ContribAuthor">Rajappa Vaidyanathan</span>. </span><span class="cited-content_cbyCitation_article-title">Development of a Scalable Synthesis of BMS-978587 Featuring a Stereospecific Suzuki Coupling of a Cyclopropane Carboxylic Acid. </span><span class="cited-content_cbyCitation_journal-name">Organic Process Research & Development</span><span> <strong>2018,</strong> <em>22 </em>
                                    (7)
                                     , 888-897. <a href="https://doi.org/10.1021/acs.oprd.8b00171" title="DOI URL">https://doi.org/10.1021/acs.oprd.8b00171</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.oprd.8b00171&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.oprd.8b00171%26sid%3Dliteratum%253Aachs%26jtitle%3DOrganic%2520Process%2520Research%2520%2526%2520Development%26atitle%3DDevelopment%252Bof%252Ba%252BScalable%252BSynthesis%252Bof%252BBMS-978587%252BFeaturing%252Ba%252BStereospecific%252BSuzuki%252BCoupling%252Bof%252Ba%252BCyclopropane%252BCarboxylic%252BAcid%26aulast%3DMaity%26aufirst%3DPrantik%26date%3D2018%26date%3D2018%26date%3D2018%26date%3D24052018%26date%3D11072018%26volume%3D22%26issue%3D7%26spage%3D888%26epage%3D897" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Travis T.  Wager</span>, <span class="hlFld-ContribAuthor ">Thomas  Chappie</span>, <span class="hlFld-ContribAuthor ">David  Horton</span>, <span class="hlFld-ContribAuthor ">Ramalakshmi Y.  Chandrasekaran</span>, <span class="hlFld-ContribAuthor ">Brian  Samas</span>, <span class="hlFld-ContribAuthor ">Elizabeth R.  Dunn-Sims</span>, <span class="hlFld-ContribAuthor ">Cathleen  Hsu</span>, <span class="hlFld-ContribAuthor ">Nawshaba  Nawreen</span>, <span class="hlFld-ContribAuthor ">Michelle A.  Vanase-Frawley</span>, <span class="hlFld-ContribAuthor ">Rebecca E.  O’Connor</span>, <span class="hlFld-ContribAuthor ">Christopher J.  Schmidt</span>, <span class="hlFld-ContribAuthor ">Keith  Dlugolenski</span>, <span class="hlFld-ContribAuthor ">Nancy C.  Stratman</span>, <span class="hlFld-ContribAuthor ">Mark J.  Majchrzak</span>, <span class="hlFld-ContribAuthor ">Bethany L.  Kormos</span>, <span class="hlFld-ContribAuthor ">David P.  Nguyen</span>, <span class="hlFld-ContribAuthor ">Aarti  Sawant-Basak</span>, and <span class="hlFld-ContribAuthor ">Andy N.  Mead</span>  . </span><span class="cited-content_cbyCitation_article-title">Dopamine D3/D2 Receptor Antagonist PF-4363467 Attenuates Opioid Drug-Seeking Behavior without Concomitant D2 Side Effects. </span><span class="cited-content_cbyCitation_journal-name">ACS Chemical Neuroscience</span><span> <strong>2017,</strong> <em>8 </em>
                                    (1)
                                     , 165-177. <a href="https://doi.org/10.1021/acschemneuro.6b00297" title="DOI URL">https://doi.org/10.1021/acschemneuro.6b00297</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acschemneuro.6b00297&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facschemneuro.6b00297%26sid%3Dliteratum%253Aachs%26jtitle%3DACS%2520Chemical%2520Neuroscience%26atitle%3DDopamine%252BD3%25252FD2%252BReceptor%252BAntagonist%252BPF-4363467%252BAttenuates%252BOpioid%252BDrug-Seeking%252BBehavior%252Bwithout%252BConcomitant%252BD2%252BSide%252BEffects%26aulast%3DWager%26aufirst%3DTravis%2BT.%26date%3D2017%26date%3D2016%26date%3D2016%26date%3D2016%26date%3D08092016%26date%3D07102016%26date%3D21102016%26date%3D18012017%26date%3D07102016%26volume%3D8%26issue%3D1%26spage%3D165%26epage%3D177" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Michael L.  Conner</span> and <span class="hlFld-ContribAuthor ">M. Kevin  Brown</span>  . </span><span class="cited-content_cbyCitation_article-title">Synthesis of 1,3-Substituted Cyclobutanes by Allenoate-Alkene [2 + 2] Cycloaddition. </span><span class="cited-content_cbyCitation_journal-name">The Journal of Organic Chemistry</span><span> <strong>2016,</strong> <em>81 </em>
                                    (17)
                                     , 8050-8060. <a href="https://doi.org/10.1021/acs.joc.6b01446" title="DOI URL">https://doi.org/10.1021/acs.joc.6b01446</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.joc.6b01446&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.joc.6b01446%26sid%3Dliteratum%253Aachs%26jtitle%3DThe%2520Journal%2520of%2520Organic%2520Chemistry%26atitle%3DSynthesis%252Bof%252B1%25252C3-Substituted%252BCyclobutanes%252Bby%252BAllenoate-Alkene%252B%25255B2%252B%25252B%252B2%25255D%252BCycloaddition%26aulast%3DConner%26aufirst%3DMichael%2BL.%26date%3D2016%26date%3D2016%26date%3D2016%26date%3D17062016%26date%3D25082016%26date%3D02092016%26volume%3D81%26issue%3D17%26spage%3D8050%26epage%3D8060" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Martin  Pettersson</span>, <span class="hlFld-ContribAuthor ">Xinjun  Hou</span>, <span class="hlFld-ContribAuthor ">Max  Kuhn</span>, <span class="hlFld-ContribAuthor ">Travis T.  Wager</span>, <span class="hlFld-ContribAuthor ">Gregory W.  Kauffman</span>, and <span class="hlFld-ContribAuthor ">Patrick R.  Verhoest</span>  . </span><span class="cited-content_cbyCitation_article-title">Quantitative Assessment of the Impact of Fluorine Substitution on P-Glycoprotein (P-gp) Mediated Efflux, Permeability, Lipophilicity, and Metabolic Stability. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2016,</strong> <em>59 </em>
                                    (11)
                                     , 5284-5296. <a href="https://doi.org/10.1021/acs.jmedchem.6b00027" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.6b00027</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.6b00027&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jmedchem.6b00027%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DQuantitative%252BAssessment%252Bof%252Bthe%252BImpact%252Bof%252BFluorine%252BSubstitution%252Bon%252BP-Glycoprotein%252B%252528P-gp%252529%252BMediated%252BEfflux%25252C%252BPermeability%25252C%252BLipophilicity%25252C%252Band%252BMetabolic%252BStability%26aulast%3DPettersson%26aufirst%3DMartin%26date%3D2016%26date%3D2016%26date%3D2016%26date%3D07012016%26date%3D26052016%26date%3D09062016%26volume%3D59%26issue%3D11%26spage%3D5284%26epage%3D5296" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Michael A.  Letavic</span>, <span class="hlFld-ContribAuthor ">Leah  Aluisio</span>, <span class="hlFld-ContribAuthor ">Richard  Apodaca</span>, <span class="hlFld-ContribAuthor ">Manoj  Bajpai</span>, <span class="hlFld-ContribAuthor ">Ann J.  Barbier</span>, <span class="hlFld-ContribAuthor ">Anne  Bonneville</span>, <span class="hlFld-ContribAuthor ">Pascal  Bonaventure</span>, <span class="hlFld-ContribAuthor ">Nicholas I.  Carruthers</span>, <span class="hlFld-ContribAuthor ">Christine  Dugovic</span>, <span class="hlFld-ContribAuthor ">Ian C.  Fraser</span>, <span class="hlFld-ContribAuthor ">Michelle L.  Kramer</span>, <span class="hlFld-ContribAuthor ">Brian  Lord</span>, <span class="hlFld-ContribAuthor ">Timothy W.  Lovenberg</span>, <span class="hlFld-ContribAuthor ">Lilian Y.  Li</span>, <span class="hlFld-ContribAuthor ">Kiev S.  Ly</span>, <span class="hlFld-ContribAuthor ">Heather  Mcallister</span>, <span class="hlFld-ContribAuthor ">Neelakandha S.  Mani</span>, <span class="hlFld-ContribAuthor ">Kirsten L.  Morton</span>, <span class="hlFld-ContribAuthor ">Anthony  Ndifor</span>, <span class="hlFld-ContribAuthor ">S. Diane  Nepomuceno</span>, <span class="hlFld-ContribAuthor ">Chennagiri R.  Pandit</span>, <span class="hlFld-ContribAuthor ">Steven B.  Sands</span>, <span class="hlFld-ContribAuthor ">Chandra R.  Shah</span>, <span class="hlFld-ContribAuthor ">Jonathan E.  Shelton</span>, <span class="hlFld-ContribAuthor ">Sandra S.  Snook</span>, <span class="hlFld-ContribAuthor ">Devin M.  Swanson</span>, and <span class="hlFld-ContribAuthor ">Wei  Xiao</span>  . </span><span class="cited-content_cbyCitation_article-title">Novel Benzamide-Based Histamine H3 Receptor Antagonists: The Identification of Two Candidates for Clinical Development. </span><span class="cited-content_cbyCitation_journal-name">ACS Medicinal Chemistry Letters</span><span> <strong>2015,</strong> <em>6 </em>
                                    (4)
                                     , 450-454. <a href="https://doi.org/10.1021/ml5005156" title="DOI URL">https://doi.org/10.1021/ml5005156</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/ml5005156&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Fml5005156%26sid%3Dliteratum%253Aachs%26jtitle%3DACS%2520Medicinal%2520Chemistry%2520Letters%26atitle%3DNovel%252BBenzamide-Based%252BHistamine%252BH3%252BReceptor%252BAntagonists%25253A%252BThe%252BIdentification%252Bof%252BTwo%252BCandidates%252Bfor%252BClinical%252BDevelopment%26aulast%3DLetavic%26aufirst%3DMichael%2BA.%26date%3D2015%26date%3D2015%26date%3D2015%26date%3D2014%26date%3D18122014%26date%3D13032015%26date%3D16032015%26date%3D09042015%26date%3D13032015%26volume%3D6%26issue%3D4%26spage%3D450%26epage%3D454" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Joel M.  Hawkins</span>, <span class="hlFld-ContribAuthor ">Pascal  Dubé</span>, <span class="hlFld-ContribAuthor ">Mark T.  Maloney</span>, <span class="hlFld-ContribAuthor ">Lulin  Wei</span>, <span class="hlFld-ContribAuthor ">Marcus  Ewing</span>, <span class="hlFld-ContribAuthor ">Stephen M.  Chesnut</span>, <span class="hlFld-ContribAuthor ">Joshua R.  Denette</span>, <span class="hlFld-ContribAuthor ">Brett M.  Lillie</span>, and <span class="hlFld-ContribAuthor ">Rajappa  Vaidyanathan</span>  . </span><span class="cited-content_cbyCitation_article-title">Synthesis of an H3 Antagonist via Sequential One-Pot Additions of a Magnesium Ate Complex and an Amine to a 1,4-Ketoester followed by Carbonyl-Directed Fluoride Addition. </span><span class="cited-content_cbyCitation_journal-name">Organic Process Research & Development</span><span> <strong>2012,</strong> <em>16 </em>
                                    (8)
                                     , 1393-1403. <a href="https://doi.org/10.1021/op300093j" title="DOI URL">https://doi.org/10.1021/op300093j</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/op300093j&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Fop300093j%26sid%3Dliteratum%253Aachs%26jtitle%3DOrganic%2520Process%2520Research%2520%2526%2520Development%26atitle%3DSynthesis%252Bof%252Ban%252BH3%252BAntagonist%252Bvia%252BSequential%252BOne-Pot%252BAdditions%252Bof%252Ba%252BMagnesium%252BAte%252BComplex%252Band%252Ban%252BAmine%252Bto%252Ba%252B1%25252C4-Ketoester%252Bfollowed%252Bby%252BCarbonyl-Directed%252BFluoride%252BAddition%26aulast%3DHawkins%26aufirst%3DJoel%2BM.%26date%3D2012%26date%3D2012%26date%3D2012%26date%3D12042012%26date%3D06082012%26date%3D17082012%26volume%3D16%26issue%3D8%26spage%3D1393%26epage%3D1403" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Sean H.  Kennedy</span>, <span class="hlFld-ContribAuthor ">Balu D.  Dherange</span>, <span class="hlFld-ContribAuthor ">Kathleen J.  Berger</span>, <span class="hlFld-ContribAuthor ">Mark D.  Levin</span>. </span><span class="cited-content_cbyCitation_article-title">Skeletal editing through direct nitrogen deletion of secondary amines. </span><span class="cited-content_cbyCitation_journal-name">Nature</span><span> <strong>2021,</strong> <em>593 </em>
                                    (7858)
                                     , 223-227. <a href="https://doi.org/10.1038/s41586-021-03448-9" title="DOI URL">https://doi.org/10.1038/s41586-021-03448-9</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1038/s41586-021-03448-9&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1038%2Fs41586-021-03448-9%26sid%3Dliteratum%253Aachs%26jtitle%3DNature%26atitle%3DSkeletal%252Bediting%252Bthrough%252Bdirect%252Bnitrogen%252Bdeletion%252Bof%252Bsecondary%252Bamines%26aulast%3DKennedy%26aufirst%3DSean%2BH.%26date%3D2021%26date%3D2021%26volume%3D593%26issue%3D7858%26spage%3D223%26epage%3D227" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Rajarshi  Mondal</span>, <span class="hlFld-ContribAuthor ">Mohamed  Agbaria</span>, <span class="hlFld-ContribAuthor ">Zackaria  Nairoukh</span>. </span><span class="cited-content_cbyCitation_article-title">Fluorinated Rings: Conformation and Application. </span><span class="cited-content_cbyCitation_journal-name">Chemistry – A European Journal</span><span> <strong>2021,</strong> <em>10 </em><a href="https://doi.org/10.1002/chem.202005425" title="DOI URL">https://doi.org/10.1002/chem.202005425</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/chem.202005425&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2Fchem.202005425%26sid%3Dliteratum%253Aachs%26jtitle%3DChemistry%2520%25E2%2580%2593%2520A%2520European%2520Journal%26atitle%3DFluorinated%252BRings%25253A%252BConformation%252Band%252BApplication%26aulast%3DMondal%26aufirst%3DRajarshi%26date%3D2021%26date%3D2021%26volume%3D10" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Martins S.  Oderinde</span>, <span class="hlFld-ContribAuthor ">Soomin  Jin</span>, <span class="hlFld-ContribAuthor ">T.G. Murali  Dhar</span>, <span class="hlFld-ContribAuthor ">Nicholas A.  Meanwell</span>, <span class="hlFld-ContribAuthor ">Arvind  Mathur</span>, <span class="hlFld-ContribAuthor ">James  Kempson</span>. </span><span class="cited-content_cbyCitation_article-title">Advances in the synthesis of three-dimensional molecular architectures by dearomatizing photocycloadditions. </span><span class="cited-content_cbyCitation_journal-name">Tetrahedron</span><span> <strong>2021,</strong> <em>26 </em>, 132087. <a href="https://doi.org/10.1016/j.tet.2021.132087" title="DOI URL">https://doi.org/10.1016/j.tet.2021.132087</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.tet.2021.132087&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.tet.2021.132087%26sid%3Dliteratum%253Aachs%26jtitle%3DTetrahedron%26atitle%3DAdvances%252Bin%252Bthe%252Bsynthesis%252Bof%252Bthree-dimensional%252Bmolecular%252Barchitectures%252Bby%252Bdearomatizing%252Bphotocycloadditions%26aulast%3DOderinde%26aufirst%3DMartins%2BS.%26date%3D2021%26volume%3D26%26spage%3D132087" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Hongzhao  Wang</span>, <span class="hlFld-ContribAuthor ">Zijian  Qin</span>, <span class="hlFld-ContribAuthor ">Aixia  Yan</span>. </span><span class="cited-content_cbyCitation_article-title">Classification models and SAR analysis on CysLT1 receptor antagonists using machine learning algorithms. </span><span class="cited-content_cbyCitation_journal-name">Molecular Diversity</span><span> <strong>2021,</strong> <em>69 </em><a href="https://doi.org/10.1007/s11030-020-10165-4" title="DOI URL">https://doi.org/10.1007/s11030-020-10165-4</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1007/s11030-020-10165-4&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1007%2Fs11030-020-10165-4%26sid%3Dliteratum%253Aachs%26jtitle%3DMolecular%2520Diversity%26atitle%3DClassification%252Bmodels%252Band%252BSAR%252Banalysis%252Bon%252BCysLT1%252Breceptor%252Bantagonists%252Busing%252Bmachine%252Blearning%252Balgorithms%26aulast%3DWang%26aufirst%3DHongzhao%26date%3D2021%26date%3D2021%26volume%3D69" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Oleksandr P.  Demchuk</span>, <span class="hlFld-ContribAuthor ">Oleksandr V.  Hryshchuk</span>, <span class="hlFld-ContribAuthor ">Bohdan V.  Vashchenko</span>, <span class="hlFld-ContribAuthor ">Serhii A.  Trofymchuk</span>, <span class="hlFld-ContribAuthor ">Kostiantyn P.  Melnykov</span>, <span class="hlFld-ContribAuthor ">Artem  Skreminskiy</span>, <span class="hlFld-ContribAuthor ">Dmitriy M.  Volochnyuk</span>, <span class="hlFld-ContribAuthor ">Oleksandr O.  Grygorenko</span>. </span><span class="cited-content_cbyCitation_article-title">Fluoroalkyl‐Containing 1,2‐Disubstituted Cyclobutanes: Advanced Building Blocks for Medicinal Chemistry. </span><span class="cited-content_cbyCitation_journal-name">European Journal of Organic Chemistry</span><span> <strong>2021,</strong> <em>2021 </em>
                                    (1)
                                     , 87-95. <a href="https://doi.org/10.1002/ejoc.202001345" title="DOI URL">https://doi.org/10.1002/ejoc.202001345</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/ejoc.202001345&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2Fejoc.202001345%26sid%3Dliteratum%253Aachs%26jtitle%3DEuropean%2520Journal%2520of%2520Organic%2520Chemistry%26atitle%3DFluoroalkyl%2525E2%252580%252590Containing%252B1%25252C2%2525E2%252580%252590Disubstituted%252BCyclobutanes%25253A%252BAdvanced%252BBuilding%252BBlocks%252Bfor%252BMedicinal%252BChemistry%26aulast%3DDemchuk%26aufirst%3DOleksandr%2BP.%26date%3D2021%26date%3D2020%26volume%3D2021%26issue%3D1%26spage%3D87%26epage%3D95" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Joseph  Jankovic</span>, <span class="hlFld-ContribAuthor ">Mark  Hallett</span>, <span class="hlFld-ContribAuthor ">Michael S.  Okun</span>, <span class="hlFld-ContribAuthor ">Cynthia  Comella</span>, <span class="hlFld-ContribAuthor ">Stanley  Fahn</span>, <span class="hlFld-ContribAuthor ">Jennifer  Goldman</span>. </span><span class="cited-content_cbyCitation_article-title">Tics and Tourette syndrome. </span><span class="cited-content_cbyCitation_journal-name"></span><span> <strong>2021,</strong>,, 418-450.e15. <a href="https://doi.org/10.1016/B978-0-323-31071-0.00015-9" title="DOI URL">https://doi.org/10.1016/B978-0-323-31071-0.00015-9</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/B978-0-323-31071-0.00015-9&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2FB978-0-323-31071-0.00015-9%26sid%3Dliteratum%253Aachs%26atitle%3DTics%252Band%252BTourette%252Bsyndrome%26aulast%3DJankovic%26aufirst%3DJoseph%26date%3D2021%26spage%3D418%26epage%3D450.e15%26pub%3DElsevier%26atitle%3DPrinciples%252Band%252BPractice%252Bof%252BMovement%252BDisorders%26date%3D2021%26volume%3D82" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Illia O.  Feskov</span>, <span class="hlFld-ContribAuthor ">Bohdan O.  Golub</span>, <span class="hlFld-ContribAuthor ">Bohdan V.  Vashchenko</span>, <span class="hlFld-ContribAuthor ">Vadym V.  Levterov</span>, <span class="hlFld-ContribAuthor ">Ivan S.  Kondratov</span>, <span class="hlFld-ContribAuthor ">Oleksandr O.  Grygorenko</span>, <span class="hlFld-ContribAuthor ">Günter  Haufe</span>. </span><span class="cited-content_cbyCitation_article-title">GABA Analogues and Related Mono-/Bifunctional Building Blocks Derived from the Fluorocyclobutane Scaffold. </span><span class="cited-content_cbyCitation_journal-name">European Journal of Organic Chemistry</span><span> <strong>2020,</strong> <em>2020 </em>
                                    (30)
                                     , 4755-4767. <a href="https://doi.org/10.1002/ejoc.202000733" title="DOI URL">https://doi.org/10.1002/ejoc.202000733</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/ejoc.202000733&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2Fejoc.202000733%26sid%3Dliteratum%253Aachs%26jtitle%3DEuropean%2520Journal%2520of%2520Organic%2520Chemistry%26atitle%3DGABA%252BAnalogues%252Band%252BRelated%252BMono-%25252FBifunctional%252BBuilding%252BBlocks%252BDerived%252Bfrom%252Bthe%252BFluorocyclobutane%252BScaffold%26aulast%3DFeskov%26aufirst%3DIllia%2BO.%26date%3D2020%26date%3D2020%26volume%3D2020%26issue%3D30%26spage%3D4755%26epage%3D4767" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Guillaume  Ernouf</span>, <span class="hlFld-ContribAuthor ">Egor  Chirkin</span>, <span class="hlFld-ContribAuthor ">Lydia  Rhyman</span>, <span class="hlFld-ContribAuthor ">Ponnadurai  Ramasami</span>, <span class="hlFld-ContribAuthor ">Jean‐Christophe  Cintrat</span>. </span><span class="cited-content_cbyCitation_article-title">Photochemical Strain‐Release‐Driven Cyclobutylation of C(sp
              3
              )‐Centered Radicals. </span><span class="cited-content_cbyCitation_journal-name">Angewandte Chemie</span><span> <strong>2020,</strong> <em>132 </em>
                                    (7)
                                     , 2640-2644. <a href="https://doi.org/10.1002/ange.201908951" title="DOI URL">https://doi.org/10.1002/ange.201908951</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/ange.201908951&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2Fange.201908951%26sid%3Dliteratum%253Aachs%26jtitle%3DAngewandte%2520Chemie%26atitle%3DPhotochemical%252BStrain%2525E2%252580%252590Release%2525E2%252580%252590Driven%252BCyclobutylation%252Bof%252BC%252528sp%252B3%252B%252529%2525E2%252580%252590Centered%252BRadicals%26aulast%3DErnouf%26aufirst%3DGuillaume%26date%3D2020%26date%3D2019%26volume%3D132%26issue%3D7%26spage%3D2640%26epage%3D2644" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Guillaume  Ernouf</span>, <span class="hlFld-ContribAuthor ">Egor  Chirkin</span>, <span class="hlFld-ContribAuthor ">Lydia  Rhyman</span>, <span class="hlFld-ContribAuthor ">Ponnadurai  Ramasami</span>, <span class="hlFld-ContribAuthor ">Jean‐Christophe  Cintrat</span>. </span><span class="cited-content_cbyCitation_article-title">Photochemical Strain‐Release‐Driven Cyclobutylation of C(sp
              3
              )‐Centered Radicals. </span><span class="cited-content_cbyCitation_journal-name">Angewandte Chemie International Edition</span><span> <strong>2020,</strong> <em>59 </em>
                                    (7)
                                     , 2618-2622. <a href="https://doi.org/10.1002/anie.201908951" title="DOI URL">https://doi.org/10.1002/anie.201908951</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/anie.201908951&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2Fanie.201908951%26sid%3Dliteratum%253Aachs%26jtitle%3DAngewandte%2520Chemie%2520International%2520Edition%26atitle%3DPhotochemical%252BStrain%2525E2%252580%252590Release%2525E2%252580%252590Driven%252BCyclobutylation%252Bof%252BC%252528sp%252B3%252B%252529%2525E2%252580%252590Centered%252BRadicals%26aulast%3DErnouf%26aufirst%3DGuillaume%26date%3D2020%26volume%3D59%26issue%3D7%26spage%3D2618%26epage%3D2622" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">C. Rose  Kennedy</span>, <span class="hlFld-ContribAuthor ">Hongyu  Zhong</span>, <span class="hlFld-ContribAuthor ">Matthew V.  Joannou</span>, <span class="hlFld-ContribAuthor ">Paul J.  Chirik</span>. </span><span class="cited-content_cbyCitation_article-title">Pyridine(diimine) Iron Diene Complexes Relevant to Catalytic [2+2]‐Cycloaddition Reactions. </span><span class="cited-content_cbyCitation_journal-name">Advanced Synthesis & Catalysis</span><span> <strong>2020,</strong> <em>362 </em>
                                    (2)
                                     , 404-416. <a href="https://doi.org/10.1002/adsc.201901289" title="DOI URL">https://doi.org/10.1002/adsc.201901289</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/adsc.201901289&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2Fadsc.201901289%26sid%3Dliteratum%253Aachs%26jtitle%3DAdvanced%2520Synthesis%2520%2526%2520Catalysis%26atitle%3DPyridine%252528diimine%252529%252BIron%252BDiene%252BComplexes%252BRelevant%252Bto%252BCatalytic%252B%25255B2%25252B2%25255D%2525E2%252580%252590Cycloaddition%252BReactions%26aulast%3DKennedy%26aufirst%3DC.%2BRose%26date%3D2020%26date%3D2019%26volume%3D362%26issue%3D2%26spage%3D404%26epage%3D416" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Zachary J.  Garlets</span>, <span class="hlFld-ContribAuthor ">Benjamin D.  Wertz</span>, <span class="hlFld-ContribAuthor ">Wenbin  Liu</span>, <span class="hlFld-ContribAuthor ">Eric A.  Voight</span>, <span class="hlFld-ContribAuthor ">Huw M.L.  Davies</span>. </span><span class="cited-content_cbyCitation_article-title">Regio- and Stereoselective Rhodium(II)-Catalyzed C–H Functionalization of Cyclobutanes. </span><span class="cited-content_cbyCitation_journal-name">Chem</span><span> <strong>2020,</strong> <em>6 </em>
                                    (1)
                                     , 304-313. <a href="https://doi.org/10.1016/j.chempr.2019.12.014" title="DOI URL">https://doi.org/10.1016/j.chempr.2019.12.014</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.chempr.2019.12.014&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.chempr.2019.12.014%26sid%3Dliteratum%253Aachs%26jtitle%3DChem%26atitle%3DRegio-%252Band%252BStereoselective%252BRhodium%252528II%252529-Catalyzed%252BC%2525E2%252580%252593H%252BFunctionalization%252Bof%252BCyclobutanes%26aulast%3DGarlets%26aufirst%3DZachary%2BJ.%26date%3D2020%26volume%3D6%26issue%3D1%26spage%3D304%26epage%3D313" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Helen A.  Clement</span>, <span class="hlFld-ContribAuthor ">Michele  Boghi</span>, <span class="hlFld-ContribAuthor ">Rory M.  McDonald</span>, <span class="hlFld-ContribAuthor ">Louise  Bernier</span>, <span class="hlFld-ContribAuthor ">Jotham W.  Coe</span>, <span class="hlFld-ContribAuthor ">William  Farrell</span>, <span class="hlFld-ContribAuthor ">Christopher J.  Helal</span>, <span class="hlFld-ContribAuthor ">Matthew R.  Reese</span>, <span class="hlFld-ContribAuthor ">Neal W.  Sach</span>, <span class="hlFld-ContribAuthor ">Jack C.  Lee</span>, <span class="hlFld-ContribAuthor ">Dennis G.  Hall</span>. </span><span class="cited-content_cbyCitation_article-title">High‐Throughput Ligand Screening Enables the Enantioselective Conjugate Borylation of Cyclobutenones to Access Synthetically Versatile Tertiary Cyclobutylboronates. </span><span class="cited-content_cbyCitation_journal-name">Angewandte Chemie</span><span> <strong>2019,</strong> <em>131 </em>
                                    (51)
                                     , 18576-18580. <a href="https://doi.org/10.1002/ange.201909308" title="DOI URL">https://doi.org/10.1002/ange.201909308</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/ange.201909308&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2Fange.201909308%26sid%3Dliteratum%253Aachs%26jtitle%3DAngewandte%2520Chemie%26atitle%3DHigh%2525E2%252580%252590Throughput%252BLigand%252BScreening%252BEnables%252Bthe%252BEnantioselective%252BConjugate%252BBorylation%252Bof%252BCyclobutenones%252Bto%252BAccess%252BSynthetically%252BVersatile%252BTertiary%252BCyclobutylboronates%26aulast%3DClement%26aufirst%3DHelen%2BA.%26date%3D2019%26date%3D2019%26volume%3D131%26issue%3D51%26spage%3D18576%26epage%3D18580" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Helen A.  Clement</span>, <span class="hlFld-ContribAuthor ">Michele  Boghi</span>, <span class="hlFld-ContribAuthor ">Rory M.  McDonald</span>, <span class="hlFld-ContribAuthor ">Louise  Bernier</span>, <span class="hlFld-ContribAuthor ">Jotham W.  Coe</span>, <span class="hlFld-ContribAuthor ">William  Farrell</span>, <span class="hlFld-ContribAuthor ">Christopher J.  Helal</span>, <span class="hlFld-ContribAuthor ">Matthew R.  Reese</span>, <span class="hlFld-ContribAuthor ">Neal W.  Sach</span>, <span class="hlFld-ContribAuthor ">Jack C.  Lee</span>, <span class="hlFld-ContribAuthor ">Dennis G.  Hall</span>. </span><span class="cited-content_cbyCitation_article-title">High‐Throughput Ligand Screening Enables the Enantioselective Conjugate Borylation of Cyclobutenones to Access Synthetically Versatile Tertiary Cyclobutylboronates. </span><span class="cited-content_cbyCitation_journal-name">Angewandte Chemie International Edition</span><span> <strong>2019,</strong> <em>58 </em>
                                    (51)
                                     , 18405-18409. <a href="https://doi.org/10.1002/anie.201909308" title="DOI URL">https://doi.org/10.1002/anie.201909308</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/anie.201909308&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2Fanie.201909308%26sid%3Dliteratum%253Aachs%26jtitle%3DAngewandte%2520Chemie%2520International%2520Edition%26atitle%3DHigh%2525E2%252580%252590Throughput%252BLigand%252BScreening%252BEnables%252Bthe%252BEnantioselective%252BConjugate%252BBorylation%252Bof%252BCyclobutenones%252Bto%252BAccess%252BSynthetically%252BVersatile%252BTertiary%252BCyclobutylboronates%26aulast%3DClement%26aufirst%3DHelen%2BA.%26date%3D2019%26date%3D2019%26volume%3D58%26issue%3D51%26spage%3D18405%26epage%3D18409" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Nakisa  Ghamari</span>, <span class="hlFld-ContribAuthor ">Omid  Zarei</span>, <span class="hlFld-ContribAuthor ">José-Antonio  Arias-Montaño</span>, <span class="hlFld-ContribAuthor ">David  Reiner</span>, <span class="hlFld-ContribAuthor ">Siavoush  Dastmalchi</span>, <span class="hlFld-ContribAuthor ">Holger  Stark</span>, <span class="hlFld-ContribAuthor ">Maryam  Hamzeh-Mivehroud</span>. </span><span class="cited-content_cbyCitation_article-title">Histamine H3 receptor antagonists/inverse agonists: Where do they go?. </span><span class="cited-content_cbyCitation_journal-name">Pharmacology & Therapeutics</span><span> <strong>2019,</strong> <em>200 </em>, 69-84. <a href="https://doi.org/10.1016/j.pharmthera.2019.04.007" title="DOI URL">https://doi.org/10.1016/j.pharmthera.2019.04.007</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.pharmthera.2019.04.007&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.pharmthera.2019.04.007%26sid%3Dliteratum%253Aachs%26jtitle%3DPharmacology%2520%2526%2520Therapeutics%26atitle%3DHistamine%252BH3%252Breceptor%252Bantagonists%25252Finverse%252Bagonists%25253A%252BWhere%252Bdo%252Bthey%252Bgo%25253F%26aulast%3DGhamari%26aufirst%3DNakisa%26date%3D2019%26volume%3D200%26spage%3D69%26epage%3D84" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">David  Schaller</span>, <span class="hlFld-ContribAuthor ">Stefanie  Hagenow</span>, <span class="hlFld-ContribAuthor ">Holger  Stark</span>, <span class="hlFld-ContribAuthor ">Gerhard  Wolber</span>, . </span><span class="cited-content_cbyCitation_article-title">Ligand-guided homology modeling drives identification of novel histamine H3 receptor ligands. </span><span class="cited-content_cbyCitation_journal-name">PLOS ONE</span><span> <strong>2019,</strong> <em>14 </em>
                                    (6)
                                     , e0218820. <a href="https://doi.org/10.1371/journal.pone.0218820" title="DOI URL">https://doi.org/10.1371/journal.pone.0218820</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1371/journal.pone.0218820&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1371%2Fjournal.pone.0218820%26sid%3Dliteratum%253Aachs%26jtitle%3DPLOS%2520ONE%26atitle%3DLigand-guided%252Bhomology%252Bmodeling%252Bdrives%252Bidentification%252Bof%252Bnovel%252Bhistamine%252BH3%252Breceptor%252Bligands%26aulast%3DSchaller%26aufirst%3DDavid%26date%3D2019%26date%3D2019%26volume%3D14%26issue%3D6%26spage%3De0218820" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Toshiro  Yamashita</span>, <span class="hlFld-ContribAuthor ">Hitoaki  Nishikawa</span>, <span class="hlFld-ContribAuthor ">Tetsuji  Kawamoto</span>. </span><span class="cited-content_cbyCitation_article-title">Scale-up synthesis of a deuterium-labeled cis-cyclobutane-1,3-Dicarboxylic acid derivative using continuous photo flow chemistry. </span><span class="cited-content_cbyCitation_journal-name">Tetrahedron</span><span> <strong>2019,</strong> <em>75 </em>
                                    (5)
                                     , 617-623. <a href="https://doi.org/10.1016/j.tet.2018.12.037" title="DOI URL">https://doi.org/10.1016/j.tet.2018.12.037</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.tet.2018.12.037&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.tet.2018.12.037%26sid%3Dliteratum%253Aachs%26jtitle%3DTetrahedron%26atitle%3DScale-up%252Bsynthesis%252Bof%252Ba%252Bdeuterium-labeled%252Bcis-cyclobutane-1%25252C3-Dicarboxylic%252Bacid%252Bderivative%252Busing%252Bcontinuous%252Bphoto%252Bflow%252Bchemistry%26aulast%3DYamashita%26aufirst%3DToshiro%26date%3D2019%26volume%3D75%26issue%3D5%26spage%3D617%26epage%3D623" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Vinayak Vishnu  Pagar</span>, <span class="hlFld-ContribAuthor ">T. V.  RajanBabu</span>. </span><span class="cited-content_cbyCitation_article-title">Tandem catalysis for asymmetric coupling of ethylene and enynes to functionalized cyclobutanes. </span><span class="cited-content_cbyCitation_journal-name">Science</span><span> <strong>2018,</strong> <em>361 </em>
                                    (6397)
                                     , 68-72. <a href="https://doi.org/10.1126/science.aat6205" title="DOI URL">https://doi.org/10.1126/science.aat6205</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1126/science.aat6205&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1126%2Fscience.aat6205%26sid%3Dliteratum%253Aachs%26jtitle%3DScience%26atitle%3DTandem%252Bcatalysis%252Bfor%252Basymmetric%252Bcoupling%252Bof%252Bethylene%252Band%252Benynes%252Bto%252Bfunctionalized%252Bcyclobutanes%26aulast%3DPagar%26aufirst%3DVinayak%2BVishnu%26date%3D2018%26date%3D2018%26volume%3D361%26issue%3D6397%26spage%3D68%26epage%3D72" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Jian  Xin</span>, <span class="hlFld-ContribAuthor ">Min  Hu</span>, <span class="hlFld-ContribAuthor ">Qian  Liu</span>, <span class="hlFld-ContribAuthor ">Tian Tai  Zhang</span>, <span class="hlFld-ContribAuthor ">Dong Mei  Wang</span>, <span class="hlFld-ContribAuthor ">Song  Wu</span>. </span><span class="cited-content_cbyCitation_article-title">Design, synthesis, and biological evaluation of novel iso-flavones derivatives as H
              3
              R antagonists. </span><span class="cited-content_cbyCitation_journal-name">Journal of Enzyme Inhibition and Medicinal Chemistry</span><span> <strong>2018,</strong> <em>33 </em>
                                    (1)
                                     , 1545-1553. <a href="https://doi.org/10.1080/14756366.2018.1509212" title="DOI URL">https://doi.org/10.1080/14756366.2018.1509212</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1080/14756366.2018.1509212&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1080%2F14756366.2018.1509212%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Enzyme%2520Inhibition%2520and%2520Medicinal%2520Chemistry%26atitle%3DDesign%25252C%252Bsynthesis%25252C%252Band%252Bbiological%252Bevaluation%252Bof%252Bnovel%252Biso-flavones%252Bderivatives%252Bas%252BH%252B3%252BR%252Bantagonists%26aulast%3DXin%26aufirst%3DJian%26date%3D2018%26date%3D2018%26volume%3D33%26issue%3D1%26spage%3D1545%26epage%3D1553" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Gang  Wen</span>, <span class="hlFld-ContribAuthor ">Qian  Liu</span>, <span class="hlFld-ContribAuthor ">Huabin  Hu</span>, <span class="hlFld-ContribAuthor ">Dongmei  Wang</span>, <span class="hlFld-ContribAuthor ">Song  Wu</span>. </span><span class="cited-content_cbyCitation_article-title">Design, synthesis, biological evaluation, and molecular docking of novel flavones as H
              3
              R inhibitors. </span><span class="cited-content_cbyCitation_journal-name">Chemical Biology & Drug Design</span><span> <strong>2017,</strong> <em>90 </em>
                                    (4)
                                     , 580-589. <a href="https://doi.org/10.1111/cbdd.12981" title="DOI URL">https://doi.org/10.1111/cbdd.12981</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1111/cbdd.12981&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1111%2Fcbdd.12981%26sid%3Dliteratum%253Aachs%26jtitle%3DChemical%2520Biology%2520%2526%2520Drug%2520Design%26atitle%3DDesign%25252C%252Bsynthesis%25252C%252Bbiological%252Bevaluation%25252C%252Band%252Bmolecular%252Bdocking%252Bof%252Bnovel%252Bflavones%252Bas%252BH%252B3%252BR%252Binhibitors%26aulast%3DWen%26aufirst%3DGang%26date%3D2017%26date%3D2017%26volume%3D90%26issue%3D4%26spage%3D580%26epage%3D589" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Eleni  Pontiki</span>, <span class="hlFld-ContribAuthor ">Dimitra  Hadjipavlou-Litina</span>. </span><span class="cited-content_cbyCitation_article-title">QSAR models on H
              4
              receptor antagonists associated with inflammation and anaphylaxis. </span><span class="cited-content_cbyCitation_journal-name">Journal of Biomolecular Structure and Dynamics</span><span> <strong>2017,</strong> <em>35 </em>
                                    (5)
                                     , 968-1005. <a href="https://doi.org/10.1080/07391102.2016.1166986" title="DOI URL">https://doi.org/10.1080/07391102.2016.1166986</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1080/07391102.2016.1166986&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1080%2F07391102.2016.1166986%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Biomolecular%2520Structure%2520and%2520Dynamics%26atitle%3DQSAR%252Bmodels%252Bon%252BH%252B4%252Breceptor%252Bantagonists%252Bassociated%252Bwith%252Binflammation%252Band%252Banaphylaxis%26aulast%3DPontiki%26aufirst%3DEleni%26date%3D2017%26date%3D2016%26volume%3D35%26issue%3D5%26spage%3D968%26epage%3D1005" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Jean-Dominique  Gallezot</span>, <span class="hlFld-ContribAuthor ">Beata  Planeta</span>, <span class="hlFld-ContribAuthor ">Nabeel  Nabulsi</span>, <span class="hlFld-ContribAuthor ">Donna  Palumbo</span>, <span class="hlFld-ContribAuthor ">Xiaoxi  Li</span>, <span class="hlFld-ContribAuthor ">Jing  Liu</span>, <span class="hlFld-ContribAuthor ">Carolyn  Rowinski</span>, <span class="hlFld-ContribAuthor ">Kristin  Chidsey</span>, <span class="hlFld-ContribAuthor ">David  Labaree</span>, <span class="hlFld-ContribAuthor ">Jim  Ropchan</span>, <span class="hlFld-ContribAuthor ">Shu-Fei  Lin</span>, <span class="hlFld-ContribAuthor ">Aarti  Sawant-Basak</span>, <span class="hlFld-ContribAuthor ">Timothy J  McCarthy</span>, <span class="hlFld-ContribAuthor ">Anne W  Schmidt</span>, <span class="hlFld-ContribAuthor ">Yiyun  Huang</span>, <span class="hlFld-ContribAuthor ">Richard E  Carson</span>. </span><span class="cited-content_cbyCitation_article-title">Determination of receptor occupancy in the presence of mass dose: [
              11
              C]GSK189254 PET imaging of histamine H
              3
              receptor occupancy by PF-03654746. </span><span class="cited-content_cbyCitation_journal-name">Journal of Cerebral Blood Flow & Metabolism</span><span> <strong>2017,</strong> <em>37 </em>
                                    (3)
                                     , 1095-1107. <a href="https://doi.org/10.1177/0271678X16650697" title="DOI URL">https://doi.org/10.1177/0271678X16650697</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1177/0271678X16650697&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1177%2F0271678X16650697%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Cerebral%2520Blood%2520Flow%2520%2526%2520Metabolism%26atitle%3DDetermination%252Bof%252Breceptor%252Boccupancy%252Bin%252Bthe%252Bpresence%252Bof%252Bmass%252Bdose%25253A%252B%25255B%252B11%252BC%25255DGSK189254%252BPET%252Bimaging%252Bof%252Bhistamine%252BH%252B3%252Breceptor%252Boccupancy%252Bby%252BPF-03654746%26aulast%3DGallezot%26aufirst%3DJean-Dominique%26date%3D2017%26date%3D2016%26volume%3D37%26issue%3D3%26spage%3D1095%26epage%3D1107" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Aarti  Sawant-Basak</span>, <span class="hlFld-ContribAuthor ">Laigao  Chen</span>, <span class="hlFld-ContribAuthor ">Christopher L.  Shaffer</span>, <span class="hlFld-ContribAuthor ">Donna  Palumbo</span>, <span class="hlFld-ContribAuthor ">Anne  Schmidt</span>, <span class="hlFld-ContribAuthor ">Elaine  Tseng</span>, <span class="hlFld-ContribAuthor ">Douglas K.  Spracklin</span>, <span class="hlFld-ContribAuthor ">Jean-Dominique  Gallezot</span>, <span class="hlFld-ContribAuthor ">David  Labaree</span>, <span class="hlFld-ContribAuthor ">Nabeel  Nabulsi</span>, <span class="hlFld-ContribAuthor ">Yiyun  Huang</span>, <span class="hlFld-ContribAuthor ">Richard E.  Carson</span>, <span class="hlFld-ContribAuthor ">Timothy  McCarthy</span>. </span><span class="cited-content_cbyCitation_article-title">Quantitative projection of human brain penetration of the H
              3
              antagonist PF-03654746 by integrating rat-derived brain partitioning and PET receptor occupancy. </span><span class="cited-content_cbyCitation_journal-name">Xenobiotica</span><span> <strong>2017,</strong> <em>47 </em>
                                    (2)
                                     , 119-126. <a href="https://doi.org/10.3109/00498254.2016.1166531" title="DOI URL">https://doi.org/10.3109/00498254.2016.1166531</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.3109/00498254.2016.1166531&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.3109%2F00498254.2016.1166531%26sid%3Dliteratum%253Aachs%26jtitle%3DXenobiotica%26atitle%3DQuantitative%252Bprojection%252Bof%252Bhuman%252Bbrain%252Bpenetration%252Bof%252Bthe%252BH%252B3%252Bantagonist%252BPF-03654746%252Bby%252Bintegrating%252Brat-derived%252Bbrain%252Bpartitioning%252Band%252BPET%252Breceptor%252Boccupancy%26aulast%3DSawant-Basak%26aufirst%3DAarti%26date%3D2017%26date%3D2016%26volume%3D47%26issue%3D2%26spage%3D119%26epage%3D126" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Panayiotis A.  Procopiou</span>, <span class="hlFld-ContribAuthor ">Rachael A.  Ancliff</span>, <span class="hlFld-ContribAuthor ">Paul M.  Gore</span>, <span class="hlFld-ContribAuthor ">Ashley P.  Hancock</span>, <span class="hlFld-ContribAuthor ">Simon T.  Hodgson</span>, <span class="hlFld-ContribAuthor ">Duncan S.  Holmes</span>, <span class="hlFld-ContribAuthor ">Steven P.  Keeling</span>, <span class="hlFld-ContribAuthor ">Brian E.  Looker</span>, <span class="hlFld-ContribAuthor ">Nigel A.  Parr</span>, <span class="hlFld-ContribAuthor ">James E.  Rowedder</span>, <span class="hlFld-ContribAuthor ">Robert J.  Slack</span>. </span><span class="cited-content_cbyCitation_article-title">The discovery of quinoline based single-ligand human H 1 and H 3 receptor antagonists. </span><span class="cited-content_cbyCitation_journal-name">Bioorganic & Medicinal Chemistry Letters</span><span> <strong>2016,</strong> <em>26 </em>
                                    (24)
                                     , 5855-5859. <a href="https://doi.org/10.1016/j.bmcl.2016.11.022" title="DOI URL">https://doi.org/10.1016/j.bmcl.2016.11.022</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bmcl.2016.11.022&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bmcl.2016.11.022%26sid%3Dliteratum%253Aachs%26jtitle%3DBioorganic%2520%2526%2520Medicinal%2520Chemistry%2520Letters%26atitle%3DThe%252Bdiscovery%252Bof%252Bquinoline%252Bbased%252Bsingle-ligand%252Bhuman%252BH%252B1%252Band%252BH%252B3%252Breceptor%252Bantagonists%26aulast%3DProcopiou%26aufirst%3DPanayiotis%2BA.%26date%3D2016%26volume%3D26%26issue%3D24%26spage%3D5855%26epage%3D5859" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Christophe  Genicot</span>, <span class="hlFld-ContribAuthor ">Laurent  Provins</span>. </span><span class="cited-content_cbyCitation_article-title">Lead Generation Paved the Way for the Discovery of a Novel H
              3
              Inverse Agonist Clinical Candidate. </span><span class="cited-content_cbyCitation_journal-name"></span><span> <strong>2016,</strong>,, 513-546. <a href="https://doi.org/10.1002/9783527677047.ch18" title="DOI URL">https://doi.org/10.1002/9783527677047.ch18</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/9783527677047.ch18&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2F9783527677047.ch18%26sid%3Dliteratum%253Aachs%26atitle%3DLead%252BGeneration%252BPaved%252Bthe%252BWay%252Bfor%252Bthe%252BDiscovery%252Bof%252Ba%252BNovel%252BH%252B3%252BInverse%252BAgonist%252BClinical%252BCandidate%26aulast%3DGenicot%26aufirst%3DChristophe%26date%3D2016%26date%3D2016%26spage%3D513%26epage%3D546%26pub%3DWiley%26atitle%3DLead%252BGeneration%26aulast%3DHolenz%26aufirst%3DJ%25C3%25B6rg%26date%3D2016%26date%3D2016%26volume%3D42" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">B.  Sadek</span>, <span class="hlFld-ContribAuthor ">D.  Łażewska</span>, <span class="hlFld-ContribAuthor ">S.  Hagenow</span>, <span class="hlFld-ContribAuthor ">K.  Kieć-Kononowicz</span>, <span class="hlFld-ContribAuthor ">H.  Stark</span>. </span><span class="cited-content_cbyCitation_article-title">Histamine H3R Antagonists: From Scaffold Hopping to Clinical Candidates. </span><span class="cited-content_cbyCitation_journal-name"></span><span> <strong>2016,</strong>,, 109-155. <a href="https://doi.org/10.1007/978-3-319-40308-3_5" title="DOI URL">https://doi.org/10.1007/978-3-319-40308-3_5</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1007/978-3-319-40308-3_5&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1007%2F978-3-319-40308-3_5%26sid%3Dliteratum%253Aachs%26atitle%3DHistamine%252BH3R%252BAntagonists%25253A%252BFrom%252BScaffold%252BHopping%252Bto%252BClinical%252BCandidates%26aulast%3DSadek%26aufirst%3DB.%26date%3D2016%26date%3D2016%26spage%3D109%26epage%3D155%26pub%3DSpringer%2520International%2520Publishing%26atitle%3DHistamine%252BReceptors%26aulast%3DBlandina%26aufirst%3DPatrizio%26date%3D2016%26volume%3D28" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Anton V.  Chernykh</span>, <span class="hlFld-ContribAuthor ">Dmytro S.  Radchenko</span>, <span class="hlFld-ContribAuthor ">Alla V.  Chernykh</span>, <span class="hlFld-ContribAuthor ">Ivan S.  Kondratov</span>, <span class="hlFld-ContribAuthor ">Nataliya A.  Tolmachova</span>, <span class="hlFld-ContribAuthor ">Olexandr P.  Datsenko</span>, <span class="hlFld-ContribAuthor ">Maxim A.  Kurkunov</span>, <span class="hlFld-ContribAuthor ">Sergey X.  Zozulya</span>, <span class="hlFld-ContribAuthor ">Yuri P.  Kheylik</span>, <span class="hlFld-ContribAuthor ">Katharina  Bartels</span>, <span class="hlFld-ContribAuthor ">Constantin G.  Daniliuc</span>, <span class="hlFld-ContribAuthor ">Günter  Haufe</span>. </span><span class="cited-content_cbyCitation_article-title">Synthesis and Physicochemical Properties of 3-Fluorocyclobutylamines. </span><span class="cited-content_cbyCitation_journal-name">European Journal of Organic Chemistry</span><span> <strong>2015,</strong> <em>2015 </em>
                                    (29)
                                     , 6466-6471. <a href="https://doi.org/10.1002/ejoc.201500746" title="DOI URL">https://doi.org/10.1002/ejoc.201500746</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/ejoc.201500746&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2Fejoc.201500746%26sid%3Dliteratum%253Aachs%26jtitle%3DEuropean%2520Journal%2520of%2520Organic%2520Chemistry%26atitle%3DSynthesis%252Band%252BPhysicochemical%252BProperties%252Bof%252B3-Fluorocyclobutylamines%26aulast%3DChernykh%26aufirst%3DAnton%2BV.%26date%3D2015%26date%3D2015%26volume%3D2015%26issue%3D29%26spage%3D6466%26epage%3D6471" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Michelle L.  North</span>, <span class="hlFld-ContribAuthor ">Mena  Soliman</span>, <span class="hlFld-ContribAuthor ">Terry  Walker</span>, <span class="hlFld-ContribAuthor ">Lisa M.  Steacy</span>, <span class="hlFld-ContribAuthor ">Anne K.  Ellis</span>. </span><span class="cited-content_cbyCitation_article-title">Controlled Allergen Challenge Facilities and Their Unique Contributions to Allergic Rhinitis Research. </span><span class="cited-content_cbyCitation_journal-name">Current Allergy and Asthma Reports</span><span> <strong>2015,</strong> <em>15 </em>
                                    (4)
                                     <a href="https://doi.org/10.1007/s11882-015-0514-4" title="DOI URL">https://doi.org/10.1007/s11882-015-0514-4</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1007/s11882-015-0514-4&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1007%2Fs11882-015-0514-4%26sid%3Dliteratum%253Aachs%26jtitle%3DCurrent%2520Allergy%2520and%2520Asthma%2520Reports%26atitle%3DControlled%252BAllergen%252BChallenge%252BFacilities%252Band%252BTheir%252BUnique%252BContributions%252Bto%252BAllergic%252BRhinitis%252BResearch%26aulast%3DNorth%26aufirst%3DMichelle%2BL.%26date%3D2015%26date%3D2015%26volume%3D15%26issue%3D4" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Lara  Campana</span>, <span class="hlFld-ContribAuthor ">John  Iredale</span>. </span><span class="cited-content_cbyCitation_article-title">Matrix Metalloproteinases and Their Inhibitors. </span><span class="cited-content_cbyCitation_journal-name"></span><span> <strong>2015,</strong>,, 107-124. <a href="https://doi.org/10.1016/B978-0-12-800134-9.00007-5" title="DOI URL">https://doi.org/10.1016/B978-0-12-800134-9.00007-5</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/B978-0-12-800134-9.00007-5&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2FB978-0-12-800134-9.00007-5%26sid%3Dliteratum%253Aachs%26atitle%3DMatrix%252BMetalloproteinases%252Band%252BTheir%252BInhibitors%26aulast%3DCampana%26aufirst%3DLara%26date%3D2015%26spage%3D107%26epage%3D124%26pub%3DElsevier%26atitle%3DStellate%252BCells%252Bin%252BHealth%252Band%252BDisease%26date%3D2015%26volume%3D1832" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Katarina  Nikolic</span>, <span class="hlFld-ContribAuthor ">Slavica  Filipic</span>, <span class="hlFld-ContribAuthor ">Danica  Agbaba</span>, <span class="hlFld-ContribAuthor ">Holger  Stark</span>. </span><span class="cited-content_cbyCitation_article-title">Procognitive Properties of Drugs with Single and Multitargeting H
              3
              Receptor Antagonist Activities. </span><span class="cited-content_cbyCitation_journal-name">CNS Neuroscience & Therapeutics</span><span> <strong>2014,</strong> <em>20 </em>
                                    (7)
                                     , 613-623. <a href="https://doi.org/10.1111/cns.12279" title="DOI URL">https://doi.org/10.1111/cns.12279</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1111/cns.12279&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1111%2Fcns.12279%26sid%3Dliteratum%253Aachs%26jtitle%3DCNS%2520Neuroscience%2520%2526%2520Therapeutics%26atitle%3DProcognitive%252BProperties%252Bof%252BDrugs%252Bwith%252BSingle%252Band%252BMultitargeting%252BH%252B3%252BReceptor%252BAntagonist%252BActivities%26aulast%3DNikolic%26aufirst%3DKatarina%26date%3D2014%26date%3D2014%26volume%3D20%26issue%3D7%26spage%3D613%26epage%3D623" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Dorota  Łażewska</span>, <span class="hlFld-ContribAuthor ">Katarzyna  Kieć-Kononowicz</span>. </span><span class="cited-content_cbyCitation_article-title">New developments around histamine H
              3
              receptor antagonists/inverse agonists: a patent review (2010 – present). </span><span class="cited-content_cbyCitation_journal-name">Expert Opinion on Therapeutic Patents</span><span> <strong>2014,</strong> <em>24 </em>
                                    (1)
                                     , 89-111. <a href="https://doi.org/10.1517/13543776.2014.848197" title="DOI URL">https://doi.org/10.1517/13543776.2014.848197</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1517/13543776.2014.848197&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1517%2F13543776.2014.848197%26sid%3Dliteratum%253Aachs%26jtitle%3DExpert%2520Opinion%2520on%2520Therapeutic%2520Patents%26atitle%3DNew%252Bdevelopments%252Baround%252Bhistamine%252BH%252B3%252Breceptor%252Bantagonists%25252Finverse%252Bagonists%25253A%252Ba%252Bpatent%252Breview%252B%2525282010%252B%2525E2%252580%252593%252Bpresent%252529%26aulast%3D%25C5%2581a%25C5%25BCewska%26aufirst%3DDorota%26date%3D2014%26date%3D2013%26volume%3D24%26issue%3D1%26spage%3D89%26epage%3D111" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Zhongli  Gao</span>, <span class="hlFld-ContribAuthor ">William J.  Hurst</span>, <span class="hlFld-ContribAuthor ">Werngard  Czechtizky</span>, <span class="hlFld-ContribAuthor ">Daniel  Hall</span>, <span class="hlFld-ContribAuthor ">Nicolas  Moindrot</span>, <span class="hlFld-ContribAuthor ">Raisa  Nagorny</span>, <span class="hlFld-ContribAuthor ">Philippe  Pichat</span>, <span class="hlFld-ContribAuthor ">David  Stefany</span>, <span class="hlFld-ContribAuthor ">James A.  Hendrix</span>, <span class="hlFld-ContribAuthor ">Pascal G.  George</span>. </span><span class="cited-content_cbyCitation_article-title">Identification and profiling of 3,5-dimethyl-isoxazole-4-carboxylic acid [2-methyl-4-((2S,3′S)-2-methyl-[1,3′]bipyrrolidinyl-1′-yl)phenyl] amide as histamine H3 receptor antagonist for the treatment of depression. </span><span class="cited-content_cbyCitation_journal-name">Bioorganic & Medicinal Chemistry Letters</span><span> <strong>2013,</strong> <em>23 </em>
                                    (23)
                                     , 6269-6273. <a href="https://doi.org/10.1016/j.bmcl.2013.09.081" title="DOI URL">https://doi.org/10.1016/j.bmcl.2013.09.081</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bmcl.2013.09.081&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bmcl.2013.09.081%26sid%3Dliteratum%253Aachs%26jtitle%3DBioorganic%2520%2526%2520Medicinal%2520Chemistry%2520Letters%26atitle%3DIdentification%252Band%252Bprofiling%252Bof%252B3%25252C5-dimethyl-isoxazole-4-carboxylic%252Bacid%252B%25255B2-methyl-4-%252528%2525282S%25252C3%2525E2%252580%2525B2S%252529-2-methyl-%25255B1%25252C3%2525E2%252580%2525B2%25255Dbipyrrolidinyl-1%2525E2%252580%2525B2-yl%252529phenyl%25255D%252Bamide%252Bas%252Bhistamine%252BH3%252Breceptor%252Bantagonist%252Bfor%252Bthe%252Btreatment%252Bof%252Bdepression%26aulast%3DGao%26aufirst%3DZhongli%26date%3D2013%26volume%3D23%26issue%3D23%26spage%3D6269%26epage%3D6273" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">David M.  Wilson</span>, <span class="hlFld-ContribAuthor ">James  Apps</span>, <span class="hlFld-ContribAuthor ">Nicholas  Bailey</span>, <span class="hlFld-ContribAuthor ">Mark J.  Bamford</span>, <span class="hlFld-ContribAuthor ">Isabel J.  Beresford</span>, <span class="hlFld-ContribAuthor ">Michael A.  Briggs</span>, <span class="hlFld-ContribAuthor ">Andrew R.  Calver</span>, <span class="hlFld-ContribAuthor ">Barry  Crook</span>, <span class="hlFld-ContribAuthor ">Robert P.  Davis</span>, <span class="hlFld-ContribAuthor ">Susannah  Davis</span>, <span class="hlFld-ContribAuthor ">David K.  Dean</span>, <span class="hlFld-ContribAuthor ">Leanne  Harris</span>, <span class="hlFld-ContribAuthor ">Tom D.  Heightman</span>, <span class="hlFld-ContribAuthor ">Terry  Panchal</span>, <span class="hlFld-ContribAuthor ">Christopher A.  Parr</span>, <span class="hlFld-ContribAuthor ">Nigel  Quashie</span>, <span class="hlFld-ContribAuthor ">Jon G.A.  Steadman</span>, <span class="hlFld-ContribAuthor ">Joanne  Schogger</span>, <span class="hlFld-ContribAuthor ">Sanjeet S.  Sehmi</span>, <span class="hlFld-ContribAuthor ">Tania O.  Stean</span>, <span class="hlFld-ContribAuthor ">Andrew K.  Takle</span>, <span class="hlFld-ContribAuthor ">Brenda K.  Trail</span>, <span class="hlFld-ContribAuthor ">Trevor  White</span>, <span class="hlFld-ContribAuthor ">Jason  Witherington</span>, <span class="hlFld-ContribAuthor ">Angela  Worby</span>, <span class="hlFld-ContribAuthor ">Andrew D.  Medhurst</span>. </span><span class="cited-content_cbyCitation_article-title">The discovery of the benzazepine class of histamine H3 receptor antagonists. </span><span class="cited-content_cbyCitation_journal-name">Bioorganic & Medicinal Chemistry Letters</span><span> <strong>2013,</strong> <em>23 </em>
                                    (24)
                                     , 6897-6901. <a href="https://doi.org/10.1016/j.bmcl.2013.09.089" title="DOI URL">https://doi.org/10.1016/j.bmcl.2013.09.089</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bmcl.2013.09.089&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bmcl.2013.09.089%26sid%3Dliteratum%253Aachs%26jtitle%3DBioorganic%2520%2526%2520Medicinal%2520Chemistry%2520Letters%26atitle%3DThe%252Bdiscovery%252Bof%252Bthe%252Bbenzazepine%252Bclass%252Bof%252Bhistamine%252BH3%252Breceptor%252Bantagonists%26aulast%3DWilson%26aufirst%3DDavid%2BM.%26date%3D2013%26volume%3D23%26issue%3D24%26spage%3D6897%26epage%3D6901" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">David M.  Wilson</span>, <span class="hlFld-ContribAuthor ">James  Apps</span>, <span class="hlFld-ContribAuthor ">Nicholas  Bailey</span>, <span class="hlFld-ContribAuthor ">Mark J.  Bamford</span>, <span class="hlFld-ContribAuthor ">Isabel J.  Beresford</span>, <span class="hlFld-ContribAuthor ">Kim  Brackenborough</span>, <span class="hlFld-ContribAuthor ">Michael A.  Briggs</span>, <span class="hlFld-ContribAuthor ">Stephen  Brough</span>, <span class="hlFld-ContribAuthor ">Andrew R.  Calver</span>, <span class="hlFld-ContribAuthor ">Barry  Crook</span>, <span class="hlFld-ContribAuthor ">Rebecca K.  Davis</span>, <span class="hlFld-ContribAuthor ">Robert P.  Davis</span>, <span class="hlFld-ContribAuthor ">Susannah  Davis</span>, <span class="hlFld-ContribAuthor ">David K.  Dean</span>, <span class="hlFld-ContribAuthor ">Leanne  Harris</span>, <span class="hlFld-ContribAuthor ">Teresa  Heslop</span>, <span class="hlFld-ContribAuthor ">Vicky  Holland</span>, <span class="hlFld-ContribAuthor ">Phillip  Jeffrey</span>, <span class="hlFld-ContribAuthor ">Terrance A.  Panchal</span>, <span class="hlFld-ContribAuthor ">Christopher A.  Parr</span>, <span class="hlFld-ContribAuthor ">Nigel  Quashie</span>, <span class="hlFld-ContribAuthor ">Joanne  Schogger</span>, <span class="hlFld-ContribAuthor ">Sanjeet S.  Sehmi</span>, <span class="hlFld-ContribAuthor ">Tania O.  Stean</span>, <span class="hlFld-ContribAuthor ">Jon G.A.  Steadman</span>, <span class="hlFld-ContribAuthor ">Brenda  Trail</span>, <span class="hlFld-ContribAuthor ">Jeffrey  Wald</span>, <span class="hlFld-ContribAuthor ">Angela  Worby</span>, <span class="hlFld-ContribAuthor ">Andrew K.  Takle</span>, <span class="hlFld-ContribAuthor ">Jason  Witherington</span>, <span class="hlFld-ContribAuthor ">Andrew D.  Medhurst</span>. </span><span class="cited-content_cbyCitation_article-title">Identification of clinical candidates from the benzazepine class of histamine H3 receptor antagonists. </span><span class="cited-content_cbyCitation_journal-name">Bioorganic & Medicinal Chemistry Letters</span><span> <strong>2013,</strong> <em>23 </em>
                                    (24)
                                     , 6890-6896. <a href="https://doi.org/10.1016/j.bmcl.2013.09.090" title="DOI URL">https://doi.org/10.1016/j.bmcl.2013.09.090</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bmcl.2013.09.090&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bmcl.2013.09.090%26sid%3Dliteratum%253Aachs%26jtitle%3DBioorganic%2520%2526%2520Medicinal%2520Chemistry%2520Letters%26atitle%3DIdentification%252Bof%252Bclinical%252Bcandidates%252Bfrom%252Bthe%252Bbenzazepine%252Bclass%252Bof%252Bhistamine%252BH3%252Breceptor%252Bantagonists%26aulast%3DWilson%26aufirst%3DDavid%2BM.%26date%3D2013%26volume%3D23%26issue%3D24%26spage%3D6890%26epage%3D6896" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Zhongli  Gao</span>, <span class="hlFld-ContribAuthor ">William J.  Hurst</span>, <span class="hlFld-ContribAuthor ">Werngard  Czechtizky</span>, <span class="hlFld-ContribAuthor ">Dominique  Francon</span>, <span class="hlFld-ContribAuthor ">Guy  Griebel</span>, <span class="hlFld-ContribAuthor ">Raisa  Nagorny</span>, <span class="hlFld-ContribAuthor ">Philippe  Pichat</span>, <span class="hlFld-ContribAuthor ">Lothar  Schwink</span>, <span class="hlFld-ContribAuthor ">Siegfried  Stengelin</span>, <span class="hlFld-ContribAuthor ">James A.  Hendrix</span>, <span class="hlFld-ContribAuthor ">Pascal G.  George</span>. </span><span class="cited-content_cbyCitation_article-title">Discovery of a potent, selective, and orally bioavailable histamine H3 receptor antagonist SAR110068 for the treatment of sleep–wake disorders. </span><span class="cited-content_cbyCitation_journal-name">Bioorganic & Medicinal Chemistry Letters</span><span> <strong>2013,</strong> <em>23 </em>
                                    (22)
                                     , 6141-6145. <a href="https://doi.org/10.1016/j.bmcl.2013.09.006" title="DOI URL">https://doi.org/10.1016/j.bmcl.2013.09.006</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bmcl.2013.09.006&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bmcl.2013.09.006%26sid%3Dliteratum%253Aachs%26jtitle%3DBioorganic%2520%2526%2520Medicinal%2520Chemistry%2520Letters%26atitle%3DDiscovery%252Bof%252Ba%252Bpotent%25252C%252Bselective%25252C%252Band%252Borally%252Bbioavailable%252Bhistamine%252BH3%252Breceptor%252Bantagonist%252BSAR110068%252Bfor%252Bthe%252Btreatment%252Bof%252Bsleep%2525E2%252580%252593wake%252Bdisorders%26aulast%3DGao%26aufirst%3DZhongli%26date%3D2013%26volume%3D23%26issue%3D22%26spage%3D6141%26epage%3D6145" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Li  Tang</span>, <span class="hlFld-ContribAuthor ">Liying  Zhao</span>, <span class="hlFld-ContribAuthor ">Lingjuan  Hong</span>, <span class="hlFld-ContribAuthor ">Fenyan  Yang</span>, <span class="hlFld-ContribAuthor ">Rong  Sheng</span>, <span class="hlFld-ContribAuthor ">Jianzhong  Chen</span>, <span class="hlFld-ContribAuthor ">Ying  Shi</span>, <span class="hlFld-ContribAuthor ">Naimin  Zhou</span>, <span class="hlFld-ContribAuthor ">Yongzhou  Hu</span>. </span><span class="cited-content_cbyCitation_article-title">Design and synthesis of novel 3-substituted-indole derivatives as selective H3 receptor antagonists and potent free radical scavengers. </span><span class="cited-content_cbyCitation_journal-name">Bioorganic & Medicinal Chemistry</span><span> <strong>2013,</strong> <em>21 </em>
                                    (19)
                                     , 5936-5944. <a href="https://doi.org/10.1016/j.bmc.2013.07.051" title="DOI URL">https://doi.org/10.1016/j.bmc.2013.07.051</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bmc.2013.07.051&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bmc.2013.07.051%26sid%3Dliteratum%253Aachs%26jtitle%3DBioorganic%2520%2526%2520Medicinal%2520Chemistry%26atitle%3DDesign%252Band%252Bsynthesis%252Bof%252Bnovel%252B3-substituted-indole%252Bderivatives%252Bas%252Bselective%252BH3%252Breceptor%252Bantagonists%252Band%252Bpotent%252Bfree%252Bradical%252Bscavengers%26aulast%3DTang%26aufirst%3DLi%26date%3D2013%26volume%3D21%26issue%3D19%26spage%3D5936%26epage%3D5944" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Nicolas  Levoin</span>, <span class="hlFld-ContribAuthor ">Olivier  Labeeuw</span>, <span class="hlFld-ContribAuthor ">Stéphane  Krief</span>, <span class="hlFld-ContribAuthor ">Thierry  Calmels</span>, <span class="hlFld-ContribAuthor ">Olivia  Poupardin-Olivier</span>, <span class="hlFld-ContribAuthor ">Isabelle  Berrebi-Bertrand</span>, <span class="hlFld-ContribAuthor ">Jeanne-Marie  Lecomte</span>, <span class="hlFld-ContribAuthor ">Jean-Charles  Schwartz</span>, <span class="hlFld-ContribAuthor ">Marc  Capet</span>. </span><span class="cited-content_cbyCitation_article-title">Determination of the binding mode and interacting amino-acids for dibasic H3 receptor antagonists. </span><span class="cited-content_cbyCitation_journal-name">Bioorganic & Medicinal Chemistry</span><span> <strong>2013,</strong> <em>21 </em>
                                    (15)
                                     , 4526-4529. <a href="https://doi.org/10.1016/j.bmc.2013.05.035" title="DOI URL">https://doi.org/10.1016/j.bmc.2013.05.035</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bmc.2013.05.035&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bmc.2013.05.035%26sid%3Dliteratum%253Aachs%26jtitle%3DBioorganic%2520%2526%2520Medicinal%2520Chemistry%26atitle%3DDetermination%252Bof%252Bthe%252Bbinding%252Bmode%252Band%252Binteracting%252Bamino-acids%252Bfor%252Bdibasic%252BH3%252Breceptor%252Bantagonists%26aulast%3DLevoin%26aufirst%3DNicolas%26date%3D2013%26volume%3D21%26issue%3D15%26spage%3D4526%26epage%3D4529" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Zhongli  Gao</span>, <span class="hlFld-ContribAuthor ">William J.  Hurst</span>, <span class="hlFld-ContribAuthor ">Etienne  Guillot</span>, <span class="hlFld-ContribAuthor ">Werngard  Czechtizky</span>, <span class="hlFld-ContribAuthor ">Ulrike  Lukasczyk</span>, <span class="hlFld-ContribAuthor ">Raisa  Nagorny</span>, <span class="hlFld-ContribAuthor ">Marie-Pierre  Pruniaux</span>, <span class="hlFld-ContribAuthor ">Lothar  Schwink</span>, <span class="hlFld-ContribAuthor ">Juan Antonio  Sanchez</span>, <span class="hlFld-ContribAuthor ">Siegfried  Stengelin</span>, <span class="hlFld-ContribAuthor ">Lei  Tang</span>, <span class="hlFld-ContribAuthor ">Irvin  Winkler</span>, <span class="hlFld-ContribAuthor ">James A.  Hendrix</span>, <span class="hlFld-ContribAuthor ">Pascal G.  George</span>. </span><span class="cited-content_cbyCitation_article-title">Discovery of aryl ureas and aryl amides as potent and selective histamine H3 receptor antagonists for the treatment of obesity (Part I). </span><span class="cited-content_cbyCitation_journal-name">Bioorganic & Medicinal Chemistry Letters</span><span> <strong>2013,</strong> <em>23 </em>
                                    (11)
                                     , 3416-3420. <a href="https://doi.org/10.1016/j.bmcl.2013.03.080" title="DOI URL">https://doi.org/10.1016/j.bmcl.2013.03.080</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bmcl.2013.03.080&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bmcl.2013.03.080%26sid%3Dliteratum%253Aachs%26jtitle%3DBioorganic%2520%2526%2520Medicinal%2520Chemistry%2520Letters%26atitle%3DDiscovery%252Bof%252Baryl%252Bureas%252Band%252Baryl%252Bamides%252Bas%252Bpotent%252Band%252Bselective%252Bhistamine%252BH3%252Breceptor%252Bantagonists%252Bfor%252Bthe%252Btreatment%252Bof%252Bobesity%252B%252528Part%252BI%252529%26aulast%3DGao%26aufirst%3DZhongli%26date%3D2013%26volume%3D23%26issue%3D11%26spage%3D3416%26epage%3D3420" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Zhongli  Gao</span>, <span class="hlFld-ContribAuthor ">William J.  Hurst</span>, <span class="hlFld-ContribAuthor ">Etienne  Guillot</span>, <span class="hlFld-ContribAuthor ">Werngard  Czechtizky</span>, <span class="hlFld-ContribAuthor ">Ulrike  Lukasczyk</span>, <span class="hlFld-ContribAuthor ">Raisa  Nagorny</span>, <span class="hlFld-ContribAuthor ">Marie-Pierre  Pruniaux</span>, <span class="hlFld-ContribAuthor ">Lothar  Schwink</span>, <span class="hlFld-ContribAuthor ">Juan Antonio  Sanchez</span>, <span class="hlFld-ContribAuthor ">Siegfried  Stengelin</span>, <span class="hlFld-ContribAuthor ">Lei  Tang</span>, <span class="hlFld-ContribAuthor ">Irvin  Winkler</span>, <span class="hlFld-ContribAuthor ">James A.  Hendrix</span>, <span class="hlFld-ContribAuthor ">Pascal G.  George</span>. </span><span class="cited-content_cbyCitation_article-title">Discovery of aryl ureas and aryl amides as potent and selective histamine H3 receptor antagonists for the treatment of obesity (Part II). </span><span class="cited-content_cbyCitation_journal-name">Bioorganic & Medicinal Chemistry Letters</span><span> <strong>2013,</strong> <em>23 </em>
                                    (11)
                                     , 3421-3426. <a href="https://doi.org/10.1016/j.bmcl.2013.03.081" title="DOI URL">https://doi.org/10.1016/j.bmcl.2013.03.081</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bmcl.2013.03.081&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bmcl.2013.03.081%26sid%3Dliteratum%253Aachs%26jtitle%3DBioorganic%2520%2526%2520Medicinal%2520Chemistry%2520Letters%26atitle%3DDiscovery%252Bof%252Baryl%252Bureas%252Band%252Baryl%252Bamides%252Bas%252Bpotent%252Band%252Bselective%252Bhistamine%252BH3%252Breceptor%252Bantagonists%252Bfor%252Bthe%252Btreatment%252Bof%252Bobesity%252B%252528Part%252BII%252529%26aulast%3DGao%26aufirst%3DZhongli%26date%3D2013%26volume%3D23%26issue%3D11%26spage%3D3421%26epage%3D3426" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Christopher  Southan</span>, <span class="hlFld-ContribAuthor ">Antony J.  Williams</span>, <span class="hlFld-ContribAuthor ">Sean  Ekins</span>. </span><span class="cited-content_cbyCitation_article-title">Challenges and recommendations for obtaining chemical structures of industry-provided repurposing candidates. </span><span class="cited-content_cbyCitation_journal-name">Drug Discovery Today</span><span> <strong>2013,</strong> <em>18 </em>
                                    (1-2)
                                     , 58-70. <a href="https://doi.org/10.1016/j.drudis.2012.11.005" title="DOI URL">https://doi.org/10.1016/j.drudis.2012.11.005</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.drudis.2012.11.005&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.drudis.2012.11.005%26sid%3Dliteratum%253Aachs%26jtitle%3DDrug%2520Discovery%2520Today%26atitle%3DChallenges%252Band%252Brecommendations%252Bfor%252Bobtaining%252Bchemical%252Bstructures%252Bof%252Bindustry-provided%252Brepurposing%252Bcandidates%26aulast%3DSouthan%26aufirst%3DChristopher%26date%3D2013%26volume%3D18%26issue%3D1-2%26spage%3D58%26epage%3D70" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Laurent  Provins</span>, <span class="hlFld-ContribAuthor ">Frédéric  Denonne</span>, <span class="hlFld-ContribAuthor ">Sylvain  Célanire</span>, <span class="hlFld-ContribAuthor ">Bernard  Christophe</span>, <span class="hlFld-ContribAuthor ">Sabine  Defays</span>, <span class="hlFld-ContribAuthor ">Christel  Delaunoy</span>, <span class="hlFld-ContribAuthor ">Marie-Laure  Delporte</span>, <span class="hlFld-ContribAuthor ">Thierry  Demaude</span>, <span class="hlFld-ContribAuthor ">Véronique  Durieu</span>, <span class="hlFld-ContribAuthor ">Michel  Gillard</span>, <span class="hlFld-ContribAuthor ">Delphine  Hubert</span>, <span class="hlFld-ContribAuthor ">Yves  Lamberty</span>, <span class="hlFld-ContribAuthor ">Geneviève  Lorent</span>, <span class="hlFld-ContribAuthor ">Anne  Valade</span>, <span class="hlFld-ContribAuthor ">Alain  Vanbellinghen</span>, <span class="hlFld-ContribAuthor ">Nathalie  Van houtvin</span>. </span><span class="cited-content_cbyCitation_article-title">Lead Optimization of Thiazolo[5,4-
              c
              ]piperidines: 3-Cyclobutoxy Linker as a Key Spacer for H
              3
              R Inverse Agonists. </span><span class="cited-content_cbyCitation_journal-name">ChemMedChem</span><span> <strong>2012,</strong> <em>7 </em>
                                    (12)
                                     , 2087-2092. <a href="https://doi.org/10.1002/cmdc.201200406" title="DOI URL">https://doi.org/10.1002/cmdc.201200406</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/cmdc.201200406&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2Fcmdc.201200406%26sid%3Dliteratum%253Aachs%26jtitle%3DChemMedChem%26atitle%3DLead%252BOptimization%252Bof%252BThiazolo%25255B5%25252C4-%252Bc%252B%25255Dpiperidines%25253A%252B3-Cyclobutoxy%252BLinker%252Bas%252Ba%252BKey%252BSpacer%252Bfor%252BH%252B3%252BR%252BInverse%252BAgonists%26aulast%3DProvins%26aufirst%3DLaurent%26date%3D2012%26date%3D2012%26volume%3D7%26issue%3D12%26spage%3D2087%26epage%3D2092" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Graham  Lunn</span>, <span class="hlFld-ContribAuthor ">Charles E.  Mowbray</span>, <span class="hlFld-ContribAuthor ">Wai L. S.  Liu</span>, <span class="hlFld-ContribAuthor ">Valerie M.  Joynson</span>, <span class="hlFld-ContribAuthor ">Tanya  Hay</span>, <span class="hlFld-ContribAuthor ">Michael  Yeadon</span>. </span><span class="cited-content_cbyCitation_article-title">The discovery and profile of PF-0868087, a CNS-sparing histamine H3 receptor antagonist for the treatment of allergic rhinitis. </span><span class="cited-content_cbyCitation_journal-name">Med. Chem. Commun.</span><span> <strong>2012,</strong> <em>3 </em>
                                    (3)
                                     , 339-343. <a href="https://doi.org/10.1039/C2MD00276K" title="DOI URL">https://doi.org/10.1039/C2MD00276K</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1039/C2MD00276K&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1039%2FC2MD00276K%26sid%3Dliteratum%253Aachs%26jtitle%3DMed.%2520Chem.%2520Commun.%26atitle%3DThe%252Bdiscovery%252Band%252Bprofile%252Bof%252BPF-0868087%25252C%252Ba%252BCNS-sparing%252Bhistamine%252BH3%252Breceptor%252Bantagonist%252Bfor%252Bthe%252Btreatment%252Bof%252Ballergic%252Brhinitis%26aulast%3DLunn%26aufirst%3DGraham%26date%3D2012%26date%3D2012%26volume%3D3%26issue%3D3%26spage%3D339%26epage%3D343" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li></ol></div></div></div></div></div><div class="article_content-right" id="article_content-right" tabindex="0"><div class="tab tab--flex"><div class="tab__close"><i class="icon-close" tabindex="0" aria-label="close the sidebar."></i></div><ul role="tablist" class="rlist tab__nav"><li role="presentation" class="active"><a id="pane-m1con" href="#pane-m1" aria-controls="pane-m1" role="tab" data-toggle="tab" title="Figures" aria-selected="true" class="active empty" aria-label="Figures"><i class="icon-image"></i><span>Figures</span></a></li><li role="presentation"><a id="pane-m2con" href="#pane-m2" aria-controls="pane-m2" role="tab" data-toggle="tab" title="References" aria-selected="false" class="empty"><i class="icon-link"></i><span>References</span></a></li><li role="presentation"><a id="pane-m3con" href="#pane-m3" aria-controls="pane-m3" role="tab" data-toggle="tab" title="Support Info" aria-selected="false" class="empty tab__nav-suppInfo"><i class="icon-supporting-info"></i><span>Support Info</span></a></li></ul><div class="paneContainer"><ul class="rlist tab__content"><li id="pane-m1" aria-labelledby="pane-m1" class="tab__pane tab__pane-figures active empty"><figure data-id="f_tgr1" data-index="0" class="article__inlineFigure"><h2 class="fig-label">Abstract</h2><img class="rightTab-fig internalNav" src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2011/jmcmar.2011.54.issue-21/jm200939b/production/images/medium/jm-2011-00939b_0017.gif" alt="" id="tgr1" /></img><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2011/jmcmar.2011.54.issue-21/jm200939b/production/images/large/jm-2011-00939b_0017.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm200939b&amp;id=f_tgr1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig1" data-index="1" class="article__inlineFigure"><h2 class="fig-label">Figure 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2011/jmcmar.2011.54.issue-21/jm200939b/production/images/medium/jm-2011-00939b_0001.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2011/jmcmar.2011.54.issue-21/jm200939b/production/images/large/jm-2011-00939b_0001.jpeg" id="rightTab-gr1" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 1. (A) Histaminergic neuron. H<sub>3</sub> autoreceptor, endogenous histamine (HA), acts at presynaptic H<sub>3</sub> autoreceptors to reduce HA synthesis and release (a negative feedback loop). (B) Nonhistaminergic neuron. Blockade of the H<sub>3</sub> heteroreceptors should modulate the release of other neurotransmitters.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2011/jmcmar.2011.54.issue-21/jm200939b/production/images/large/jm-2011-00939b_0001.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm200939b&amp;id=fig1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig2" data-index="2" class="article__inlineFigure"><h2 class="fig-label">Figure 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2011/jmcmar.2011.54.issue-21/jm200939b/production/images/medium/jm-2011-00939b_0002.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2011/jmcmar.2011.54.issue-21/jm200939b/production/images/large/jm-2011-00939b_0002.jpeg" id="rightTab-gr2" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 2. H<sub>3</sub> receptor antagonist <b>1</b> emerged from a high-throughput screen (HTS). Subsequent to our identification of HTS hit <b>1</b>, it was reported in the literature by Morini et al.<a onclick="showRef(event, 'ref23'); return false;" href="javascript:void(0);" class="ref ref23">(23)</a></p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2011/jmcmar.2011.54.issue-21/jm200939b/production/images/large/jm-2011-00939b_0002.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm200939b&amp;id=fig2"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig3" data-index="3" class="article__inlineFigure"><h2 class="fig-label">Figure 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2011/jmcmar.2011.54.issue-21/jm200939b/production/images/medium/jm-2011-00939b_0003.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2011/jmcmar.2011.54.issue-21/jm200939b/production/images/large/jm-2011-00939b_0003.jpeg" id="rightTab-gr3" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 3. (A) Isostere analysis of biaryl moiety vs cyclobutylaryl, where the black oval denotes motifs to be compared (isostere): molecular modeling and overlap of biaryl (gray) and cyclobutylaryl (green) compounds. The two nitrogen atoms maintain an approximately equal distance from each other in both molecules. (B) Same molecular overlap matched to surface of DNA structure (in blue, PDB code <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=302D">302D</a>). As designed, the cyclobutyl ring (green) is not a matched fit in the minor groove of DNA because of the bulkier cyclobutyl ring relative to the biaryl motif (gray).</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2011/jmcmar.2011.54.issue-21/jm200939b/production/images/large/jm-2011-00939b_0003.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm200939b&amp;id=fig3"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig4" data-index="4" class="article__inlineFigure"><h2 class="fig-label">Figure 4</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2011/jmcmar.2011.54.issue-21/jm200939b/production/images/medium/jm-2011-00939b_0005.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2011/jmcmar.2011.54.issue-21/jm200939b/production/images/large/jm-2011-00939b_0005.jpeg" id="rightTab-gr4" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 4. (A) Electron microscopy image of rat lung, phospholipidosis “foamy macrophage” induced by <b>2</b> in drug-treated group at 400 mg/kg: multilamellated bodies (∗); <i>N</i> = nucleus; TEM 10000× magnification. (B) Electron microscopy image of drug storage. Cytoarchitecture of dog heart includes the presence of multiple cardiomyocyte vacuoles (CMV, ∗) induced by <b>2</b> within the cytoplasm of cardiomyocytes: ID = intercalated disk of cardiac muscle; G = glycogen; TEM 1000× magnification.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2011/jmcmar.2011.54.issue-21/jm200939b/production/images/large/jm-2011-00939b_0005.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm200939b&amp;id=fig4"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig5" data-index="5" class="article__inlineFigure"><h2 class="fig-label">Figure 5</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2011/jmcmar.2011.54.issue-21/jm200939b/production/images/medium/jm-2011-00939b_0006.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2011/jmcmar.2011.54.issue-21/jm200939b/production/images/large/jm-2011-00939b_0006.jpeg" id="rightTab-gr5" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 5. Development of a design strategy to remove safety liabilities. The two-pronged strategy uses prospective design (focusing on optimal physical properties) and the development and validation of an in vitro screening assay to identify PL liability at an early stage.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2011/jmcmar.2011.54.issue-21/jm200939b/production/images/large/jm-2011-00939b_0006.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm200939b&amp;id=fig5"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig6" data-index="6" class="article__inlineFigure"><h2 class="fig-label">Figure 6</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2011/jmcmar.2011.54.issue-21/jm200939b/production/images/medium/jm-2011-00939b_0012.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2011/jmcmar.2011.54.issue-21/jm200939b/production/images/large/jm-2011-00939b_0012.jpeg" id="rightTab-gr6" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 6. Path to the H<sub>3</sub> receptor antagonist clinical candidates. The red circles represent areas targeted for improvement, and the green circles represent improvements made to that molecule. The in silico phospholipidosis (PL) cutoff of ≤90 and the in vitro PL assay target of ≥100 μM were used to identify compounds with reduced risk of observing PL in vivo. Labels + (finding) and – (no findings) denote risk in in vitro micronucleus (IVMN) or findings for phospholipidosis (PL) and cardiomyocyte vacuoles (CMV) in an exploratory toxicology study (ETS).</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2011/jmcmar.2011.54.issue-21/jm200939b/production/images/large/jm-2011-00939b_0012.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm200939b&amp;id=fig6"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="sch1" data-index="7" class="article__inlineFigure"><h2 class="fig-label">Scheme 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2011/jmcmar.2011.54.issue-21/jm200939b/production/images/medium/jm-2011-00939b_0013.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2011/jmcmar.2011.54.issue-21/jm200939b/production/images/large/jm-2011-00939b_0013.jpeg" id="rightTab-gr7" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 1. Synthesis of Lead Compounds <b>2</b> and <b>3</b><sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2011/jmcmar.2011.54.issue-21/jm200939b/production/images/large/jm-2011-00939b_0013.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm200939b&amp;id=sch1"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions: (a) KO-<i>t</i>-Bu, benzyl bromide, THF, rt (69%); (b) <i>p</i>-TsOH (cat.), acetone/water, 65 °C (58%); (c) (i) 1-(4-bromobenzyl)pyrrolidine, <i>n</i>-BuLi, THF, −78 °C, (ii) <b>8</b>, THF, −78 °C (71%); (d) triethylsilane, TFA, 75 °C (taken on crude); (e) palladium black, 45 psi of H<sub>2</sub>, EtOH, rt (two steps, 79%); (f) <i>p</i>-toluenesulfonyl chloride, pyridine, CH<sub>2</sub>Cl<sub>2</sub>, 0 °C to rt (93%); (g) <b>12a</b>, morpholine, DMA, 120 °C (61%); (h) <b>12b</b>, Mg turnings, MeOH, rt (73%); (i) KO-<i>t</i>-Bu, THF, 2-chloropyrimidine, rt (89%).</p></p></figure><figure data-id="sch2" data-index="8" class="article__inlineFigure"><h2 class="fig-label">Scheme 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2011/jmcmar.2011.54.issue-21/jm200939b/production/images/medium/jm-2011-00939b_0014.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2011/jmcmar.2011.54.issue-21/jm200939b/production/images/large/jm-2011-00939b_0014.jpeg" id="rightTab-gr8" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 2. Synthesis of Lead Compound <b>4</b><sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2011/jmcmar.2011.54.issue-21/jm200939b/production/images/large/jm-2011-00939b_0014.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm200939b&amp;id=sch2"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions: (a) T3P, pyrrolidine, EtOAc, rt (96%); (b) BH<sub>3</sub>·THF, THF, rt (74%); (c) (i) <i>n</i>-BuLi, 3-oxocyclobutanecarboxylic acid, THF, −78 °C to rt; (ii) T3P, CH<sub>3</sub>NH<sub>2</sub>, rt (48%); (d) TFA, DCE, 75 °C (taken on crude); (e) Rh(Ph<sub>3</sub>P)<sub>3</sub>Cl, H<sub>2</sub> (45 psi), EtOH, 60 °C (two steps, 37%); (f) BH<sub>3</sub>·THF, THF, 70 °C (77%); (g) Ac<sub>2</sub>O, Et<sub>3</sub>N, CH<sub>2</sub>Cl<sub>2</sub>, 0 °C (>95%).</p></p></figure><figure data-id="sch3" data-index="9" class="article__inlineFigure"><h2 class="fig-label">Scheme 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2011/jmcmar.2011.54.issue-21/jm200939b/production/images/medium/jm-2011-00939b_0015.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2011/jmcmar.2011.54.issue-21/jm200939b/production/images/large/jm-2011-00939b_0015.jpeg" id="rightTab-gr9" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 3. Synthesis of Compound <b>5</b><sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2011/jmcmar.2011.54.issue-21/jm200939b/production/images/large/jm-2011-00939b_0015.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm200939b&amp;id=sch3"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions: (a) pyrrolidine, CH<sub>3</sub>CN, 10 °C to rt (90%); (b) (i) <i>n</i>-BuLi, 3-oxocyclobutanecarboxylic acid, THF, −78 °C, (ii) ethylmethylamine, T3P, EtOAc, rt (60%); (c) TFA, CH<sub>2</sub>Cl<sub>2</sub>, reflux (taken on crude); (d) 10% Pd/C, H<sub>2</sub> (45 psi), EtOH, rt (two steps, 71%).</p></p></figure><figure data-id="sch4" data-index="10" class="article__inlineFigure"><h2 class="fig-label">Scheme 4</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2011/jmcmar.2011.54.issue-21/jm200939b/production/images/medium/jm-2011-00939b_0016.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2011/jmcmar.2011.54.issue-21/jm200939b/production/images/large/jm-2011-00939b_0016.jpeg" id="rightTab-gr10" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 4. Synthesis of Clinical Candidates <b>6</b> and <b>7</b><sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2011/jmcmar.2011.54.issue-21/jm200939b/production/images/large/jm-2011-00939b_0016.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm200939b&amp;id=sch4"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions: (a) (i) <i>n</i>-BuLi, 3-oxocyclobutanecarboxylic acid, THF, −78 °C, (ii) ethylamine or isobutylamine, T3P, EtOAc, rt (R = ethyl, 49%; R = isobutyl, 63%); (b) BAST, CH<sub>2</sub>Cl<sub>2</sub>, −78 °C (R = ethyl, 58%; R = isobutyl, 85%).</p></p></figure></li><li id="pane-m2" aria-labelledby="pane-m2" class="tab__pane tab__pane-references empty"><div class="refs-header-label"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="rightTab-_i69">References</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_51287" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_51287" class="dropBlock__holder"></div></div></div></div></div><hr /></hr></div><p class="rightTab-references-count">
            This article references 52 other publications.
        </p><ol id="rightTab-references" class="useLabel"><li id="rightTab-ref1"><div class="reference"><strong class="refLabel"><a href="#ref1" class="rightTabRefNumLink">1</a></strong><div class="NLM_citation" id="rightTab-cit1"><span><span class="NLM_contrib-group">Ash, A. S. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schild, H. O.</span><span> </span><span class="NLM_article-title">Receptors mediating some actions of histamine</span> <span class="citation_source-journal">Br. J. Pharmacol. Chemother.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1966</span><span class="NLM_x">, </span> <span class="NLM_volume">27</span><span class="NLM_x">, </span> <span class="NLM_fpage">427</span><span class="NLM_x">–</span> <span class="NLM_lpage">439</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=16&amp;doi=10.1021%2Fjm200939b&amp;key=10.1111%2Fj.1476-5381.1966.tb01674.x" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=8&amp;doi=10.1021%2Fjm200939b&amp;key=4381779" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=32&amp;doi=10.1021%2Fjm200939b&amp;key=1%3ACAS%3A528%3ADyaF28Xks1yit7k%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=27&publication_year=1966&pages=427-439&author=A.+S.+F.+Ashauthor=H.+O.+Schild&title=Receptors+mediating+some+actions+of+histamine"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit1R"><div class="casContent"><span class="casTitleNuber">1</span><div class="casTitle"><span class="NLM_cas:atitle">Receptors mediating some action of histamine</span></div><div class="casAuthors">Ash, A. S. F.; Schild, J. O.</div><div class="citationInfo"><span class="NLM_cas:title">British Journal of Pharmacology and Chemotherapy</span>
        (<span class="NLM_cas:date">1966</span>),
    <span class="NLM_cas:volume">27</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">427-39</span>CODEN:
                <span class="NLM_cas:coden">BJPCAL</span>;
        ISSN:<span class="NLM_cas:issn">0366-0826</span>.
    </div><div class="casAbstract">The characteristics of some histamine receptors were investigated by comparing the relative activities of several histamine analogs.  Three prepns. were used: the perfused rat stomach for gastric secretory action; the isolated rat uterus, stimulated with carbachol, for smooth muscle inhibitory action; and the isolated guinea pig ileum for smooth muscle stimulatory action.  N-Methylhistamine, N-benzylhistamine, N,N-diethylhistamine,β-chloroethylimidazole, β-3,5-pyrazolethylamine, β-2- and β-4-pyridylethylamine, and β-phenylethylamine stimulated rat gastric acid secretion and inhibited rat uterus.  The mode of action of β-chloroethylimidazole differed from that of histamine.  There was a marked correlation between the relative activities of the other compds. on the two prepns.  The receptors for isoprenaline inrat uterus were differentiated from those for histamine by means of the β-blocking drugs dichloroisoprenaline and pronethalol.  On guinea pig ileum, substitution of the terminal amino group of histamine by Me had little effect on activity, but substitution by larger groups or modification of the ring markedly diminished activity.  β-4-Pyridylethylamine, as well as compds. more closely related to histamine, had an affinity for histamine receptors in guinea pig ileum.  The symbol H1 is suggested for receptors which are specifically antagonized by low concns. of antihistamine drugs.  No specific antagonists were found for the actions of histamine on rat uterus and stomach.  These actions are therefore unlikely to be mediated by H1 receptors.  The relative activities of several histamine analogs support the differentiation of histamine receptors into at least two classes.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoQA5V9HgMkJbVg90H21EOLACvtfcHk0lhsSmIoku0i1A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaF28Xks1yit7k%253D&md5=36ca8d52720ac9ec43e1f2aec38b6b72</span></div><a href="/servlet/linkout?suffix=cit1&amp;dbid=16384&amp;doi=10.1111%2Fj.1476-5381.1966.tb01674.x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Fj.1476-5381.1966.tb01674.x%26sid%3Dliteratum%253Aachs%26aulast%3DAsh%26aufirst%3DA.%2BS.%2BF.%26aulast%3DSchild%26aufirst%3DH.%2BO.%26atitle%3DReceptors%2520mediating%2520some%2520actions%2520of%2520histamine%26jtitle%3DBr.%2520J.%2520Pharmacol.%2520Chemother.%26date%3D1966%26volume%3D27%26spage%3D427%26epage%3D439" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref2"><div class="reference"><strong class="refLabel"><a href="#ref2" class="rightTabRefNumLink">2</a></strong><div class="NLM_citation" id="rightTab-cit2"><span><span class="NLM_contrib-group">Black, J. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Duncan, W. A. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Durant, C. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ganellin, C. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Parsons, E. M.</span><span> </span><span class="NLM_article-title">Definition and antagonism of histamine H<sub>2</sub>-receptors</span> <span class="citation_source-journal">Nature</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1972</span><span class="NLM_x">, </span> <span class="NLM_volume">236</span><span class="NLM_x">, </span> <span class="NLM_fpage">385</span><span class="NLM_x">–</span> <span class="NLM_lpage">390</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=16&amp;doi=10.1021%2Fjm200939b&amp;key=10.1038%2F236385a0" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=8&amp;doi=10.1021%2Fjm200939b&amp;key=4401751" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=32&amp;doi=10.1021%2Fjm200939b&amp;key=1%3ACAS%3A528%3ADyaE38XksVehsLc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=236&publication_year=1972&pages=385-390&author=J.+W.+Blackauthor=W.+A.+M.+Duncanauthor=C.+J.+Durantauthor=C.+R.+Ganellinauthor=E.+M.+Parsons&title=Definition+and+antagonism+of+histamine+H2-receptors"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit2R"><div class="casContent"><span class="casTitleNuber">2</span><div class="casTitle"><span class="NLM_cas:atitle">Definition and antagonism of histamine H2-receptors</span></div><div class="casAuthors">Black, J. W.; Duncan, W. A. M.; Durant, C. J.; Ganellin, C. R.; Parsons, E. M.</div><div class="citationInfo"><span class="NLM_cas:title">Nature (London, United Kingdom)</span>
        (<span class="NLM_cas:date">1972</span>),
    <span class="NLM_cas:volume">236</span>
        (<span class="NLM_cas:issue">5347</span>),
    <span class="NLM_cas:pages">385-90</span>CODEN:
                <span class="NLM_cas:coden">NATUAS</span>;
        ISSN:<span class="NLM_cas:issn">0028-0836</span>.
    </div><div class="casAbstract">Burimamide (I) [34970-69-9] competitively antagonized the effects of histamine (II) [51-45-6] in a dose-related manner in guinea pig atria and rat uterus; both of these tissues contain H2-receptors which are classified on the basis of II reactivity not responsive to antagonism by mepyramine [91-84-9].  I did not antagonize the β-receptor stimulant isoprenaline in guinea pig atrium or rat uterus.  I caused a slight noncompetitive inhibition of II-induced contraction in the guinea pig ileum, a tissue known to contain H1-receptors which are susceptible to antagonism by mepyramine.  I inhibited II- and pentagastrin (III) [5534-95-2]-induced, but not vagally-stimulated, gastric acid secretion in rats.  The 50% effective dose (ED50) of I for inhibition of max. II-stimulated gastric secretion in cats was 2.3 .tim. 10-5 moles/kg and for max. III-stimulated secretion was 1.6 .tim. 10-5 moles/kg.  In dogs, an ED50 of 1.9 .tim. 10-5 moles I/kg was found for inhibition of max. stimulation by II; results were similar for III-stimulated or food-stimulated secretion.  In humans, an infusion of 3 .tim. 10-1 g I hr decreased max. III-stimulated gastric acid secretion by 80% after 90 min.; results were similar with II-induced gastric secretion.  In cats, 3 .tim. 10-6 moles I/kg/min for 30 min blocked the hypotensive effect of 2 .tim. 10-8 - 2 .tim. 10-7 moles II/kg.  With 2 .tim. 10-9 moles II/kg, the hypotensive action was only partially blocked by 1 .tim. 10-2g mepyramine/kg; the resistant part of the hypotensive effect could be antagonized completely by 3 .tim. 10-7 moles I/kg/30 min.  The cardiovascular effects of II therefore involve both H1 and H2 receptors.  I is now defined as an antagonist of H2 receptors.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGptoDdXVcvFCrVg90H21EOLACvtfcHk0lhe353HZs1KuA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaE38XksVehsLc%253D&md5=90eb7d2efdd4383433a3acb92ebc2044</span></div><a href="/servlet/linkout?suffix=cit2&amp;dbid=16384&amp;doi=10.1038%2F236385a0&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252F236385a0%26sid%3Dliteratum%253Aachs%26aulast%3DBlack%26aufirst%3DJ.%2BW.%26aulast%3DDuncan%26aufirst%3DW.%2BA.%2BM.%26aulast%3DDurant%26aufirst%3DC.%2BJ.%26aulast%3DGanellin%26aufirst%3DC.%2BR.%26aulast%3DParsons%26aufirst%3DE.%2BM.%26atitle%3DDefinition%2520and%2520antagonism%2520of%2520histamine%2520H2-receptors%26jtitle%3DNature%26date%3D1972%26volume%3D236%26spage%3D385%26epage%3D390" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref3"><div class="reference"><strong class="refLabel"><a href="#ref3" class="rightTabRefNumLink">3</a></strong><div class="NLM_citation" id="rightTab-cit3"><span><span class="NLM_contrib-group">Celanire, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wijtmans, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Talaga, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Leurs, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">de Esch, I. J. P.</span><span> </span><span class="NLM_article-title">Keynote review: histamine H<sub>3</sub> receptor antagonists reach out for the clinic</span> <span class="citation_source-journal">Drug Discovery Today</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">10</span><span class="NLM_x">, </span> <span class="NLM_fpage">1613</span><span class="NLM_x">–</span> <span class="NLM_lpage">1627</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=10&publication_year=2005&pages=1613-1627&author=S.+Celanireauthor=M.+Wijtmansauthor=P.+Talagaauthor=R.+Leursauthor=I.+J.+P.+de+Esch&title=Keynote+review%3A+histamine+H3+receptor+antagonists+reach+out+for+the+clinic"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit3&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DCelanire%26aufirst%3DS.%26aulast%3DWijtmans%26aufirst%3DM.%26aulast%3DTalaga%26aufirst%3DP.%26aulast%3DLeurs%26aufirst%3DR.%26aulast%3Dde%2BEsch%26aufirst%3DI.%2BJ.%2BP.%26atitle%3DKeynote%2520review%253A%2520histamine%2520H3%2520receptor%2520antagonists%2520reach%2520out%2520for%2520the%2520clinic%26jtitle%3DDrug%2520Discovery%2520Today%26date%3D2005%26volume%3D10%26spage%3D1613%26epage%3D1627" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref4"><div class="reference"><strong class="refLabel"><a href="#ref4" class="rightTabRefNumLink">4</a></strong><div class="NLM_citation" id="rightTab-cit4"><span><span class="NLM_contrib-group">Łażewska, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kieć-Kononowicz, K.</span><span> </span><span class="NLM_article-title">Recent advances in histamine H<sub>3</sub> receptor antagonists/inverse agonists</span> <span class="citation_source-journal">Expert Opin. Ther. Pat.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">20</span><span class="NLM_x">, </span> <span class="NLM_fpage">1147</span><span class="NLM_x">–</span> <span class="NLM_lpage">1169</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=16&amp;doi=10.1021%2Fjm200939b&amp;key=10.1517%2F13543776.2010.509346" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=8&amp;doi=10.1021%2Fjm200939b&amp;key=20716022" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=32&amp;doi=10.1021%2Fjm200939b&amp;key=1%3ACAS%3A528%3ADC%252BC3cXhtVCntLnE" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=20&publication_year=2010&pages=1147-1169&author=D.+%C5%81a%C5%BCewskaauthor=K.+Kie%C4%87-Kononowicz&title=Recent+advances+in+histamine+H3+receptor+antagonists%2Finverse+agonists"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit4R"><div class="casContent"><span class="casTitleNuber">4</span><div class="casTitle"><span class="NLM_cas:atitle">Recent advances in histamine H3 receptor antagonists/inverse agonists</span></div><div class="casAuthors">Lazewska, Dorota; Kiec-Kononowicz, Katarzyna</div><div class="citationInfo"><span class="NLM_cas:title">Expert Opinion on Therapeutic Patents</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">20</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">1147-1169</span>CODEN:
                <span class="NLM_cas:coden">EOTPEG</span>;
        ISSN:<span class="NLM_cas:issn">1354-3776</span>.
    
            (<span class="NLM_cas:orgname">Informa Healthcare</span>)
        </div><div class="casAbstract">A review.  Importance of the field: Histamine H3 receptor (H3R) antagonists/inverse agonists can be therapeutically useful in the treatment of various CNS, metabolic syndrome and allergic disorders, and constitute an attractive target in the search for new drugs.  However, several drug candidates have been rejected because of unwanted effects.  There is, therefore, a strong need to develop new H3R ligands.  Areas covered in this review: A review was conducted of recent advances in the search for H3R antagonists/inverse agonists as reflected by patent applications/patents over the last 3 years.  What the reader will gain: A total of around 100 patent applications/patents along with selected peer-reviewed publications are surveyed.  These involve antagonists/inverse agonists of H3R, which the authors have divided into five groups.  The above-mentioned compds. were evaluated for their potential utility in the treatment of narcolepsy, attention deficit hyperactivity disorder, epilepsy, Alzheimer's disease, schizophrenia, obesity and neuropathic pain.  Take home message: Several H3R antagonists/inverse agonists appear to be promising drug candidates, including at least 15 compds. undergoing evaluation in clin. development.  Esp. interesting is pitolisant, which is progressing through to Phase III clin. trials.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqRVSNfy6q5wrVg90H21EOLACvtfcHk0lhe353HZs1KuA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXhtVCntLnE&md5=033312a9f907c9b0b7d6652977b3cbc5</span></div><a href="/servlet/linkout?suffix=cit4&amp;dbid=16384&amp;doi=10.1517%2F13543776.2010.509346&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1517%252F13543776.2010.509346%26sid%3Dliteratum%253Aachs%26aulast%3D%25C5%2581a%25C5%25BCewska%26aufirst%3DD.%26aulast%3DKie%25C4%2587-Kononowicz%26aufirst%3DK.%26atitle%3DRecent%2520advances%2520in%2520histamine%2520H3%2520receptor%2520antagonists%252Finverse%2520agonists%26jtitle%3DExpert%2520Opin.%2520Ther.%2520Pat.%26date%3D2010%26volume%3D20%26spage%3D1147%26epage%3D1169" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref5"><div class="reference"><strong class="refLabel"><a href="#ref5" class="rightTabRefNumLink">5</a></strong><div class="NLM_citation" id="rightTab-cit5"><span><span class="NLM_contrib-group">Passani, M. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lin, J.-S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hancock, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Crochet, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Blandina, P.</span><span> </span><span class="NLM_article-title">The histamine H<sub>3</sub> receptor as a novel therapeutic target for cognitive and sleep disorders</span> <span class="citation_source-journal">Trends Pharmacol. Sci.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">25</span><span class="NLM_x">, </span> <span class="NLM_fpage">618</span><span class="NLM_x">–</span> <span class="NLM_lpage">625</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=25&publication_year=2004&pages=618-625&author=M.+B.+Passaniauthor=J.-S.+Linauthor=A.+Hancockauthor=S.+Crochetauthor=P.+Blandina&title=The+histamine+H3+receptor+as+a+novel+therapeutic+target+for+cognitive+and+sleep+disorders"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit5&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DPassani%26aufirst%3DM.%2BB.%26aulast%3DLin%26aufirst%3DJ.-S.%26aulast%3DHancock%26aufirst%3DA.%26aulast%3DCrochet%26aufirst%3DS.%26aulast%3DBlandina%26aufirst%3DP.%26atitle%3DThe%2520histamine%2520H3%2520receptor%2520as%2520a%2520novel%2520therapeutic%2520target%2520for%2520cognitive%2520and%2520sleep%2520disorders%26jtitle%3DTrends%2520Pharmacol.%2520Sci.%26date%3D2004%26volume%3D25%26spage%3D618%26epage%3D625" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref6"><div class="reference"><strong class="refLabel"><a href="#ref6" class="rightTabRefNumLink">6</a></strong><div class="NLM_citation" id="rightTab-cit6"><span><span class="NLM_contrib-group">Barbier, A. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bradbury, M. J.</span><span> </span><span class="NLM_article-title">Histaminergic control of sleep–wake cycles: recent therapeutic advances for sleep and wake disorders</span> <span class="citation_source-journal">CNS Neurol. Disord.: Drug Targets</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">6</span><span class="NLM_x">, </span> <span class="NLM_fpage">31</span><span class="NLM_x">–</span> <span class="NLM_lpage">43</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=16&amp;doi=10.1021%2Fjm200939b&amp;key=10.2174%2F187152707779940790" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=8&amp;doi=10.1021%2Fjm200939b&amp;key=17305552" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=32&amp;doi=10.1021%2Fjm200939b&amp;key=1%3ACAS%3A528%3ADC%252BD2sXis1alsbk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=2007&pages=31-43&author=A.+J.+Barbierauthor=M.+J.+Bradbury&title=Histaminergic+control+of+sleep%E2%80%93wake+cycles%3A+recent+therapeutic+advances+for+sleep+and+wake+disorders"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit6R"><div class="casContent"><span class="casTitleNuber">6</span><div class="casTitle"><span class="NLM_cas:atitle">Histaminergic control of sleep-wake cycles: recent therapeutic advances for sleep and wake disorders</span></div><div class="casAuthors">Barbier, A. J.; Bradbury, M. J.</div><div class="citationInfo"><span class="NLM_cas:title">CNS & Neurological Disorders: Drug Targets</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">6</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">31-43</span>CODEN:
                <span class="NLM_cas:coden">CNDDA3</span>;
        ISSN:<span class="NLM_cas:issn">1871-5273</span>.
    
            (<span class="NLM_cas:orgname">Bentham Science Publishers Ltd.</span>)
        </div><div class="casAbstract">A review.  The role of histaminergic neurotransmission in the promotion of waking has been extensively studied in preclin. species.  Appreciation for the role of histamine continues to expand with increasing understanding of the interaction of histamine within the broad network of neuromodulators that regulate sleep and wake.  The effects of histamine on waking are transduced through the H1 and the H3 receptors in the central nervous system.  Brain penetrant over-the-counter antihistamines comprised of antagonist actions at H1 receptors as well as varying degrees of antimuscarinic properties are marketed as sleep aids, based on their well-known daytime drowsiness side effects.  The data supporting their use as sedatives, however, are not consistent.  H3 receptors are presynaptic receptors that limit histamine release as well as that of monoamine neurotransmitters thought to participate in the maintenance of waking.  In this review, we discuss the existing studies on various antihistamines and antagonists of the H1 receptor in the regulation of sleep in preclin. studies, normal subjects and in subjects with sleep disorders.  In addn., we review the current data available on the use of ligands at H3 receptors for the modulation of sleep and wake.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpcdA_sS0bH2LVg90H21EOLACvtfcHk0ligLC-5STTv1Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXis1alsbk%253D&md5=ab8fd3a7b40ee363db2882471ca68d06</span></div><a href="/servlet/linkout?suffix=cit6&amp;dbid=16384&amp;doi=10.2174%2F187152707779940790&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2174%252F187152707779940790%26sid%3Dliteratum%253Aachs%26aulast%3DBarbier%26aufirst%3DA.%2BJ.%26aulast%3DBradbury%26aufirst%3DM.%2BJ.%26atitle%3DHistaminergic%2520control%2520of%2520sleep%25E2%2580%2593wake%2520cycles%253A%2520recent%2520therapeutic%2520advances%2520for%2520sleep%2520and%2520wake%2520disorders%26jtitle%3DCNS%2520Neurol.%2520Disord.%253A%2520Drug%2520Targets%26date%3D2007%26volume%3D6%26spage%3D31%26epage%3D43" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref7"><div class="reference"><strong class="refLabel"><a href="#ref7" class="rightTabRefNumLink">7</a></strong><div class="NLM_citation" id="rightTab-cit7"><span><span class="NLM_contrib-group">Levander, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Haegermark, O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Staahle, M.</span><span> </span><span class="NLM_article-title">Peripheral antihistamine and central sedative effects of three H<sub>1</sub>-receptor antagonists</span> <span class="citation_source-journal">Eur. J. Clin. Pharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1985</span><span class="NLM_x">, </span> <span class="NLM_volume">28</span><span class="NLM_x">, </span> <span class="NLM_fpage">523</span><span class="NLM_x">–</span> <span class="NLM_lpage">529</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=28&publication_year=1985&pages=523-529&author=S.+Levanderauthor=O.+Haegermarkauthor=M.+Staahle&title=Peripheral+antihistamine+and+central+sedative+effects+of+three+H1-receptor+antagonists"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit7&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DLevander%26aufirst%3DS.%26aulast%3DHaegermark%26aufirst%3DO.%26aulast%3DStaahle%26aufirst%3DM.%26atitle%3DPeripheral%2520antihistamine%2520and%2520central%2520sedative%2520effects%2520of%2520three%2520H1-receptor%2520antagonists%26jtitle%3DEur.%2520J.%2520Clin.%2520Pharmacol.%26date%3D1985%26volume%3D28%26spage%3D523%26epage%3D529" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref8"><div class="reference"><strong class="refLabel"><a href="#ref8" class="rightTabRefNumLink">8</a></strong><div class="NLM_citation" id="rightTab-cit8"><span><span class="NLM_contrib-group">Arrang, J. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Garbarg, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schwartz, J. C.</span><span> </span><span class="NLM_article-title">Autoinhibition of brain histamine release mediated by a novel class (H<sub>3</sub>) of histamine receptor</span> <span class="citation_source-journal">Nature</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1983</span><span class="NLM_x">, </span> <span class="NLM_volume">302</span><span class="NLM_x">, </span> <span class="NLM_fpage">832</span><span class="NLM_x">–</span> <span class="NLM_lpage">837</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=302&publication_year=1983&pages=832-837&author=J.+M.+Arrangauthor=M.+Garbargauthor=J.+C.+Schwartz&title=Autoinhibition+of+brain+histamine+release+mediated+by+a+novel+class+%28H3%29+of+histamine+receptor"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit8&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DArrang%26aufirst%3DJ.%2BM.%26aulast%3DGarbarg%26aufirst%3DM.%26aulast%3DSchwartz%26aufirst%3DJ.%2BC.%26atitle%3DAutoinhibition%2520of%2520brain%2520histamine%2520release%2520mediated%2520by%2520a%2520novel%2520class%2520%2528H3%2529%2520of%2520histamine%2520receptor%26jtitle%3DNature%26date%3D1983%26volume%3D302%26spage%3D832%26epage%3D837" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref9"><div class="reference"><strong class="refLabel"><a href="#ref9" class="rightTabRefNumLink">9</a></strong><div class="NLM_citation" id="rightTab-cit9"><span><span class="NLM_contrib-group">Brown, R. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stevens, D. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Haas, H. L.</span><span> </span><span class="NLM_article-title">The physiology of brain histamine</span> <span class="citation_source-journal">Prog. Neurobiol. (Oxford, U. K.)</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2001</span><span class="NLM_x">, </span> <span class="NLM_volume">63</span><span class="NLM_x">, </span> <span class="NLM_fpage">637</span><span class="NLM_x">–</span> <span class="NLM_lpage">672</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=16&amp;doi=10.1021%2Fjm200939b&amp;key=10.1016%2FS0301-0082%2800%2900039-3" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=8&amp;doi=10.1021%2Fjm200939b&amp;key=11164999" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=32&amp;doi=10.1021%2Fjm200939b&amp;key=1%3ACAS%3A528%3ADC%252BD3MXntlOktg%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=63&publication_year=2001&pages=637-672&author=R.+E.+Brownauthor=D.+R.+Stevensauthor=H.+L.+Haas&title=The+physiology+of+brain+histamine"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit9R"><div class="casContent"><span class="casTitleNuber">9</span><div class="casTitle"><span class="NLM_cas:atitle">The physiology of brain histamine</span></div><div class="casAuthors">Brown, R. E.; Stevens, D. R.; Haas, H. L.</div><div class="citationInfo"><span class="NLM_cas:title">Progress in Neurobiology (Oxford, United Kingdom)</span>
        (<span class="NLM_cas:date">2001</span>),
    <span class="NLM_cas:volume">63</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">637-672</span>CODEN:
                <span class="NLM_cas:coden">PGNBA5</span>;
        ISSN:<span class="NLM_cas:issn">0301-0082</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Science Ltd.</span>)
        </div><div class="casAbstract">A review, with ∼375 refs.  Histamine-releasing neurons are located exclusively in the TM of the hypothalamus, from where they project to practically all brain regions, with ventral areas (hypothalamus, basal forebrain, amygdala) receiving a particularly strong innervation.  The intrinsic electrophysiol. properties of TM neurons (slow spontaneous firing, broad action potentials, deep afterhyperpolarizations, etc.) are extremely similar to other aminergic neurons.  Their firing rate varies across the sleep-wake cycle, being highest during waking and lowest during rapid-eye movement sleep.  In contrast to other aminergic neurons somatodendritic autoreceptors (H3) do not activate an inwardly rectifying potassium channel but instead control firing by inhibiting voltage-dependent calcium channels.  Histamine release is enhanced under extreme conditions such as dehydration or hypoglycemia or by a variety of stressors.  Histamine activates four types of receptors.  H1 receptors are mainly postsynaptically located and are coupled pos. to phospholipase C. High densities are found esp. in the hypothalamus and other limbic regions.  Activation of these receptors causes large depolarizations via blockade of a leak potassium conductance, activation of a non-specific cation channel or activation of a sodium-calcium exchanger.  H2 receptors are also mainly postsynaptically located and are coupled pos. to adenylyl cyclase.  High densities are found in hippocampus, amygdala and basal ganglia.  Activation of these receptors also leads to mainly excitatory effects through blockade of calcium-dependent potassium channels and modulation of the hyperpolarization-activated cation channel.  H3 receptors are exclusively presynaptically located and are neg. coupled to adenylyl cyclase.  High densities are found in the basal ganglia.  These receptors mediated presynaptic inhibition of histamine release and the release of other neurotransmitters, most likely via inhibition of presynaptic calcium channels.  Finally, histamine modulates the glutamate NMDA receptor via an action at the polyamine binding site.  The central histamine system is involved in many central nervous system functions: arousal; anxiety; activation of the sympathetic nervous system; the stress-related release of hormones from the pituitary and of central aminergic neurotransmitters; antinociception; water retention and suppression of eating.  A role for the neuronal histamine system as a danger response system is proposed.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGojnBKJrphchrVg90H21EOLACvtfcHk0ligLC-5STTv1Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3MXntlOktg%253D%253D&md5=7d9e9c1c91cf00ebe5d5212fc6cb883c</span></div><a href="/servlet/linkout?suffix=cit9&amp;dbid=16384&amp;doi=10.1016%2FS0301-0082%2800%2900039-3&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0301-0082%252800%252900039-3%26sid%3Dliteratum%253Aachs%26aulast%3DBrown%26aufirst%3DR.%2BE.%26aulast%3DStevens%26aufirst%3DD.%2BR.%26aulast%3DHaas%26aufirst%3DH.%2BL.%26atitle%3DThe%2520physiology%2520of%2520brain%2520histamine%26jtitle%3DProg.%2520Neurobiol.%2520%2528Oxford%252C%2520U.%2520K.%2529%26date%3D2001%26volume%3D63%26spage%3D637%26epage%3D672" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref10"><div class="reference"><strong class="refLabel"><a href="#ref10" class="rightTabRefNumLink">10</a></strong><div class="NLM_citation" id="rightTab-cit10"><span><span class="NLM_contrib-group">Esbenshade, T. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Browman, K. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bitner, R. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Strakhova, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cowart, M. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brioni, J. D.</span><span> </span><span class="NLM_article-title">The histamine H<sub>3</sub> receptor: an attractive target for the treatment of cognitive disorders</span> <span class="citation_source-journal">Br. J. Pharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">154</span><span class="NLM_x">, </span> <span class="NLM_fpage">1166</span><span class="NLM_x">–</span> <span class="NLM_lpage">1181</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=16&amp;doi=10.1021%2Fjm200939b&amp;key=10.1038%2Fbjp.2008.147" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=8&amp;doi=10.1021%2Fjm200939b&amp;key=18469850" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=32&amp;doi=10.1021%2Fjm200939b&amp;key=1%3ACAS%3A528%3ADC%252BD1cXosVCjtL4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=154&publication_year=2008&pages=1166-1181&author=T.+A.+Esbenshadeauthor=K.+E.+Browmanauthor=R.+S.+Bitnerauthor=M.+Strakhovaauthor=M.+D.+Cowartauthor=J.+D.+Brioni&title=The+histamine+H3+receptor%3A+an+attractive+target+for+the+treatment+of+cognitive+disorders"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit10R"><div class="casContent"><span class="casTitleNuber">10</span><div class="casTitle"><span class="NLM_cas:atitle">The histamine H3 receptor: an attractive target for the treatment of cognitive disorders</span></div><div class="casAuthors">Esbenshade, T. A.; Browman, K. E.; Bitner, R. S.; Strakhova, M.; Cowart, M. D.; Brioni, J. D.</div><div class="citationInfo"><span class="NLM_cas:title">British Journal of Pharmacology</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">154</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">1166-1181</span>CODEN:
                <span class="NLM_cas:coden">BJPCBM</span>;
        ISSN:<span class="NLM_cas:issn">0007-1188</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A review.  The histamine H3 receptor, first described in 1983 as a histamine autoreceptor and later shown to also function as a heteroreceptor that regulates the release of other neurotransmitters, has been the focus of research by numerous labs. as it represents an attractive drug target for a no. of indications including cognition.  The purpose of this review is to acquaint the reader with the current understanding of H3 receptor localization and function as a modulator of neurotransmitter release and its effects on cognitive processes, as well as to provide an update on selected H3 antagonists in various states of preclin. and clin. advancement.  Blockade of centrally localized H3 receptors by selective H3 receptor antagonists has been shown to enhance the release of neurotransmitters such as histamine, ACh, dopamine and norepinephrine, among others, which play important roles in cognitive processes.  The cognitive-enhancing effects of H3 antagonists across multiple cognitive domains in a wide no. of preclin. cognition models also bolster confidence in this therapeutic approach for the treatment of attention deficit hyperactivity disorder, Alzheimer's disease and schizophrenia.  However, although a no. of clin. studies examg. the efficacy of H3 receptor antagonists for a variety of cognitive disorders are currently underway, no clin. proof of concept for an H3 receptor antagonist has been reported to date.  The discovery of effective H3 antagonists as therapeutic agents for the novel treatment of cognitive disorders will only be accomplished through continued research efforts that further our insights into the functions of the H3 receptor.  British Journal of Pharmacol. (2008) 154, 1166-1181; doi:10.1038/bjp.2008.147; published online 12 May 2008.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr2N2Dg3cdZfrVg90H21EOLACvtfcHk0ljHHm1nQ2l0OA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXosVCjtL4%253D&md5=05bcda7b1140e9d16b4ca4072902d925</span></div><a href="/servlet/linkout?suffix=cit10&amp;dbid=16384&amp;doi=10.1038%2Fbjp.2008.147&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fbjp.2008.147%26sid%3Dliteratum%253Aachs%26aulast%3DEsbenshade%26aufirst%3DT.%2BA.%26aulast%3DBrowman%26aufirst%3DK.%2BE.%26aulast%3DBitner%26aufirst%3DR.%2BS.%26aulast%3DStrakhova%26aufirst%3DM.%26aulast%3DCowart%26aufirst%3DM.%2BD.%26aulast%3DBrioni%26aufirst%3DJ.%2BD.%26atitle%3DThe%2520histamine%2520H3%2520receptor%253A%2520an%2520attractive%2520target%2520for%2520the%2520treatment%2520of%2520cognitive%2520disorders%26jtitle%3DBr.%2520J.%2520Pharmacol.%26date%3D2008%26volume%3D154%26spage%3D1166%26epage%3D1181" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref11"><div class="reference"><strong class="refLabel"><a href="#ref11" class="rightTabRefNumLink">11</a></strong><div class="NLM_citation" id="rightTab-cit11"><span><span class="NLM_contrib-group">Tzavara, E. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bymaster, F. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Overshiner, C. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Davis, R. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Perry, K. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wolff, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McKinzie, D. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Witkin, J. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nomikos, G. G.</span><span> </span><span class="NLM_article-title">Procholinergic and memory enhancing properties of the selective norepinephrine uptake inhibitor atomoxetine</span> <span class="citation_source-journal">Mol. Psychiatry</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">11</span><span class="NLM_x">, </span> <span class="NLM_fpage">187</span><span class="NLM_x">–</span> <span class="NLM_lpage">195</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=16&amp;doi=10.1021%2Fjm200939b&amp;key=10.1038%2Fsj.mp.4001763" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=8&amp;doi=10.1021%2Fjm200939b&amp;key=16231039" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=32&amp;doi=10.1021%2Fjm200939b&amp;key=1%3ACAS%3A528%3ADC%252BD28XnsV2mtA%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=11&publication_year=2006&pages=187-195&author=E.+T.+Tzavaraauthor=F.+P.+Bymasterauthor=C.+D.+Overshinerauthor=R.+J.+Davisauthor=K.+W.+Perryauthor=M.+Wolffauthor=D.+L.+McKinzieauthor=J.+M.+Witkinauthor=G.+G.+Nomikos&title=Procholinergic+and+memory+enhancing+properties+of+the+selective+norepinephrine+uptake+inhibitor+atomoxetine"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit11R"><div class="casContent"><span class="casTitleNuber">11</span><div class="casTitle"><span class="NLM_cas:atitle">Procholinergic and memory enhancing properties of the selective norepinephrine uptake inhibitor atomoxetine</span></div><div class="casAuthors">Tzavara, E. T.; Bymaster, F. P.; Overshiner, C. D.; Davis, R. J.; Perry, K. W.; Wolff, M.; McKinzie, D. L.; Witkin, J. M.; Nomikos, G. G.</div><div class="citationInfo"><span class="NLM_cas:title">Molecular Psychiatry</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">11</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">187-195</span>CODEN:
                <span class="NLM_cas:coden">MOPSFQ</span>;
        ISSN:<span class="NLM_cas:issn">1359-4184</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">Atomoxetine has been approved by the FDA as the first new drug in 30 years for the treatment of attention deficit/hyperactivity disorder (ADHD).  As a selective norepinephrine uptake inhibitor and a nonstimulant, atomoxetine has a different mechanism of action from the stimulant drugs used up to now for the treatment of ADHD.  Since brain acetylcholine (ACh) has been assocd. with memory, attention and motivation, processes dysregulated in ADHD, we investigated the effects of atomoxetine on cholinergic neurotransmission.  We showed here that, in rats, atomoxetine (0.3-3 mg/kg, i.p.), - increases in vivo extracellular levels of ACh in cortical but not subcortical brain regions.  The marked increase of cortical ACh induced by atomoxetine was dependent upon norepinephrine α-1 and/or dopamine D1 receptor activation.  We obsd. similar increases in cortical and hippocampal ACh release with methylphenidate (1 and 3 mg/kg, i.p.) - currently the most commonly prescribed medication for the treatment of ADHD - and with the norepinephrine uptake inhibitor reboxetine (3-30 mg/kg, i.p.).  Since drugs that increase cholinergic neurotransmission are used in the treatment of cognitive dysfunction and dementias, we also investigated the effects of atomoxetine on memory tasks.  We showed that, consistent with its cortical procholinergic and catecholamine-enhancing profile, atomoxetine (1-3 mg/kg, p.o.) significantly ameliorated performance in the object recognition test and the radial arm-maze test.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp_B1VE6vP6MbVg90H21EOLACvtfcHk0ljHHm1nQ2l0OA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28XnsV2mtA%253D%253D&md5=afa062abf68eb50e31afd533d27a1c10</span></div><a href="/servlet/linkout?suffix=cit11&amp;dbid=16384&amp;doi=10.1038%2Fsj.mp.4001763&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fsj.mp.4001763%26sid%3Dliteratum%253Aachs%26aulast%3DTzavara%26aufirst%3DE.%2BT.%26aulast%3DBymaster%26aufirst%3DF.%2BP.%26aulast%3DOvershiner%26aufirst%3DC.%2BD.%26aulast%3DDavis%26aufirst%3DR.%2BJ.%26aulast%3DPerry%26aufirst%3DK.%2BW.%26aulast%3DWolff%26aufirst%3DM.%26aulast%3DMcKinzie%26aufirst%3DD.%2BL.%26aulast%3DWitkin%26aufirst%3DJ.%2BM.%26aulast%3DNomikos%26aufirst%3DG.%2BG.%26atitle%3DProcholinergic%2520and%2520memory%2520enhancing%2520properties%2520of%2520the%2520selective%2520norepinephrine%2520uptake%2520inhibitor%2520atomoxetine%26jtitle%3DMol.%2520Psychiatry%26date%3D2006%26volume%3D11%26spage%3D187%26epage%3D195" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref12"><div class="reference"><strong class="refLabel"><a href="#ref12" class="rightTabRefNumLink">12</a></strong><div class="NLM_citation" id="rightTab-cit12"><span><span class="NLM_contrib-group">Horner, W. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Johnson, D. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schmidt, A. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rollema, H.</span><span> </span><span class="NLM_article-title">Methylphenidate and atomoxetine increase histamine release in rat prefrontal cortex</span> <span class="citation_source-journal">Eur. J. Pharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">558</span><span class="NLM_x">, </span> <span class="NLM_fpage">96</span><span class="NLM_x">–</span> <span class="NLM_lpage">97</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=16&amp;doi=10.1021%2Fjm200939b&amp;key=10.1016%2Fj.ejphar.2006.11.048" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=8&amp;doi=10.1021%2Fjm200939b&amp;key=17198700" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=32&amp;doi=10.1021%2Fjm200939b&amp;key=1%3ACAS%3A528%3ADC%252BD2sXhvVGnsr0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=558&publication_year=2007&pages=96-97&author=W.+E.+Hornerauthor=D.+E.+Johnsonauthor=A.+W.+Schmidtauthor=H.+Rollema&title=Methylphenidate+and+atomoxetine+increase+histamine+release+in+rat+prefrontal+cortex"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit12R"><div class="casContent"><span class="casTitleNuber">12</span><div class="casTitle"><span class="NLM_cas:atitle">Methylphenidate and atomoxetine increase histamine release in rat prefrontal cortex</span></div><div class="casAuthors">Horner, Weldon E.; Johnson, David E.; Schmidt, Anne W.; Rollema, Hans</div><div class="citationInfo"><span class="NLM_cas:title">European Journal of Pharmacology</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">558</span>
        (<span class="NLM_cas:issue">1-3</span>),
    <span class="NLM_cas:pages">96-97</span>CODEN:
                <span class="NLM_cas:coden">EJPHAZ</span>;
        ISSN:<span class="NLM_cas:issn">0014-2999</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">Using microdialysis in rat prefrontal cortex, we found that 1 mg/kg of the stimulant methylphenidate and the non-stimulant atomoxetine, two widely used treatments for Attention Deficit/Hyperactivity Disorder (ADHD), produce robust increases in the extracellular levels of histamine, which plays a key role in attention, learning and memory.  While the clin. response to ADHD drugs is typically attributed to modulation of norepinephrine and dopamine, this finding suggests enhanced histamine release may contribute to their efficacy as ADHD treatments.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr4UinWVjCBJLVg90H21EOLACvtfcHk0ljHHm1nQ2l0OA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXhvVGnsr0%253D&md5=a3112bec5974a993095d38e8c8eb5f5c</span></div><a href="/servlet/linkout?suffix=cit12&amp;dbid=16384&amp;doi=10.1016%2Fj.ejphar.2006.11.048&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.ejphar.2006.11.048%26sid%3Dliteratum%253Aachs%26aulast%3DHorner%26aufirst%3DW.%2BE.%26aulast%3DJohnson%26aufirst%3DD.%2BE.%26aulast%3DSchmidt%26aufirst%3DA.%2BW.%26aulast%3DRollema%26aufirst%3DH.%26atitle%3DMethylphenidate%2520and%2520atomoxetine%2520increase%2520histamine%2520release%2520in%2520rat%2520prefrontal%2520cortex%26jtitle%3DEur.%2520J.%2520Pharmacol.%26date%3D2007%26volume%3D558%26spage%3D96%26epage%3D97" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref13"><div class="reference"><strong class="refLabel"><a href="#ref13" class="rightTabRefNumLink">13</a></strong><div class="NLM_citation" id="rightTab-cit13"><span>FDA. Atomoxetine (Marketed as Strattera) Information,<span class="NLM_x"> </span><span class="NLM_year">2005</span>. <a href="http://www.fda.gov/Drugs/DrugSafety/PostmarketDrugSafetyInformationforPatientsandProviders/ucm107912.htm" class="extLink">http://www.fda.gov/Drugs/DrugSafety/PostmarketDrugSafetyInformationforPatientsandProviders/ucm107912.htm</a></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=FDA.+Atomoxetine+%28Marketed+as+Strattera%29+Information%2C+2005.+http%3A%2F%2Fwww.fda.gov%2FDrugs%2FDrugSafety%2FPostmarketDrugSafetyInformationforPatientsandProviders%2Fucm107912.htm"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit13&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dweb%26sid%3Dliteratum%253Aachs%26date%3D2005" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref14"><div class="reference"><strong class="refLabel"><a href="#ref14" class="rightTabRefNumLink">14</a></strong><div class="NLM_citation" id="rightTab-cit14"><span><span class="NLM_contrib-group">Wernicke, J. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kratochvil, C. J.</span><span> </span><span class="NLM_article-title">Safety profile of atomoxetine in the treatment of children and adolescents with ADHD</span> <span class="citation_source-journal">J. Clin. Psychiatry</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2002</span><span class="NLM_x">, </span> <span class="NLM_volume">63</span><span class="NLM_x"> (</span><span class="NLM_issue">Suppl. 12</span><span class="NLM_x">) </span> <span class="NLM_fpage">50</span><span class="NLM_x">–</span> <span class="NLM_lpage">55</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=8&amp;doi=10.1021%2Fjm200939b&amp;key=12562062" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=32&amp;doi=10.1021%2Fjm200939b&amp;key=1%3ACAS%3A528%3ADC%252BD3sXit1Oi" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=63&publication_year=2002&pages=50-55&issue=Suppl.+12&author=J.+F.+Wernickeauthor=C.+J.+Kratochvil&title=Safety+profile+of+atomoxetine+in+the+treatment+of+children+and+adolescents+with+ADHD"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit14R"><div class="casContent"><span class="casTitleNuber">14</span><div class="casTitle"><span class="NLM_cas:atitle">Safety profile of atomoxetine in the treatment of children and adolescents with ADHD</span></div><div class="casAuthors">Wernicke, J. F.; Kratochvil, Christopher J.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Clinical Psychiatry</span>
        (<span class="NLM_cas:date">2002</span>),
    <span class="NLM_cas:volume">63</span>
        (<span class="NLM_cas:issue">Suppl. 12</span>),
    <span class="NLM_cas:pages">50-55</span>CODEN:
                <span class="NLM_cas:coden">JCLPDE</span>;
        ISSN:<span class="NLM_cas:issn">0160-6689</span>.
    
            (<span class="NLM_cas:orgname">Physicians Postgraduate Press, Inc.</span>)
        </div><div class="casAbstract">A review.  Atomoxetine is a selective norepinephrine reuptake inhibitor that is being developed for the treatment of attention-deficit/hyperactivity disorder (ADHD).  Atomoxetine will be the first nonstimulant medication approved by the U.S.  Food and Drug Administration (FDA) for the treatment of ADHD.  Throughout the testing phases, more than 2000 children and adolescents have been exposed to atomoxetine in clin. trials, with both the no. of exposures and the length of exposure time increasing.  Serious adverse events have not been clearly assocd. with the drug, and there have been few discontinuations due to adverse events.  The most common drug-related event reported in trials has been decreased appetite and an initial period of wt. loss followed by an apparently normal rate of wt. gain.  These events tend to appear early in the course of treatment with atomoxetine and then decline.  Atomoxetine has also been assocd. with mild increases in blood pressure and pulse that plateau during treatment and resolve upon discontinuation.  There have been no effects seen on the QT interval, and the cytochrome P 450 2D6 metab. of patients seems to have little effect on safety or tolerability of the drug.  This article will review the data from completed and ongoing clin. trials available at the time the New Drug Application was submitted to the FDA.  Described are serious adverse events, discontinuations, and treatment-emergent adverse events.  Specifically, cardiac effects and effects on wt., height, and metab. that are related to treatment of ADHD with atomoxetine in children and adolescents are discussed.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpUejL3GHHM2bVg90H21EOLACvtfcHk0lg_Ec2BrqDfVw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3sXit1Oi&md5=9fe9b3296c1ae0363f1e42b23222a526</span></div><a href="/servlet/linkout?suffix=cit14&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DWernicke%26aufirst%3DJ.%2BF.%26aulast%3DKratochvil%26aufirst%3DC.%2BJ.%26atitle%3DSafety%2520profile%2520of%2520atomoxetine%2520in%2520the%2520treatment%2520of%2520children%2520and%2520adolescents%2520with%2520ADHD%26jtitle%3DJ.%2520Clin.%2520Psychiatry%26date%3D2002%26volume%3D63%26issue%3DSuppl.%252012%26spage%3D50%26epage%3D55" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref15"><div class="reference"><strong class="refLabel"><a href="#ref15" class="rightTabRefNumLink">15</a></strong><div class="NLM_citation" id="rightTab-cit15"><span><span class="NLM_contrib-group">Fermini, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fossa, A. A.</span><span> </span><span class="NLM_article-title">The impact of drug-induced QT interval prolongation on drug discovery and development</span> <span class="citation_source-journal">Nat. Rev. Drug Discovery</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">2</span><span class="NLM_x">, </span> <span class="NLM_fpage">439</span><span class="NLM_x">–</span> <span class="NLM_lpage">447</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=2&publication_year=2003&pages=439-447&author=B.+Ferminiauthor=A.+A.+Fossa&title=The+impact+of+drug-induced+QT+interval+prolongation+on+drug+discovery+and+development"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit15&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DFermini%26aufirst%3DB.%26aulast%3DFossa%26aufirst%3DA.%2BA.%26atitle%3DThe%2520impact%2520of%2520drug-induced%2520QT%2520interval%2520prolongation%2520on%2520drug%2520discovery%2520and%2520development%26jtitle%3DNat.%2520Rev.%2520Drug%2520Discovery%26date%3D2003%26volume%3D2%26spage%3D439%26epage%3D447" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref16"><div class="reference"><strong class="refLabel"><a href="#ref16" class="rightTabRefNumLink">16</a></strong><div class="NLM_citation" id="rightTab-cit16"><span><span class="NLM_contrib-group">Hosea, N. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Collard, W. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cole, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Maurer, T. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fang, R. X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jones, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kakar, S. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nakai, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Smith, B. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Webster, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Beaumont, K.</span><span> </span><span class="NLM_article-title">Prediction of human pharmacokinetics from preclinical information: comparative accuracy of quantitative prediction approaches</span> <span class="citation_source-journal">J. Clin. Pharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">49</span><span class="NLM_x">, </span> <span class="NLM_fpage">513</span><span class="NLM_x">–</span> <span class="NLM_lpage">533</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=16&amp;doi=10.1021%2Fjm200939b&amp;key=10.1177%2F0091270009333209" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=8&amp;doi=10.1021%2Fjm200939b&amp;key=19299532" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=32&amp;doi=10.1021%2Fjm200939b&amp;key=1%3ACAS%3A528%3ADC%252BD1MXlsFWmu74%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=49&publication_year=2009&pages=513-533&author=N.+A.+Hoseaauthor=W.+T.+Collardauthor=S.+Coleauthor=T.+S.+Maurerauthor=R.+X.+Fangauthor=H.+Jonesauthor=S.+M.+Kakarauthor=Y.+Nakaiauthor=B.+J.+Smithauthor=R.+Websterauthor=K.+Beaumont&title=Prediction+of+human+pharmacokinetics+from+preclinical+information%3A+comparative+accuracy+of+quantitative+prediction+approaches"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit16R"><div class="casContent"><span class="casTitleNuber">16</span><div class="casTitle"><span class="NLM_cas:atitle">Prediction of human pharmacokinetics from preclinical information: comparative accuracy of quantitative prediction approaches</span></div><div class="casAuthors">Hosea, Natilie A.; Collard, Wendy T.; Cole, Susan; Maurer, Tristan S.; Fang, Rick X.; Jones, Hannah; Kakar, Shefali M.; Nakai, Yasuhiro; Smith, Bill J.; Webster, Rob; Beaumont, Kevin</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Clinical Pharmacology</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">49</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">513-533</span>CODEN:
                <span class="NLM_cas:coden">JCPCBR</span>;
        ISSN:<span class="NLM_cas:issn">0091-2700</span>.
    
            (<span class="NLM_cas:orgname">Sage Publications</span>)
        </div><div class="casAbstract">A review.  Quant. prediction of human pharmacokinetics is crit. in assessing the viability of drug candidates and in detg. first-in-human dosing.  Numerous prediction methodologies, incorporating both in vitro and preclin. in vivo data, have been developed in recent years, each with advantages and disadvantages.  However, the lack of a comprehensive data set, both preclin. and clin., has limited efforts to evaluate the optimal strategy (or strategies) that results in quant. predictions of human pharmacokinetics.  To address this issue, the authors conducted a retrospective anal. using 50 proprietary compds. for which in vitro, preclin. pharmacokinetic data and oral single-dose human pharmacokinetic data were available.  Five predictive strategies, involving either allometry or use of unbound intrinsic clearance from microsomes or hepatocytes, were then compared for their ability to predict human oral clearance, half-life through predictions of systemic clearance, vol. of distribution, and bioavailability.  Use of a single-species scaling approach with rat, dog, or monkey was as accurate as or more accurate than using multiple-species allometry.  For those compds. cleared almost exclusively by P 450-mediated pathways, scaling from human liver microsomes was as predictive as single-species scaling of clearance based on data from rat, dog, or monkey.  These data suggest that use of predictive methods involving either single-species in vivo data or in vitro human liver microsomes can quant. predict human in vivo pharmacokinetics and suggest the possibility of streamlining the predictive methodol. through use of a single species or use only of human in vitro microsomal prepns.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrg67HcwS4O4LVg90H21EOLACvtfcHk0lg_Ec2BrqDfVw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXlsFWmu74%253D&md5=a0941d53fe43392f8fb1562ee546705e</span></div><a href="/servlet/linkout?suffix=cit16&amp;dbid=16384&amp;doi=10.1177%2F0091270009333209&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1177%252F0091270009333209%26sid%3Dliteratum%253Aachs%26aulast%3DHosea%26aufirst%3DN.%2BA.%26aulast%3DCollard%26aufirst%3DW.%2BT.%26aulast%3DCole%26aufirst%3DS.%26aulast%3DMaurer%26aufirst%3DT.%2BS.%26aulast%3DFang%26aufirst%3DR.%2BX.%26aulast%3DJones%26aufirst%3DH.%26aulast%3DKakar%26aufirst%3DS.%2BM.%26aulast%3DNakai%26aufirst%3DY.%26aulast%3DSmith%26aufirst%3DB.%2BJ.%26aulast%3DWebster%26aufirst%3DR.%26aulast%3DBeaumont%26aufirst%3DK.%26atitle%3DPrediction%2520of%2520human%2520pharmacokinetics%2520from%2520preclinical%2520information%253A%2520comparative%2520accuracy%2520of%2520quantitative%2520prediction%2520approaches%26jtitle%3DJ.%2520Clin.%2520Pharmacol.%26date%3D2009%26volume%3D49%26spage%3D513%26epage%3D533" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref17"><div class="reference"><strong class="refLabel"><a href="#ref17" class="rightTabRefNumLink">17</a></strong><div class="NLM_citation" id="rightTab-cit17"><span><span class="NLM_contrib-group">Gao, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yao, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mathieu, H. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Maurer, T. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Troutman, M. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Scott, D. O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ruggeri, R. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lin, J.</span><span> </span><span class="NLM_article-title">In silico modeling of nonspecific binding to human liver microsomes</span> <span class="citation_source-journal">Drug Metab. Dispos.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">36</span><span class="NLM_x">, </span> <span class="NLM_fpage">2130</span><span class="NLM_x">–</span> <span class="NLM_lpage">2135</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=36&publication_year=2008&pages=2130-2135&author=H.+Gaoauthor=L.+Yaoauthor=H.+W.+Mathieuauthor=Y.+Zhangauthor=T.+S.+Maurerauthor=M.+D.+Troutmanauthor=D.+O.+Scottauthor=R.+B.+Ruggeriauthor=J.+Lin&title=In+silico+modeling+of+nonspecific+binding+to+human+liver+microsomes"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit17&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DGao%26aufirst%3DH.%26aulast%3DYao%26aufirst%3DL.%26aulast%3DMathieu%26aufirst%3DH.%2BW.%26aulast%3DZhang%26aufirst%3DY.%26aulast%3DMaurer%26aufirst%3DT.%2BS.%26aulast%3DTroutman%26aufirst%3DM.%2BD.%26aulast%3DScott%26aufirst%3DD.%2BO.%26aulast%3DRuggeri%26aufirst%3DR.%2BB.%26aulast%3DLin%26aufirst%3DJ.%26atitle%3DIn%2520silico%2520modeling%2520of%2520nonspecific%2520binding%2520to%2520human%2520liver%2520microsomes%26jtitle%3DDrug%2520Metab.%2520Dispos.%26date%3D2008%26volume%3D36%26spage%3D2130%26epage%3D2135" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref18"><div class="reference"><strong class="refLabel"><a href="#ref18" class="rightTabRefNumLink">18</a></strong><div class="NLM_citation" id="rightTab-cit18"><span><span class="NLM_contrib-group">Walker, J.</span><span> </span><span class="NLM_article-title">Some new curarizing agents</span> <span class="citation_source-journal">J. Chem. Soc.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1950</span><span class="NLM_x">, </span> <span class="NLM_fpage">193</span><span class="NLM_x">–</span> <span class="NLM_lpage">197</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=1950&pages=193-197&author=J.+Walker&title=Some+new+curarizing+agents"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit18&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DWalker%26aufirst%3DJ.%26atitle%3DSome%2520new%2520curarizing%2520agents%26jtitle%3DJ.%2520Chem.%2520Soc.%26date%3D1950%26spage%3D193%26epage%3D197" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref19"><div class="reference"><strong class="refLabel"><a href="#ref19" class="rightTabRefNumLink">19</a></strong><div class="NLM_citation" id="rightTab-cit19"><span><span class="NLM_contrib-group">Sasaki, J. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Arey, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Eastmond, D. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Parks, K. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Grosovsky, A. J.</span><span> </span><span class="NLM_article-title">Genotoxicity induced in human lymphoblasts by atmospheric reaction products of naphthalene and phenanthrene</span> <span class="citation_source-journal">Mutat. Res., Genet. Toxicol. Environ. Mutagen.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1997</span><span class="NLM_x">, </span> <span class="NLM_volume">393</span><span class="NLM_x">, </span> <span class="NLM_fpage">23</span><span class="NLM_x">–</span> <span class="NLM_lpage">35</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=393&publication_year=1997&pages=23-35&author=J.+C.+Sasakiauthor=J.+Areyauthor=D.+A.+Eastmondauthor=K.+K.+Parksauthor=A.+J.+Grosovsky&title=Genotoxicity+induced+in+human+lymphoblasts+by+atmospheric+reaction+products+of+naphthalene+and+phenanthrene"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit19&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DSasaki%26aufirst%3DJ.%2BC.%26aulast%3DArey%26aufirst%3DJ.%26aulast%3DEastmond%26aufirst%3DD.%2BA.%26aulast%3DParks%26aufirst%3DK.%2BK.%26aulast%3DGrosovsky%26aufirst%3DA.%2BJ.%26atitle%3DGenotoxicity%2520induced%2520in%2520human%2520lymphoblasts%2520by%2520atmospheric%2520reaction%2520products%2520of%2520naphthalene%2520and%2520phenanthrene%26jtitle%3DMutat.%2520Res.%252C%2520Genet.%2520Toxicol.%2520Environ.%2520Mutagen.%26date%3D1997%26volume%3D393%26spage%3D23%26epage%3D35" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref20"><div class="reference"><strong class="refLabel"><a href="#ref20" class="rightTabRefNumLink">20</a></strong><div class="NLM_citation" id="rightTab-cit20"><span><span class="NLM_contrib-group">Smith, C. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Davies, G. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dodson, E. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Moore, M. H.</span><span> </span><span class="NLM_article-title">DNA–nogalamycin interactions: the crystal structure of d(TGATCA) complexed with nogalamycin</span> <span class="citation_source-journal">Biochemistry</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1995</span><span class="NLM_x">, </span> <span class="NLM_volume">34</span><span class="NLM_x">, </span> <span class="NLM_fpage">415</span><span class="NLM_x">–</span> <span class="NLM_lpage">425</span></span><div class="citationLinks">[<a href="/doi/10.1021/bi00002a005" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=34&publication_year=1995&pages=415-425&author=C.+K.+Smithauthor=G.+J.+Daviesauthor=E.+J.+Dodsonauthor=M.+H.+Moore&title=DNA%E2%80%93nogalamycin+interactions%3A+the+crystal+structure+of+d%28TGATCA%29+complexed+with+nogalamycin"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit20&amp;dbid=16384&amp;doi=10.1021%2Fbi00002a005&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fbi00002a005%26sid%3Dliteratum%253Aachs%26aulast%3DSmith%26aufirst%3DC.%2BK.%26aulast%3DDavies%26aufirst%3DG.%2BJ.%26aulast%3DDodson%26aufirst%3DE.%2BJ.%26aulast%3DMoore%26aufirst%3DM.%2BH.%26atitle%3DDNA%25E2%2580%2593nogalamycin%2520interactions%253A%2520the%2520crystal%2520structure%2520of%2520d%2528TGATCA%2529%2520complexed%2520with%2520nogalamycin%26jtitle%3DBiochemistry%26date%3D1995%26volume%3D34%26spage%3D415%26epage%3D425" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref21"><div class="reference"><strong class="refLabel"><a href="#ref21" class="rightTabRefNumLink">21</a></strong><div class="NLM_citation" id="rightTab-cit21"><span><span class="NLM_contrib-group">Feigon, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Denny, W. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Leupin, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kearns, D. R.</span><span> </span><span class="NLM_article-title">Interactions of antitumor drugs with natural DNA: proton NMR study of binding mode and kinetics</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1984</span><span class="NLM_x">, </span> <span class="NLM_volume">27</span><span class="NLM_x">, </span> <span class="NLM_fpage">450</span><span class="NLM_x">–</span> <span class="NLM_lpage">465</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm00370a007" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=27&publication_year=1984&pages=450-465&author=J.+Feigonauthor=W.+A.+Dennyauthor=W.+Leupinauthor=D.+R.+Kearns&title=Interactions+of+antitumor+drugs+with+natural+DNA%3A+proton+NMR+study+of+binding+mode+and+kinetics"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit21&amp;dbid=16384&amp;doi=10.1021%2Fjm00370a007&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm00370a007%26sid%3Dliteratum%253Aachs%26aulast%3DFeigon%26aufirst%3DJ.%26aulast%3DDenny%26aufirst%3DW.%2BA.%26aulast%3DLeupin%26aufirst%3DW.%26aulast%3DKearns%26aufirst%3DD.%2BR.%26atitle%3DInteractions%2520of%2520antitumor%2520drugs%2520with%2520natural%2520DNA%253A%2520proton%2520NMR%2520study%2520of%2520binding%2520mode%2520and%2520kinetics%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D1984%26volume%3D27%26spage%3D450%26epage%3D465" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref22"><div class="reference"><strong class="refLabel"><a href="#ref22" class="rightTabRefNumLink">22</a></strong><div class="NLM_citation" id="rightTab-cit22"><span><span class="NLM_contrib-group">Hancock, A. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Diehl, M. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Faghih, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bush, E. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Krueger, K. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Krishna, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Miller, T. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wilcox, D. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nguyen, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pratt, J. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cowart, M. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Esbenshade, T. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jacobson, P. B.</span><span> </span><span class="NLM_article-title">In vitro optimization of structure activity relationships of analogues of A-331440 combining radioligand receptor binding assays and micronucleus assays of potential antiobesity histamine H<sub>3</sub> receptor antagonists</span> <span class="citation_source-journal">Basic Clin. Pharmacol. Toxicol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">95</span><span class="NLM_x">, </span> <span class="NLM_fpage">144</span><span class="NLM_x">–</span> <span class="NLM_lpage">152</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=16&amp;doi=10.1021%2Fjm200939b&amp;key=10.1111%2Fj.1742-7843.2004.950307.x" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=8&amp;doi=10.1021%2Fjm200939b&amp;key=15447739" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=32&amp;doi=10.1021%2Fjm200939b&amp;key=1%3ACAS%3A528%3ADC%252BD2cXosFyiu7o%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=95&publication_year=2004&pages=144-152&author=A.+A.+Hancockauthor=M.+S.+Diehlauthor=R.+Faghihauthor=E.+N.+Bushauthor=K.+M.+Kruegerauthor=G.+Krishnaauthor=T.+R.+Millerauthor=D.+M.+Wilcoxauthor=P.+Nguyenauthor=J.+K.+Prattauthor=M.+D.+Cowartauthor=T.+A.+Esbenshadeauthor=P.+B.+Jacobson&title=In+vitro+optimization+of+structure+activity+relationships+of+analogues+of+A-331440+combining+radioligand+receptor+binding+assays+and+micronucleus+assays+of+potential+antiobesity+histamine+H3+receptor+antagonists"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit22R"><div class="casContent"><span class="casTitleNuber">22</span><div class="casTitle"><span class="NLM_cas:atitle">In vitro optimization of structure activity relationships of analogs of A-331440 combining radioligand receptor binding assays and micronucleus assays of potential antiobesity histamine H3 receptor antagonists</span></div><div class="casAuthors">Hancock, Arthur A.; Diehl, Marilyn S.; Faghih, Ramin; Bush, Eugene N.; Krueger, Kathleen M.; Krishna, Gopala; Miller, Thomas R.; Wilcox, Denise M.; Nguyen, Phong; Pratt, John K.; Cowart, Marlon D.; Eshenshade, Timothy A.; Jacobson, Peer B.</div><div class="citationInfo"><span class="NLM_cas:title">Basic & Clinical Pharmacology & Toxicology</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">95</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">144-152</span>CODEN:
                <span class="NLM_cas:coden">BCPTBO</span>;
        ISSN:<span class="NLM_cas:issn">1742-7835</span>.
    
            (<span class="NLM_cas:orgname">Blackwell Publishing Ltd.</span>)
        </div><div class="casAbstract">A-331440 {4'-[3-(3(R)-(dimethylamino)-pyrrolidin-1-yl)-propoxy]-biphenyl-4-carbonitrile}, a potent and selective antagonist of histamine H3 receptors, yielded pos. results in an in vitro micronucleus assay, predictive of genotoxicity in vivo.  Because this compd. has highly favorable properties and potential as an antiobesity agent, new compds. of this general chem. class were sought that would retain or improve upon the high potency and selectivity of A-331440 for H3 receptors, but would lack the potential for genotoxicity obtained with that compd.  Our working hypothesis was that the biphenyl rings in A-331440 might contribute to interactions with DNA and thereby predispose toward genotoxicity.  Toward this end, several analogs were prepd., with substituents introduced onto the biaryl ring to alter the orientation, electronegativity, and polarity of this moiety, and were tested for their radioligand binding potency and selectivity and their propensity to induce genotoxicity in the in vitro micronucleus assay.  Using this strategy, novel compds. were discovered that retained or improved upon the potency and selectivity of A-331440 for H3 receptors and were devoid of genotoxicity in vitro.  Of these, the simple mono- and di-fluorinated analogs (A-417022 [4'-{3-[(3R)-3-(dimethylamino)-1-pyrrolidinyl]propoxy}-3'-fluoro-1,1'-biphenyl-4-carbonitrile] and A-423579 [4'-{3-[(3R)-3-(dimethylamino)-1-pyrrolidinyl]-propoxy}-3',5'-difluoro-1,1'-biphenyl-4-carbonitrile] resp.) were found to bind to H3 receptors at least as potently as A-331440, while lacking genotoxicity in the micronucleus assay.  The reason of the lack of genotoxicity of the fluorinated analogs is unclear, but is esp. noteworthy in light of the general principle that fluorine and hydrogen are very similar in size.  Therefore, these fluorinated analogs of A-331440 represented the most potent and potentially safest compds. for further evaluation as antiobesity leads.  Preliminary findings with one of these examples, A-417022, in a mouse model of obesity are presented.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqsB-CdUg04qLVg90H21EOLACvtfcHk0lhXhOWvq6QAag"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXosFyiu7o%253D&md5=dd639fa35ed75d531d83b6fc8f662087</span></div><a href="/servlet/linkout?suffix=cit22&amp;dbid=16384&amp;doi=10.1111%2Fj.1742-7843.2004.950307.x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Fj.1742-7843.2004.950307.x%26sid%3Dliteratum%253Aachs%26aulast%3DHancock%26aufirst%3DA.%2BA.%26aulast%3DDiehl%26aufirst%3DM.%2BS.%26aulast%3DFaghih%26aufirst%3DR.%26aulast%3DBush%26aufirst%3DE.%2BN.%26aulast%3DKrueger%26aufirst%3DK.%2BM.%26aulast%3DKrishna%26aufirst%3DG.%26aulast%3DMiller%26aufirst%3DT.%2BR.%26aulast%3DWilcox%26aufirst%3DD.%2BM.%26aulast%3DNguyen%26aufirst%3DP.%26aulast%3DPratt%26aufirst%3DJ.%2BK.%26aulast%3DCowart%26aufirst%3DM.%2BD.%26aulast%3DEsbenshade%26aufirst%3DT.%2BA.%26aulast%3DJacobson%26aufirst%3DP.%2BB.%26atitle%3DIn%2520vitro%2520optimization%2520of%2520structure%2520activity%2520relationships%2520of%2520analogues%2520of%2520A-331440%2520combining%2520radioligand%2520receptor%2520binding%2520assays%2520and%2520micronucleus%2520assays%2520of%2520potential%2520antiobesity%2520histamine%2520H3%2520receptor%2520antagonists%26jtitle%3DBasic%2520Clin.%2520Pharmacol.%2520Toxicol.%26date%3D2004%26volume%3D95%26spage%3D144%26epage%3D152" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref23"><div class="reference"><strong class="refLabel"><a href="#ref23" class="rightTabRefNumLink">23</a></strong><div class="NLM_citation" id="rightTab-cit23"><span><span class="NLM_contrib-group">Morini, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Comini, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rivara, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rivara, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lorenzi, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bordi, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mor, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Flammini, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bertoni, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ballabeni, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Barocelli, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Plazzi, P. V.</span><span> </span><span class="NLM_article-title">Dibasic non-imidazole histamine H<sub>3</sub> receptor antagonists with a rigid biphenyl scaffold</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">16</span><span class="NLM_x">, </span> <span class="NLM_fpage">4063</span><span class="NLM_x">–</span> <span class="NLM_lpage">4067</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=16&publication_year=2006&pages=4063-4067&author=G.+Moriniauthor=M.+Cominiauthor=M.+Rivaraauthor=S.+Rivaraauthor=S.+Lorenziauthor=F.+Bordiauthor=M.+Morauthor=L.+Flamminiauthor=S.+Bertoniauthor=V.+Ballabeniauthor=E.+Barocelliauthor=P.+V.+Plazzi&title=Dibasic+non-imidazole+histamine+H3+receptor+antagonists+with+a+rigid+biphenyl+scaffold"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit23&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DMorini%26aufirst%3DG.%26aulast%3DComini%26aufirst%3DM.%26aulast%3DRivara%26aufirst%3DM.%26aulast%3DRivara%26aufirst%3DS.%26aulast%3DLorenzi%26aufirst%3DS.%26aulast%3DBordi%26aufirst%3DF.%26aulast%3DMor%26aufirst%3DM.%26aulast%3DFlammini%26aufirst%3DL.%26aulast%3DBertoni%26aufirst%3DS.%26aulast%3DBallabeni%26aufirst%3DV.%26aulast%3DBarocelli%26aufirst%3DE.%26aulast%3DPlazzi%26aufirst%3DP.%2BV.%26atitle%3DDibasic%2520non-imidazole%2520histamine%2520H3%2520receptor%2520antagonists%2520with%2520a%2520rigid%2520biphenyl%2520scaffold%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2006%26volume%3D16%26spage%3D4063%26epage%3D4067" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref24"><div class="reference"><strong class="refLabel"><a href="#ref24" class="rightTabRefNumLink">24</a></strong><div class="NLM_citation" id="rightTab-cit24"><span><span class="NLM_contrib-group">Clark, G. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Squire, C. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gray, E. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Leupin, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Neidle, S.</span><span> </span><span class="NLM_article-title">Designer DNA-binding drugs: the crystal structure of a meta-hydroxy analogue of Hoechst 33258 bound to d(CGCGAATTCGCG)<sub>2</sub></span> <span class="citation_source-journal">Nucleic Acids Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1996</span><span class="NLM_x">, </span> <span class="NLM_volume">24</span><span class="NLM_x">, </span> <span class="NLM_fpage">4882</span><span class="NLM_x">–</span> <span class="NLM_lpage">4889</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=24&publication_year=1996&pages=4882-4889&author=G.+R.+Clarkauthor=C.+J.+Squireauthor=E.+J.+Grayauthor=W.+Leupinauthor=S.+Neidle&title=Designer+DNA-binding+drugs%3A+the+crystal+structure+of+a+meta-hydroxy+analogue+of+Hoechst+33258+bound+to+d%28CGCGAATTCGCG%292"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit24&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DClark%26aufirst%3DG.%2BR.%26aulast%3DSquire%26aufirst%3DC.%2BJ.%26aulast%3DGray%26aufirst%3DE.%2BJ.%26aulast%3DLeupin%26aufirst%3DW.%26aulast%3DNeidle%26aufirst%3DS.%26atitle%3DDesigner%2520DNA-binding%2520drugs%253A%2520the%2520crystal%2520structure%2520of%2520a%2520meta-hydroxy%2520analogue%2520of%2520Hoechst%252033258%2520bound%2520to%2520d%2528CGCGAATTCGCG%25292%26jtitle%3DNucleic%2520Acids%2520Res.%26date%3D1996%26volume%3D24%26spage%3D4882%26epage%3D4889" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref25"><div class="reference"><strong class="refLabel"><a href="#ref25" class="rightTabRefNumLink">25</a></strong><div class="NLM_citation" id="rightTab-cit25"><span><span class="NLM_contrib-group">Miller, V. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stresser, D. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Blanchard, A. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Turner, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Crespi, C. L.</span><span> </span><span class="NLM_article-title">Fluorometric high-throughput screening for inhibitors of cytochrome P450</span> <span class="citation_source-journal">Ann. N.Y. Acad. Sci.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2000</span><span class="NLM_x">, </span> <span class="NLM_volume">919</span><span class="NLM_x">, </span> <span class="NLM_fpage">26</span><span class="NLM_x">–</span> <span class="NLM_lpage">32</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=919&publication_year=2000&pages=26-32&author=V.+P.+Millerauthor=D.+M.+Stresserauthor=A.+P.+Blanchardauthor=S.+Turnerauthor=C.+L.+Crespi&title=Fluorometric+high-throughput+screening+for+inhibitors+of+cytochrome+P450"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit25&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DMiller%26aufirst%3DV.%2BP.%26aulast%3DStresser%26aufirst%3DD.%2BM.%26aulast%3DBlanchard%26aufirst%3DA.%2BP.%26aulast%3DTurner%26aufirst%3DS.%26aulast%3DCrespi%26aufirst%3DC.%2BL.%26atitle%3DFluorometric%2520high-throughput%2520screening%2520for%2520inhibitors%2520of%2520cytochrome%2520P450%26jtitle%3DAnn.%2520N.Y.%2520Acad.%2520Sci.%26date%3D2000%26volume%3D919%26spage%3D26%26epage%3D32" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref26"><div class="reference"><strong class="refLabel"><a href="#ref26" class="rightTabRefNumLink">26</a></strong><div class="NLM_citation" id="rightTab-cit26"><span><span class="NLM_contrib-group">Aubrecht, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Osowski, J. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Persaud, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cheung, J. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ackerman, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lopes, S. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ku, W. W.</span><span> </span><span class="NLM_article-title">Bioluminescent Salmonella reverse mutation assay: a screen for detecting mutagenicity with high throughput attributes</span> <span class="citation_source-journal">Mutagenesis</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">22</span><span class="NLM_x">, </span> <span class="NLM_fpage">335</span><span class="NLM_x">–</span> <span class="NLM_lpage">342</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=22&publication_year=2007&pages=335-342&author=J.+Aubrechtauthor=J.+J.+Osowskiauthor=P.+Persaudauthor=J.+R.+Cheungauthor=J.+Ackermanauthor=S.+H.+Lopesauthor=W.+W.+Ku&title=Bioluminescent+Salmonella+reverse+mutation+assay%3A+a+screen+for+detecting+mutagenicity+with+high+throughput+attributes"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit26&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DAubrecht%26aufirst%3DJ.%26aulast%3DOsowski%26aufirst%3DJ.%2BJ.%26aulast%3DPersaud%26aufirst%3DP.%26aulast%3DCheung%26aufirst%3DJ.%2BR.%26aulast%3DAckerman%26aufirst%3DJ.%26aulast%3DLopes%26aufirst%3DS.%2BH.%26aulast%3DKu%26aufirst%3DW.%2BW.%26atitle%3DBioluminescent%2520Salmonella%2520reverse%2520mutation%2520assay%253A%2520a%2520screen%2520for%2520detecting%2520mutagenicity%2520with%2520high%2520throughput%2520attributes%26jtitle%3DMutagenesis%26date%3D2007%26volume%3D22%26spage%3D335%26epage%3D342" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref27"><div class="reference"><strong class="refLabel"><a href="#ref27" class="rightTabRefNumLink">27</a></strong><div class="NLM_citation" id="rightTab-cit27"><span><span class="NLM_contrib-group">Homiski, M. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Muehlbauer, P. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dobo, K. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schuler, M. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Aubrecht, J.</span><span> </span><span class="NLM_article-title">Concordance analysis of an in vitro micronucleus screening assay and the regulatory chromosome aberration assay using pharmaceutical drug candidates</span> <span class="citation_source-journal">Environ. Mol. Mutagen.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">51</span><span class="NLM_x">, </span> <span class="NLM_fpage">39</span><span class="NLM_x">–</span> <span class="NLM_lpage">47</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=51&publication_year=2010&pages=39-47&author=M.+L.+Homiskiauthor=P.+A.+Muehlbauerauthor=K.+L.+Doboauthor=M.+J.+Schulerauthor=J.+Aubrecht&title=Concordance+analysis+of+an+in+vitro+micronucleus+screening+assay+and+the+regulatory+chromosome+aberration+assay+using+pharmaceutical+drug+candidates"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit27&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DHomiski%26aufirst%3DM.%2BL.%26aulast%3DMuehlbauer%26aufirst%3DP.%2BA.%26aulast%3DDobo%26aufirst%3DK.%2BL.%26aulast%3DSchuler%26aufirst%3DM.%2BJ.%26aulast%3DAubrecht%26aufirst%3DJ.%26atitle%3DConcordance%2520analysis%2520of%2520an%2520in%2520vitro%2520micronucleus%2520screening%2520assay%2520and%2520the%2520regulatory%2520chromosome%2520aberration%2520assay%2520using%2520pharmaceutical%2520drug%2520candidates%26jtitle%3DEnviron.%2520Mol.%2520Mutagen.%26date%3D2010%26volume%3D51%26spage%3D39%26epage%3D47" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref28"><div class="reference"><strong class="refLabel"><a href="#ref28" class="rightTabRefNumLink">28</a></strong><div class="NLM_citation" id="rightTab-cit28"><span><span class="NLM_contrib-group">Feng, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mills, J. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Davidson, R. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mireles, R. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Janiszewski, J. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Troutman, M. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">de Morais, S. M.</span><span> </span><span class="NLM_article-title">In vitro P-glycoprotein assays to predict the in vivo interactions of P-glycoprotein with drugs in the central nervous system</span> <span class="citation_source-journal">Drug Metab. Dispos.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">36</span><span class="NLM_x">, </span> <span class="NLM_fpage">268</span><span class="NLM_x">–</span> <span class="NLM_lpage">275</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=16&amp;doi=10.1021%2Fjm200939b&amp;key=10.1124%2Fdmd.107.017434" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=8&amp;doi=10.1021%2Fjm200939b&amp;key=17962372" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=32&amp;doi=10.1021%2Fjm200939b&amp;key=1%3ACAS%3A528%3ADC%252BD1cXht1yktbc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=36&publication_year=2008&pages=268-275&author=B.+Fengauthor=J.+B.+Millsauthor=R.+E.+Davidsonauthor=R.+J.+Mirelesauthor=J.+S.+Janiszewskiauthor=M.+D.+Troutmanauthor=S.+M.+de+Morais&title=In+vitro+P-glycoprotein+assays+to+predict+the+in+vivo+interactions+of+P-glycoprotein+with+drugs+in+the+central+nervous+system"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit28R"><div class="casContent"><span class="casTitleNuber">28</span><div class="casTitle"><span class="NLM_cas:atitle">In vitro P-glycoprotein assays to predict the in vivo interactions of P-glycoprotein with drugs in the central nervous system</span></div><div class="casAuthors">Feng, Bo; Mills, Jessica B.; Davidson, Ralph E.; Mireles, Rouchelle J.; Janiszewski, John S.; Troutman, Matthew D.; de Morais, Sonia M.</div><div class="citationInfo"><span class="NLM_cas:title">Drug Metabolism and Disposition</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">36</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">268-275</span>CODEN:
                <span class="NLM_cas:coden">DMDSAI</span>;
        ISSN:<span class="NLM_cas:issn">0090-9556</span>.
    
            (<span class="NLM_cas:orgname">American Society for Pharmacology and Experimental Therapeutics</span>)
        </div><div class="casAbstract">Thirty-one structurally diverse marketed central nervous system (CNS)-active drugs, one active metabolite, and seven non-CNS-active compds. were tested in three P-glycoprotein (P-gp) in vitro assays: transwell assays using MDCK, human MDR1-MDCK, and mouse Mdr1a-MDCK cells, ATPase, and calcein AM inhibition.  Addnl., the permeability for these compds. was measured in two in vitro models: parallel artificial membrane permeation assay and apical-to-basolateral apparent permeability in MDCK.  The exposure of the same set of compds. in brain and plasma was measured in P-gp knockout (KO) and wild-type (WT) mice after s.c. administration.  One drug and its metabolite, risperidone and 9-hydroxyrisperidone, of the 32 CNS compds., and 6 of the 7 non-CNS drugs were detd. to have pos. efflux using ratio of ratios in MDR1-MDCK vs. MDCK transwell assays.  Data from transwell studies correlated well with the brain-to-plasma area under the curve ratios between P-gp KO and WT mice for the 32 CNS compds.  In addn., 3300 Pfizer compds. were tested in MDR1-MDCK and Mdr1a-MDCK transwell assays, with a good correlation (R2 = 0.92) between the efflux ratios in human MDR1-MDCK and mouse Mdr1a-MDCK cells.  Permeability data showed that the majority of the 32 CNS compds. have moderate to high passive permeability.  This work has demonstrated that in vitro transporter assays help in understanding the role of P-gp-mediated efflux activity in detg. the disposition of CNS drugs in vivo, and the transwell assay is a valuable in vitro assay to evaluate human P-gp interaction with compds. for assessing brain penetration of new chem. entities to treat CNS disorders.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqsQyRSOySyGLVg90H21EOLACvtfcHk0lh-FQhkupEaCg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXht1yktbc%253D&md5=bbf8b6969bd6d6b3d741b6ef9e7853f3</span></div><a href="/servlet/linkout?suffix=cit28&amp;dbid=16384&amp;doi=10.1124%2Fdmd.107.017434&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1124%252Fdmd.107.017434%26sid%3Dliteratum%253Aachs%26aulast%3DFeng%26aufirst%3DB.%26aulast%3DMills%26aufirst%3DJ.%2BB.%26aulast%3DDavidson%26aufirst%3DR.%2BE.%26aulast%3DMireles%26aufirst%3DR.%2BJ.%26aulast%3DJaniszewski%26aufirst%3DJ.%2BS.%26aulast%3DTroutman%26aufirst%3DM.%2BD.%26aulast%3Dde%2BMorais%26aufirst%3DS.%2BM.%26atitle%3DIn%2520vitro%2520P-glycoprotein%2520assays%2520to%2520predict%2520the%2520in%2520vivo%2520interactions%2520of%2520P-glycoprotein%2520with%2520drugs%2520in%2520the%2520central%2520nervous%2520system%26jtitle%3DDrug%2520Metab.%2520Dispos.%26date%3D2008%26volume%3D36%26spage%3D268%26epage%3D275" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref29"><div class="reference"><strong class="refLabel"><a href="#ref29" class="rightTabRefNumLink">29</a></strong><div class="NLM_citation" id="rightTab-cit29"><span><span class="NLM_contrib-group">Fox, G. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pan, J. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Esbenshade, T. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bitner, R. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nikkel, A. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Miller, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kang, C. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bennani, Y. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Black, L. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Faghih, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hancock, A. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Decker, M. W.</span><span> </span><span class="NLM_article-title">Differential in vivo effects of H<sub>3</sub> receptor ligands in a new mouse dipsogenia model</span> <span class="citation_source-journal">Pharmacol., Biochem. Behav.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2002</span><span class="NLM_x">, </span> <span class="NLM_volume">72</span><span class="NLM_x">, </span> <span class="NLM_fpage">741</span><span class="NLM_x">–</span> <span class="NLM_lpage">750</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref29/cit29&amp;dbid=16&amp;doi=10.1021%2Fjm200939b&amp;key=10.1016%2FS0091-3057%2802%2900745-1" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref29/cit29&amp;dbid=8&amp;doi=10.1021%2Fjm200939b&amp;key=12175472" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref29/cit29&amp;dbid=32&amp;doi=10.1021%2Fjm200939b&amp;key=1%3ACAS%3A528%3ADC%252BD38Xjt1Sksbg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=72&publication_year=2002&pages=741-750&author=G.+B.+Foxauthor=J.+B.+Panauthor=T.+A.+Esbenshadeauthor=R.+S.+Bitnerauthor=A.+L.+Nikkelauthor=T.+Millerauthor=C.+H.+Kangauthor=Y.+L.+Bennaniauthor=L.+A.+Blackauthor=R.+Faghihauthor=A.+A.+Hancockauthor=M.+W.+Decker&title=Differential+in+vivo+effects+of+H3+receptor+ligands+in+a+new+mouse+dipsogenia+model"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit29R"><div class="casContent"><span class="casTitleNuber">29</span><div class="casTitle"><span class="NLM_cas:atitle">Differential in vivo effects of H3 receptor ligands in a new mouse dipsogenia model</span></div><div class="casAuthors">Fox, Gerard B.; Pan, Jia Bao; Esbenshade, Timothy A.; Bitner, R. Scott; Nikkel, Arthur L.; Miller, Tom; Kang, Chae Hee; Bennani, Youssef L.; Black, Lawrence A.; Faghih, Ramin; Hancock, Arthur A.; Decker, Michael W.</div><div class="citationInfo"><span class="NLM_cas:title">Pharmacology, Biochemistry and Behavior</span>
        (<span class="NLM_cas:date">2002</span>),
    <span class="NLM_cas:volume">72</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">741-750</span>CODEN:
                <span class="NLM_cas:coden">PBBHAU</span>;
        ISSN:<span class="NLM_cas:issn">0091-3057</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Science Inc.</span>)
        </div><div class="casAbstract">The selective H3 receptor agonist (R)-α-methylhistamine [(R)-α-MeHA] stimulates drinking in the adult rat.  In the present study, we investigated the role of the H3 receptor in mediating this behavior in a new dipsogenia model using the CD-1 mouse.  In addn., the putative inverse agonists ciproxifan, thioperamide and clobenpropit; the reported antagonist (1R,2R)-4-[2-(5,5-dimethylhex-1-ynyl)cyclopropyl]imidazole (GT-2331); and the putative neutral antagonist/weak partial agonist proxyfan were evaluated for possible differences in pharmacol. activity in this new model.  Water intake increased over baseline in a dose-related manner following i.p. administration of 80, 160 or 240 μmol/kg (R)-α-MeHA, but this effect was dependent on age (P30<P60<P80=P120).  [3H]-N-α-methylhistamine binding studies showed no change in H3 receptor d. for the whole mouse brain at these ages.  All subsequent studies employed P80 mice dosed with 240 μmol/kg (R)-α-MeHA.  Ciproxifan (0.001-30 μmol/kg), thioperamide (0.01-10 μmol/kg), clobenpropit (0.1-30 μmol/kg) and GT-2331 (0.03-10 μmol/kg) attenuated drinking dose-dependently, blocking the response completely at the highest doses in each case.  In contrast, proxyfan (0.001-10 μmol/kg) only partially attenuated drinking elicited by (R)-α-MeHA: coadministration of proxyfan and ciproxifan resulted in an attenuation of ciproxifan's effects.  This new dipsogenia model provides the first in vivo behavioral evidence for possible pharmacol. differences between three putative H3 receptor inverse agonists, GT-2331 and proxyfan.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrtc-PysOlv_7Vg90H21EOLACvtfcHk0lh-FQhkupEaCg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD38Xjt1Sksbg%253D&md5=74c56dfbae7a6bdbf7bf7bc166ef8807</span></div><a href="/servlet/linkout?suffix=cit29&amp;dbid=16384&amp;doi=10.1016%2FS0091-3057%2802%2900745-1&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0091-3057%252802%252900745-1%26sid%3Dliteratum%253Aachs%26aulast%3DFox%26aufirst%3DG.%2BB.%26aulast%3DPan%26aufirst%3DJ.%2BB.%26aulast%3DEsbenshade%26aufirst%3DT.%2BA.%26aulast%3DBitner%26aufirst%3DR.%2BS.%26aulast%3DNikkel%26aufirst%3DA.%2BL.%26aulast%3DMiller%26aufirst%3DT.%26aulast%3DKang%26aufirst%3DC.%2BH.%26aulast%3DBennani%26aufirst%3DY.%2BL.%26aulast%3DBlack%26aufirst%3DL.%2BA.%26aulast%3DFaghih%26aufirst%3DR.%26aulast%3DHancock%26aufirst%3DA.%2BA.%26aulast%3DDecker%26aufirst%3DM.%2BW.%26atitle%3DDifferential%2520in%2520vivo%2520effects%2520of%2520H3%2520receptor%2520ligands%2520in%2520a%2520new%2520mouse%2520dipsogenia%2520model%26jtitle%3DPharmacol.%252C%2520Biochem.%2520Behav.%26date%3D2002%26volume%3D72%26spage%3D741%26epage%3D750" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref30"><div class="reference"><strong class="refLabel"><a href="#ref30" class="rightTabRefNumLink">30</a></strong><div class="NLM_citation" id="rightTab-cit30"><span><span class="NLM_contrib-group">McLeod, R. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rizzo, C. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">West, R. E.,  Jr.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Aslanian, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McCormick, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bryant, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hsieh, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Korfmacher, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mingo, G. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Varty, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Williams, S. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shih, N.-Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Egan, R. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hey, J. A.</span><span> </span><span class="NLM_article-title">Pharmacological characterization of the novel histamine H<sub>3</sub>-receptor antagonist <i>N</i>-(3,5-dichlorophenyl)-<i>N′</i>-[[4-(1<i>H</i>-imidazol-4-ylmethyl)phenyl]-methyl]-urea (SCH 79687)</span> <span class="citation_source-journal">J. Pharmacol. Exp. Ther.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">305</span><span class="NLM_x">, </span> <span class="NLM_fpage">1037</span><span class="NLM_x">–</span> <span class="NLM_lpage">1044</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=16&amp;doi=10.1021%2Fjm200939b&amp;key=10.1124%2Fjpet.103.049254" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=8&amp;doi=10.1021%2Fjm200939b&amp;key=12649305" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=32&amp;doi=10.1021%2Fjm200939b&amp;key=1%3ACAS%3A528%3ADC%252BD3sXkt1Snsbc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=305&publication_year=2003&pages=1037-1044&author=R.+L.+McLeodauthor=C.+A.+Rizzoauthor=R.+E.+Westauthor=R.+Aslanianauthor=K.+McCormickauthor=M.+Bryantauthor=Y.+Hsiehauthor=W.+Korfmacherauthor=G.+G.+Mingoauthor=L.+Vartyauthor=S.+M.+Williamsauthor=N.-Y.+Shihauthor=R.+W.+Eganauthor=J.+A.+Hey&title=Pharmacological+characterization+of+the+novel+histamine+H3-receptor+antagonist+N-%283%2C5-dichlorophenyl%29-N%E2%80%B2-%5B%5B4-%281H-imidazol-4-ylmethyl%29phenyl%5D-methyl%5D-urea+%28SCH+79687%29"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit30R"><div class="casContent"><span class="casTitleNuber">30</span><div class="casTitle"><span class="NLM_cas:atitle">Pharmacological characterization of the novel histamine H3-receptor antagonist N-(3,5-dichlorophenyl)-N'-[[4-(1H-imidazol-4-ylmethyl)phenyl]methyl]urea (SCH 79687)</span></div><div class="casAuthors">McLeod, Robbie L.; Rizzo, Charlie A.; West, Robert E., Jr.; Aslanian, Robert; McCormick, Kevin; Bryant, Matthew; Hsieh, Yunsheng; Korfmacher, Walter; Mingo, Garfield G.; Varty, Loriann; Williams, Shirley M.; Shih, Neng-Yang; Egan, Robert W.; Hey, John A.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Pharmacology and Experimental Therapeutics</span>
        (<span class="NLM_cas:date">2003</span>),
    <span class="NLM_cas:volume">305</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">1037-1044</span>CODEN:
                <span class="NLM_cas:coden">JPETAB</span>;
        ISSN:<span class="NLM_cas:issn">0022-3565</span>.
    
            (<span class="NLM_cas:orgname">American Society for Pharmacology and Experimental Therapeutics</span>)
        </div><div class="casAbstract">We present the pharmacol. and pharmacokinetic profiles of a novel histamine H3 receptor antagonist SCH 79687.  The H3-receptor binding Ki values for SCH 79687 were 1.9 and 13 nM in the rat and guinea pig (GP), resp.  The Kj values for SCH 79687 at histamine H1 and H2 receptors were greater than 1 μM.  SCH 79687 showed a 41- and 82-fold binding selectivity for the H3 receptor over α2A-adrenoceptors and imidazoline I2, and >500-fold H3 selectivity compared with over 60 addnl. receptors.  The pA2 value for SCH 79687 in the GP ileum elec. field-stimulated (EFS) contraction was 9.6±0.3.  Similar H3 antagonist activity was obsd. in the EFS cryopreserved and fresh tissue isolated human saphenous vein (HSV) assays (pKb = 9.4±0.3 and 10.1±0.4).  SCH 79687 (30 nM) did not block clonidine-induced inhibition of EFS-induced contractions in HSV.  SCH 79687 (ED50 = 0.3 mg/kg i.v.) attenuated (R)-α-methylhistamine inhibition of sympathetic hypertensive responses in the GP.  At the time of activity evaluation, the GP plasma SCH 79687 concn. was 25 ng/mL at the dose of 0.3 mg/kg i.v.  In feline nasal studies, combined administration of SCH 79687 (3 mg/kg i.v.) and the H1-antagonist loratadine (3 mg/kg i.v.), at individual doses that do not produce decongestion, inhibited the compd. 48/80-induced congestion by 47%.  The α-adrenergic agonist phenylpropanolamine (PPA; 1 mg/kg i.v.) also attenuated compd. 48/80 nasal responses by 42%.  Unlike the H3/H1 combination that did not affect blood pressure (BP), PPA (1 mg/kg i.v.) significantly increased BP compared with control animals by a max. of 31 mm Hg.  Orally, SCH 79687 (10 mg/kg) plus loratadine (10 mg/kg) also produced decongestion without effects on BP.  In pharmacokinetic studies, oral dosing with SCH 79687 in the rat (10 mg/kg) and monkey (3 mg/kg) achieved plasma Cmax and area under the curve values greater than 1.5 and 12.1 μg · h/mL, resp.  SCH 79687 is an orally active H3 antagonist with a good pharmacokinetic profile that, in combination with an H1 antagonist, demonstrates decongestant efficacy comparable with oral sympathomimetic decongestants but without hypertensive liabilities.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrhbbuVnZwB77Vg90H21EOLACvtfcHk0lh-FQhkupEaCg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3sXkt1Snsbc%253D&md5=79cfdefeca31c9ad658be8cc0d591084</span></div><a href="/servlet/linkout?suffix=cit30&amp;dbid=16384&amp;doi=10.1124%2Fjpet.103.049254&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1124%252Fjpet.103.049254%26sid%3Dliteratum%253Aachs%26aulast%3DMcLeod%26aufirst%3DR.%2BL.%26aulast%3DRizzo%26aufirst%3DC.%2BA.%26aulast%3DWest%26aufirst%3DR.%2BE.%26aulast%3DAslanian%26aufirst%3DR.%26aulast%3DMcCormick%26aufirst%3DK.%26aulast%3DBryant%26aufirst%3DM.%26aulast%3DHsieh%26aufirst%3DY.%26aulast%3DKorfmacher%26aufirst%3DW.%26aulast%3DMingo%26aufirst%3DG.%2BG.%26aulast%3DVarty%26aufirst%3DL.%26aulast%3DWilliams%26aufirst%3DS.%2BM.%26aulast%3DShih%26aufirst%3DN.-Y.%26aulast%3DEgan%26aufirst%3DR.%2BW.%26aulast%3DHey%26aufirst%3DJ.%2BA.%26atitle%3DPharmacological%2520characterization%2520of%2520the%2520novel%2520histamine%2520H3-receptor%2520antagonist%2520N-%25283%252C5-dichlorophenyl%2529-N%25E2%2580%25B2-%255B%255B4-%25281H-imidazol-4-ylmethyl%2529phenyl%255D-methyl%255D-urea%2520%2528SCH%252079687%2529%26jtitle%3DJ.%2520Pharmacol.%2520Exp.%2520Ther.%26date%3D2003%26volume%3D305%26spage%3D1037%26epage%3D1044" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref31"><div class="reference"><strong class="refLabel"><a href="#ref31" class="rightTabRefNumLink">31</a></strong><div class="NLM_citation" id="rightTab-cit31"><span><span class="NLM_contrib-group">Smith, D. A.; van de Waterbeemd, H.; Walker, D. K.</span> <span class="citation_source-book">Pharmacokinetics and Metabolism in Drug Design</span>, <span class="NLM_edition">2</span>nd ed.; <span class="NLM_publisher-name">Wiley-VCH Verlag GmbH & Co. KGaA</span>: <span class="NLM_publisher-loc">New York</span>,<span class="NLM_x"> </span><span class="NLM_year">2006</span><span class="NLM_x">; </span>pp  <span class="NLM_fpage">19</span><span class="NLM_x">–</span> <span class="NLM_lpage">37</span>.</span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref31/cit31&amp;dbid=16&amp;doi=10.1021%2Fjm200939b&amp;key=10.1002%2F3527608222.ch2" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2006&pages=19-37&author=D.+A.+Smith&author=H.+van+de+Waterbeemd&author=D.+K.+Walker&title=Pharmacokinetics+and+Metabolism+in+Drug+Design"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit31&amp;dbid=16384&amp;doi=10.1002%2F3527608222.ch2&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dbook%26id%3Ddoi%3A10.1002%252F3527608222.ch2%26sid%3Dliteratum%253Aachs%26aulast%3DSmith%26aufirst%3DD.%2BA.%26btitle%3DPharmacokinetics%2520and%2520Metabolism%2520in%2520Drug%2520Design%26pub%3DWiley-VCH%2520Verlag%2520GmbH%2520%2526%2520Co.%2520KGaA%26date%3D2006%26spage%3D19%26epage%3D37" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref32"><div class="reference"><strong class="refLabel"><a href="#ref32" class="rightTabRefNumLink">32</a></strong><div class="NLM_citation" id="rightTab-cit32"><span><span class="NLM_contrib-group">Price, D. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Blagg, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jones, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Greene, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wager, T.</span><span> </span><span class="NLM_article-title">Physicochemical drug properties associated with in vivo toxicological outcomes: a review</span> <span class="citation_source-journal">Expert Opin. Drug Metab. Toxicol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">5</span><span class="NLM_x">, </span> <span class="NLM_fpage">921</span><span class="NLM_x">–</span> <span class="NLM_lpage">931</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref32/cit32&amp;dbid=16&amp;doi=10.1021%2Fjm200939b&amp;key=10.1517%2F17425250903042318" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref32/cit32&amp;dbid=8&amp;doi=10.1021%2Fjm200939b&amp;key=19519283" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref32/cit32&amp;dbid=32&amp;doi=10.1021%2Fjm200939b&amp;key=1%3ACAS%3A528%3ADC%252BD1MXovVCjtb0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=5&publication_year=2009&pages=921-931&author=D.+A.+Priceauthor=J.+Blaggauthor=L.+Jonesauthor=N.+Greeneauthor=T.+Wager&title=Physicochemical+drug+properties+associated+with+in+vivo+toxicological+outcomes%3A+a+review"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit32R"><div class="casContent"><span class="casTitleNuber">32</span><div class="casTitle"><span class="NLM_cas:atitle">Physicochemical drug properties associated with in vivo toxicological outcomes: a review</span></div><div class="casAuthors">Price, David A.; Blagg, Julian; Jones, Lyn; Greene, Nigel; Wager, Travis</div><div class="citationInfo"><span class="NLM_cas:title">Expert Opinion on Drug Metabolism & Toxicology</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">5</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">921-931</span>CODEN:
                <span class="NLM_cas:coden">EODMAP</span>;
        ISSN:<span class="NLM_cas:issn">1742-5255</span>.
    
            (<span class="NLM_cas:orgname">Informa Healthcare</span>)
        </div><div class="casAbstract">A review.  The genesis of any toxicol. or safety outcome is multifactorial and complex; for this reason, it can be difficult for drug discovery projects to factor the avoidance of toxicity outcomes into their target design.  A focus on readily measurable parameters from high-throughput in vitro assays (e.g., primary potency, clearance) is easier to handle and have become the mainstays of drug discovery projects.  However, the fundamental origins of adverse safety or toxicity findings can be considered as deriving from four parameters, all of which are in the control of the drug designer.  These can be described as primary pharmacol., off target pharmacol., the presence of a defined structural fragment that can be assocd. with adverse outcomes and the overall physicochem. properties of the mol. that may predispose it to adverse outcomes.  In the drug discovery community, there has been recognition for many years of the influence of physicochem. drug properties (in particular lipophilicity) on the toxicol. profile of compds., and recent research is now beginning to quantify that risk in a probabilistic sense.  This review focuses on the overall properties of classes of mols. that are assocd. with an increased probability of adverse outcomes in in vivo studies.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpU8kwwUsaFIrVg90H21EOLACvtfcHk0li5-M7OzAuxFw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXovVCjtb0%253D&md5=bd1cca3634afda14de2f8aa115d7d55e</span></div><a href="/servlet/linkout?suffix=cit32&amp;dbid=16384&amp;doi=10.1517%2F17425250903042318&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1517%252F17425250903042318%26sid%3Dliteratum%253Aachs%26aulast%3DPrice%26aufirst%3DD.%2BA.%26aulast%3DBlagg%26aufirst%3DJ.%26aulast%3DJones%26aufirst%3DL.%26aulast%3DGreene%26aufirst%3DN.%26aulast%3DWager%26aufirst%3DT.%26atitle%3DPhysicochemical%2520drug%2520properties%2520associated%2520with%2520in%2520vivo%2520toxicological%2520outcomes%253A%2520a%2520review%26jtitle%3DExpert%2520Opin.%2520Drug%2520Metab.%2520Toxicol.%26date%3D2009%26volume%3D5%26spage%3D921%26epage%3D931" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref33"><div class="reference"><strong class="refLabel"><a href="#ref33" class="rightTabRefNumLink">33</a></strong><div class="NLM_citation" id="rightTab-cit33"><span><span class="NLM_contrib-group">Hughes, J. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Blagg, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Price, D. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bailey, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">DeCrescenzo, G. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Devraj, R. V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ellsworth, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fobian, Y. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gibbs, M. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gilles, R. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Greene, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Huang, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Krieger-Burke, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Loesel, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wager, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Whiteley, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, Y.</span><span> </span><span class="NLM_article-title">Physiochemical drug properties associated with in vivo toxicological outcomes</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">18</span><span class="NLM_x">, </span> <span class="NLM_fpage">4872</span><span class="NLM_x">–</span> <span class="NLM_lpage">4875</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref33/cit33&amp;dbid=16&amp;doi=10.1021%2Fjm200939b&amp;key=10.1016%2Fj.bmcl.2008.07.071" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref33/cit33&amp;dbid=8&amp;doi=10.1021%2Fjm200939b&amp;key=18691886" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref33/cit33&amp;dbid=32&amp;doi=10.1021%2Fjm200939b&amp;key=1%3ACAS%3A528%3ADC%252BD1cXhtVOnsbjE" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=18&publication_year=2008&pages=4872-4875&author=J.+D.+Hughesauthor=J.+Blaggauthor=D.+A.+Priceauthor=S.+Baileyauthor=G.+A.+DeCrescenzoauthor=R.+V.+Devrajauthor=E.+Ellsworthauthor=Y.+M.+Fobianauthor=M.+E.+Gibbsauthor=R.+W.+Gillesauthor=N.+Greeneauthor=E.+Huangauthor=T.+Krieger-Burkeauthor=J.+Loeselauthor=T.+Wagerauthor=L.+Whiteleyauthor=Y.+Zhang&title=Physiochemical+drug+properties+associated+with+in+vivo+toxicological+outcomes"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit33R"><div class="casContent"><span class="casTitleNuber">33</span><div class="casTitle"><span class="NLM_cas:atitle">Physiochemical drug properties associated with in vivo toxicological outcomes</span></div><div class="casAuthors">Hughes, Jason D.; Blagg, Julian; Price, David A.; Bailey, Simon; DeCrescenzo, Gary A.; Devraj, Rajesh V.; Ellsworth, Edmund; Fobian, Yvette M.; Gibbs, Michael E.; Gilles, Richard W.; Greene, Nigel; Huang, Enoch; Krieger-Burke, Teresa; Loesel, Jens; Wager, Travis; Whiteley, Larry; Zhang, Yao</div><div class="citationInfo"><span class="NLM_cas:title">Bioorganic & Medicinal Chemistry Letters</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">18</span>
        (<span class="NLM_cas:issue">17</span>),
    <span class="NLM_cas:pages">4872-4875</span>CODEN:
                <span class="NLM_cas:coden">BMCLE8</span>;
        ISSN:<span class="NLM_cas:issn">0960-894X</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ltd.</span>)
        </div><div class="casAbstract">Relationships between physicochem. drug properties and toxicity were inferred from a data set consisting of animal in vivo toleration (IVT) studies on 245 preclin. Pfizer compds.; an increased likelihood of toxic events was found for less polar, more lipophilic compds.  This trend held across a wide range of types of toxicity and across a broad swath of chem. space.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrPMmGEpVF0mbVg90H21EOLACvtfcHk0li5-M7OzAuxFw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXhtVOnsbjE&md5=80ea5ced359112a363f38b3545cd7646</span></div><a href="/servlet/linkout?suffix=cit33&amp;dbid=16384&amp;doi=10.1016%2Fj.bmcl.2008.07.071&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmcl.2008.07.071%26sid%3Dliteratum%253Aachs%26aulast%3DHughes%26aufirst%3DJ.%2BD.%26aulast%3DBlagg%26aufirst%3DJ.%26aulast%3DPrice%26aufirst%3DD.%2BA.%26aulast%3DBailey%26aufirst%3DS.%26aulast%3DDeCrescenzo%26aufirst%3DG.%2BA.%26aulast%3DDevraj%26aufirst%3DR.%2BV.%26aulast%3DEllsworth%26aufirst%3DE.%26aulast%3DFobian%26aufirst%3DY.%2BM.%26aulast%3DGibbs%26aufirst%3DM.%2BE.%26aulast%3DGilles%26aufirst%3DR.%2BW.%26aulast%3DGreene%26aufirst%3DN.%26aulast%3DHuang%26aufirst%3DE.%26aulast%3DKrieger-Burke%26aufirst%3DT.%26aulast%3DLoesel%26aufirst%3DJ.%26aulast%3DWager%26aufirst%3DT.%26aulast%3DWhiteley%26aufirst%3DL.%26aulast%3DZhang%26aufirst%3DY.%26atitle%3DPhysiochemical%2520drug%2520properties%2520associated%2520with%2520in%2520vivo%2520toxicological%2520outcomes%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2008%26volume%3D18%26spage%3D4872%26epage%3D4875" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref34"><div class="reference"><strong class="refLabel"><a href="#ref34" class="rightTabRefNumLink">34</a></strong><div class="NLM_citation" id="rightTab-cit34"><span><span class="NLM_contrib-group">Wager, T. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chandrasekaran, R. Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hou, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Troutman, M. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Verhoest, P. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Villalobos, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Will, Y.</span><span> </span><span class="NLM_article-title">Defining desirable central nervous system drug space through the alignment of molecular properties, in vitro ADME, and safety attributes</span> <span class="citation_source-journal">ACS Chem. Neurosci.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">1</span><span class="NLM_x">, </span> <span class="NLM_fpage">420</span><span class="NLM_x">–</span> <span class="NLM_lpage">434</span></span><div class="citationLinks">[<a href="/doi/10.1021/cn100007x" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref34/cit34&amp;dbid=32&amp;doi=10.1021%2Fjm200939b&amp;key=1%3ACAS%3A528%3ADC%252BC3cXjvVaqtbk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=1&publication_year=2010&pages=420-434&author=T.+T.+Wagerauthor=R.+Y.+Chandrasekaranauthor=X.+Houauthor=M.+D.+Troutmanauthor=P.+R.+Verhoestauthor=A.+Villalobosauthor=Y.+Will&title=Defining+desirable+central+nervous+system+drug+space+through+the+alignment+of+molecular+properties%2C+in+vitro+ADME%2C+and+safety+attributes"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit34R"><div class="casContent"><span class="casTitleNuber">34</span><div class="casTitle"><span class="NLM_cas:atitle">Defining Desirable Central Nervous System Drug Space through the Alignment of Molecular Properties, in Vitro ADME, and Safety Attributes</span></div><div class="casAuthors">Wager, Travis T.; Chandrasekaran, Ramalakshmi Y.; Hou, Xinjun; Troutman, Matthew D.; Verhoest, Patrick R.; Villalobos, Anabella; Will, Yvonne</div><div class="citationInfo"><span class="NLM_cas:title">ACS Chemical Neuroscience</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">1</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">420-434</span>CODEN:
                <span class="NLM_cas:coden">ACNCDM</span>;
        ISSN:<span class="NLM_cas:issn">1948-7193</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">As part of our effort to increase survival of drug candidates and to move our medicinal chem. design to higher probability space for success in the Neuroscience therapeutic area, we embarked on a detailed study of the property space for a collection of central nervous system (CNS) mols.  We carried out a thorough anal. of properties for 119 marketed CNS drugs and a set of 108 Pfizer CNS candidates.  In particular, we focused on understanding the relationships between physicochem. properties, in vitro ADME (absorption, distribution, metab., and elimination) attributes, primary pharmacol. binding efficiencies, and in vitro safety data for these two sets of compds.  This scholarship provides guidance for the design of CNS mols. in a property space with increased probability of success and may lead to the identification of druglike candidates with favorable safety profiles that can successfully test hypotheses in the clinic.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqvEMBo2f34BrVg90H21EOLACvtfcHk0lg0NaFcwCb8iQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXjvVaqtbk%253D&md5=85716be86290fd85e93c6b8d5621683c</span></div><a href="/servlet/linkout?suffix=cit34&amp;dbid=16384&amp;doi=10.1021%2Fcn100007x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fcn100007x%26sid%3Dliteratum%253Aachs%26aulast%3DWager%26aufirst%3DT.%2BT.%26aulast%3DChandrasekaran%26aufirst%3DR.%2BY.%26aulast%3DHou%26aufirst%3DX.%26aulast%3DTroutman%26aufirst%3DM.%2BD.%26aulast%3DVerhoest%26aufirst%3DP.%2BR.%26aulast%3DVillalobos%26aufirst%3DA.%26aulast%3DWill%26aufirst%3DY.%26atitle%3DDefining%2520desirable%2520central%2520nervous%2520system%2520drug%2520space%2520through%2520the%2520alignment%2520of%2520molecular%2520properties%252C%2520in%2520vitro%2520ADME%252C%2520and%2520safety%2520attributes%26jtitle%3DACS%2520Chem.%2520Neurosci.%26date%3D2010%26volume%3D1%26spage%3D420%26epage%3D434" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref35"><div class="reference"><strong class="refLabel"><a href="#ref35" class="rightTabRefNumLink">35</a></strong><div class="NLM_citation" id="rightTab-cit35"><span><span class="NLM_contrib-group">Wenlock, M. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Austin, R. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Barton, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Davis, A. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Leeson, P. D.</span><span> </span><span class="NLM_article-title">A comparison of physiochemical property profiles of development and marketed oral drugs</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">46</span><span class="NLM_x">, </span> <span class="NLM_fpage">1250</span><span class="NLM_x">–</span> <span class="NLM_lpage">1256</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm021053p" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref35/cit35&amp;dbid=32&amp;doi=10.1021%2Fjm200939b&amp;key=1%3ACAS%3A528%3ADC%252BD3sXhslSlsbY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=46&publication_year=2003&pages=1250-1256&author=M.+C.+Wenlockauthor=R.+P.+Austinauthor=P.+Bartonauthor=A.+M.+Davisauthor=P.+D.+Leeson&title=A+comparison+of+physiochemical+property+profiles+of+development+and+marketed+oral+drugs"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit35R"><div class="casContent"><span class="casTitleNuber">35</span><div class="casTitle"><span class="NLM_cas:atitle">A Comparison of Physiochemical Property Profiles of Development and Marketed Oral Drugs</span></div><div class="casAuthors">Wenlock, Mark C.; Austin, Rupert P.; Barton, Patrick; Davis, Andrew M.; Leeson, Paul D.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2003</span>),
    <span class="NLM_cas:volume">46</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">1250-1256</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">The process of drug discovery applies rigorous selection pressures.  Marketed oral drugs will generally possess favorable physiochem. properties with respect to absorption, metab., distribution, and clearance.  This paper describes a study in which the distributions of physiochem. properties of oral drugs in different phases of clin. development are compared to those already marketed.  The aim is to identify the trends in physiochem. properties that favor a drug's successful passage through clin. development and on to the market.  Two libraries were created, one of current development oral drugs and one of marketed oral drugs.  Statistical anal. of the two showed that the mean mol. wt. of orally administered drugs in development decreases on passing through each of the different clin. phases and gradually converges toward the mean mol. wt. of marketed oral drugs.  It is also clear that the most lipophilic compds. are being discontinued from development.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoF0PksUFJq0bVg90H21EOLACvtfcHk0lg0NaFcwCb8iQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3sXhslSlsbY%253D&md5=b9809c803a61ec99a1b4171e97952452</span></div><a href="/servlet/linkout?suffix=cit35&amp;dbid=16384&amp;doi=10.1021%2Fjm021053p&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm021053p%26sid%3Dliteratum%253Aachs%26aulast%3DWenlock%26aufirst%3DM.%2BC.%26aulast%3DAustin%26aufirst%3DR.%2BP.%26aulast%3DBarton%26aufirst%3DP.%26aulast%3DDavis%26aufirst%3DA.%2BM.%26aulast%3DLeeson%26aufirst%3DP.%2BD.%26atitle%3DA%2520comparison%2520of%2520physiochemical%2520property%2520profiles%2520of%2520development%2520and%2520marketed%2520oral%2520drugs%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2003%26volume%3D46%26spage%3D1250%26epage%3D1256" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref36"><div class="reference"><strong class="refLabel"><a href="#ref36" class="rightTabRefNumLink">36</a></strong><div class="NLM_citation" id="rightTab-cit36"><span><span class="NLM_contrib-group">Veber, D. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Johnson, S. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cheng, H.-Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Smith, B. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ward, K. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kopple, K. D.</span><span> </span><span class="NLM_article-title">Molecular properties that influence the oral bioavailability of drug candidates</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2002</span><span class="NLM_x">, </span> <span class="NLM_volume">45</span><span class="NLM_x">, </span> <span class="NLM_fpage">2615</span><span class="NLM_x">–</span> <span class="NLM_lpage">2623</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm020017n" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref36/cit36&amp;dbid=32&amp;doi=10.1021%2Fjm200939b&amp;key=1%3ACAS%3A528%3ADC%252BD38XjsFCmt7g%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=45&publication_year=2002&pages=2615-2623&author=D.+F.+Veberauthor=S.+R.+Johnsonauthor=H.-Y.+Chengauthor=B.+R.+Smithauthor=K.+W.+Wardauthor=K.+D.+Kopple&title=Molecular+properties+that+influence+the+oral+bioavailability+of+drug+candidates"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit36R"><div class="casContent"><span class="casTitleNuber">36</span><div class="casTitle"><span class="NLM_cas:atitle">Molecular Properties That Influence the Oral Bioavailability of Drug Candidates</span></div><div class="casAuthors">Veber, Daniel F.; Johnson, Stephen R.; Cheng, Hung-Yuan; Smith, Brian R.; Ward, Keith W.; Kopple, Kenneth D.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2002</span>),
    <span class="NLM_cas:volume">45</span>
        (<span class="NLM_cas:issue">12</span>),
    <span class="NLM_cas:pages">2615-2623</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Oral bioavailability measurements in rats for over 1100 drug candidates studied at Smith-Kline Beecham Pharmaceuticals (now Glaxo Smith-Kline) have allowed us to analyze the relative importance of mol. properties considered to influence that drug property.  Reduced mol. flexibility, as measured by the no. of rotatable bonds, and low polar surface area or total hydrogen bond count (sum of donors and acceptors) are found to be important predictors of good oral bioavailability, independent of mol. wt.  That on av. both the no. of rotatable bonds and polar surface area or hydrogen bond count tend to increase with mol. wt. may in part explain the success of the mol. wt. parameter in predicting oral bioavailability.  The commonly applied mol. wt. cutoff at 500 does not itself significantly sep. compds. with poor oral bioavailability from those with acceptable values in this extensive data set.  Our observations suggest that compds. which meet only the 2 criteria of (1) 10 or fewer rotatable bonds and (2) polar surface area ≤140 Å2 (or 12 or fewer H-bond donors and acceptors) will have a high probability of good oral bioavailability in the rat.  Data sets for the artificial membrane permeation rate and for clearance in the rat were also examd.  Reduced polar surface area correlates better with increased permeation rate than does lipophilicity (C log P), and increased rotatable bond count has a neg. effect on the permeation rate.  A threshold permeation rate is a prerequisite of oral bioavailability.  The rotatable bond count does not correlate with the data examd. here for the in vivo clearance rate in the rat.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr3JtJEkO7yVLVg90H21EOLACvtfcHk0lg0NaFcwCb8iQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD38XjsFCmt7g%253D&md5=eaad26ed6a259de82ad65a8834fc397d</span></div><a href="/servlet/linkout?suffix=cit36&amp;dbid=16384&amp;doi=10.1021%2Fjm020017n&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm020017n%26sid%3Dliteratum%253Aachs%26aulast%3DVeber%26aufirst%3DD.%2BF.%26aulast%3DJohnson%26aufirst%3DS.%2BR.%26aulast%3DCheng%26aufirst%3DH.-Y.%26aulast%3DSmith%26aufirst%3DB.%2BR.%26aulast%3DWard%26aufirst%3DK.%2BW.%26aulast%3DKopple%26aufirst%3DK.%2BD.%26atitle%3DMolecular%2520properties%2520that%2520influence%2520the%2520oral%2520bioavailability%2520of%2520drug%2520candidates%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2002%26volume%3D45%26spage%3D2615%26epage%3D2623" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref37"><div class="reference"><strong class="refLabel"><a href="#ref37" class="rightTabRefNumLink">37</a></strong><div class="NLM_citation" id="rightTab-cit37"><span><span class="NLM_contrib-group">Proudfoot, J. R.</span><span> </span><span class="NLM_article-title">The evolution of synthetic oral drug properties</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">15</span><span class="NLM_x">, </span> <span class="NLM_fpage">1087</span><span class="NLM_x">–</span> <span class="NLM_lpage">1090</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref37/cit37&amp;dbid=16&amp;doi=10.1021%2Fjm200939b&amp;key=10.1016%2Fj.bmcl.2004.12.024" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref37/cit37&amp;dbid=8&amp;doi=10.1021%2Fjm200939b&amp;key=15686918" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref37/cit37&amp;dbid=32&amp;doi=10.1021%2Fjm200939b&amp;key=1%3ACAS%3A528%3ADC%252BD2MXos1Cmsw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=15&publication_year=2005&pages=1087-1090&author=J.+R.+Proudfoot&title=The+evolution+of+synthetic+oral+drug+properties"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit37R"><div class="casContent"><span class="casTitleNuber">37</span><div class="casTitle"><span class="NLM_cas:atitle">The evolution of synthetic oral drug properties</span></div><div class="casAuthors">Proudfoot, John R.</div><div class="citationInfo"><span class="NLM_cas:title">Bioorganic & Medicinal Chemistry Letters</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">15</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">1087-1090</span>CODEN:
                <span class="NLM_cas:coden">BMCLE8</span>;
        ISSN:<span class="NLM_cas:issn">0960-894X</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">A review.  An anal. of the properties of 1791 synthetic, oral drugs approved and/or marketed since 1937 demonstrates that the median mol. wt. of oral drugs has increased substantially over the past 60 years.  Fewer than 5% of approved/marketed oral drugs have more than 4-H bond donors and just 2% have MW > 500 and >3 H-bond donors.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqJrtZI0e95g7Vg90H21EOLACvtfcHk0liZWVnnNJyOGg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXos1Cmsw%253D%253D&md5=f393b9b972482a471185c4de545bfc75</span></div><a href="/servlet/linkout?suffix=cit37&amp;dbid=16384&amp;doi=10.1016%2Fj.bmcl.2004.12.024&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmcl.2004.12.024%26sid%3Dliteratum%253Aachs%26aulast%3DProudfoot%26aufirst%3DJ.%2BR.%26atitle%3DThe%2520evolution%2520of%2520synthetic%2520oral%2520drug%2520properties%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2005%26volume%3D15%26spage%3D1087%26epage%3D1090" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref38"><div class="reference"><strong class="refLabel"><a href="#ref38" class="rightTabRefNumLink">38</a></strong><div class="NLM_citation" id="rightTab-cit38"><span><span class="NLM_contrib-group">Pajouhesh, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lenz, G. R.</span><span> </span><span class="NLM_article-title">Medicinal chemical properties of successful central nervous system drugs</span> <span class="citation_source-journal">NeuroRx</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">2</span><span class="NLM_x">, </span> <span class="NLM_fpage">541</span><span class="NLM_x">–</span> <span class="NLM_lpage">553</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref38/cit38&amp;dbid=16&amp;doi=10.1021%2Fjm200939b&amp;key=10.1602%2Fneurorx.2.4.541" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref38/cit38&amp;dbid=8&amp;doi=10.1021%2Fjm200939b&amp;key=16489364" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref38/cit38&amp;dbid=32&amp;doi=10.1021%2Fjm200939b&amp;key=1%3ACAS%3A280%3ADC%252BD28%252FpvVKqsg%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=2&publication_year=2005&pages=541-553&author=H.+Pajouheshauthor=G.+R.+Lenz&title=Medicinal+chemical+properties+of+successful+central+nervous+system+drugs"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit38R"><div class="casContent"><span class="casTitleNuber">38</span><div class="casTitle"><span class="NLM_cas:atitle">Medicinal chemical properties of successful central nervous system drugs</span></div><div class="casAuthors">Pajouhesh Hassan; Lenz George R</div><div class="citationInfo"><span class="NLM_cas:title">NeuroRx : the journal of the American Society for Experimental NeuroTherapeutics</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">2</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">541-53</span>
        ISSN:<span class="NLM_cas:issn">1545-5343</span>.
    </div><div class="casAbstract">Fundamental physiochemical features of CNS drugs are related to their ability to penetrate the blood-brain barrier affinity and exhibit CNS activity.  Factors relevant to the success of CNS drugs are reviewed.  CNS drugs show values of molecular weight, lipophilicity, and hydrogen bond donor and acceptor that in general have a smaller range than general therapeutics.  Pharmacokinetic properties can be manipulated by the medicinal chemist to a significant extent.  The solubility, permeability, metabolic stability, protein binding, and human ether-ago-go-related gene inhibition of CNS compounds need to be optimized simultaneously with potency, selectivity, and other biological parameters.  The balance between optimizing the physiochemical and pharmacokinetic properties to make the best compromises in properties is critical for designing new drugs likely to penetrate the blood brain barrier and affect relevant biological systems.  This review is intended as a guide to designing CNS therapeutic agents with better drug-like properties.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcT_ncsy3yuEinl8icjszYl0fW6udTcc2eZQznPVObkn4Lntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BD28%252FpvVKqsg%253D%253D&md5=0815084e2d107b9243b785d0782dfc3a</span></div><a href="/servlet/linkout?suffix=cit38&amp;dbid=16384&amp;doi=10.1602%2Fneurorx.2.4.541&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1602%252Fneurorx.2.4.541%26sid%3Dliteratum%253Aachs%26aulast%3DPajouhesh%26aufirst%3DH.%26aulast%3DLenz%26aufirst%3DG.%2BR.%26atitle%3DMedicinal%2520chemical%2520properties%2520of%2520successful%2520central%2520nervous%2520system%2520drugs%26jtitle%3DNeuroRx%26date%3D2005%26volume%3D2%26spage%3D541%26epage%3D553" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref39"><div class="reference"><strong class="refLabel"><a href="#ref39" class="rightTabRefNumLink">39</a></strong><div class="NLM_citation" id="rightTab-cit39"><span><span class="NLM_contrib-group">Lipinski, C. A.</span><span> </span><span class="NLM_article-title">Filtering in drug discovery</span> <span class="citation_source-journal">Annu. Rep. Comput. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">1</span><span class="NLM_x">, </span> <span class="NLM_fpage">155</span><span class="NLM_x">–</span> <span class="NLM_lpage">168</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref39/cit39&amp;dbid=16&amp;doi=10.1021%2Fjm200939b&amp;key=10.1016%2FS1574-1400%2805%2901011-X" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref39/cit39&amp;dbid=32&amp;doi=10.1021%2Fjm200939b&amp;key=1%3ACAS%3A528%3ADC%252BD2MXmsV2ksbg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=1&publication_year=2005&pages=155-168&author=C.+A.+Lipinski&title=Filtering+in+drug+discovery"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit39R"><div class="casContent"><span class="casTitleNuber">39</span><div class="casTitle"><span class="NLM_cas:atitle">Filtering in drug discovery</span></div><div class="casAuthors">Lipinski, Christopher A.</div><div class="citationInfo"><span class="NLM_cas:title">Annual Reports in Computational Chemistry</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">1</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">155-168</span>CODEN:
                <span class="NLM_cas:coden">ARCCC3</span>;
        ISSN:<span class="NLM_cas:issn">1574-1400</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">A review focuses on recent advances in filtering in drug discovery.  Filtering is used in a global broad sense to include exclusionary as well as inclusionary criteria and encompasses several topics related to the discovery of drugs.  Such topics include computational definitions of drug-likeness, pos. filters for drug-like activity, lead-likeness as a concept, oral activity filters, central nervous system drug filters, intestinal permeability filters, drug metab. parameter filters, promiscuous compd. filters, and agrochem. filters.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrIvJpIrP50ZLVg90H21EOLACvtfcHk0liZWVnnNJyOGg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXmsV2ksbg%253D&md5=94a637b4ce6077b2d896c4111eb42c72</span></div><a href="/servlet/linkout?suffix=cit39&amp;dbid=16384&amp;doi=10.1016%2FS1574-1400%2805%2901011-X&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS1574-1400%252805%252901011-X%26sid%3Dliteratum%253Aachs%26aulast%3DLipinski%26aufirst%3DC.%2BA.%26atitle%3DFiltering%2520in%2520drug%2520discovery%26jtitle%3DAnnu.%2520Rep.%2520Comput.%2520Chem.%26date%3D2005%26volume%3D1%26spage%3D155%26epage%3D168" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref40"><div class="reference"><strong class="refLabel"><a href="#ref40" class="rightTabRefNumLink">40</a></strong><div class="NLM_citation" id="rightTab-cit40"><span><span class="NLM_contrib-group">Hitchcock, S. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pennington, L. D.</span><span> </span><span class="NLM_article-title">Structure–brain exposure relationships</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">49</span><span class="NLM_x">, </span> <span class="NLM_fpage">7559</span><span class="NLM_x">–</span> <span class="NLM_lpage">7583</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm060642i" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=49&publication_year=2006&pages=7559-7583&author=S.+A.+Hitchcockauthor=L.+D.+Pennington&title=Structure%E2%80%93brain+exposure+relationships"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit40&amp;dbid=16384&amp;doi=10.1021%2Fjm060642i&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm060642i%26sid%3Dliteratum%253Aachs%26aulast%3DHitchcock%26aufirst%3DS.%2BA.%26aulast%3DPennington%26aufirst%3DL.%2BD.%26atitle%3DStructure%25E2%2580%2593brain%2520exposure%2520relationships%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2006%26volume%3D49%26spage%3D7559%26epage%3D7583" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref41"><div class="reference"><strong class="refLabel"><a href="#ref41" class="rightTabRefNumLink">41</a></strong><div class="NLM_citation" id="rightTab-cit41"><span><span class="NLM_contrib-group">Ploemen, J.-P. H. T. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kelder, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hafmans, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">van de Sandt, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">van Burgsteden, J. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Salemink, P. J. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">van Esch, E.</span><span> </span><span class="NLM_article-title">Use of physicochemical calculation of pKa and CLogP to predict phospholipidosis-inducing potential: a case study with structurally related piperazines</span> <span class="citation_source-journal">Exp. Toxicol. Pathol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">55</span><span class="NLM_x">, </span> <span class="NLM_fpage">347</span><span class="NLM_x">–</span> <span class="NLM_lpage">355</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref41/cit41&amp;dbid=8&amp;doi=10.1021%2Fjm200939b&amp;key=15088636" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref41/cit41&amp;dbid=32&amp;doi=10.1021%2Fjm200939b&amp;key=1%3ACAS%3A528%3ADC%252BD2cXksFGltL0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=55&publication_year=2004&pages=347-355&author=J.-P.+H.+T.+M.+Ploemenauthor=J.+Kelderauthor=T.+Hafmansauthor=H.+van+de+Sandtauthor=J.+A.+van+Burgstedenauthor=P.+J.+M.+Saleminkauthor=E.+van+Esch&title=Use+of+physicochemical+calculation+of+pKa+and+CLogP+to+predict+phospholipidosis-inducing+potential%3A+a+case+study+with+structurally+related+piperazines"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit41R"><div class="casContent"><span class="casTitleNuber">41</span><div class="casTitle"><span class="NLM_cas:atitle">Use of physicochemical calculation of pKa and CLogP to predict phospholipidosis-inducing potential: a case study with structurally related piperazines</span></div><div class="casAuthors">Ploemen, Jan-Peter H. T. M.; Kelder, Jan; Hafmans, Theo; van de Sandt, Han; van Burgsteden, Johan A.; Salemink, Paul J. M.; van Esch, Eric</div><div class="citationInfo"><span class="NLM_cas:title">Experimental and Toxicologic Pathology</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">55</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">347-355</span>CODEN:
                <span class="NLM_cas:coden">ETPAEK</span>;
        ISSN:<span class="NLM_cas:issn">0940-2993</span>.
    
            (<span class="NLM_cas:orgname">Elsevier GmbH</span>)
        </div><div class="casAbstract">Several cationic amphiphilic compds. are known to induce phospholipidosis, a condition primarily characterized by excessive accumulation of phospholipids in different cell types, giving the affected cells a finely foamy appearance.  Excessive storage of lamellar membranous intralysosomal inclusion bodies is the hallmark for phospholipidosis on the electron microscopic level.  In case of alveolar phospholipidosis, foamy macrophages accumulate within the alveolar spaces of the lung.  Based on such findings in a one-year toxicity study with gepirone in rats, we studied the mol. properties of this compd. and compds. suspected of being phospholipidosis inducers by means of physicochem. calcns.  Physicochem. mol. calcns. of mol. wt., ClogP (partition coeff. octanol/water), logD at pH 7.4, and pKa were performed, for the cationic amphiphilic compds. chlorpromazine, amiodarone, imipramine, propranolol and fluoxetine, and for the structurally related compds. 1-phenylpiperazine (1-PHP), gepirone (and its major metabolites, 3-OH-gepirone and 1-pyrimidinylpiperazine [1-PP]), and buspirone.  ClogP and calcd. pKa cluster differently for the amphiphilic drugs compared to the chem. series of piperazines.  In line with this anal., lamellar inclusion bodies were found in an in vitro validation expt. in the human monoblastoid cell line U-937, incubated for 96 h at 10 μg/mL with cationic amphiphilic drugs (amiodarone, imipramine, or propranolol).  No such lamellar inclusion bodies were seen for any of the compds. from the chem. series of piperazines including gepirone and its metabolites.  The data presented support the use of simple physicochem. calcns. of ClogP and pKa to discriminate rapidly between compds. suspected of being phospholipidosis inducers.  Finally, the discriminative power of these physicochem. ClogP and pKa calcns. to predict phospholipidosis-inducing potential was further validated by extension of the set of compds.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo-qnA3_zghvbVg90H21EOLACvtfcHk0liBr0fm5PUMDg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXksFGltL0%253D&md5=caf5e68d3d5356dfef1cc29dbaf5ca87</span></div><a href="/servlet/linkout?suffix=cit41&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DPloemen%26aufirst%3DJ.-P.%2BH.%2BT.%2BM.%26aulast%3DKelder%26aufirst%3DJ.%26aulast%3DHafmans%26aufirst%3DT.%26aulast%3Dvan%2Bde%2BSandt%26aufirst%3DH.%26aulast%3Dvan%2BBurgsteden%26aufirst%3DJ.%2BA.%26aulast%3DSalemink%26aufirst%3DP.%2BJ.%2BM.%26aulast%3Dvan%2BEsch%26aufirst%3DE.%26atitle%3DUse%2520of%2520physicochemical%2520calculation%2520of%2520pKa%2520and%2520CLogP%2520to%2520predict%2520phospholipidosis-inducing%2520potential%253A%2520a%2520case%2520study%2520with%2520structurally%2520related%2520piperazines%26jtitle%3DExp.%2520Toxicol.%2520Pathol.%26date%3D2004%26volume%3D55%26spage%3D347%26epage%3D355" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref42"><div class="reference"><strong class="refLabel"><a href="#ref42" class="rightTabRefNumLink">42</a></strong><div class="NLM_citation" id="rightTab-cit42"><span><span class="NLM_contrib-group">Morelli, J. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Buehrle, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pognan, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Barone, L. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fieles, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ciaccio, P. J.</span><span> </span><span class="NLM_article-title">Validation of an in vitro screen for phospholipidosis using a high-content biology platform</span> <span class="citation_source-journal">Cell Biol. Toxicol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">22</span><span class="NLM_x">, </span> <span class="NLM_fpage">15</span><span class="NLM_x">–</span> <span class="NLM_lpage">27</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref42/cit42&amp;dbid=16&amp;doi=10.1021%2Fjm200939b&amp;key=10.1007%2Fs10565-006-0176-z" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref42/cit42&amp;dbid=8&amp;doi=10.1021%2Fjm200939b&amp;key=16463016" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref42/cit42&amp;dbid=32&amp;doi=10.1021%2Fjm200939b&amp;key=1%3ACAS%3A528%3ADC%252BD28XhtFWmur4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=22&publication_year=2006&pages=15-27&author=J.+K.+Morelliauthor=M.+Buehrleauthor=F.+Pognanauthor=L.+R.+Baroneauthor=W.+Fielesauthor=P.+J.+Ciaccio&title=Validation+of+an+in+vitro+screen+for+phospholipidosis+using+a+high-content+biology+platform"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit42R"><div class="casContent"><span class="casTitleNuber">42</span><div class="casTitle"><span class="NLM_cas:atitle">Validation of an in vitro screen for phospholipidosis using a high-content biology platform</span></div><div class="casAuthors">Morelli, J. K.; Buehrle, M.; Pognan, F.; Barone, L. R.; Fieles, W.; Ciaccio, P. J.</div><div class="citationInfo"><span class="NLM_cas:title">Cell Biology and Toxicology</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">22</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">15-27</span>CODEN:
                <span class="NLM_cas:coden">CBTOE2</span>;
        ISSN:<span class="NLM_cas:issn">0742-2091</span>.
    
            (<span class="NLM_cas:orgname">Springer</span>)
        </div><div class="casAbstract">Several cationic amphiphilic drugs cause local or systemic phospholipidosis (PLD) after chronic exposure in preclin. species.  PLD is characterized by the accumulation of drug, phospholipid, and concentric lamellar bodies in cellular lysosomes.  The authors have developed a fluorescence-based in vitro screen that is predictive of PLD using the Cellomics ArrayScan high-content screening platform, which captures and analyzes images from 96-well cell culture microtiter plates using multichannel fluorescence microscopy.  I-13.35 adherent mouse spleen macrophage cells were cultured with drug and a fluorescently tagged phospholipid, N-(7-nitrobenz-2-oxa-1,3-diazol-4-yl)-1,2-dihexadecanoyl-sn-glycero-3-phosphoethanolamine (NBD-PE).  Drug concns. were used in a range from 1 to 100 μmol/L.  After 24 h incubations, the cells were fixed with formalin.  NBD-PE uptake was quantified in controls and treated cells.  Nuclei were identified by Hoechst 33258 staining and dead cells were identified using ethidium homodimer-2 incorporation.  Thus, confounding accumulation of NBD-PE due to cytotoxicity that produces false-pos. results at high concns. was eliminated from quantitation by ethidium staining and employing cell gating (dead cell rejection).  The assay was found to be both sensitive and selective in that 26 of 28 pos., phospholipidogenic controls and 8 of 8 neg., nonphospholipidogenic controls were correctly called.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo5jzENAdqu-rVg90H21EOLACvtfcHk0liBr0fm5PUMDg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28XhtFWmur4%253D&md5=8492308f1a1e0970baf602304fbd1f44</span></div><a href="/servlet/linkout?suffix=cit42&amp;dbid=16384&amp;doi=10.1007%2Fs10565-006-0176-z&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252Fs10565-006-0176-z%26sid%3Dliteratum%253Aachs%26aulast%3DMorelli%26aufirst%3DJ.%2BK.%26aulast%3DBuehrle%26aufirst%3DM.%26aulast%3DPognan%26aufirst%3DF.%26aulast%3DBarone%26aufirst%3DL.%2BR.%26aulast%3DFieles%26aufirst%3DW.%26aulast%3DCiaccio%26aufirst%3DP.%2BJ.%26atitle%3DValidation%2520of%2520an%2520in%2520vitro%2520screen%2520for%2520phospholipidosis%2520using%2520a%2520high-content%2520biology%2520platform%26jtitle%3DCell%2520Biol.%2520Toxicol.%26date%3D2006%26volume%3D22%26spage%3D15%26epage%3D27" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref43"><div class="reference"><strong class="refLabel"><a href="#ref43" class="rightTabRefNumLink">43</a></strong><div class="NLM_citation" id="rightTab-cit43"><span><span class="NLM_contrib-group">Hjelle, J. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ruben, Z.</span><span> </span><span class="NLM_article-title">Investigations in intracellular drug storage: localization of disobutamide in lysosomal and nonlysosomal vesicles</span> <span class="citation_source-journal">Toxicol. Appl. Pharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1989</span><span class="NLM_x">, </span> <span class="NLM_volume">101</span><span class="NLM_x">, </span> <span class="NLM_fpage">70</span><span class="NLM_x">–</span> <span class="NLM_lpage">82</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref43/cit43&amp;dbid=16&amp;doi=10.1021%2Fjm200939b&amp;key=10.1016%2F0041-008X%2889%2990213-5" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref43/cit43&amp;dbid=8&amp;doi=10.1021%2Fjm200939b&amp;key=2799819" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref43/cit43&amp;dbid=32&amp;doi=10.1021%2Fjm200939b&amp;key=1%3ACAS%3A528%3ADyaL1MXmtVyltLc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=101&publication_year=1989&pages=70-82&author=J.+T.+Hjelleauthor=Z.+Ruben&title=Investigations+in+intracellular+drug+storage%3A+localization+of+disobutamide+in+lysosomal+and+nonlysosomal+vesicles"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit43R"><div class="casContent"><span class="casTitleNuber">43</span><div class="casTitle"><span class="NLM_cas:atitle">Investigations in intracellular drug storage:  localization of disobutamide in lysosomal and nonlysosomal vesicles</span></div><div class="casAuthors">Hjelle, J. Thomas; Ruben, Zadok</div><div class="citationInfo"><span class="NLM_cas:title">Toxicology and Applied Pharmacology</span>
        (<span class="NLM_cas:date">1989</span>),
    <span class="NLM_cas:volume">101</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">70-82</span>CODEN:
                <span class="NLM_cas:coden">TXAPA9</span>;
        ISSN:<span class="NLM_cas:issn">0041-008X</span>.
    </div><div class="casAbstract">In the investigation of the dynamic nature of intracellular drug-induced storage disorder assocd. with clear cytoplasmic vacuoles (CCV), rat urinary bladder carcinoma cells (RBT CC-8) were cultured with [14C]disobutamide.  Cell monolayers were then harvested and anal. cell fractionation techniques were employed to examine the assocn. of disobutamide with the various subcellular fractions.  Disobutamide distributed in 2 modes: as a free, organelle-independent fraction and as a light membrane-assocd. fraction that overlapped with markers for the plasma membrane, endoplasmic reticulum, and lysosomes.  The similarity in buoyant densities of these organelles derived from RBT CC-8 cells precluded resoln. of these structures by isopycnic centrifugation.  In addnl. expts., disobutamide was incubated in vitro with a suspension of isolated rabbit renal proximal tubules.  In these cells, anal. fractionation showed that the drug localized predominantly to lysosomes and to a sep. light membrane fraction that was clearly resolved from the markers for the endoplasmic reticulum, brush border, mitochondria, and peroxisomes; this fraction overlapped with the most buoyant aspects of the Golgi app. and basolateral plasma membrane.  The buoyant d. of this disobutamide-assocd. nonlysosomal fraction was 1.11 g/mL.  Electron microscopy of the disobutamide-exposed tubules showed a substantial formation of apical vesicles, esp. small, smooth-surfaced vesicles, typical of the endocytic app.  From these findings and based on the physicochem. properties of the cationic moiety of disobutamide, its is concluded that the drug localizes in lysosomal and nonlysosomal acidic vesicles.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrPyjOyPDTslrVg90H21EOLACvtfcHk0liBr0fm5PUMDg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaL1MXmtVyltLc%253D&md5=8897fa2728c7adb4364ed6b655592f71</span></div><a href="/servlet/linkout?suffix=cit43&amp;dbid=16384&amp;doi=10.1016%2F0041-008X%2889%2990213-5&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252F0041-008X%252889%252990213-5%26sid%3Dliteratum%253Aachs%26aulast%3DHjelle%26aufirst%3DJ.%2BT.%26aulast%3DRuben%26aufirst%3DZ.%26atitle%3DInvestigations%2520in%2520intracellular%2520drug%2520storage%253A%2520localization%2520of%2520disobutamide%2520in%2520lysosomal%2520and%2520nonlysosomal%2520vesicles%26jtitle%3DToxicol.%2520Appl.%2520Pharmacol.%26date%3D1989%26volume%3D101%26spage%3D70%26epage%3D82" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref44"><div class="reference"><strong class="refLabel"><a href="#ref44" class="rightTabRefNumLink">44</a></strong><div class="NLM_citation" id="rightTab-cit44"><span><span class="NLM_contrib-group">Rorig, K. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ruben, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Anderson, S. N.</span><span> </span><span class="NLM_article-title">Structural determinants of cationic amphiphilic amines which induce clear cytoplasmic vacuoles in cultured cells</span> <span class="citation_source-journal">Proc. Soc. Exp. Biol. Med.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1987</span><span class="NLM_x">, </span> <span class="NLM_volume">184</span><span class="NLM_x">, </span> <span class="NLM_fpage">165</span><span class="NLM_x">–</span> <span class="NLM_lpage">171</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref44/cit44&amp;dbid=16&amp;doi=10.1021%2Fjm200939b&amp;key=10.3181%2F00379727-184-42462" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref44/cit44&amp;dbid=8&amp;doi=10.1021%2Fjm200939b&amp;key=3809171" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref44/cit44&amp;dbid=32&amp;doi=10.1021%2Fjm200939b&amp;key=1%3ACAS%3A528%3ADyaL2sXhsVyqtLY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=184&publication_year=1987&pages=165-171&author=K.+J.+Rorigauthor=Z.+Rubenauthor=S.+N.+Anderson&title=Structural+determinants+of+cationic+amphiphilic+amines+which+induce+clear+cytoplasmic+vacuoles+in+cultured+cells"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit44R"><div class="casContent"><span class="casTitleNuber">44</span><div class="casTitle"><span class="NLM_cas:atitle">Structural determinants of cationic amphiphilic amines which induce clear cytoplasmic vacuoles in cultured cells</span></div><div class="casAuthors">Rorig, Kurt J.; Ruben, Zadok; Anderson, Steven N.</div><div class="citationInfo"><span class="NLM_cas:title">Proceedings of the Society for Experimental Biology and Medicine</span>
        (<span class="NLM_cas:date">1987</span>),
    <span class="NLM_cas:volume">184</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">165-71</span>CODEN:
                <span class="NLM_cas:coden">PSEBAA</span>;
        ISSN:<span class="NLM_cas:issn">0037-9727</span>.
    </div><div class="casAbstract">To delineate the structural determinants of amines that induce clear cytoplasmic vacuoles (CCV), cultured rat urinary bladder carcinoma and rabbit aorta muscle cells were exposed to numerous cationic drugs and chems. and examd. by phase light microscopy.  The cationic moiety of these cationic amphiphilic amines (CAA) was responsible for the induction of CCV.  The very potent inducers were compds. that had 2 strongly basic amine (cationic) centers.  The bistertiary amines were particularly potent inducers.  Aliph. diamines of minimal lipophilicity induced CCV, thus showing that an amphiphilic structural feature, though present in many CAA drugs, is not necessary for CCV induction.  The distance between the 2 cationic centers was irrelevant to the induction of CCV.  Apparently, CCV are a manifestation of intracellular (e.g., intralysosomal) drug storage.  These structural delineations will be useful in future drug design and for further understanding of drug-cell interactions.  Based on these findings, an antiarrhythmic CAA was synthesized which did not induce CCV.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq8_MXsnvupRLVg90H21EOLACvtfcHk0lhehcwEYfgj9Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaL2sXhsVyqtLY%253D&md5=90aba7e3fd9de52d94e7323f5a2800f2</span></div><a href="/servlet/linkout?suffix=cit44&amp;dbid=16384&amp;doi=10.3181%2F00379727-184-42462&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.3181%252F00379727-184-42462%26sid%3Dliteratum%253Aachs%26aulast%3DRorig%26aufirst%3DK.%2BJ.%26aulast%3DRuben%26aufirst%3DZ.%26aulast%3DAnderson%26aufirst%3DS.%2BN.%26atitle%3DStructural%2520determinants%2520of%2520cationic%2520amphiphilic%2520amines%2520which%2520induce%2520clear%2520cytoplasmic%2520vacuoles%2520in%2520cultured%2520cells%26jtitle%3DProc.%2520Soc.%2520Exp.%2520Biol.%2520Med.%26date%3D1987%26volume%3D184%26spage%3D165%26epage%3D171" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref45"><div class="reference"><strong class="refLabel"><a href="#ref45" class="rightTabRefNumLink">45</a></strong><div class="NLM_citation" id="rightTab-cit45"><span><span class="NLM_contrib-group">Ertl, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rohde, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Selzer, P.</span><span> </span><span class="NLM_article-title">Fast calculation of molecular polar surface area as a sum of fragment-based contributions and its application to the prediction of drug transport properties</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2000</span><span class="NLM_x">, </span> <span class="NLM_volume">43</span><span class="NLM_x">, </span> <span class="NLM_fpage">3714</span><span class="NLM_x">–</span> <span class="NLM_lpage">3717</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm000942e" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref45/cit45&amp;dbid=32&amp;doi=10.1021%2Fjm200939b&amp;key=1%3ACAS%3A528%3ADC%252BD3cXmsFeitb4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=43&publication_year=2000&pages=3714-3717&author=P.+Ertlauthor=B.+Rohdeauthor=P.+Selzer&title=Fast+calculation+of+molecular+polar+surface+area+as+a+sum+of+fragment-based+contributions+and+its+application+to+the+prediction+of+drug+transport+properties"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit45R"><div class="casContent"><span class="casTitleNuber">45</span><div class="casTitle"><span class="NLM_cas:atitle">Fast Calculation of Molecular Polar Surface Area as a Sum of Fragment-Based Contributions and Its Application to the Prediction of Drug Transport Properties</span></div><div class="casAuthors">Ertl, Peter; Rohde, Bernhard; Selzer, Paul</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2000</span>),
    <span class="NLM_cas:volume">43</span>
        (<span class="NLM_cas:issue">20</span>),
    <span class="NLM_cas:pages">3714-3717</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Mol. polar surface area (PSA), i.e., surface belonging to polar atoms, is a descriptor that was shown to correlate well with passive mol. transport through membranes and, therefore, allows prediction of transport properties of drugs.  The calcn. of PSA, however, is rather time-consuming because of the necessity to generate a reasonable 3D mol. geometry and the calcn. of the surface itself.  A new approach for the calcn. of the PSA is presented here, based on the summation of tabulated surface contributions of polar fragments.  The method, termed topol. PSA (TPSA), provides results which are practically identical with the 3D PSA (the correlation coeff. between 3D PSA and fragment-based TPSA for 34 810 mols. from the World Drug Index is 0.99), while the computation speed is 2-3 orders of magnitude faster.  The new methodol. may, therefore, be used for fast bioavailability screening of virtual libraries having millions of mols.  This article describes the new methodol. and shows the results of validation studies based on sets of published absorption data, including intestinal absorption, Caco-2 monolayer penetration, and blood-brain barrier penetration.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrhP6Qncx_h6LVg90H21EOLACvtfcHk0lhehcwEYfgj9Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3cXmsFeitb4%253D&md5=23ae4e7708bd8ddeb4a24ad160a29bd6</span></div><a href="/servlet/linkout?suffix=cit45&amp;dbid=16384&amp;doi=10.1021%2Fjm000942e&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm000942e%26sid%3Dliteratum%253Aachs%26aulast%3DErtl%26aufirst%3DP.%26aulast%3DRohde%26aufirst%3DB.%26aulast%3DSelzer%26aufirst%3DP.%26atitle%3DFast%2520calculation%2520of%2520molecular%2520polar%2520surface%2520area%2520as%2520a%2520sum%2520of%2520fragment-based%2520contributions%2520and%2520its%2520application%2520to%2520the%2520prediction%2520of%2520drug%2520transport%2520properties%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2000%26volume%3D43%26spage%3D3714%26epage%3D3717" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref46"><div class="reference"><strong class="refLabel"><a href="#ref46" class="rightTabRefNumLink">46</a></strong><div class="NLM_citation" id="rightTab-cit46"><span><span class="NLM_contrib-group">Hanumegowda, U. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wenke, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Regueiro-Ren, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yordanova, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Corradi, J. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Adams, S. P.</span><span> </span><span class="NLM_article-title">Phospholipidosis as a function of basicity, lipophilicity, and volume of distribution of compounds</span> <span class="citation_source-journal">Chem. Res. Toxicol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">23</span><span class="NLM_x">, </span> <span class="NLM_fpage">749</span><span class="NLM_x">–</span> <span class="NLM_lpage">755</span></span><div class="citationLinks">[<a href="/doi/10.1021/tx9003825" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref46/cit46&amp;dbid=32&amp;doi=10.1021%2Fjm200939b&amp;key=1%3ACAS%3A528%3ADC%252BC3cXktVeqtLw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=23&publication_year=2010&pages=749-755&author=U.+M.+Hanumegowdaauthor=G.+Wenkeauthor=A.+Regueiro-Renauthor=R.+Yordanovaauthor=J.+P.+Corradiauthor=S.+P.+Adams&title=Phospholipidosis+as+a+function+of+basicity%2C+lipophilicity%2C+and+volume+of+distribution+of+compounds"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit46R"><div class="casContent"><span class="casTitleNuber">46</span><div class="casTitle"><span class="NLM_cas:atitle">Phospholipidosis as a Function of Basicity, Lipophilicity, and Volume of Distribution of Compounds</span></div><div class="casAuthors">Hanumegowda, Umesh M.; Wenke, Gottfried; Regueiro-Ren, Alicia; Yordanova, Roumyana; Corradi, John P.; Adams, Stephen P.</div><div class="citationInfo"><span class="NLM_cas:title">Chemical Research in Toxicology</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">23</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">749-755</span>CODEN:
                <span class="NLM_cas:coden">CRTOEC</span>;
        ISSN:<span class="NLM_cas:issn">0893-228X</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Drug-induced phospholipidosis (PLD) is an adaptive histol. alteration that is seen with various marketed drugs and often encountered during drug development.  Various in silico and in vitro cell-based methods have been developed to predict the PLD-inducing potential of compds.  These methods rely on the inherent physicochem. properties of the mol. and, as such, tend to overpredict compds. as PLD inducers.  Recognizing that the distribution of compds. into tissues or tissue accumulation is likely a key factor in PLD induction, in addn. to key physicochem. properties, we developed a model to predict PLD in vivo using the measures of basicity (pKa), lipophilicity (ClogP), and vol. of distribution (Vd).  Using sets of PLD inducers and noninducers, we demonstrate improved concordance with this method.  Furthermore, we propose a screening paradigm that includes a combination of various methods to predict the in vivo PLD-inducing potential of compds., which may be esp. useful in lead identification and optimization processes in drug discovery.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrJNq2nVkAysrVg90H21EOLACvtfcHk0lhehcwEYfgj9Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXktVeqtLw%253D&md5=471380f65644ba0db549660acf6b4d8d</span></div><a href="/servlet/linkout?suffix=cit46&amp;dbid=16384&amp;doi=10.1021%2Ftx9003825&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Ftx9003825%26sid%3Dliteratum%253Aachs%26aulast%3DHanumegowda%26aufirst%3DU.%2BM.%26aulast%3DWenke%26aufirst%3DG.%26aulast%3DRegueiro-Ren%26aufirst%3DA.%26aulast%3DYordanova%26aufirst%3DR.%26aulast%3DCorradi%26aufirst%3DJ.%2BP.%26aulast%3DAdams%26aufirst%3DS.%2BP.%26atitle%3DPhospholipidosis%2520as%2520a%2520function%2520of%2520basicity%252C%2520lipophilicity%252C%2520and%2520volume%2520of%2520distribution%2520of%2520compounds%26jtitle%3DChem.%2520Res.%2520Toxicol.%26date%3D2010%26volume%3D23%26spage%3D749%26epage%3D755" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref47"><div class="reference"><strong class="refLabel"><a href="#ref47" class="rightTabRefNumLink">47</a></strong><div class="NLM_citation" id="rightTab-cit47"><span><span class="NLM_contrib-group">Simplício, A. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Clancy, J. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gilmer, J. F.</span><span> </span><span class="NLM_article-title">Prodrugs for amines</span> <span class="citation_source-journal">Molecules</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">13</span><span class="NLM_x">, </span> <span class="NLM_fpage">519</span><span class="NLM_x">–</span> <span class="NLM_lpage">547</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref47/cit47&amp;dbid=16&amp;doi=10.1021%2Fjm200939b&amp;key=10.3390%2Fmolecules13030519" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref47/cit47&amp;dbid=8&amp;doi=10.1021%2Fjm200939b&amp;key=18463563" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref47/cit47&amp;dbid=32&amp;doi=10.1021%2Fjm200939b&amp;key=1%3ACAS%3A280%3ADC%252BD1czgtFSqtQ%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=13&publication_year=2008&pages=519-547&author=A.+L.+Simpl%C3%ADcioauthor=J.+M.+Clancyauthor=J.+F.+Gilmer&title=Prodrugs+for+amines"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit47R"><div class="casContent"><span class="casTitleNuber">47</span><div class="casTitle"><span class="NLM_cas:atitle">Prodrugs for amines</span></div><div class="casAuthors">Simplicio Ana L; Clancy John M; Gilmer John F</div><div class="citationInfo"><span class="NLM_cas:title">Molecules (Basel, Switzerland)</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">13</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">519-47</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">The purpose of this work is to review the published strategies for the production of prodrugs of amines.  The review is divided in two main groups of approaches: those that rely on enzymatic activation and those that take advantage of physiological chemical conditions for release of the drugs.  A compilation of the most important approaches is presented in the form of a table, where the main advantages and disadvantages of each strategy are also referred.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcQqXISolqenaDdblLE_E9PWfW6udTcc2eb_ozb0EzoBPbntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BD1czgtFSqtQ%253D%253D&md5=ebdca0c3524c2de9c015d2a152777027</span></div><a href="/servlet/linkout?suffix=cit47&amp;dbid=16384&amp;doi=10.3390%2Fmolecules13030519&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.3390%252Fmolecules13030519%26sid%3Dliteratum%253Aachs%26aulast%3DSimpl%25C3%25ADcio%26aufirst%3DA.%2BL.%26aulast%3DClancy%26aufirst%3DJ.%2BM.%26aulast%3DGilmer%26aufirst%3DJ.%2BF.%26atitle%3DProdrugs%2520for%2520amines%26jtitle%3DMolecules%26date%3D2008%26volume%3D13%26spage%3D519%26epage%3D547" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref48"><div class="reference"><strong class="refLabel"><a href="#ref48" class="rightTabRefNumLink">48</a></strong><div class="NLM_citation" id="rightTab-cit48"><span><span class="NLM_contrib-group">Wager, T. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hou, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Verhoest, P. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Villalobos, A.</span><span> </span><span class="NLM_article-title">Moving beyond rules: the development of a central nervous system multiparameter optimization (CNS MPO) approach to enable alignment of druglike properties</span> <span class="citation_source-journal">ACS Chem. Neurosci.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">1</span><span class="NLM_x">, </span> <span class="NLM_fpage">435</span><span class="NLM_x">–</span> <span class="NLM_lpage">449</span></span><div class="citationLinks">[<a href="/doi/10.1021/cn100008c" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref48/cit48&amp;dbid=32&amp;doi=10.1021%2Fjm200939b&amp;key=1%3ACAS%3A528%3ADC%252BC3cXjvVejtr8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=1&publication_year=2010&pages=435-449&author=T.+T.+Wagerauthor=X.+Houauthor=P.+R.+Verhoestauthor=A.+Villalobos&title=Moving+beyond+rules%3A+the+development+of+a+central+nervous+system+multiparameter+optimization+%28CNS+MPO%29+approach+to+enable+alignment+of+druglike+properties"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit48R"><div class="casContent"><span class="casTitleNuber">48</span><div class="casTitle"><span class="NLM_cas:atitle">Moving beyond Rules: The Development of a Central Nervous System Multiparameter Optimization (CNS MPO) Approach To Enable Alignment of Druglike Properties</span></div><div class="casAuthors">Wager, Travis T.; Hou, Xinjun; Verhoest, Patrick R.; Villalobos, Anabella</div><div class="citationInfo"><span class="NLM_cas:title">ACS Chemical Neuroscience</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">1</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">435-449</span>CODEN:
                <span class="NLM_cas:coden">ACNCDM</span>;
        ISSN:<span class="NLM_cas:issn">1948-7193</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">The interplay among commonly used physicochem. properties in drug design was examd. and utilized to create a prospective design tool focused on the alignment of key druglike attributes.  Using a set of six physicochem. parameters ((a) lipophilicity, calcd. partition coeff. (ClogP); (b) calcd. distribution coeff. at pH = 7.4 (ClogD); (c) mol. wt. (MW); (d) topol. polar surface area (TPSA); (e) no. of hydrogen bond donors (HBD); (f) most basic center (pKa)), a druglikeness central nervous system multiparameter optimization (CNS MPO) algorithm was built and applied to a set of marketed CNS drugs (N = 119) and Pfizer CNS candidates (N = 108), as well as to a large diversity set of Pfizer proprietary compds. (N = 11 303).  The novel CNS MPO algorithm showed that 74% of marketed CNS drugs displayed a high CNS MPO score (MPO desirability score ≥ 4, using a scale of 0-6), in comparison to 60% of the Pfizer CNS candidates.  This anal. suggests that this algorithm could potentially be used to identify compds. with a higher probability of successfully testing hypotheses in the clinic.  In addn., a relationship between an increasing CNS MPO score and alignment of key in vitro attributes of drug discovery (favorable permeability, P-glycoprotein (P-gp) efflux, metabolic stability, and safety) was seen in the marketed CNS drug set, the Pfizer candidate set, and the Pfizer proprietary diversity set.  The CNS MPO scoring function offers advantages over hard cutoffs or utilization of single parameters to optimize structure-activity relationships (SAR) by expanding medicinal chem. design space through a holistic assessment approach.  Based on six physicochem. properties commonly used by medicinal chemists, the CNS MPO function may be used prospectively at the design stage to accelerate the identification of compds. with increased probability of success.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqB3Mvkgm_X5bVg90H21EOLACvtfcHk0liwF_LVXTqHMw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXjvVejtr8%253D&md5=e94998f65a420be6ee4dec4a987cb983</span></div><a href="/servlet/linkout?suffix=cit48&amp;dbid=16384&amp;doi=10.1021%2Fcn100008c&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fcn100008c%26sid%3Dliteratum%253Aachs%26aulast%3DWager%26aufirst%3DT.%2BT.%26aulast%3DHou%26aufirst%3DX.%26aulast%3DVerhoest%26aufirst%3DP.%2BR.%26aulast%3DVillalobos%26aufirst%3DA.%26atitle%3DMoving%2520beyond%2520rules%253A%2520the%2520development%2520of%2520a%2520central%2520nervous%2520system%2520multiparameter%2520optimization%2520%2528CNS%2520MPO%2529%2520approach%2520to%2520enable%2520alignment%2520of%2520druglike%2520properties%26jtitle%3DACS%2520Chem.%2520Neurosci.%26date%3D2010%26volume%3D1%26spage%3D435%26epage%3D449" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref49"><div class="reference"><strong class="refLabel"><a href="#ref49" class="rightTabRefNumLink">49</a></strong><div class="NLM_citation" id="rightTab-cit49"><span><span class="NLM_contrib-group">Stevens, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">De Kimpe, N.</span><span> </span><span class="NLM_article-title">A new entry into 2-azabicyclo[2.1.1]hexanes via 3-(chloromethyl)cyclobutanone</span> <span class="citation_source-journal">J. Org. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1996</span><span class="NLM_x">, </span> <span class="NLM_volume">61</span><span class="NLM_x">, </span> <span class="NLM_fpage">2174</span><span class="NLM_x">–</span> <span class="NLM_lpage">2178</span></span><div class="citationLinks">[<a href="/doi/10.1021/jo951865b" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=61&publication_year=1996&pages=2174-2178&author=C.+Stevensauthor=N.+De+Kimpe&title=A+new+entry+into+2-azabicyclo%5B2.1.1%5Dhexanes+via+3-%28chloromethyl%29cyclobutanone"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit49&amp;dbid=16384&amp;doi=10.1021%2Fjo951865b&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjo951865b%26sid%3Dliteratum%253Aachs%26aulast%3DStevens%26aufirst%3DC.%26aulast%3DDe%2BKimpe%26aufirst%3DN.%26atitle%3DA%2520new%2520entry%2520into%25202-azabicyclo%255B2.1.1%255Dhexanes%2520via%25203-%2528chloromethyl%2529cyclobutanone%26jtitle%3DJ.%2520Org.%2520Chem.%26date%3D1996%26volume%3D61%26spage%3D2174%26epage%3D2178" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref50"><div class="reference"><strong class="refLabel"><a href="#ref50" class="rightTabRefNumLink">50</a></strong><div class="NLM_citation" id="rightTab-cit50"><span><span class="NLM_contrib-group">Schultz, A. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McCloskey, P. J.</span><span> </span><span class="NLM_article-title">Carboxamide and carbalkoxy group directed stereoselective iridium-catalyzed homogeneous olefin hydrogenations</span> <span class="citation_source-journal">J. Org. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1985</span><span class="NLM_x">, </span> <span class="NLM_volume">50</span><span class="NLM_x">, </span> <span class="NLM_fpage">5905</span><span class="NLM_x">–</span> <span class="NLM_lpage">5907</span></span><div class="citationLinks">[<a href="/doi/10.1021/jo00350a105" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=50&publication_year=1985&pages=5905-5907&author=A.+G.+Schultzauthor=P.+J.+McCloskey&title=Carboxamide+and+carbalkoxy+group+directed+stereoselective+iridium-catalyzed+homogeneous+olefin+hydrogenations"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit50&amp;dbid=16384&amp;doi=10.1021%2Fjo00350a105&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjo00350a105%26sid%3Dliteratum%253Aachs%26aulast%3DSchultz%26aufirst%3DA.%2BG.%26aulast%3DMcCloskey%26aufirst%3DP.%2BJ.%26atitle%3DCarboxamide%2520and%2520carbalkoxy%2520group%2520directed%2520stereoselective%2520iridium-catalyzed%2520homogeneous%2520olefin%2520hydrogenations%26jtitle%3DJ.%2520Org.%2520Chem.%26date%3D1985%26volume%3D50%26spage%3D5905%26epage%3D5907" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref51"><div class="reference"><strong class="refLabel"><a href="#ref51" class="rightTabRefNumLink">51</a></strong><div class="NLM_citation" id="rightTab-cit51"><span><span class="NLM_contrib-group">Ertl, P.</span><span> </span><span class="NLM_article-title">Polar surface area</span> <span class="citation_source-journal">Methods Princ. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">37</span><span class="NLM_x">, </span> <span class="NLM_fpage">111</span><span class="NLM_x">–</span> <span class="NLM_lpage">126</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref51/cit51&amp;dbid=32&amp;doi=10.1021%2Fjm200939b&amp;key=1%3ACAS%3A528%3ADC%252BD1cXmtFyjurs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=37&publication_year=2008&pages=111-126&author=P.+Ertl&title=Polar+surface+area"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit51R"><div class="casContent"><span class="casTitleNuber">51</span><div class="casTitle"><span class="NLM_cas:atitle">Polar surface area</span></div><div class="casAuthors">Ertl, Peter</div><div class="citationInfo"><span class="NLM_cas:title">Methods and Principles in Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">37</span>
        (<span class="NLM_cas:issue">Molecular Drug Properties</span>),
    <span class="NLM_cas:pages">111-126</span>CODEN:
                <span class="NLM_cas:coden">MPMCE3</span>;
        ISSN:<span class="NLM_cas:issn">1432-4636</span>.
    
            (<span class="NLM_cas:orgname">Wiley-VCH Verlag GmbH & Co. KGaA</span>)
        </div><div class="casAbstract">A review on the application of polar surface area (PSA) for prediction of drug transport properties and in virtual screening, calcn. of PSA, and correlation of PSA with other mol. descriptors.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq1fbBsoe-2AbVg90H21EOLACvtfcHk0liwF_LVXTqHMw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXmtFyjurs%253D&md5=bb6de7704ffc98d18d1d6de9c1590755</span></div><a href="/servlet/linkout?suffix=cit51&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DErtl%26aufirst%3DP.%26atitle%3DPolar%2520surface%2520area%26jtitle%3DMethods%2520Princ.%2520Med.%2520Chem.%26date%3D2008%26volume%3D37%26spage%3D111%26epage%3D126" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref52"><div class="reference"><strong class="refLabel"><a href="#ref52" class="rightTabRefNumLink">52</a></strong><div class="NLM_citation" id="rightTab-cit52"><span><span class="NLM_contrib-group">Wager, T. T.; Chandrasekaran, R. Y.; Butler, T. W.</span><span> </span><span class="NLM_article-title">Preparation of Pyrrolidinylmethylphenylcyclobutanecarboxamides as Histamine H3 Receptor Antagonists</span>. PCT Int. Appl. WO2007049123,<span class="NLM_x"> </span><span class="NLM_year">2007</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2007&author=T.+T.+Wager&author=R.+Y.+Chandrasekaran&author=T.+W.+Butler&title=Preparation+of+Pyrrolidinylmethylphenylcyclobutanecarboxamides+as+Histamine+H3+Receptor+Antagonists"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit52&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DWager%26aufirst%3DT.%2BT.%26atitle%3DPreparation%2520of%2520Pyrrolidinylmethylphenylcyclobutanecarboxamides%2520as%2520Histamine%2520H3%2520Receptor%2520Antagonists%26date%3D2007" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li></ol></li><li id="pane-m3" aria-labelledby="pane-m3" class="tab__pane tab__pane-suppInfo empty"><div class="accessionCode mb-5"><div class="toolbar-section accession-codes"><ul><li><a href="http://www.rcsb.org/pdb/search/structidSearch.do?structureId=302D" onclick="trackOutboundLink('http://www.rcsb.org/pdb/search/structidSearch.do?structureId=302D','PDB','302D'); return false;">PDB: 302D</a></li></ul></div></div><h2 class="supp-info-label">Supporting Information</h2><div class="article_supporting-info" id="rightTab-notes-1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="rightTab-rightTab-_i66"><a href="/doi/suppl/10.1021/jm200939b">Supporting Information</a></h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a class="" href="#"><span>Jump To</span><i class="icon-angle-down"></i></a><div class="dropBlock__holder" data-db-target-of="sectionsDB_23340"></div></div></div></div></div><hr /></hr><p class="last">Cerep profile of lead compounds and spectral data for intermediates and final compounds. This material is available free of charge via the Internet at <a class="extLink" href="http://pubs.acs.org">http://pubs.acs.org</a>.</p><div class="supInfoBoxOnFTP "><div class="sup-info-attachments"><ul><li><a class="suppl-anchor" href="/doi/suppl/10.1021/jm200939b/suppl_file/jm200939b_si_001.pdf">jm200939b_si_001.pdf (2.59 MB)</a></li></ul></div></div><div id="rightTab-figshare-widget"></div><br /></br><div class="TermsAndConditionsDropzoneRight" data-pb-dropzone="TermsAndConditionsDropzoneRight"><div data-widget-def="UX3HTMLWidget" data-widget-id="b84e6b6c-b4d0-4427-b286-3cf14d52d013" class="mb-4">
        



        
        <h2 style="font-size: 1rem;margin-bottom: 10px;">Terms & Conditions</h2>
<p>Most electronic Supporting Information files are available without a subscription to ACS Web Editions. Such files may be downloaded by article for research use (if there is a public use license linked to the relevant article, that license may permit other uses). Permission may be obtained from ACS for other uses through requests via the RightsLink permission system:
<a href="/page/copyright/permissions.html" title="RightsLink">http://pubs.acs.org/page/copyright/permissions.html</a>.</p>

        </div></div></div></li></ul><div class="recommendedDropzone7" data-pb-dropzone="recommendedDropzone7"><div data-ajaxurl="/pb/widgets/ux3/ux3-showRecommend?widgetId=b272b1fe-ab4e-454f-940c-a3deaf223d23&amp;doi=10.1021%2Fjm200939b&amp;pbContext=%3BrequestedJournal%3Ajournal%3Ajmcmar%3Bjournal%3Ajournal%3Ajmcmar%3Bpage%3Astring%3AArticle%2FChapter+View%3Bissue%3Aissue%3A10.1021%2Fjmcmar.2011.54.issue-21%3Bctype%3Astring%3AJournal+Content%3Bwgroup%3Astring%3AACHS+website+Group%3Barticle%3Aarticle%3A10.1021%2Fjm200939b%3Bwebsite%3Awebsite%3Aacspubs%3BpageGroup%3Astring%3APublication+Pages%3BsubPage%3Astring%3AFull+Text" class="show-recommended-placeholder"></div>




        
        <script>
$(document).ready(function() {
  setTimeout(function() {
    var myLink = $(".show-recommended").find("a").not("[href='http://acsmediakit.org']").not("[href='javascript:void(0);']");
    myLink.attr("href", function(i, href) {
        return href + '?ref=recommended';
    });
  }, 5000);
});
</script></div></div></div></div></div></div></div><div class="col-xs-12.clearfix"><div class="article_qv-xs-container"><div class="article_qv-xs"><ul><li><a href="#" title="In This Article"><span>In This Article</span></a></li><li><a href="#" title="Figures" data-slide-target=".tab__pane-figures" class="w-slide__btn slide-active"><i class="icon-image"></i><span>Figures</span></a></li><li><a href="#" title="References" data-slide-target=".tab__pane-references" class="w-slide__btn slide-active"><i class="icon-link"></i><span>References</span></a></li><li><a href="#" title="Supporting Information" data-slide-target=".tab__pane-suppInfo" class="w-slide__btn slide-active"><i class="icon-supporting-info"></i><span>Supporting Information</span></a></li><li><a href="#" title="Recommended Articles" data-slide-target=".recommendedDropzone7" class="show-recommended-qv w-slide__btn slide-active" target="_self"><i class="icon-newspaper-o"></i><span>Recommended Articles</span></a></li></ul><a title="PDF" href="/doi/pdf/10.1021/jm200939b" class="button_primary"><i class="icon-file-pdf-o"></i>PDF  <span class="filesize">[
                4MB]
            </span></a></div></div></div></div></div></div></article></main>




        
        <footer class="footer">



        
        <div class="footer_first-row" id="partners">
	<div class="container">
		<div class="row">
			<div class="col-xs-12">
				<div class="footer_first-row_title">
					<h2>
						Partners
					</h2>
				</div>
				<div class="footer_first-row_logos">
					<div>
						<a href="http://www.atypon.com/">
							<img src="/pb-assets/images/footer_logos/logo-atypon-1525376610217.png" alt="Atypon">
						</a>
					</div>
					<div>
						<a href="http://www.chorusaccess.org/">
							<img src="/pb-assets/images/footer_logos/logo-chorus-1525375622947.png" alt="Chorus">
						</a>
					</div>
					<div>
						<a href="http://publicationethics.org/">
							<img src="/pb-assets/images/footer_logos/logo-cope-1525375622977.png" alt="Cope publication ethics">
						</a>
					</div>
					<div>
						<a href="http://www.projectcounter.org/">
							<img src="/pb-assets/images/footer_logos/logo-counter-1523044519173.jpg" alt="Project Counter">
						</a>
					</div>
					<div>
						<a href="http://www.crossref.org/">
							<img src="/pb-assets/images/footer_logos/logo-crossref-1525377362093.png" alt="Crossref">
						</a>
					</div>
					<div>
						<a href="http://www.crossref.org/crosscheck/index.html">
							<img src="/pb-assets/images/footer_logos/logo-crosscheck-1525375623000.png" alt="Crossref similarity check">
						</a>
					</div>
					<div>
						<a href="http://www.orcid.org/">
							<img src="/pb-assets/images/footer_logos/logo-orcid-1525375623187.png" alt="Orcid Connecting Research and Researchers">
						</a>
					</div>
					<div>
						<a href="http://www.portico.org/">
							<img src="/pb-assets/images/footer_logos/logo-portico-1525375623203.png" alt="Portico digital preservation service">
						</a>
					</div>
				</div>
			</div>
		</div>
	</div>
</div>





        
        <div class="footer_second-row col-xs-12 gutterless ">









        <div data-widget-def="ux3-layout-widget" data-widget-id="f963f9aa-5ade-4a09-8515-e6cd8e6364cf" class="row container">
        



        
        <div class="col-xs-12">



        
        <div class="footer_second-row_left col-md-2 gutterless ">



        
        <a href="/"><img src="/pb-assets/images/pubslogo-small-1444685090580.png" alt="ACS Publications"></a>
<div class="footer_menu">
	<ul>
		<li class="footer_menu_address">
			<span>
				1155 Sixteenth Street N.W.
			</span>
		</li>
		<li class="footer_menu_address">
			<span>
				Washington, DC 20036
			</span>
		</li>

		<li class="footer_menu_copyright">
			<a href="http://www.acs.org/content/acs/en/copyright.html">
				Copyright © 2021<br>
				American Chemical Society
			</a>
		</li>
	</ul>
</div>
</div><div class="footer_second-row_middle col-md-2 gutterless "></div><div class="footer_second-row_right col-md-8 gutterless ">



        
        <div class="footer_second-row_about col-xs-4">



        
        <h2>About</h2>
<ul>
    <li><a href="/page/about-us.html">About ACS Publications</a></li>
    <li><a href="http://acsopenscience.org">ACS & Open Access</a></li>
    <li><a href="https://www.acs.org/content/acs/en/membership/member-benefits/publications-discounts.html">ACS Membership</a></li>
</ul>
</div><div class="footer_second-row_resources col-xs-5">



        
        <h2>Resources and Information</h2>
<ul>
	<li><a href="/action/showPublications?pubType=journal">Journals A-Z</a></li>
	<li><a href="/action/showPublications?pubType=book">Books and Reference</a></li>
    <li><a href="http://acsmediakit.org/digital/acs-pubs/?utm_source=Footer&amp;utm_medium=Pubs&amp;utm_campaign=CEN">Advertising Media Kit</a></li>
    <li><a href="https://solutions.acs.org">Institutional Sales</a></li>
    <li><a href="https://publish.acs.org/publish/">ACS Publishing Center</a></li>
    <li><a href="http://www.acs.org/content/acs/en/privacy.html">Privacy Policy</a></li>
    <li><a href="https://www.acs.org/content/acs/en/terms.html">Terms of Use</a></li>
</ul>
</div><div class="footer_second-row_support col-xs-3">



        
        <h2>Support & Contact</h2>
<ul>
    <li><a href="https://acs.service-now.com/acs">Help</a></li>
    <li><a href="#" onclick="SnapEngage.startLink();return false;" class="help help-chat">Live Chat</a></li>
    <li><a href="https://acs.service-now.com/acs">FAQ</a></li>
</ul>
</div>
</div>




        
        <div class="footer_social_section col-xs-12">



        
        <div class="footer_social_header">
	<h2>Connect with ACS Publications</h2>
</div>
<div class="footer_social">
	<ul>
		<li>
			<a href="https://preferences.acspubs.org/journals" class="icon-envelope-o" aria-label="email">
			</a>
		</li>
		<li>
			<a href="https://www.facebook.com/ACSPublications/" class="icon-facebook" aria-label="facebook" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="https://twitter.com/ACSPublications" class="icon-twitter" aria-label="twitter" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="https://www.youtube.com/user/AmerChemSoc" class="icon-youtube-play" aria-label="youtube" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="/page/follow.html?widget=follow-pane-rss" class="icon-rss" aria-label="rss feed">
			</a>
		</li>
	</ul>
</div>

</div>
</div>

        </div>
    
</div>
</footer>




        
        <script>
(function(){
	
	/*Event Tracking for RIS menu dropdown - Article pages*/

	$('.cit-download-dropdown_button').on('click',function(e)
	{	
		e.preventDefault();
	    ga('send', 'event', 'Citation', 'Export', 'Main');
	});


	$('.cit-download-dropdown_content ul li').on('click',function(e)
	{	
	//	e.preventDefault();
	    var idx = $(this).index();
	    
	    var label = '';
	    if (idx === 0 ) {
	    	label = 'Citation';
	    } else if (idx === 1 ) {
	    	label = 'Abstract';
	    } else if (idx === 2 ) {
	    	label = 'Reference';
	    } else if (idx === 3 ) {
	    	label = 'More Options';
	    }
	   ga('send', 'event', 'Citation', 'Export', label);
	});

	$('.header_contnav-next a').on('click', function(e){
        e.preventDefault();
        ga('send', 'event', 'Article', 'Top', 'Right Arrow');
	}); 

 	$('.header_contnav-pre a').on('click', function(e){
	    e.preventDefault();
	     ga('send', 'event', 'Article', 'Top', 'Left Arrow');
	}); 

	$('.share_button').on('click', function(e){
		e.preventDefault();
		ga('send', 'event', 'Article', 'Top', 'Share');
	});

	$("#pane-m1con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'Figures');
	});

	$("#pane-m2con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'References');
	});

	$("#pane-m3con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'Supporting Info');
	});

	$('.tab__close').on('click', function(){
		ga('send', 'event', 'Article', 'Sidebar', 'Close');
	}); 



})();

</script>






        
        <div aria-live="polite" aria-atomic="true" class="achs-mendeley"><input type="hidden" name="tokenEndpoint" value="https://sso.acs.org/mendeley/token" class="tokenEndpoint"/></input><input type="hidden" name="appID" value="literatum" class="appID"/></input><input type="hidden" name="reopen-mendeley-modal-after-reload" class="reopen-mendeley-modal-after-reload"/></input><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><div class="achs-mendeley_table"><div class="achs-mendeley_row"><div class="achs-mendeley_cell loop-trap"><div class="achs-mendeley_container"><a title="Close" aria-label="close" tabindex="0" class="achs-mendeley_close"><i aria-hidden="true" class="icon-close"></i></a><div class="achs-mendeley_dropzone1"><div class="achs-mendeley_dropzone1_state1">



        
        <p style="font-weight: bold;">Pair your accounts.</p>
<p>Export articles to Mendeley</p>
<p>Get article recommendations from ACS based on references in your Mendeley library.</p>
</div><div class="achs-mendeley_dropzone1_state2">



        
        <p style="font-weight: bold;">Pair your accounts.</p>
<p>Export articles to Mendeley</p>
<p>Get article recommendations from ACS based on references in your Mendeley library.</p>
</div><div class="achs-mendeley_dropzone1_state3">



        
        <p style="font-weight: bold;">You’ve supercharged your research process with ACS and Mendeley!</p>
</div></div><div class="achs-mendeley_continue-header"><button class="achs-mendeley_continue-btn"><span class="achs-mendeley_buttonText">Continue</span></button></div><div class="achs-mendeley_steps"><div class="achs-mendeley_steps_row"><div class="achs-mendeley_steps_cell achs-mendeley_acsLogin"><h6>STEP 1:</h6><button class="button_primary achs-mendeley_acsLogin_button"><span class="achs-mendeley_buttonText">Login with ACS ID</span><span class="achs-mendeley_success_buttonText">Logged in Success</span></button><span class="achs-mendeley_acsLogin_label">Click to create an ACS ID</span><i class="icon-if-arrow-right"></i></div><div class="achs-mendeley_steps_cell achs-mendeley_login"><h6>STEP 2:</h6><button class="button_primary achs-mendeley_login_button"><i class="icon-mendeley"></i><span class="achs-mendeley_buttonText">Login with Mendeley</span><span class="achs-mendeley_success_buttonText">Logged in Success</span></button><a href="https://id.elsevier.com/as/authorization.oauth2?state=c33c27125763433d4d32a15accaacc18&amp;prompt=login&amp;scope=openid%20email%20profile%20els_auth_info&amp;authType=SINGLE_SIGN_IN&amp;response_type=code&amp;platSite=MDY%2Fmendeley&amp;redirect_uri=https%3A%2F%2Fwww.mendeley.com%2Fcallback%2F&amp;client_id=MENDELEY" title="Create a Mendeley account">Create a Mendeley account</a></div></div></div><div class="achs-mendeley_dropzone2"><div class="achs-mendeley_dropzone2_state1">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div><div class="achs-mendeley_dropzone2_state2">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div><div class="achs-mendeley_dropzone2_state3">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div></div></div></div></div></div></div><div class="achs-mendeley_alert"><div class="achs-mendeley_alert_table"><div class="achs-mendeley_alert_row"><div class="achs-mendeley_alert_cell"><div class="achs-mendeley_alert_container"><a title="Close" aria-label="close" class="achs-mendeley_alert_close"><i aria-hidden="true" class="icon-close"></i></a><div role="alert" aria-live="polite" aria-atomic="true" class="achs-mendeley_alert_dropzone">



        
        <p>Please login with your ACS ID before connecting to your Mendeley account.</p><button class="button_tertiary achs-mendeley_acsLogin_button mendeley-acs-custom-login-btn" onclick="loginToAcsSso(event); return false;">Login with ACS ID</button>

<script>
 function loginToAcsSso(event){
 event.preventDefault();
 $('.achs-mendeley_acsLogin .achs-mendeley_acsLogin_button').trigger('click');
 }
</script>
</div><div class="achs-mendeley_alert_error-msg"></div></div></div></div></div><div class="pairing-expired-dialog-container"><div class="pairing-expired-dialog"><div class="pairing-expired-dialog_top-btns"><span class="pairing-expired-dialog_heading">MENDELEY PAIRING EXPIRED</span><button onClick="UX.achsMendeley.reconnectOnClickHandler();" class="pairing-expired-dialog_reconnect">Reconnect</button></div><div class="pairing-expired-dialog_content"><span>Your Mendeley pairing has expired. Please reconnect</span></div></div></div></div>




        
        <style type="text/css">
#gdpr-message-modal {
    display: none;
    /* Hidden by default */
    position: fixed;
    /* Stay in place */
    z-index: 2;
    /* Sit on top */
    /*padding-top: 100px;*/
    /* Location of the box */
    left: 0;
    bottom: 0;
    width: 100%;
    /* Full width */
    /*height: 100%;*/
    /* Full height */
    overflow: auto;
    /* Enable scroll if needed */
    /*background-color: rgb(0,0,0);*/
    /* Fallback color */
    /*background-color: rgba(0,0,0,0.4);*/
    /* Black w/ opacity */
}
#gdpr-message-content {
    font-family: Arial;
    background-color: #005083;
    color: #fff;
    margin: auto;
    padding: 5px 0 10px 0;
    /*border: 1px solid #888;*/
    box-shadow: 0 -1px 3px #666;
    width: 100%;
    display: block;
    bottom: 0;
}
#gdpr-message-container {
    /*width: 1130px;*/
    margin: 0 auto;
}
.gdpr-innerwrap {
    display: block;
    /*width: 1100px;*/
    margin: 0 auto;
    text-align: center;
}
#gdpr-message-content h1 {
    color: #0629b5;
    font-size: 26px;
    margin: 0.5em 0 0 0;
    border-bottom: solid 2px #4c7fb9;
    display: inline;
    padding-bottom: 10px;
}
#gdpr-message-content h4 {
    display: inline-block;
    margin-left: 0;
    margin-right: 14px;
    margin-top: 13px;
    /*width: 980px;*/
    font-size: 14px;
    font-weight: normal;
}
#gdpr-message-content p {
    font-size: 14px;
    margin: 2em 2em 0.5em 0em;
    text-align: left;
    font-weight: bold;
}
#gdpr-message-content a,
#gdpr-message-content a:hover {
    color: #9bcfff;
}
.gdpr-listwrap {
    display: block;
    margin-bottom: 10px;
    min-height: 100px;
    min-width: 200px;
}
#gdpr-message-content ul {
    margin-top: 20px;
    font-size: 13px;
}
#gdpr-ul1 {
    display: inline-block;
    float: left;
}
#gdpr-ul2 {
    display: inline-block;
    margin-left: 10px;
}
#gdpr-message-content ul li {
    margin-top: 4px;
}
a#gdpr-con-btn,
a#gdpr-con-btn:hover {
    width: 110px;
    height: 35px;
    background: #fec82a;
    background-image: none;
    background-image: -webkit-gradient(linear, 50% 0%, 50% 100%, color-stop(0%, #fec82a), color-stop(100%, #daa301));
    background-image: -webkit-linear-gradient(top, #fec82a, #daa301);
    background-image: -moz-linear-gradient(top, #fec82a, #daa301);
    background-image: -o-linear-gradient(top, #fec82a, #daa301);
    background-image: linear-gradient(top, #fec82a, #daa301);
    border-radius: 4px;
    color: #004a7b;
    display: inline-block;
    text-decoration: none;
    line-height: 35px;
    text-align: center;
    margin-top: 5px;
    /*margin-right: 14px;*/
    /*float: right;*/
    font-weight: bold;
}
#gdpr-message-btn {
    width: 60px;
    height: 38px;
    background: #4b8fc2;
    border-radius: 4px;
    color: white;
    display: inline-block;
    margin-top: -4px;
    font-size: 12px;
}
a#closebtn {
    float: right;
    color: #d4e5ef;
}
#gdpr-input {
    width: 200px;
    height: 30px;
    border-radius: 3px;
    border-width: 1px;
    box-shadow: none;
    margin-right: 10px;
    font-size: 14px;
    outline: none;
    padding-left: 2px;
    display: inline-block;
    float: left;
}
#gdpr-message-content p.gdpr_err {
    font-size: 15px;
    margin-top: 10px;
}
#gdpr-message-modal.mobile, #gdpr-message-modal.mobile .gdpr-message-content {
    height: 160px;
}
@media only screen and (min-width: 1026px) and (max-width: 1368px) {
	#gdpr-message-content h4 {
		width: 80%;
		text-align: left;
	}
}
</style>

<div id="gdpr-message-modal">
    <div id="gdpr-message-content">
        
	        <div class="gdpr-innerwrap container">
	            <h4>This website uses cookies to improve your user experience. By continuing to use the site, you are accepting our use of cookies. <a href="http://www.acs.org/content/acs/en/privacy.html">Read the ACS privacy policy</a>.</h4>
	            <a href="#" id="gdpr-con-btn">CONTINUE</a>
	        </div>
        
    </div>
</div>

<script type="text/javascript">
"use strict"
//Script checks gdpr cookie and submits form
	/* 
	Create an in-page pop-up message, only for the InfoCentral homepage, that will gather email registrants for the library marketing list.
	 
	Needs the end point
	*/

var infoCentralCapture = (function() {

    //Detect mobile device
    window.mobilecheck = function() {
        var check = false;
        (function(a){if(/(android|bb\d+|meego).+mobile|avantgo|bada\/|blackberry|blazer|compal|elaine|fennec|hiptop|iemobile|ip(hone|od)|iris|kindle|lge |maemo|midp|mmp|mobile.+firefox|netfront|opera m(ob|in)i|palm( os)?|phone|p(ixi|re)\/|plucker|pocket|psp|series(4|6)0|symbian|treo|up\.(browser|link)|vodafone|wap|windows ce|xda|xiino/i.test(a)||/1207|6310|6590|3gso|4thp|50[1-6]i|770s|802s|a wa|abac|ac(er|oo|s\-)|ai(ko|rn)|al(av|ca|co)|amoi|an(ex|ny|yw)|aptu|ar(ch|go)|as(te|us)|attw|au(di|\-m|r |s )|avan|be(ck|ll|nq)|bi(lb|rd)|bl(ac|az)|br(e|v)w|bumb|bw\-(n|u)|c55\/|capi|ccwa|cdm\-|cell|chtm|cldc|cmd\-|co(mp|nd)|craw|da(it|ll|ng)|dbte|dc\-s|devi|dica|dmob|do(c|p)o|ds(12|\-d)|el(49|ai)|em(l2|ul)|er(ic|k0)|esl8|ez([4-7]0|os|wa|ze)|fetc|fly(\-|_)|g1 u|g560|gene|gf\-5|g\-mo|go(\.w|od)|gr(ad|un)|haie|hcit|hd\-(m|p|t)|hei\-|hi(pt|ta)|hp( i|ip)|hs\-c|ht(c(\-| |_|a|g|p|s|t)|tp)|hu(aw|tc)|i\-(20|go|ma)|i230|iac( |\-|\/)|ibro|idea|ig01|ikom|im1k|inno|ipaq|iris|ja(t|v)a|jbro|jemu|jigs|kddi|keji|kgt( |\/)|klon|kpt |kwc\-|kyo(c|k)|le(no|xi)|lg( g|\/(k|l|u)|50|54|\-[a-w])|libw|lynx|m1\-w|m3ga|m50\/|ma(te|ui|xo)|mc(01|21|ca)|m\-cr|me(rc|ri)|mi(o8|oa|ts)|mmef|mo(01|02|bi|de|do|t(\-| |o|v)|zz)|mt(50|p1|v )|mwbp|mywa|n10[0-2]|n20[2-3]|n30(0|2)|n50(0|2|5)|n7(0(0|1)|10)|ne((c|m)\-|on|tf|wf|wg|wt)|nok(6|i)|nzph|o2im|op(ti|wv)|oran|owg1|p800|pan(a|d|t)|pdxg|pg(13|\-([1-8]|c))|phil|pire|pl(ay|uc)|pn\-2|po(ck|rt|se)|prox|psio|pt\-g|qa\-a|qc(07|12|21|32|60|\-[2-7]|i\-)|qtek|r380|r600|raks|rim9|ro(ve|zo)|s55\/|sa(ge|ma|mm|ms|ny|va)|sc(01|h\-|oo|p\-)|sdk\/|se(c(\-|0|1)|47|mc|nd|ri)|sgh\-|shar|sie(\-|m)|sk\-0|sl(45|id)|sm(al|ar|b3|it|t5)|so(ft|ny)|sp(01|h\-|v\-|v )|sy(01|mb)|t2(18|50)|t6(00|10|18)|ta(gt|lk)|tcl\-|tdg\-|tel(i|m)|tim\-|t\-mo|to(pl|sh)|ts(70|m\-|m3|m5)|tx\-9|up(\.b|g1|si)|utst|v400|v750|veri|vi(rg|te)|vk(40|5[0-3]|\-v)|vm40|voda|vulc|vx(52|53|60|61|70|80|81|83|85|98)|w3c(\-| )|webc|whit|wi(g |nc|nw)|wmlb|wonu|x700|yas\-|your|zeto|zte\-/i.test(a.substr(0,4))) check = true;})(navigator.userAgent||navigator.vendor||window.opera);
              return check;
        };

    var _isMobile = window.mobilecheck();
    if (_isMobile) {
        $('#gdpr-message-modal').addClass('mobile');
    }

    var emailValid = "",
        time = 3000,
        btnStatus = true,
        errorStatus = false,
        errormessage = "<p class='gdpr_err'><b>Please Enter a valid email address<b><p>";

    function init() {
        setTimeout(function() {
            var cookieExist = getCookie("gdpr");
            if (cookieExist) {
                //console.log("gdpr cookie exist");
                return false;
            } else {
                //console.log("gdpr cookie does not exist")
                gdprMessage();
            }
            //Events
            $('#closebtn').on("click", hideForm);

            //Handle submit
            $('#gdpr-message-btn').on("click", function(event) {
                handleClick();
            });

            // //Hide if clicked outside div - TO DO stop handling click after submit
            // $(document).click(function(event) {
            // 	event.stopPropagation();
            //   console.log(event.target);
            //   if (!$(event.target).closest("#gdpr-message-content").length) {
            //     $("body").find("#gdpr-message-modal").hide();
            //     $(this).off();
            //   }
            // });
            $('#gdpr-con-btn').click(function() {
                setCookie("gdpr", "true");
                hideForm();
            });
        }, time);
    }

    //Show the message
    function gdprMessage() {
        //console.log("Show GDPR Message");
        var tMessage, emailInput, messageButton, ewrap;

        $('#gdpr-message-modal').show();
    }

    function handleClick() {
        //console.log($("#gdpr-input").val());
        emailValid = validateEmail($("#gdpr-input").val());
        if (emailValid) {
            //Submit the form
            //Hide form
            if ($('.gdpr_err')) {
                $('.gdpr_err').hide();
            }

            $("#gdpr-message-content")
                //If successful then...
            setCookie("gdpr", "true");
            //console.log("emailValid " + emailValid + " submiting form");
        } else {
            //Show error message
            gdprErrorMessage();
            //console.log("emailValid " + emailValid);
        }
    }

    function gdprErrorMessage() {
        if (errorStatus) {
            return false;
        } else {
            errorStatus = true;
            $("#gdpr-message-content").append(errormessage);
        }
    }

    function validateEmail(email) {
        var re = /^(([^<>()\[\]\\.,;:\s@"]+(\.[^<>()\[\]\\.,;:\s@"]+)*)|(".+"))@((\[[0-9]{1,3}\.[0-9]{1,3}\.[0-9]{1,3}\.[0-9]{1,3}\])|(([a-zA-Z\-0-9]+\.)+[a-zA-Z]{2,}))$/;
        return re.test(String(email).toLowerCase());
    }

    function setCookie(name, value) {
        var expires = "";
        expires = "; expires=Fri, 31 Dec 9999 23:59:59 GMT";
        document.cookie = name + "=" + (value || "") + expires + "; path=/";
    }

    function getCookie(name) {
        var match = document.cookie.match(new RegExp(name + '=([^;]+)'));
        if (match) return match[1];
    }

    function hideForm() { //And set cookie
        $('#gdpr-message-modal').hide();
        setCookie("gdpr", "false");
        ga('send', 'event', 'Pubs GDPR', 'GDPR Modal', 'GDPR Dismissal');
    }

    return {
        init: init
    }
})();

$(document).ready(infoCentralCapture.init);
</script>





        
        <script>
    //Top nav tracking

    (function(){
        $('.header_my-activity a:first').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Activity')
            ga('send', 'event', 'Top Nav', 'Button', 'Activity');
        })


        $('.pubModal_button').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Publications')
            ga('send', 'event', 'Top Nav', 'Button', 'Publications');
        }) 

        $('.header_burger-menu_button').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Hamburger');
            ga('send', 'event', 'Top Nav', 'Button', 'Hamburger');
        }) 

        // $('.header_burger-menu_content ul li').on('click', function(e){
        //     // e.preventDefault();
        //     var idx = $(this).index();
        //     console.log('Menu item' + idx)
        // })
    })();
    
    
</script>




        
        
<script type="text/javascript">
    adroll_adv_id = "3LBZJ4KXKBF2PJ46QCMT3X";
    adroll_pix_id = "6EITYRDI4FFGJPSZQ62UJJ";

    (function () {
        var _onload = function(){
            if (document.readyState && !/loaded|complete/.test(document.readyState)){setTimeout(_onload, 10);return}
            if (!window.__adroll_loaded){__adroll_loaded=true;setTimeout(_onload, 50);return}
            var scr = document.createElement("script");
            var host = (("https:" == document.location.protocol) ? "https://s.adroll.com" : "http://a.adroll.com");
            scr.setAttribute('async', 'true');
            scr.type = "text/javascript";
            scr.src = host + "/j/roundtrip.js";
            ((document.getElementsByTagName('head') || [null])[0] ||
                document.getElementsByTagName('script')[0].parentNode).appendChild(scr);
        };
        if (window.addEventListener) {window.addEventListener('load', _onload, false);}
        else {window.attachEvent('onload', _onload)}
    }());
</script>










        
        <div class="activity-container hidden-lg hidden-md"><div class="recentlyViewed" style="right: -100%;"><div class="activity_title_container"><span class="activity_title">Recently Viewed</span><a href="javascript:void(0)" class="activity_back"><i class="icon-angle-left"></i></a></div></div></div>




        
        <script>
$(document).ready(function(){
    var cookie = "";
    var uri = "/doi/full/10.1021/html_original_uri?id=123";
    console.log("ACSPubs2 start");
    $.getJSON('https://extreme-ip-lookup.com/json/', function(data, status) {
            if ( status == 'success' ) {
                $.each(data, function(i, field){
                    cookie=cookie.concat(i+' = '+field+" - ");
                });
                
            } else {
                    cookie=status;
            }

            cookie1 = cookie;
            cookie = cookie1 + "; path=/; domain=.acs.org";
            //document.cookie = "ACSPubs2= "+ btoa(cookie) ;
            $.cookie("ACSPubs2", btoa(cookie), {path: '/'}); // Session cookie valid across the entire site.
            //TODO send cookie val to the controller for logging
            console.log("ACSPubs2 success");
    })
    .fail(function(xx, status, err){
        cookie="error: 127.0.0.1";
        //document.cookie = "ACSPubs2= "+ btoa(cookie) ;
        $.cookie("ACSPubs2", btoa(cookie), {path: '/'}); // Session cookie valid across the entire site.
        console.log("ACSPubs2 failed");
        //TODO send cookie val to the controller for logging
    });
});    
</script>





        
        



        
    

        </div>
    </div>





	

    <script>if (typeof define !== 'undefined')
    if (define.amd)
        define.amd = false</script><script src="/products/achs/releasedAssets/js/build.lazyload.bundle-191cb5c7d88ed9894acd.js"></script><script src="/products/achs/releasedAssets/js/main.bundle-524acd43b3dccf6df3df.js"></script>

<script type="text/javascript" src="/wro/kfa7~product.js"></script>































    












<script defer src="https://static.cloudflareinsights.com/beacon.min.js" data-cf-beacon='{"rayId":"679980107d0c3dc4","token":"d4e766cffbf14806ad37e095398b9c5f","version":"2021.7.0","si":10}'></script>
</body>
</html>
